# adapted from example clinical annotation from BIODATACATALYST, original filename - CCDG_13607_B01_GRM_WGS_2019-02-19_chr1.recalibrated_variants.annotated.clinical
CHROM	POS	ID	REF	ALT	FILTER	ALLELE	EFFECT	IMPACT	GENE	GENEID	FEATURE	FEATUREID	HGVS_C	HGVC_P	RANK	CDNA_POS/LEN	AA_POS/LEN	CDS_POS/LEN	DISTANCE	ERRORS	LOF	NMD	ExAC_AF	1000Gp3_RA_GF	1000Gp3_RR_GF	1000Gp3_HomC	1000Gp3_AA_GF	1000Gp3_AF	CLNSIG	CLNDBN	CLNDSDBID	CLNDSDB	Regulome_dbSNP141	COSMIC_CNT	OMIM_MENDELIAN_MUT_ID	OMIM_NONDIS_DELDUP_INHRT	OMIM_MENDELIAN_MUT_PHENO	OMIM_MENDELIAN_DELDUP_PHENO	OMIM_SUSCEPT_DELDUP_ID	OMIM_SUSCEPT_MUT_INHRT	OMIM_SUSCEPT_DELDUP_PHENO	OMIM_NONDIS_MUT_ID	OMIM_NONDIS_DELDUP_ID	OMIM_NONDIS_MUT_PHENO	OMIM_NONDIS_MUT_INHRT	OMIM_SUSCEPT_MUT_ID	OMIM_MENDELIAN_MUT_INHRT	OMIM_MENDELIAN_DELDUP_ID	OMIM_SUSCEPT_DELDUP_INHRT	OMIM_MENDELIAN_DELDUP_INHRT	OMIM_NONDIS_DELDUP_PHENO	OMIM_SUSCEPT_MUT_PHENO	MutationAssessor_pred	MutationTaster_pred	phastCons20way_mammalian	GERP++_RS	Uniprot_id_Polyphen2	Polyphen2_HVAR_pred	Polyphen2_HDIV_pred	GERP++_NR	Uniprot_aapos_Polyphen2	CADD_phred	phyloP20way_mammalian	SIFT_pred	MGI_mouse_gene	Essential_gene	LoFtool_score	RVIS_percentile	RVIS	ZFIN_zebrafish_phenotype_tag	GDI-Phred	Entrez_gene_id	ZFIN_zebrafish_gene	Pathway(BioCarta)_short	GDI	dbSNPBuildID	repeats	ACMG_GENE	ACMG_PATH	ACMG_INHRT	ACMG_MIM_GENE	AR_GENE
chr1	1020239	rs201073369	G	C	PASS	C	missense_variant	MODERATE	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.67G>C	p.Val23Leu	1/36	117/7323	23/2045	67/6138	NA	NA	NA	NA	0.014	0.014377	0.984026	2464,4	0.00159744	0.00878594	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	N	0.464	1.04	AGRIN_HUMAN	B	B	2.05	23	3.288	0.767	T	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	137	NA	NA	NA	NA	NA	NA
chr1	1022260	rs6657048	C	T	PASS	T	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.261C>T	p.Asp87Asp	2/36	311/7323	87/2045	261/6138	NA	NA	NA	NA	0.02	0.0591054	0.9377	2348,8	0.00319489	0.0327476	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	116	NA	NA	NA	NA	NA	NA
chr1	1040679	rs544749044	C	T	PASS	T	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.526C>T	p.Leu176Leu	4/36	576/7323	176/2045	526/6138	NA	NA	NA	NA	6.847e-05	0.00199681	0.998003	2499,0	0	0.000998403	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	142	NA	NA	NA	NA	NA	NA
chr1	1044017	rs143324306	G	A	PASS	A	missense_variant	MODERATE	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.1993G>A	p.Glu665Lys	10/36	2043/7323	665/2045	1993/6138	NA	NA	NA	NA	0.003088	0.00199681	0.998003	2499,0	0	0.000998403	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	L	D	0.287	4.44	AGRIN_HUMAN	D	D	4.44	665	24.5	0.953	./T	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	134	NA	NA	NA	NA	NA	NA
chr1	1044134	rs28484890	C	G	PASS	G	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.2025C>G	p.Gly675Gly	11/36	2075/7323	675/2045	2025/6138	NA	NA	NA	NA	0.003421	0.0219649	0.978035	2449,0	0	0.0109824	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	125	NA	NA	NA	NA	NA	NA
chr1	1045393	rs75774767	C	T	PASS	T	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.2406C>T	p.Gly802Gly	14/36	2456/7323	802/2045	2406/6138	NA	NA	NA	NA	0.003409	0.0219649	0.978035	2449,0	0	0.0109824	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	131	NA	NA	NA	NA	NA	NA
chr1	1045444	rs112039851	G	C	PASS	C	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.2457G>C	p.Gly819Gly	14/36	2507/7323	819/2045	2457/6138	NA	NA	NA	NA	0.012	0.0491214	0.948083	2374,7	0.00279553	0.0273562	255	not_specified	CN169374	MedGen	NA	2	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	132	NA	NA	NA	NA	NA	NA
chr1	1046833	rs150132566	G	C	PASS	C	missense_variant	MODERATE	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.3264G>C	p.Leu1088Phe	19/36	3314/7323	1088/2045	3264/6138	NA	NA	NA	NA	0.006156	0.0283546	0.970847	2431,2	0.000798722	0.014976	255	not_specified	CN169374	MedGen	NA	1	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	L	N	0.004	-8.38	AGRIN_HUMAN	B	B	4.19	1088	0.001	-2.568	./T	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	134	NA	NA	NA	NA	NA	NA
chr1	1046833	rs150132566	G	T	PASS	T	missense_variant	MODERATE	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.3264G>T	p.Leu1088Phe	19/36	3314/7323	1088/2045	3264/6138	NA	NA	NA	NA	7.537e-05	NA	NA	NA	NA	NA	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	L	N	0.004	-8.38	AGRIN_HUMAN	B	B	4.19	1088	0.001	-2.568	./T	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	134	NA	NA	NA	NA	NA	NA
chr1	1047342	rs142416636	A	G	PASS	G	missense_variant	MODERATE	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.3404A>G	p.Gln1135Arg	20/36	3454/7323	1135/2045	3404/6138	NA	NA	NA	NA	0.014	0.0247604	0.973642	2438,4	0.00159744	0.0139776	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	M	D	0.997	4.16	AGRIN_HUMAN	P	D	4.16	1135	23.7	1.081	./D	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	134	NA	NA	NA	NA	NA	NA
chr1	1047403	rs146358566	T	C	PASS	C	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.3465T>C	p.Ala1155Ala	20/36	3515/7323	1155/2045	3465/6138	NA	NA	NA	NA	0.005059	0.0159744	0.983626	2463,1	0.000399361	0.00838658	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	134	NA	NA	NA	NA	NA	NA
chr1	1047464	rs76264143	G	C	PASS	C	intron_variant	MODIFIER	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.3516+10G>C	NA	20/35	NA	NA	NA	NA	NA	NA	NA	0.057	0.0710863	0.925719	2318,8	0.00319489	0.038738	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	132	NA	NA	NA	NA	NA	NA
chr1	1047626	rs75361935	C	T	PASS	T	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.3570C>T	p.Arg1190Arg	21/36	3620/7323	1190/2045	3570/6138	NA	NA	NA	NA	0.003575	0.0219649	0.978035	2449,0	0	0.0109824	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	131	NA	NA	NA	NA	NA	NA
chr1	1047876	rs536657086	C	T	PASS	T	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.3732C>T	p.His1244His	22/36	3782/7323	1244/2045	3732/6138	NA	NA	NA	NA	4.164e-05	0.000399361	0.999601	2503,0	0	0.000199681	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	142	NA	NA	NA	NA	NA	NA
chr1	1048126	rs139294803	C	T	PASS	T	missense_variant	MODERATE	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.3866C>T	p.Pro1289Leu	23/36	3916/7323	1289/2045	3866/6138	NA	NA	NA	NA	0.004388	0.0163738	0.983227	2462,1	0.000399361	0.00858626	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	N	0	-4.13	AGRIN_HUMAN	B	B	3.6	1289	0.128	-1.219	./T	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	134	NA	NA	NA	NA	NA	NA
chr1	1048224	rs184970403	C	T	PASS	T	missense_variant	MODERATE	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.3964C>T	p.Arg1322Trp	23/36	4014/7323	1322/2045	3964/6138	NA	NA	NA	NA	0.001381	0.0155751	0.984425	2465,0	0	0.00778754	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	L	N	0.006	0.061	AGRIN_HUMAN	B	D	4.38	1322	14.80	0.771	./T	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	135	NA	NA	NA	NA	NA	NA
chr1	1048232	rs201483077	G	A	PASS	A	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.3972G>A	p.Pro1324Pro	23/36	4022/7323	1324/2045	3972/6138	NA	NA	NA	NA	0.001338	0.0155751	0.984425	2465,0	0	0.00778754	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	137	NA	NA	NA	NA	NA	NA
chr1	1049389	rs75767981	C	T	PASS	T	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.4452C>T	p.Thr1484Thr	25/36	4502/7323	1484/2045	4452/6138	NA	NA	NA	NA	0.003208	0.0215655	0.978435	2450,0	0	0.0107827	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	131	NA	NA	NA	NA	NA	NA
chr1	1049591	rs111818381	G	A	PASS	A	missense_variant	MODERATE	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.4540G>A	p.Ala1514Thr	26/36	4590/7323	1514/2045	4540/6138	NA	NA	NA	NA	0.006602	0.00798722	0.991613	2483,1	0.000399361	0.00439297	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	N	0	-1.43	AGRIN_HUMAN	B	B	4.51	1514	0.023	-2.708	./T	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	132	NA	NA	NA	NA	NA	NA
chr1	1049791	rs115019873	C	T	PASS	T	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.4740C>T	p.Arg1580Arg	26/36	4790/7323	1580/2045	4740/6138	NA	NA	NA	NA	0.00433	0.043131	0.955671	2393,3	0.00119808	0.0227636	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	132	NA	NA	NA	NA	NA	NA
chr1	1050446	rs17160775	G	A	PASS	A	missense_variant	MODERATE	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.4996G>A	p.Val1666Ile	29/36	5046/7323	1666/2045	4996/6138	NA	NA	NA	NA	0.013	0.0814696	0.913339	2287,13	0.00519169	0.0459265	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	P	0.995	1.54	AGRIN_HUMAN	B	B	4.68	1666	11.95	0.055	./T	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	123	NA	NA	NA	NA	NA	NA
chr1	1050446	rs17160775	G	A	PASS	A	upstream_gene_variant	MODIFIER	RP11-54O7.14	ENSG00000242590	transcript	ENST00000418300.1	n.-4587G>A	NA	NA	NA	NA	NA	4587	NA	NA	NA	0.013	0.0814696	0.913339	2287,13	0.00519169	0.0459265	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	P	0.995	1.54	AGRIN_HUMAN	B	B	4.68	1666	11.95	0.055	./T	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	123	NA	NA	NA	NA	NA	NA
chr1	1051357	rs17160781	T	C	PASS	C	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.5358T>C	p.Gly1786Gly	31/36	5408/7323	1786/2045	5358/6138	NA	NA	NA	NA	0.02	0.126997	0.857428	2147,39	0.0155751	0.0790735	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	123	NA	NA	NA	NA	NA	NA
chr1	1051357	rs17160781	T	C	PASS	C	upstream_gene_variant	MODIFIER	RP11-54O7.14	ENSG00000242590	transcript	ENST00000418300.1	n.-3676T>C	NA	NA	NA	NA	NA	3676	NA	NA	NA	0.02	0.126997	0.857428	2147,39	0.0155751	0.0790735	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	123	NA	NA	NA	NA	NA	NA
chr1	1051762	rs17778478	C	T	PASS	T	synonymous_variant	LOW	AGRN	ENSG00000188157	transcript	ENST00000379370.6	c.5598C>T	p.Thr1866Thr	33/36	5648/7323	1866/2045	5598/6138	NA	NA	NA	NA	0.005183	0.0183706	0.98123	2457,1	0.000399361	0.00958466	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	123	NA	NA	NA	NA	NA	NA
chr1	1051762	rs17778478	C	T	PASS	T	upstream_gene_variant	MODIFIER	RP11-54O7.14	ENSG00000242590	transcript	ENST00000418300.1	n.-3271C>T	NA	NA	NA	NA	NA	3271	NA	NA	NA	0.005183	0.0183706	0.98123	2457,1	0.000399361	0.00958466	255	not_specified	CN169374	MedGen	NA	NA	615120(3)	NA	Myasthenic~syndrome~congenital~8~with~pre-~and~postsynaptic~defects	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agrn	E	4.21E-01	37.33191791	-0.224542487	abnormal	6.86990	375790	agrn	NA	1338.6014	123	NA	NA	NA	NA	NA	NA
chr1	1232972	rs397514717	C	T	PASS	T	missense_variant	MODERATE	B3GALT6	ENSG00000176022	transcript	ENST00000379198.3	c.694C>T	p.Arg232Cys	1/1	708/2777	232/329	694/990	NA	NA	NA	NA	1.745e-05	0.000798722	0.999201	2502,0	0	0.000399361	5	Spondyloepimetaphyseal_dysplasia_with_joint_laxity	C0432243:271640:ORPHA93359:254100000	MedGen:OMIM:Orphanet:SNOMED_CT	NA	1	271640(3),615349(3)	NA	Spondyloepimetaphyseal~dysplasia~with~joint~laxity~type~1~with~or~without~fractures,Ehlers-Danlos~syndrome~progeroid~type~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	L	D	0.999	2.99	B3GT6_HUMAN	P	D	3.9	232	24.6	0.891	T	B3galt6	NA	NA	NA	NA	NA	5.32791	126792	NA	NA	720.15343	136	NA	NA	NA	NA	NA	NA
chr1	1232972	rs397514717	C	T	PASS	T	upstream_gene_variant	MODIFIER	SDF4	ENSG00000078808	transcript	ENST00000360001.10	c.-4179G>A	NA	NA	NA	NA	NA	971	NA	NA	NA	1.745e-05	0.000798722	0.999201	2502,0	0	0.000399361	5	Spondyloepimetaphyseal_dysplasia_with_joint_laxity	C0432243:271640:ORPHA93359:254100000	MedGen:OMIM:Orphanet:SNOMED_CT	NA	1	271640(3),615349(3)	NA	Spondyloepimetaphyseal~dysplasia~with~joint~laxity~type~1~with~or~without~fractures,Ehlers-Danlos~syndrome~progeroid~type~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	L	D	0.999	2.99	B3GT6_HUMAN	P	D	3.9	232	24.6	0.891	T	B3galt6	NA	NA	NA	NA	NA	5.32791	126792	NA	NA	720.15343	136	NA	NA	NA	NA	NA	NA
chr1	2028260	rs41307846	G	A	PASS	A	missense_variant	MODERATE	GABRD	ENSG00000187730	transcript	ENST00000378585.5	c.659G>A	p.Arg220His	6/9	759/1928	220/452	659/1359	NA	NA	NA	NA	0.017	0.0115815	0.988419	2475,0	0	0.00579073	255|255|255	Generalized_epilepsy_with_febrile_seizures_plus_type_5|Epilepsy\x2c_juvenile_myoclonic_7|Epilepsy\x2c_idiopathic_generalized_10	C3150401|C2751604|C2751603:613060	MedGen|MedGen|MedGen:OMIM	NA	NA	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AD	NA	NA	NA	NA	NA	613060(3),613060(3),613060(3)	NA	607872(4)	NA	IC	NA	{Epilepsy~juvenile~myoclonic~susceptibility~to},{Epilepsy~idiopathic~generalized~10},{Epilepsy~generalized~with~febrile~seizures~plus~type~5~susceptibility~to}	N	D	0.996	1.47	GBRD_HUMAN	B	B	3.47	220	19.55	0.135	T	Gabrd	E	1.18E-02	21.65015334	-0.510624372	NA	1.57817	2563	NA	NA	60.3441	127	NA	NA	NA	NA	NA	NA
chr1	2229183	rs144874401	C	T	PASS	T	synonymous_variant	LOW	SKI	ENSG00000157933	transcript	ENST00000378536.4	c.417C>T	p.Ile139Ile	1/7	489/5613	139/728	417/2187	NA	NA	NA	NA	0.0006393	0.000399361	0.999601	2503,0	0	0.000199681	255|2	not_specified|Shprintzen-Goldberg_syndrome	CN169374|C1321551:182212:83092002	MedGen|MedGen:OMIM:SNOMED_CT	NA	NA	182212(3)	NA	Shprintzen-Goldberg~syndrome	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ski	E	NA	NA	NA	abnormal	3.89213	6497	skia	NA	335.72865	134	NA	NA	NA	NA	NA	NA
chr1	2229564	rs149642284	C	T	PASS	T	synonymous_variant	LOW	SKI	ENSG00000157933	transcript	ENST00000378536.4	c.798C>T	p.Ala266Ala	1/7	870/5613	266/728	798/2187	NA	NA	NA	NA	0.0007619	0.00159744	0.998403	2500,0	0	0.000798722	255|3	not_specified|Thoracic_aortic_aneurysm_and_aortic_dissection	CN169374|CN118826:ORPHA91387	MedGen|MedGen:Orphanet	NA	NA	182212(3)	NA	Shprintzen-Goldberg~syndrome	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ski	E	NA	NA	NA	abnormal	3.89213	6497	skia	NA	335.72865	134	NA	NA	NA	NA	NA	NA
chr1	2303352	rs75280988	C	T	PASS	T	missense_variant	MODERATE	SKI	ENSG00000157933	transcript	ENST00000378536.4	c.1163C>T	p.Ala388Val	3/7	1235/5613	388/728	1163/2187	NA	NA	NA	NA	0.003838	0.00359425	0.996406	2495,0	0	0.00179712	255|2	not_specified|Shprintzen-Goldberg_syndrome	CN169374|C1321551:182212:83092002	MedGen|MedGen:OMIM:SNOMED_CT	NA	1	182212(3)	NA	Shprintzen-Goldberg~syndrome	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	L	N	0.028	3.15	SKI_HUMAN	B	B	4.08	388	11.00	0.058	T	Ski	E	NA	NA	NA	abnormal	3.89213	6497	skia	NA	335.72865	131	NA	NA	NA	NA	NA	NA
chr1	2303385	rs141862996	C	T	PASS	T	missense_variant	MODERATE	SKI	ENSG00000157933	transcript	ENST00000378536.4	c.1196C>T	p.Ala399Val	3/7	1268/5613	399/728	1196/2187	NA	NA	NA	NA	0.0004448	0.00239617	0.997604	2498,0	0	0.00119808	255|3	not_specified|Shprintzen-Goldberg_syndrome	CN169374|C1321551:182212:83092002	MedGen|MedGen:OMIM:SNOMED_CT	NA	NA	182212(3)	NA	Shprintzen-Goldberg~syndrome	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	M	D	0.941	3.95	SKI_HUMAN	D	D	3.95	399	23.4	0.923	T	Ski	E	NA	NA	NA	abnormal	3.89213	6497	skia	NA	335.72865	134	NA	NA	NA	NA	NA	NA
chr1	2304411	rs144279718	T	C	PASS	C	synonymous_variant	LOW	SKI	ENSG00000157933	transcript	ENST00000378536.4	c.1593T>C	p.Pro531Pro	5/7	1665/5613	531/728	1593/2187	NA	NA	NA	NA	0.0003206	0.000399361	0.999601	2503,0	0	0.000199681	255	not_specified	CN169374	MedGen	NA	NA	182212(3)	NA	Shprintzen-Goldberg~syndrome	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ski	E	NA	NA	NA	abnormal	3.89213	6497	skia	NA	335.72865	134	NA	NA	NA	NA	NA	NA
chr1	2406580	rs61752093	CAG	C	PASS	C	frameshift_variant	HIGH	PEX10	ENSG00000157911	transcript	ENST00000288774.7	c.874_875delCT	p.Leu292fs	5/6	903/2871	292/346	874/1041	NA	NA	(PEX10|ENSG00000157911|1|1.00)	NA	4.943e-05	NA	NA	NA	NA	NA	5	Zellweger_syndrome	C0043459:214100:ORPHA912:88469006	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	614871(3),614870(3)	NA	Peroxisome~biogenesis~disorder~6B,Peroxisome~biogenesis~disorder~6A~(Zellweger)	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pex10	NA	2.34E-01	34.81953291	-0.26629572	NA	2.61859	5192	NA	NA	144.47811	129	NA	NA	NA	NA	NA	NA
chr1	2406580	rs61752093	CAG	C	PASS	C	downstream_gene_variant	MODIFIER	RER1	ENSG00000157916	transcript	ENST00000488353.2	c.*3457_*3458delAG	NA	NA	NA	NA	NA	3365	NA	(PEX10|ENSG00000157911|1|1.00)	NA	4.943e-05	NA	NA	NA	NA	NA	5	Zellweger_syndrome	C0043459:214100:ORPHA912:88469006	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	614871(3),614870(3)	NA	Peroxisome~biogenesis~disorder~6B,Peroxisome~biogenesis~disorder~6A~(Zellweger)	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pex10	NA	2.34E-01	34.81953291	-0.26629572	NA	2.61859	5192	NA	NA	144.47811	129	NA	NA	NA	NA	NA	NA
chr1	2408761	rs2494598	T	C	PASS	C	synonymous_variant	LOW	PEX10	ENSG00000157911	transcript	ENST00000288774.7	c.291A>G	p.Thr97Thr	3/6	319/2871	97/346	291/1041	NA	NA	NA	NA	0.77	0.40016	0.101038	253,1249	0.498802	0.698882	255|2	not_specified|Zellweger_syndrome	CN169374|C0043459:214100:ORPHA912:88469006	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	614871(3),614870(3)	NA	Peroxisome~biogenesis~disorder~6B,Peroxisome~biogenesis~disorder~6A~(Zellweger)	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pex10	NA	2.34E-01	34.81953291	-0.26629572	NA	2.61859	5192	NA	NA	144.47811	100	NA	NA	NA	NA	NA	NA
chr1	2408773	rs1143016	G	A	PASS	A	synonymous_variant	LOW	PEX10	ENSG00000157911	transcript	ENST00000288774.7	c.279C>T	p.Gly93Gly	3/6	307/2871	93/346	279/1041	NA	NA	NA	NA	0.053	0.0367412	0.961661	2408,4	0.00159744	0.0199681	255|3	not_specified|Zellweger_syndrome	CN169374|C0043459:214100:ORPHA912:88469006	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	614871(3),614870(3)	NA	Peroxisome~biogenesis~disorder~6B,Peroxisome~biogenesis~disorder~6A~(Zellweger)	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pex10	NA	2.34E-01	34.81953291	-0.26629572	NA	2.61859	5192	NA	NA	144.47811	86	NA	NA	NA	NA	NA	NA
chr1	3430888	rs201654872	G	A	PASS	A	missense_variant	MODERATE	PRDM16	ENSG00000142611	transcript	ENST00000270722.9	c.3301G>A	p.Val1101Met	15/17	3350/8690	1101/1276	3301/3831	NA	NA	NA	NA	0.003529	0.00599042	0.99401	2489,0	0	0.00299521	5|2|2	Dilated_cardiomyopathy_1LL|Left_ventricular_noncompaction_8|not_specified	CN178850|C3809288:615373|CN169374	MedGen|MedGen:OMIM|MedGen	NA	NA	615373(3),615373(3)	NA	Left~ventricular~noncompaction~8,Cardiomyopathy~dilated~1LL	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	607872(4)	NA	IC	NA	NA	N	N/N/N/N/N/N/N/N	0.01	1.66	PRD16_HUMAN/././.	B	P/B/P/B	4.03	1101,1101,1100,1100	11.36	0.019	T	Prdm16	E	1.01E-01	4.063458363	-1.424032938	abnormal	6.69837	63976	prdm16	NA	1261.89174	136	NA	NA	NA	NA	NA	NA
chr1	5863916	rs374146357	G	A	PASS	A	synonymous_variant	LOW	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.4114C>T	p.Leu1372Leu	29/30	4380/4994	1372/1426	4114/4281	NA	NA	NA	NA	0.0003226	0.00119808	0.998802	2501,0	0	0.000599042	255|0	Nephronophthisis|Renal_dysplasia_and_retinal_aplasia	C0687120:204958008|CN117960:ORPHA3156:236531005	MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	2	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	138	NA	NA	NA	NA	NA	NPHP4
chr1	5863916	rs374146357	G	A	PASS	A	upstream_gene_variant	MODIFIER	MIR4689	ENSG00000264101	transcript	ENST00000582517.1	n.-1175C>T	NA	NA	NA	NA	NA	1175	NA	NA	NA	0.0003226	0.00119808	0.998802	2501,0	0	0.000599042	255|0	Nephronophthisis|Renal_dysplasia_and_retinal_aplasia	C0687120:204958008|CN117960:ORPHA3156:236531005	MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	2	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	138	NA	NA	NA	NA	NA	NPHP4
chr1	5863955	rs369162678	G	A	PASS	A	missense_variant	MODERATE	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.4075C>T	p.Arg1359Trp	29/30	4341/4994	1359/1426	4075/4281	NA	NA	NA	NA	0.0001736	0.000399361	0.999601	2503,0	0	0.000199681	4|0|0	not_provided|Renal_dysplasia_and_retinal_aplasia|Nephronophthisis	CN221809|CN117960:ORPHA3156:236531005|C0687120:204958008	MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:SNOMED_CT	NA	1	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	M	N	0.462	3.1	NPHP4_HUMAN	P	D	5.2	1359	27.2	1.048	D	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	138	NA	NA	NA	NA	NA	NPHP4
chr1	5863955	rs369162678	G	A	PASS	A	upstream_gene_variant	MODIFIER	MIR4689	ENSG00000264101	transcript	ENST00000582517.1	n.-1214C>T	NA	NA	NA	NA	NA	1214	NA	NA	NA	0.0001736	0.000399361	0.999601	2503,0	0	0.000199681	4|0|0	not_provided|Renal_dysplasia_and_retinal_aplasia|Nephronophthisis	CN221809|CN117960:ORPHA3156:236531005|C0687120:204958008	MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:SNOMED_CT	NA	1	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	M	N	0.462	3.1	NPHP4_HUMAN	P	D	5.2	1359	27.2	1.048	D	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	138	NA	NA	NA	NA	NA	NPHP4
chr1	5864458	rs115526767	G	A	PASS	A	synonymous_variant	LOW	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.3876C>T	p.Gly1292Gly	28/30	4142/4994	1292/1426	3876/4281	NA	NA	NA	NA	0.008575	0.00878594	0.991214	2482,0	0	0.00439297	2|255|0	not_specified|Nephronophthisis|Renal_dysplasia_and_retinal_aplasia	CN169374|C0687120:204958008|CN117960:ORPHA3156:236531005	MedGen|MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	132	NA	NA	NA	NA	NA	NPHP4
chr1	5864458	rs115526767	G	A	PASS	A	upstream_gene_variant	MODIFIER	MIR4689	ENSG00000264101	transcript	ENST00000582517.1	n.-1717C>T	NA	NA	NA	NA	NA	1717	NA	NA	NA	0.008575	0.00878594	0.991214	2482,0	0	0.00439297	2|255|0	not_specified|Nephronophthisis|Renal_dysplasia_and_retinal_aplasia	CN169374|C0687120:204958008|CN117960:ORPHA3156:236531005	MedGen|MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	132	NA	NA	NA	NA	NA	NPHP4
chr1	5867109	rs113445782	G	A	PASS	A	missense_variant	MODERATE	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.3479C>T	p.Pro1160Leu	25/30	3745/4994	1160/1426	3479/4281	NA	NA	NA	NA	0.01	0.0115815	0.988419	2475,0	0	0.00579073	255|2|0	Nephronophthisis|not_specified|Renal_dysplasia_and_retinal_aplasia	C0687120:204958008|CN169374|CN117960:ORPHA3156:236531005	MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	M	D	0.012	1.9	./NPHP4_HUMAN	B	B/P	5.91	102,1160	0.334	-0.985	T	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	132	NA	NA	NA	NA	NA	NPHP4
chr1	5867109	rs113445782	G	A	PASS	A	upstream_gene_variant	MODIFIER	MIR4689	ENSG00000264101	transcript	ENST00000582517.1	n.-4368C>T	NA	NA	NA	NA	NA	4368	NA	NA	NA	0.01	0.0115815	0.988419	2475,0	0	0.00579073	255|2|0	Nephronophthisis|not_specified|Renal_dysplasia_and_retinal_aplasia	C0687120:204958008|CN169374|CN117960:ORPHA3156:236531005	MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	M	D	0.012	1.9	./NPHP4_HUMAN	B	B/P	5.91	102,1160	0.334	-0.985	T	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	132	NA	NA	NA	NA	NA	NPHP4
chr1	5874542	rs373369949	G	A	PASS	A	missense_variant	MODERATE	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.3160C>T	p.Arg1054Cys	22/30	3426/4994	1054/1426	3160/4281	NA	NA	NA	NA	8.277e-05	NA	NA	NA	NA	NA	4	not_provided	CN221809	MedGen	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	M	D	0.99	5.38	NPHP4_HUMAN	D	D	5.38	1054	33	1.048	D	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	138	NA	NA	NA	NA	NA	NPHP4
chr1	5875042	rs12084067	C	T	PASS	T	missense_variant	MODERATE	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.2876G>A	p.Arg959Gln	21/30	3142/4994	959/1426	2876/4281	NA	NA	NA	NA	0.003273	0.0219649	0.977236	2447,2	0.000798722	0.0117812	255|3	Nephronophthisis|Renal_dysplasia_and_retinal_aplasia	C0687120:204958008|CN117960:ORPHA3156:236531005	MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	M	D	0.615	4.88	NPHP4_HUMAN	B	P	4.88	959	29.0	0.934	D	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	120	NA	NA	NA	NA	NA	NPHP4
chr1	5877102	rs17028857	C	T	PASS	T	synonymous_variant	LOW	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.2808G>A	p.Thr936Thr	20/30	3074/4994	936/1426	2808/4281	NA	NA	NA	NA	0.003028	0.0251597	0.974042	2439,2	0.000798722	0.0133786	255|2|3	Nephronophthisis|not_specified|Renal_dysplasia_and_retinal_aplasia	C0687120:204958008|CN169374|CN117960:ORPHA3156:236531005	MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	123	NA	NA	NA	NA	NA	NPHP4
chr1	5890915	rs148424288	C	T	PASS	T	missense_variant	MODERATE	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.2257G>A	p.Asp753Asn	17/30	2523/4994	753/1426	2257/4281	NA	NA	NA	NA	0.0007939	0.00638978	0.99361	2488,0	0	0.00319489	2|255|0	not_specified|Nephronophthisis|Renal_dysplasia_and_retinal_aplasia	CN169374|C0687120:204958008|CN117960:ORPHA3156:236531005	MedGen|MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	M	D	0.804	5.61	NPHP4_HUMAN	D	D	5.61	753	29.0	0.892	D/.	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	134	NA	NA	NA	NA	NA	NPHP4
chr1	5890953	rs34248917	C	T	PASS	T	missense_variant	MODERATE	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.2219G>A	p.Arg740His	17/30	2485/4994	740/1426	2219/4281	NA	NA	NA	NA	0.025	0.0179712	0.981629	2458,1	0.000399361	0.00938498	255|2|3	Nephronophthisis|not_specified|Renal_dysplasia_and_retinal_aplasia	C0687120:204958008|CN169374|CN117960:ORPHA3156:236531005	MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	NA	1	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	N	N	0.052	-7.21	NPHP4_HUMAN	B	B	5.61	740	2.552	-1.63	T/.	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	126	NA	NA	NA	NA	NA	NPHP4
chr1	5904729	rs34373111	G	A	PASS	A	synonymous_variant	LOW	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.2031C>T	p.Pro677Pro	16/30	2297/4994	677/1426	2031/4281	NA	NA	NA	NA	0.002965	0.0155751	0.984026	2464,1	0.000399361	0.0081869	255|2|3	Nephronophthisis|not_specified|Renal_dysplasia_and_retinal_aplasia	C0687120:204958008|CN169374|CN117960:ORPHA3156:236531005	MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	126	NA	NA	NA	NA	NA	NPHP4
chr1	5909165	rs375051705	G	C	PASS	C	missense_variant	MODERATE	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.1490C>G	p.Pro497Arg	12/30	1756/4994	497/1426	1490/4281	NA	NA	NA	NA	0.005689	0.0191693	0.980831	2456,0	0	0.00958466	255|3	Nephronophthisis|Renal_dysplasia_and_retinal_aplasia	C0687120:204958008|CN117960:ORPHA3156:236531005	MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	M	N	0.791	3.45	NPHP4_HUMAN	D	D	3.45	497	24.2	0.953	D/.	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	138	NA	NA	NA	NA	NA	NPHP4
chr1	5909220	rs146078470	G	A	PASS	A	splice_region_variant&intron_variant	LOW	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.1442-7C>T	NA	11/29	NA	NA	NA	NA	NA	NA	NA	0.001601	0.0151757	0.984425	2465,1	0.000399361	0.00798722	255|0|0	not_specified|Renal_dysplasia_and_retinal_aplasia|Nephronophthisis	CN169374|CN117960:ORPHA3156:236531005|C0687120:204958008	MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:SNOMED_CT	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	134	NA	NA	NA	NA	NA	NPHP4
chr1	5978416	rs143323188	AG	A	PASS	A	splice_region_variant&intron_variant	LOW	NPHP4	ENSG00000131697	transcript	ENST00000378156.8	c.136-4delC	NA	2/29	NA	NA	NA	NA	NA	NA	NA	0.001999	0.0107827	0.988818	2476,1	0.000399361	0.00579073	255|3	Nephronophthisis|Renal_dysplasia_and_retinal_aplasia	C0687120:204958008|CN117960:ORPHA3156:236531005	MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	606996(3),606966(3)	NA	Senior-Loken~syndrome~4,Nephronophthisis~4	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphp4	N	2.10E-02	81.78815758	0.569383166	abnormal	6.40920	261734	nphp4	NA	1128.55982	134	NA	NA	NA	NA	NA	NPHP4
chr1	6468378	rs202191898	C	T	PASS	T	missense_variant	MODERATE	PLEKHG5	ENSG00000171680	transcript	ENST00000537245.5	c.2695G>A	p.Gly899Ser	21/22	2760/4794	899/1085	2695/3258	NA	NA	NA	NA	0.00127	0.00399361	0.996006	2494,0	0	0.00199681	5,0	Charcot-Marie-Tooth_disease\x2c_recessive_intermediate_c,not_specified	C3809309:615376:ORPHA369867,CN169374	MedGen:OMIM:Orphanet,MedGen	NA	NA	611067(3),615376(3)	NA	Spinal~muscular~atrophy~distal~autosomal~recessive~4,Charcot-Marie-Tooth~disease~recessive~intermediate~C	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	L	D/D/D/D/D/D/D/D/D/D/D/D/D	0.996	5.35	./././PKHG5_HUMAN	D	D	5.35	889,820,897,876	34	0.935	D	Plekhg5	N	8.03E-01	92.3920736	1.146346745	abnormal	9.87912	57449	plekhg5b	NA	2745.09927	136	NA	NA	NA	NA	NA	PLEKHG5
chr1	6468378	rs202191898	C	T	PASS	T	upstream_gene_variant	MODIFIER	TNFRSF25	ENSG00000215788	transcript	ENST00000377782.7	c.-2271G>A	NA	NA	NA	NA	NA	2203	NA	NA	NA	0.00127	0.00399361	0.996006	2494,0	0	0.00199681	5,0	Charcot-Marie-Tooth_disease\x2c_recessive_intermediate_c,not_specified	C3809309:615376:ORPHA369867,CN169374	MedGen:OMIM:Orphanet,MedGen	NA	NA	611067(3),615376(3)	NA	Spinal~muscular~atrophy~distal~autosomal~recessive~4,Charcot-Marie-Tooth~disease~recessive~intermediate~C	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	L	D/D/D/D/D/D/D/D/D/D/D/D/D	0.996	5.35	./././PKHG5_HUMAN	D	D	5.35	889,820,897,876	34	0.935	D	Plekhg5	N	8.03E-01	92.3920736	1.146346745	abnormal	9.87912	57449	plekhg5b	NA	2745.09927	136	NA	NA	NA	NA	NA	PLEKHG5
chr1	6475992	rs111400494	G	A	PASS	A	missense_variant	MODERATE	PLEKHG5	ENSG00000171680	transcript	ENST00000537245.5	c.325C>T	p.Arg109Cys	4/22	390/4794	109/1085	325/3258	NA	NA	NA	NA	0.002249	0.00199681	0.998003	2499,0	0	0.000998403	255|0	not_specified|Distal_spinal_muscular_atrophy	CN169374|C0393541:ORPHA53739:230247001	MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	611067(3),615376(3)	NA	Spinal~muscular~atrophy~distal~autosomal~recessive~4,Charcot-Marie-Tooth~disease~recessive~intermediate~C	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	L	D/D/D/D/D/D/D/D/D/D/D/D/D	0.615	3.52	././././PKHG5_HUMAN	B	P/B/B/P/B	4.44	99,30,107,107,86	24.4	0.902	D/D/D/D/D/D/D/D/D/T	Plekhg5	N	8.03E-01	92.3920736	1.146346745	abnormal	9.87912	57449	plekhg5b	NA	2745.09927	132	NA	NA	NA	NA	NA	PLEKHG5
chr1	7809893	rs150812083	C	G	PASS	G	missense_variant&splice_region_variant	MODERATE	PER3	ENSG00000049246	transcript	ENST00000377532.7	c.1243C>G	p.Pro415Ala	11/21	1467/6279	415/1210	1243/3633	NA	NA	NA	NA	0.005807	0.00678914	0.993211	2487,0	0	0.00339457	5	Advanced_sleep_phase_syndrome\x2c_familial\x2c_3	CN235882:616882	MedGen:OMIM	NA	NA	616882(3)	NA	?Advanced~sleep~phase~syndrome~familial~3	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	M	D/D	0.301	4.44	./././PER3_HUMAN	D	D	4.44	414,415,415,414	24.8	0.931	././D/D	Per3	N	9.78E-01	94.35598018	1.352134556	abnormal	5.33625	8863	per3	NA	722.42393	134	NA	NA	NA	NA	NA	NA
chr1	7809893	rs150812083	C	G	PASS	G	downstream_gene_variant	MODIFIER	RP3-467L1.4	ENSG00000236266	transcript	ENST00000451646.1	n.*349G>C	NA	NA	NA	NA	NA	349	NA	NA	NA	0.005807	0.00678914	0.993211	2487,0	0	0.00339457	5	Advanced_sleep_phase_syndrome\x2c_familial\x2c_3	CN235882:616882	MedGen:OMIM	NA	NA	616882(3)	NA	?Advanced~sleep~phase~syndrome~familial~3	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	M	D/D	0.301	4.44	./././PER3_HUMAN	D	D	4.44	414,415,415,414	24.8	0.931	././D/D	Per3	N	9.78E-01	94.35598018	1.352134556	abnormal	5.33625	8863	per3	NA	722.42393	134	NA	NA	NA	NA	NA	NA
chr1	7809900	rs139315125	A	G	PASS	G	missense_variant	MODERATE	PER3	ENSG00000049246	transcript	ENST00000377532.7	c.1250A>G	p.His417Arg	11/21	1474/6279	417/1210	1250/3633	NA	NA	NA	NA	0.005807	0.00678914	0.993211	2487,0	0	0.00339457	5	Advanced_sleep_phase_syndrome\x2c_familial\x2c_3	CN235882:616882	MedGen:OMIM	NA	NA	616882(3)	NA	?Advanced~sleep~phase~syndrome~familial~3	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	M	D/D	0.324	2.07	./././PER3_HUMAN	P/B/B/P	D/B/B/D	4.44	416,417,417,416	8.149	0.185	././T/T	Per3	N	9.78E-01	94.35598018	1.352134556	abnormal	5.33625	8863	per3	NA	722.42393	134	NA	NA	NA	NA	NA	NA
chr1	7809900	rs139315125	A	G	PASS	G	downstream_gene_variant	MODIFIER	RP3-467L1.4	ENSG00000236266	transcript	ENST00000451646.1	n.*342T>C	NA	NA	NA	NA	NA	342	NA	NA	NA	0.005807	0.00678914	0.993211	2487,0	0	0.00339457	5	Advanced_sleep_phase_syndrome\x2c_familial\x2c_3	CN235882:616882	MedGen:OMIM	NA	NA	616882(3)	NA	?Advanced~sleep~phase~syndrome~familial~3	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	M	D/D	0.324	2.07	./././PER3_HUMAN	P/B/B/P	D/B/B/D	4.44	416,417,417,416	8.149	0.185	././T/T	Per3	N	9.78E-01	94.35598018	1.352134556	abnormal	5.33625	8863	per3	NA	722.42393	134	NA	NA	NA	NA	NA	NA
chr1	7961850	rs772854747	G	GGTGCTGGACGGTGTCCCT	PASS	GGTGCTGGACGGTGTCCCT	intron_variant	MODIFIER	PARK7	ENSG00000116288	transcript	ENST00000338639.9	c.-24+75_-24+92dupTGTGCTGGACGGTGTCCC	NA	1/6	NA	NA	NA	NA	INFO_REALIGN_3_PRIME	NA	NA	NA	NA	NA	NA	NA	NA	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	144	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	1J42:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	1P5F:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	1PDV:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	1PE0:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	1Q2U:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	1SOA:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	1UCF:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	1UCF:B_122-B_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	2OR3:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	2OR3:B_122-B_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	2R1T:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	2R1T:B_122-B_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	2R1U:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	2R1U:B_122-B_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	2R1V:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	2R1V:B_122-B_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	2RK3:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	2RK4:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	2RK6:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3B36:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3B38:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3B3A:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3BWE:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3CY6:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3CYF:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3CZ9:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3CZA:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3EZG:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3F71:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3SF8:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	3SF8:B_122-B_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4BTE:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4MNT:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4MTC:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4N0M:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4N12:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4OGF:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4OQ4:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4P2G:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4P34:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4P35:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4P36:A_121-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4P36:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	structural_interaction_variant	HIGH	PARK7	ENSG00000116288	interaction	4ZGG:A_122-A_149:ENST00000338639	c.446A>C	NA	7/7	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	missense_variant	MODERATE	PARK7	ENSG00000116288	transcript	ENST00000338639.9	c.446A>C	p.Asp149Ala	7/7	600/949	149/189	446/570	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	7984930	rs74315352	A	C	PASS	C	upstream_gene_variant	MODIFIER	Y_RNA	ENSG00000200344	transcript	ENST00000363474.1	n.-1947T>G	NA	NA	NA	NA	NA	1947	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	Parkinson_disease_7	C1853445:606324	MedGen:OMIM	NA	NA	606324(3)	NA	Parkinson~disease~7~autosomal~recessive~early-onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A/A/A/A	0.956	5.06	PARK7_HUMAN	P	D	5.06	149	25.1	1.199	./D/D/./D/D/.	Park7	N	1.29E-01	60.09082331	0.082802743	abnormal	1.70290	11315	park7	NA	67.74927	133	NA	NA	NA	NA	NA	NA
chr1	9717608	rs28730670	C	T	PASS	T	synonymous_variant	LOW	PIK3CD	ENSG00000171608	transcript	ENST00000361110.6	c.897C>T	p.Asn299Asn	7/23	1012/3508	299/1068	897/3207	NA	NA	NA	NA	0.001598	0.014377	0.985224	2467,1	0.000399361	0.00758786	5	Immunodeficiency_14	C3714976:615513	MedGen:OMIM	NA	NA	615513(3)	NA	Immunodeficiency~14	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pik3cd	N	1.83E-01	2.724699222	-1.658985203	abnormal	3.55263	5293	pik3cd	NA	274.89339	125	NA	NA	NA	NA	NA	NA
chr1	9982630	rs150726175	G	A	PASS	A	missense_variant	MODERATE	NMNAT1	ENSG00000173614	transcript	ENST00000377205.5	c.769G>A	p.Glu257Lys	5/5	913/3781	257/279	769/840	NA	NA	NA	NA	0.0006177	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Leber_congenital_amaurosis_9|not_provided	C1837873:608553|CN221809	MedGen:OMIM|MedGen	NA	NA	608553(3)	NA	Leber~congenital~amaurosis~9	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	L	D	0.25	5.01	NMNA1_HUMAN	B	B	5.01	257	23.3	0.079	T	Nmnat1	NA	3.00E-01	64.31941496	0.148941568	NA	1.05754	64802	NA	NA	34.67179	134	NA	NA	NA	NA	NA	NA
chr1	9982630	rs150726175	G	A	PASS	A	upstream_gene_variant	MODIFIER	RP11-807G9.2	ENSG00000241326	transcript	ENST00000413148.1	n.-511G>A	NA	NA	NA	NA	NA	511	NA	NA	NA	0.0006177	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Leber_congenital_amaurosis_9|not_provided	C1837873:608553|CN221809	MedGen:OMIM|MedGen	NA	NA	608553(3)	NA	Leber~congenital~amaurosis~9	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	L	D	0.25	5.01	NMNA1_HUMAN	B	B	5.01	257	23.3	0.079	T	Nmnat1	NA	3.00E-01	64.31941496	0.148941568	NA	1.05754	64802	NA	NA	34.67179	134	NA	NA	NA	NA	NA	NA
chr1	10258594	rs12402052	C	G	PASS	G	synonymous_variant	LOW	KIF1B	ENSG00000054523	transcript	ENST00000377081.5	c.285C>G	p.Ala95Ala	3/48	364/8746	95/1823	285/5472	NA	NA	NA	NA	0.269	0.3123	0.613818	1537,185	0.0738818	0.230032	255|2|2|2	not_specified|Charcot-Marie-Tooth\x2c_Type_2|Pheochromocytoma|Neuroblastoma	CN169374|CN239171|C0031511:171300|C0027819:256700	MedGen|MedGen|MedGen:OMIM|MedGen:OMIM	NA	3	171300(3),118210(3),118210(3)	NA	Pheochromocytoma,?Charcot-Marie-Tooth~disease~type~2A1,?Charcot-Marie-Tooth~disease~type~2A1	Chromosome~1p36~deletion~syndrome	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	256700(3),256700(3)	AD,AD,AD	607872(4)	NA	IC	NA	{Neuroblastoma~susceptibility~to~1},{Neuroblastoma~susceptibility~to~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Kif1b	E	2.06E-01	3.927813163	-1.447883661	abnormal	5.27747	23095	kif1b	NA	705.73842	120	NA	NA	NA	NA	NA	NA
chr1	10324838	rs121908162	C	T	PASS	T	missense_variant	MODERATE	KIF1B	ENSG00000054523	transcript	ENST00000377081.5	c.2618C>T	p.Thr873Ile	25/48	2697/8746	873/1823	2618/5472	NA	NA	NA	NA	0.000626	0.000798722	0.999201	2502,0	0	0.000399361	255|0	Neuroblastoma_1|Charcot-Marie-Tooth_disease\x2c_type_2	C2749485|CN043576	MedGen|MedGen	NA	NA	171300(3),118210(3),118210(3)	NA	Pheochromocytoma,?Charcot-Marie-Tooth~disease~type~2A1,?Charcot-Marie-Tooth~disease~type~2A1	Chromosome~1p36~deletion~syndrome	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	256700(3),256700(3)	AD,AD,AD	607872(4)	NA	IC	NA	{Neuroblastoma~susceptibility~to~1},{Neuroblastoma~susceptibility~to~1}	N	N/N/N	0.398	4.93	././././KIF1B_HUMAN/.	B	B	5.84	859,833,873,847,873,827	17.56	0.935	T/T/T/./.	Kif1b	E	2.06E-01	3.927813163	-1.447883661	abnormal	5.27747	23095	kif1b	NA	705.73842	132	NA	NA	NA	NA	NA	NA
chr1	10345943	rs121908163	C	T	PASS	T	missense_variant	MODERATE	KIF1B	ENSG00000054523	transcript	ENST00000377081.5	c.3787C>T	p.Pro1263Ser	34/48	3866/8746	1263/1823	3787/5472	NA	NA	NA	NA	0.000173	0.000399361	0.999601	2503,0	0	0.000199681	255	Neuroblastoma_1	C2749485	MedGen	NA	NA	171300(3),118210(3),118210(3)	NA	Pheochromocytoma,?Charcot-Marie-Tooth~disease~type~2A1,?Charcot-Marie-Tooth~disease~type~2A1	Chromosome~1p36~deletion~syndrome	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	256700(3),256700(3)	AD,AD,AD	607872(4)	NA	IC	NA	{Neuroblastoma~susceptibility~to~1},{Neuroblastoma~susceptibility~to~1}	M	D/D/D	1	4.73	././././KIF1B_HUMAN/.	B	B	5.63	1249,1223,1263,1237,1263,1217	17.08	0.931	T/T/T/./.	Kif1b	E	2.06E-01	3.927813163	-1.447883661	abnormal	5.27747	23095	kif1b	NA	705.73842	132	NA	NA	NA	NA	NA	NA
chr1	10361820	rs12125492	A	G	PASS	G	synonymous_variant	LOW	KIF1B	ENSG00000054523	transcript	ENST00000377081.5	c.4299A>G	p.Pro1433Pro	39/48	4378/8746	1433/1823	4299/5472	NA	NA	NA	NA	0.113	0.140575	0.849441	2127,25	0.00998403	0.0802716	255|3|3|3	not_specified|Neuroblastoma|Charcot-Marie-Tooth\x2c_Type_2|Pheochromocytoma	CN169374|C0027819:256700|CN239171|C0031511:171300	MedGen|MedGen:OMIM|MedGen|MedGen:OMIM	NA	1	171300(3),118210(3),118210(3)	NA	Pheochromocytoma,?Charcot-Marie-Tooth~disease~type~2A1,?Charcot-Marie-Tooth~disease~type~2A1	Chromosome~1p36~deletion~syndrome	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	256700(3),256700(3)	AD,AD,AD	607872(4)	NA	IC	NA	{Neuroblastoma~susceptibility~to~1},{Neuroblastoma~susceptibility~to~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Kif1b	E	2.06E-01	3.927813163	-1.447883661	abnormal	5.27747	23095	kif1b	NA	705.73842	120	NA	NA	NA	NA	NA	NA
chr1	10375266	rs11121552	C	A	PASS	A	synonymous_variant	LOW	KIF1B	ENSG00000054523	transcript	ENST00000377081.5	c.5301C>A	p.Thr1767Thr	47/48	5380/8746	1767/1823	5301/5472	NA	NA	NA	NA	0.272	0.313099	0.611821	1532,188	0.0750799	0.231629	255|2|2|2	not_specified|Charcot-Marie-Tooth\x2c_Type_2|Neuroblastoma|Pheochromocytoma	CN169374|CN239171|C0027819:256700|C0031511:171300	MedGen|MedGen|MedGen:OMIM|MedGen:OMIM	NA	4	171300(3),118210(3),118210(3)	NA	Pheochromocytoma,?Charcot-Marie-Tooth~disease~type~2A1,?Charcot-Marie-Tooth~disease~type~2A1	Chromosome~1p36~deletion~syndrome	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	256700(3),256700(3)	AD,AD,AD	607872(4)	NA	IC	NA	{Neuroblastoma~susceptibility~to~1},{Neuroblastoma~susceptibility~to~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Kif1b	E	2.06E-01	3.927813163	-1.447883661	abnormal	5.27747	23095	kif1b	NA	705.73842	120	NA	NA	NA	NA	NA	NA
chr1	11022290	rs80356721	G	A	PASS	A	missense_variant	MODERATE	TARDBP	ENSG00000120948	transcript	ENST00000240185.7	c.881G>A	p.Gly294Glu	6/6	1237/5367	294/414	881/1245	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5,5	Amyotrophic_lateral_sclerosis_type_10,Amyotrophic_lateral_sclerosis_type_10	C2677565:612069,C2677565:612069	MedGen:OMIM,MedGen:OMIM	NA	NA	612069(3),612069(3)	NA	Frontotemporal~lobar~degeneration~TARDBP-related,Amyotrophic~lateral~sclerosis~10~with~or~without~FTD	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	607872(4)	NA	IC	NA	NA	L	D/D/D	1	5.81	./TADBP_HUMAN	B	P/B	5.81	178,294	21.2	1.048	T/.	Tardbp	E	NA	27.41802312	-0.383807564	abnormal	0.07842	23435	tardbp	NA	2.30437	131	NA	NA	NA	NA	NA	NA
chr1	11022290	rs80356721	G	A	PASS	A	downstream_gene_variant	MODIFIER	MASP2	ENSG00000009724	transcript	ENST00000400897.7	c.*4595C>T	NA	NA	NA	NA	NA	4233	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5,5	Amyotrophic_lateral_sclerosis_type_10,Amyotrophic_lateral_sclerosis_type_10	C2677565:612069,C2677565:612069	MedGen:OMIM,MedGen:OMIM	NA	NA	612069(3),612069(3)	NA	Frontotemporal~lobar~degeneration~TARDBP-related,Amyotrophic~lateral~sclerosis~10~with~or~without~FTD	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	607872(4)	NA	IC	NA	NA	L	D/D/D	1	5.81	./TADBP_HUMAN	B	P/B	5.81	178,294	21.2	1.048	T/.	Tardbp	E	NA	27.41802312	-0.383807564	abnormal	0.07842	23435	tardbp	NA	2.30437	131	NA	NA	NA	NA	NA	NA
chr1	11022290	rs80356721	G	A	PASS	A	intron_variant	MODIFIER	RP4-635E18.9	ENSG00000277726	transcript	ENST00000614757.4	c.841+40G>A	NA	6/9	NA	NA	NA	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5,5	Amyotrophic_lateral_sclerosis_type_10,Amyotrophic_lateral_sclerosis_type_10	C2677565:612069,C2677565:612069	MedGen:OMIM,MedGen:OMIM	NA	NA	612069(3),612069(3)	NA	Frontotemporal~lobar~degeneration~TARDBP-related,Amyotrophic~lateral~sclerosis~10~with~or~without~FTD	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	607872(4)	NA	IC	NA	NA	L	D/D/D	1	5.81	./TADBP_HUMAN	B	P/B	5.81	178,294	21.2	1.048	T/.	Tardbp	E	NA	27.41802312	-0.383807564	abnormal	0.07842	23435	tardbp	NA	2.30437	131	NA	NA	NA	NA	NA	NA
chr1	11046609	rs72550870	T	C	PASS	C	missense_variant	MODERATE	MASP2	ENSG00000009724	transcript	ENST00000400897.7	c.359A>G	p.Asp120Gly	3/11	375/2439	120/686	359/2061	NA	NA	NA	NA	0.022	0.0215655	0.977236	2447,3	0.00119808	0.0119808	255|2	MASP2_deficiency|not_specified	C3151085:613791:ORPHA331187|CN169374	MedGen:OMIM:Orphanet|MedGen	NA	1	613791(3)	NA	MASP2~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A/A	0.99	4.77	./MASP2_HUMAN	D	D	4.77	120	27.2	1.061	D	Masp2	N	2.73E-01	89.89148384	0.942426495	NA	6.18949	10747	NA	compPathway/lectinPathway	1037.81374	130	NA	NA	NA	NA	NA	NA
chr1	11790870	rs2274976	C	T	PASS	T	missense_variant	MODERATE	MTHFR	ENSG00000177000	transcript	ENST00000376583.7	c.1904G>A	p.Arg635Gln	12/12	1904/7044	635/697	1904/2094	NA	NA	NA	NA	0.056	0.128994	0.861022	2156,25	0.00998403	0.0744808	255|3	not_provided|Neural_tube_defects\x2c_folate-sensitive	CN221809|C1866558:601634	MedGen|MedGen:OMIM	NA	6	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	N	P/P/P/P	0.978	2.99	MTHR_HUMAN/.	B	B	5.31	594,635	17.93	-0.774	T	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	100	NA	NA	NA	NA	NA	MTHFR
chr1	11790870	rs2274976	C	T	PASS	T	downstream_gene_variant	MODIFIER	C1orf167	ENSG00000215910	transcript	ENST00000433342.5	c.*1424C>T	NA	NA	NA	NA	NA	1286	NA	NA	NA	0.056	0.128994	0.861022	2156,25	0.00998403	0.0744808	255|3	not_provided|Neural_tube_defects\x2c_folate-sensitive	CN221809|C1866558:601634	MedGen|MedGen:OMIM	NA	6	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	N	P/P/P/P	0.978	2.99	MTHR_HUMAN/.	B	B	5.31	594,635	17.93	-0.774	T	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	100	NA	NA	NA	NA	NA	MTHFR
chr1	11794419	rs1801131	T	G	PASS	G	missense_variant	MODERATE	MTHFR	ENSG00000177000	transcript	ENST00000376583.7	c.1409A>C	p.Glu470Ala	8/12	1409/7044	470/697	1409/2094	NA	NA	NA	NA	0.295	0.355032	0.573083	1435,180	0.071885	0.249401	2|255|0|255|6|3	MTHFR_deficiency\x2c_thermolabile_type|Schizophrenia\x2c_susceptibility_to|Gastrointestinal_stromal_tumor|not_provided|fluorouracil\x2c_leucovorin\x2c_and_oxaliplatin_response_-_Efficacy|Neural_tube_defects\x2c_folate-sensitive	C1856059|.|C0238198:606764:ORPHA44890|CN221809|CN236474|C1866558:601634	MedGen|.|MedGen:OMIM:Orphanet|MedGen|MedGen|MedGen:OMIM	NA	16	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	L	P/P/P/P	0.914	4.74	MTHR_HUMAN/.	B	B/P	4.74	429,470	19.89	1.061	T	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	89	NA	NA	NA	NA	NA	MTHFR
chr1	11794419	rs1801131	T	G	PASS	G	downstream_gene_variant	MODIFIER	C1orf167	ENSG00000215910	transcript	ENST00000433342.5	c.*4973T>G	NA	NA	NA	NA	NA	4835	NA	NA	NA	0.295	0.355032	0.573083	1435,180	0.071885	0.249401	2|255|0|255|6|3	MTHFR_deficiency\x2c_thermolabile_type|Schizophrenia\x2c_susceptibility_to|Gastrointestinal_stromal_tumor|not_provided|fluorouracil\x2c_leucovorin\x2c_and_oxaliplatin_response_-_Efficacy|Neural_tube_defects\x2c_folate-sensitive	C1856059|.|C0238198:606764:ORPHA44890|CN221809|CN236474|C1866558:601634	MedGen|.|MedGen:OMIM:Orphanet|MedGen|MedGen|MedGen:OMIM	NA	16	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	L	P/P/P/P	0.914	4.74	MTHR_HUMAN/.	B	B/P	4.74	429,470	19.89	1.061	T	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	89	NA	NA	NA	NA	NA	MTHFR
chr1	11794443	rs200137991	C	A	PASS	A	missense_variant	MODERATE	MTHFR	ENSG00000177000	transcript	ENST00000376583.7	c.1385G>T	p.Trp462Leu	8/12	1385/7044	462/697	1385/2094	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Homocysteinemia_due_to_MTHFR_deficiency	C1856058:236250:ORPHA395	MedGen:OMIM:Orphanet	NA	NA	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	M	D/D/D/D	1	5.02	MTHR_HUMAN/.	P	D	5.02	421,462	34	0.935	D	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	137	NA	NA	NA	NA	NA	MTHFR
chr1	11794443	rs200137991	C	A	PASS	A	downstream_gene_variant	MODIFIER	C1orf167	ENSG00000215910	transcript	ENST00000433342.5	c.*4997C>A	NA	NA	NA	NA	NA	4859	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Homocysteinemia_due_to_MTHFR_deficiency	C1856058:236250:ORPHA395	MedGen:OMIM:Orphanet	NA	NA	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	M	D/D/D/D	1	5.02	MTHR_HUMAN/.	P	D	5.02	421,462	34	0.935	D	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	137	NA	NA	NA	NA	NA	MTHFR
chr1	11795125	rs543016186	C	T	PASS	T	missense_variant	MODERATE	MTHFR	ENSG00000177000	transcript	ENST00000376583.7	c.1127G>A	p.Arg376His	6/12	1127/7044	376/697	1127/2094	NA	NA	NA	NA	4.942e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|0	Homocysteinemia_due_to_MTHFR_deficiency|Neural_tube_defects\x2c_folate-sensitive	C1856058:236250:ORPHA395|C1866558:601634	MedGen:OMIM:Orphanet|MedGen:OMIM	NA	1	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	M	D/D/D/D	0.996	3.98	MTHR_HUMAN/.	P	P	4.91	335,376	27.4	0.024	T/D/T/D	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	142	NA	NA	NA	NA	NA	MTHFR
chr1	11796313	rs200100285	T	C	PASS	C	missense_variant	MODERATE	MTHFR	ENSG00000177000	transcript	ENST00000376583.7	c.796A>G	p.Ile266Val	5/12	796/7044	266/697	796/2094	NA	NA	NA	NA	0.0001071	0.000399361	0.999601	2503,0	0	0.000199681	0,5	Neural_tube_defects\x2c_folate-sensitive,Homocysteinemia_due_to_MTHFR_deficiency	C1866558:601634,C1856058:236250:ORPHA395	MedGen:OMIM,MedGen:OMIM:Orphanet	NA	NA	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	L	D/D/D/D	0.959	1.46	MTHR_HUMAN/.	B	B	5.08	225,266	4.957	0.146	T	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	137	NA	NA	NA	NA	NA	MTHFR
chr1	11796321	rs1801133	G	A	PASS	A	missense_variant	MODERATE	MTHFR	ENSG00000177000	transcript	ENST00000376583.7	c.788C>T	p.Ala263Val	5/12	788/7044	263/697	788/2094	NA	NA	NA	NA	0.304	0.327077	0.591054	1480,205	0.081869	0.245407	2|0|255|6|6|3	MTHFR_deficiency\x2c_thermolabile_type|Gastrointestinal_stromal_tumor|not_provided|cyclophosphamide_response_-_Toxicity/ADR|carboplatin_response_-_Efficacy|Neural_tube_defects\x2c_folate-sensitive	C1856059|C0238198:606764:ORPHA44890|CN221809|CN236519|CN236495|C1866558:601634	MedGen|MedGen:OMIM:Orphanet|MedGen|MedGen|MedGen|MedGen:OMIM	NA	29	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	M	P/P/P/P	0.53	5.08	MTHR_HUMAN/.	D	D	5.08	222,263	25.0	1.048	D	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	89	NA	NA	NA	NA	NA	MTHFR
chr1	11800250	rs574132670	C	T	PASS	T	missense_variant	MODERATE	MTHFR	ENSG00000177000	transcript	ENST00000376583.7	c.671G>A	p.Arg224Gln	4/12	671/7044	224/697	671/2094	NA	NA	NA	NA	7.413e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Homocysteinemia_due_to_MTHFR_deficiency	C1856058:236250:ORPHA395	MedGen:OMIM:Orphanet	NA	3	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	M	D/D/D/D	0.881	5.76	MTHR_HUMAN/.	D	D	5.76	183,224	35	0.927	D	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	142	NA	NA	NA	NA	NA	MTHFR
chr1	11802981	rs138189536	G	A	PASS	A	missense_variant	MODERATE	MTHFR	ENSG00000177000	transcript	ENST00000376583.7	c.259C>T	p.Arg87Trp	2/12	259/7044	87/697	259/2094	NA	NA	NA	NA	0.0002224	0.000798722	0.999201	2502,0	0	0.000399361	5	Homocysteinemia_due_to_MTHFR_deficiency	C1856058:236250:ORPHA395	MedGen:OMIM:Orphanet	NA	NA	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	M	D/D/D/D	0.974	1.42	MTHR_HUMAN/.	P	D	5.66	46,87	23.7	0.09	T/T/T/T/D	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	134	NA	NA	NA	NA	NA	MTHFR
chr1	11802981	rs138189536	G	A	PASS	A	upstream_gene_variant	MODIFIER	CLCN6	ENSG00000011021	transcript	ENST00000376496.4	c.-3282G>A	NA	NA	NA	NA	NA	3279	NA	NA	NA	0.0002224	0.000798722	0.999201	2502,0	0	0.000399361	5	Homocysteinemia_due_to_MTHFR_deficiency	C1856058:236250:ORPHA395	MedGen:OMIM:Orphanet	NA	NA	236250(3),236250(3),236250(3),236250(3)	NA	Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency,Homocystinuria~due~to~MTHFR~deficiency	Chromosome~1p36~deletion~syndrome	NA	AD,AD,AR	NA	NA	NA	NA	NA	188050(3),181500(3),601634(3)	AR,AR,AR,AR	607872(4)	NA	IC	NA	{Thromboembolism~susceptibility~to},{Schizophrenia~susceptibility~to},{Neural~tube~defects~susceptibility~to}	M	D/D/D/D	0.974	1.42	MTHR_HUMAN/.	P	D	5.66	46,87	23.7	0.09	T/T/T/T/D	Mthfr	N	2.10E-01	60.71007313	0.093718683	NA	13.51805	4524	NA	NA	4524.99996	134	NA	NA	NA	NA	NA	MTHFR
chr1	11847114	rs202102042	C	T	PASS	T	missense_variant&splice_region_variant	MODERATE	NPPA	ENSG00000175206	transcript	ENST00000610706.1	c.449G>A	p.Arg150Gln	2/4	548/849	150/152	449/459	NA	NA	NA	NA	0.0003551	0.000399361	0.999601	2503,0	0	0.000199681	5	Atrial_standstill_2	C3810401:615745	MedGen:OMIM	NA	1	615745(3),612201(3)	NA	Atrial~standstill~2,Atrial~fibrillation~familial~6	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	607872(4)	NA	IC	NA	NA	M	D/D	0.999	5.65	ANF_HUMAN	D	D	5.65	150	34	0.852	D/./D	./Nppa	./N	./6.40E-01	./88.62349611	./0.859896574	NA	./6.80239	100379251/4878	NA	./alkPathway/gcrPathway/nfatPathway	./1308.42229	137	NA	NA	NA	NA	NA	NA
chr1	11847114	rs202102042	C	T	PASS	T	upstream_gene_variant	MODIFIER	NPPA-AS1_3	ENSG00000275915	transcript	ENST00000617059.1	n.-328C>T	NA	NA	NA	NA	NA	328	NA	NA	NA	0.0003551	0.000399361	0.999601	2503,0	0	0.000199681	5	Atrial_standstill_2	C3810401:615745	MedGen:OMIM	NA	1	615745(3),612201(3)	NA	Atrial~standstill~2,Atrial~fibrillation~familial~6	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	607872(4)	NA	IC	NA	NA	M	D/D	0.999	5.65	ANF_HUMAN	D	D	5.65	150	34	0.852	D/./D	./Nppa	./N	./6.40E-01	./88.62349611	./0.859896574	NA	./6.80239	100379251/4878	NA	./alkPathway/gcrPathway/nfatPathway	./1308.42229	137	NA	NA	NA	NA	NA	NA
chr1	11847114	rs202102042	C	T	PASS	T	downstream_gene_variant	MODIFIER	NPPA-AS1_1	ENSG00000276470	transcript	ENST00000622391.1	n.*3130C>T	NA	NA	NA	NA	NA	3130	NA	NA	NA	0.0003551	0.000399361	0.999601	2503,0	0	0.000199681	5	Atrial_standstill_2	C3810401:615745	MedGen:OMIM	NA	1	615745(3),612201(3)	NA	Atrial~standstill~2,Atrial~fibrillation~familial~6	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	607872(4)	NA	IC	NA	NA	M	D/D	0.999	5.65	ANF_HUMAN	D	D	5.65	150	34	0.852	D/./D	./Nppa	./N	./6.40E-01	./88.62349611	./0.859896574	NA	./6.80239	100379251/4878	NA	./alkPathway/gcrPathway/nfatPathway	./1308.42229	137	NA	NA	NA	NA	NA	NA
chr1	11847114	rs202102042	C	T	PASS	T	downstream_gene_variant	MODIFIER	NPPA-AS1_2	ENSG00000278852	transcript	ENST00000618496.1	n.*1417C>T	NA	NA	NA	NA	NA	1417	NA	NA	NA	0.0003551	0.000399361	0.999601	2503,0	0	0.000199681	5	Atrial_standstill_2	C3810401:615745	MedGen:OMIM	NA	1	615745(3),612201(3)	NA	Atrial~standstill~2,Atrial~fibrillation~familial~6	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	607872(4)	NA	IC	NA	NA	M	D/D	0.999	5.65	ANF_HUMAN	D	D	5.65	150	34	0.852	D/./D	./Nppa	./N	./6.40E-01	./88.62349611	./0.859896574	NA	./6.80239	100379251/4878	NA	./alkPathway/gcrPathway/nfatPathway	./1308.42229	137	NA	NA	NA	NA	NA	NA
chr1	11847114	rs202102042	C	T	PASS	T	intron_variant	MODIFIER	NPPA-AS1	ENSG00000242349	transcript	ENST00000446542.5	n.782-320C>T	NA	3/3	NA	NA	NA	NA	NA	NA	NA	0.0003551	0.000399361	0.999601	2503,0	0	0.000199681	5	Atrial_standstill_2	C3810401:615745	MedGen:OMIM	NA	1	615745(3),612201(3)	NA	Atrial~standstill~2,Atrial~fibrillation~familial~6	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	607872(4)	NA	IC	NA	NA	M	D/D	0.999	5.65	ANF_HUMAN	D	D	5.65	150	34	0.852	D/./D	./Nppa	./N	./6.40E-01	./88.62349611	./0.859896574	NA	./6.80239	100379251/4878	NA	./alkPathway/gcrPathway/nfatPathway	./1308.42229	137	NA	NA	NA	NA	NA	NA
chr1	11847373	rs61757261	T	G	PASS	G	missense_variant	MODERATE	NPPA	ENSG00000175206	transcript	ENST00000610706.1	c.190A>C	p.Ser64Arg	2/4	289/849	64/152	190/459	NA	NA	NA	NA	0.001894	0.00119808	0.998802	2501,0	0	0.000599042	255	Atrial_fibrillation\x2c_familial\x2c_6	C2677294:612201	MedGen:OMIM	NA	NA	615745(3),612201(3)	NA	Atrial~standstill~2,Atrial~fibrillation~familial~6	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	607872(4)	NA	IC	NA	NA	M	N/N	0.014	3.54	ANF_HUMAN	B	B	5.84	64	0.059	1.049	T/./T	./Nppa	./N	./6.40E-01	./88.62349611	./0.859896574	NA	./6.80239	100379251/4878	NA	./alkPathway/gcrPathway/nfatPathway	./1308.42229	129	NA	NA	NA	NA	NA	NA
chr1	11847373	rs61757261	T	G	PASS	G	upstream_gene_variant	MODIFIER	NPPA-AS1_3	ENSG00000275915	transcript	ENST00000617059.1	n.-69T>G	NA	NA	NA	NA	NA	69	NA	NA	NA	0.001894	0.00119808	0.998802	2501,0	0	0.000599042	255	Atrial_fibrillation\x2c_familial\x2c_6	C2677294:612201	MedGen:OMIM	NA	NA	615745(3),612201(3)	NA	Atrial~standstill~2,Atrial~fibrillation~familial~6	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	607872(4)	NA	IC	NA	NA	M	N/N	0.014	3.54	ANF_HUMAN	B	B	5.84	64	0.059	1.049	T/./T	./Nppa	./N	./6.40E-01	./88.62349611	./0.859896574	NA	./6.80239	100379251/4878	NA	./alkPathway/gcrPathway/nfatPathway	./1308.42229	129	NA	NA	NA	NA	NA	NA
chr1	11847373	rs61757261	T	G	PASS	G	downstream_gene_variant	MODIFIER	NPPA-AS1_1	ENSG00000276470	transcript	ENST00000622391.1	n.*3389T>G	NA	NA	NA	NA	NA	3389	NA	NA	NA	0.001894	0.00119808	0.998802	2501,0	0	0.000599042	255	Atrial_fibrillation\x2c_familial\x2c_6	C2677294:612201	MedGen:OMIM	NA	NA	615745(3),612201(3)	NA	Atrial~standstill~2,Atrial~fibrillation~familial~6	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	607872(4)	NA	IC	NA	NA	M	N/N	0.014	3.54	ANF_HUMAN	B	B	5.84	64	0.059	1.049	T/./T	./Nppa	./N	./6.40E-01	./88.62349611	./0.859896574	NA	./6.80239	100379251/4878	NA	./alkPathway/gcrPathway/nfatPathway	./1308.42229	129	NA	NA	NA	NA	NA	NA
chr1	11847373	rs61757261	T	G	PASS	G	downstream_gene_variant	MODIFIER	NPPA-AS1_2	ENSG00000278852	transcript	ENST00000618496.1	n.*1676T>G	NA	NA	NA	NA	NA	1676	NA	NA	NA	0.001894	0.00119808	0.998802	2501,0	0	0.000599042	255	Atrial_fibrillation\x2c_familial\x2c_6	C2677294:612201	MedGen:OMIM	NA	NA	615745(3),612201(3)	NA	Atrial~standstill~2,Atrial~fibrillation~familial~6	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	607872(4)	NA	IC	NA	NA	M	N/N	0.014	3.54	ANF_HUMAN	B	B	5.84	64	0.059	1.049	T/./T	./Nppa	./N	./6.40E-01	./88.62349611	./0.859896574	NA	./6.80239	100379251/4878	NA	./alkPathway/gcrPathway/nfatPathway	./1308.42229	129	NA	NA	NA	NA	NA	NA
chr1	11847373	rs61757261	T	G	PASS	G	intron_variant	MODIFIER	NPPA-AS1	ENSG00000242349	transcript	ENST00000446542.5	n.782-61T>G	NA	3/3	NA	NA	NA	NA	NA	NA	NA	0.001894	0.00119808	0.998802	2501,0	0	0.000599042	255	Atrial_fibrillation\x2c_familial\x2c_6	C2677294:612201	MedGen:OMIM	NA	NA	615745(3),612201(3)	NA	Atrial~standstill~2,Atrial~fibrillation~familial~6	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	607872(4)	NA	IC	NA	NA	M	N/N	0.014	3.54	ANF_HUMAN	B	B	5.84	64	0.059	1.049	T/./T	./Nppa	./N	./6.40E-01	./88.62349611	./0.859896574	NA	./6.80239	100379251/4878	NA	./alkPathway/gcrPathway/nfatPathway	./1308.42229	129	NA	NA	NA	NA	NA	NA
chr1	11948035	rs138698098	C	T	PASS	T	missense_variant	MODERATE	PLOD1	ENSG00000083444	transcript	ENST00000196061.4	c.136C>T	p.Arg46Cys	2/19	163/2940	46/727	136/2184	NA	NA	NA	NA	4.118e-05	0.000798722	0.999201	2502,0	0	0.000399361	4	Ehlers-Danlos_syndrome\x2c_hydroxylysine-deficient	C0268342:225400:ORPHA1900:25606004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	225400(3)	NA	Ehlers-Danlos~syndrome~type~VI	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	M	D/D/D	0.978	3.85	./PLOD1_HUMAN	D/P	D	4.83	93,46	34	0.931	D	Plod1	N	3.78E-01	16.09459778	-0.657684922	abnormal	11.29956	5351	plod1a	NA	3458.35803	134	NA	NA	NA	NA	NA	PLOD1
chr1	11972977	rs121913554	C	T	PASS	T	stop_gained	HIGH	PLOD1	ENSG00000083444	transcript	ENST00000196061.4	c.2008C>T	p.Arg670*	18/19	2035/2940	670/727	2008/2184	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Ehlers-Danlos_syndrome\x2c_hydroxylysine-deficient	C0268342:225400:ORPHA1900:25606004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	225400(3)	NA	Ehlers-Danlos~syndrome~type~VI	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	D/D	0.805	3.38	NA	NA	NA	5.52	NA	41	0.011	NA	Plod1	N	3.78E-01	16.09459778	-0.657684922	abnormal	11.29956	5351	plod1a	NA	3458.35803	133	NA	NA	NA	NA	NA	PLOD1
chr1	11974699	rs557317492	C	T	PASS	T	missense_variant	MODERATE	PLOD1	ENSG00000083444	transcript	ENST00000196061.4	c.2075C>T	p.Pro692Leu	19/19	2102/2940	692/727	2075/2184	NA	NA	NA	NA	0.0005189	0.00199681	0.998003	2499,0	0	0.000998403	4|0|0	Ehlers-Danlos_syndrome\x2c_hydroxylysine-deficient|Thoracic_aortic_aneurysm_and_aortic_dissection|Ehlers-Danlos_syndrome\x2c_hydroxylysine-deficient	C0268342:225400:ORPHA1900:25606004|CN118826:ORPHA91387|C0268342:225400:ORPHA1900:25606004	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:Orphanet|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	225400(3)	NA	Ehlers-Danlos~syndrome~type~VI	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	L	D/D	0.115	5.54	./PLOD1_HUMAN	B	P/B	5.54	739,692	26.5	0.932	T	Plod1	N	3.78E-01	16.09459778	-0.657684922	abnormal	11.29956	5351	plod1a	NA	3458.35803	142	NA	NA	NA	NA	NA	PLOD1
chr1	12001476	rs41278630	G	A	PASS	A	missense_variant	MODERATE	MFN2	ENSG00000116688	transcript	ENST00000235329.9	c.892G>A	p.Gly298Arg	9/19	1214/4539	298/757	892/2274	NA	NA	NA	NA	0.002051	0.00199681	0.998003	2499,0	0	0.000998403	255|3|3|3	not_specified|Charcot-Marie-Tooth_disease\x2c_type_2|Hereditary_motor_and_sensory_neuropathy|Charcot-Marie-Tooth\x2c_Type_2	CN169374|CN043576|C0027888:ORPHA140450|CN239171	MedGen|MedGen|MedGen:Orphanet|MedGen	NA	NA	601152(3),617087(3),609260(3)	NA	Hereditary~motor~and~sensory~neuropathy~VIA,Charcot-Marie-Tooth~disease~axonal~type~2A2B,Charcot-Marie-Tooth~disease~axonal~type~2A2A	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR,AD	607872(4)	NA	IC	NA	NA	N	D/D/D	0.781	5.1	MFN2_HUMAN	B	B	5.1	298	20.3	1.045	T	Mfn2	E	1.78E-02	13.10450578	-0.773369631	abnormal	1.73324	9927	mfn2	NA	69.79508	127	NA	NA	NA	NA	NA	NA
chr1	12004010	rs12069578	G	A	PASS	A	missense_variant	MODERATE	MFN2	ENSG00000116688	transcript	ENST00000235329.9	c.1179G>A	p.Met393Ile	12/19	1501/4539	393/757	1179/2274	NA	NA	NA	NA	0.0004448	0.00279553	0.997204	2497,0	0	0.00139776	255|5	not_specified|not_provided	CN169374|CN221809	MedGen|MedGen	NA	NA	601152(3),617087(3),609260(3)	NA	Hereditary~motor~and~sensory~neuropathy~VIA,Charcot-Marie-Tooth~disease~axonal~type~2A2B,Charcot-Marie-Tooth~disease~axonal~type~2A2A	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR,AD	607872(4)	NA	IC	NA	NA	N	N/N/N	0.999	1.22	MFN2_HUMAN	B	B	5.66	393	16.82	1.032	T	Mfn2	E	1.78E-02	13.10450578	-0.773369631	abnormal	1.73324	9927	mfn2	NA	69.79508	120	NA	NA	NA	NA	NA	NA
chr1	12004835	rs138382758	G	A	PASS	A	missense_variant	MODERATE	MFN2	ENSG00000116688	transcript	ENST00000235329.9	c.1403G>A	p.Arg468His	14/19	1725/4539	468/757	1403/2274	NA	NA	NA	NA	0.002199	0.00319489	0.996406	2495,1	0.000399361	0.00199681	5|255|2|3	Charcot-Marie-Tooth_disease\x2c_type_2A2|not_specified|Charcot-Marie-Tooth_disease\x2c_type_2|Hereditary_motor_and_sensory_neuropathy	C1836485:609260:ORPHA99947|CN169374|CN043576|C0027888:ORPHA140450	MedGen:OMIM:Orphanet|MedGen|MedGen|MedGen:Orphanet	NA	NA	601152(3),617087(3),609260(3)	NA	Hereditary~motor~and~sensory~neuropathy~VIA,Charcot-Marie-Tooth~disease~axonal~type~2A2B,Charcot-Marie-Tooth~disease~axonal~type~2A2A	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR,AD	607872(4)	NA	IC	NA	NA	M	A/A/A	0.978	5.79	MFN2_HUMAN	B	P	5.79	468	27.6	1.045	T	Mfn2	E	1.78E-02	13.10450578	-0.773369631	abnormal	1.73324	9927	mfn2	NA	69.79508	134	NA	NA	NA	NA	NA	NA
chr1	12004884	rs150043585	G	A	PASS	A	synonymous_variant	LOW	MFN2	ENSG00000116688	transcript	ENST00000235329.9	c.1452G>A	p.Thr484Thr	14/19	1774/4539	484/757	1452/2274	NA	NA	NA	NA	0.0007742	0.00119808	0.998802	2501,0	0	0.000599042	255|3|3|3	not_specified|Charcot-Marie-Tooth_disease\x2c_type_2|Charcot-Marie-Tooth\x2c_Type_2|Hereditary_motor_and_sensory_neuropathy	CN169374|CN043576|CN239171|C0027888:ORPHA140450	MedGen|MedGen|MedGen|MedGen:Orphanet	NA	NA	601152(3),617087(3),609260(3)	NA	Hereditary~motor~and~sensory~neuropathy~VIA,Charcot-Marie-Tooth~disease~axonal~type~2A2B,Charcot-Marie-Tooth~disease~axonal~type~2A2A	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR,AD	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mfn2	E	1.78E-02	13.10450578	-0.773369631	abnormal	1.73324	9927	mfn2	NA	69.79508	134	NA	NA	NA	NA	NA	NA
chr1	12009641	rs119103267	C	T	PASS	T	missense_variant	MODERATE	MFN2	ENSG00000116688	transcript	ENST00000235329.9	c.2119C>T	p.Arg707Trp	18/19	2441/4539	707/757	2119/2274	NA	NA	NA	NA	0.0003295	0.000399361	0.999601	2503,0	0	0.000199681	5|4|5	CHARCOT-MARIE-TOOTH_DISEASE\x2c_AXONAL\x2c_AUTOSOMAL_RECESSIVE\x2c_TYPE_2A2B|not_provided|Charcot-Marie-Tooth_disease\x2c_type_2A2	CN238096:617087|CN221809|C1836485:609260:ORPHA99947	MedGen:OMIM|MedGen|MedGen:OMIM:Orphanet	NA	NA	601152(3),617087(3),609260(3)	NA	Hereditary~motor~and~sensory~neuropathy~VIA,Charcot-Marie-Tooth~disease~axonal~type~2A2B,Charcot-Marie-Tooth~disease~axonal~type~2A2A	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR,AD	607872(4)	NA	IC	NA	NA	L	A/A/A	0.93	4.36	MFN2_HUMAN	D	D	5.28	707	35	0.038	D	Mfn2	E	1.78E-02	13.10450578	-0.773369631	abnormal	1.73324	9927	mfn2	NA	69.79508	132	NA	NA	NA	NA	NA	NA
chr1	15440577	rs515726209	G	A	PASS	A	missense_variant	MODERATE	CTRC	ENSG00000162438	transcript	ENST00000375949.4	c.217G>A	p.Ala73Thr	3/8	243/898	73/268	217/807	NA	NA	NA	NA	0.0007083	0.00159744	0.998403	2500,0	0	0.000798722	5	Hereditary_pancreatitis	C0238339:167800:ORPHA676:68072000	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	AD	NA	NA	NA	NA	NA	167800(3)	NA	607872(4)	NA	IC	NA	{Pancreatitis~chronic~susceptibility~to}	H	D/D	0.887	5.05	./CTRC_HUMAN	D	D	5.05	73	32	1.047	D	Ctrc	NA	2.80E-01	55.21939137	0.016664174	NA	2.62957	11330	NA	NA	145.59143	141	NA	NA	NA	NA	NA	NA
chr1	15445717	rs121909293	C	T	PASS	T	missense_variant	MODERATE	CTRC	ENSG00000162438	transcript	ENST00000375949.4	c.760C>T	p.Arg254Trp	7/8	786/898	254/268	760/807	NA	NA	NA	NA	0.003995	0.00319489	0.996805	2496,0	0	0.00159744	255|255	Pancreatitis\x2c_chronic\x2c_susceptibility_to|Hereditary_pancreatitis	C1969419|C0238339:167800:ORPHA676:68072000	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	1	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	AD	NA	NA	NA	NA	NA	167800(3)	NA	607872(4)	NA	IC	NA	{Pancreatitis~chronic~susceptibility~to}	M	D/D	0.929	4.68	CTRC_HUMAN	D	D	4.68	254	35	0.935	D	Ctrc	NA	2.80E-01	55.21939137	0.016664174	NA	2.62957	11330	NA	NA	145.59143	133	NA	NA	NA	NA	NA	NA
chr1	16048537	rs121909132	G	A	VQSRTrancheSNP99.80to100.00	A	missense_variant	MODERATE	CLCNKB	ENSG00000184908	transcript	ENST00000375679.8	c.610G>A	p.Ala204Thr	7/20	721/2567	204/687	610/2064	NA	NA	NA	NA	7.422e-05	0.000798722	0.999201	2502,0	0	0.000399361	5	Bartter_syndrome_type_3	C1846343:607364:ORPHA93605	MedGen:OMIM:Orphanet	NA	1	613090(3),607364(3)	NA	Bartter~syndrome~type~4b~digenic,Bartter~syndrome~type~3	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	DR,AR	607872(4)	NA	IC	NA	NA	M	A	0.11	4.68	CLCKB_HUMAN	D	D	4.68	204	26.4	0.93	D	Clcnka	NA	1.20E-01	85.30313753	0.698081425	NA	6.22752	1188	NA	NA	1051.72265	133	NA	NA	NA	NA	NA	NA
chr1	16132227	rs116506614	C	T	PASS	T	structural_interaction_variant	HIGH	EPHA2	ENSG00000142627	interaction	1MQB:B_721-B_872:ENST00000358432	c.2162G>A	NA	13/17	NA	NA	NA	NA	NA	NA	NA	0.000593	0.000399361	0.999601	2503,0	0	0.000199681	5|3	Cataract_6\x2c_age-related_cortical|Age-related_cortical_cataract	C4016349|HP:0011143:CN116874	MedGen|Human_Phenotype_Ontology:MedGen	NA	NA	116600(3)	NA	Cataract~6~multiple~types	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	L	A	0.938	6.07	EPHA2_HUMAN	P	D	6.07	721	35	0.935	T	Epha2	N	4.73E-01	16.82000472	-0.628385276	NA	4.16611	1969	NA	NA	391.87029	133	NA	NA	NA	NA	NA	NA
chr1	16132227	rs116506614	C	T	PASS	T	structural_interaction_variant	HIGH	EPHA2	ENSG00000142627	interaction	4P2K:A_721-A_872:ENST00000358432	c.2162G>A	NA	13/17	NA	NA	NA	NA	NA	NA	NA	0.000593	0.000399361	0.999601	2503,0	0	0.000199681	5|3	Cataract_6\x2c_age-related_cortical|Age-related_cortical_cataract	C4016349|HP:0011143:CN116874	MedGen|Human_Phenotype_Ontology:MedGen	NA	NA	116600(3)	NA	Cataract~6~multiple~types	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	L	A	0.938	6.07	EPHA2_HUMAN	P	D	6.07	721	35	0.935	T	Epha2	N	4.73E-01	16.82000472	-0.628385276	NA	4.16611	1969	NA	NA	391.87029	133	NA	NA	NA	NA	NA	NA
chr1	16132227	rs116506614	C	T	PASS	T	structural_interaction_variant	HIGH	EPHA2	ENSG00000142627	interaction	4PDO:A_721-A_872:ENST00000358432	c.2162G>A	NA	13/17	NA	NA	NA	NA	NA	NA	NA	0.000593	0.000399361	0.999601	2503,0	0	0.000199681	5|3	Cataract_6\x2c_age-related_cortical|Age-related_cortical_cataract	C4016349|HP:0011143:CN116874	MedGen|Human_Phenotype_Ontology:MedGen	NA	NA	116600(3)	NA	Cataract~6~multiple~types	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	L	A	0.938	6.07	EPHA2_HUMAN	P	D	6.07	721	35	0.935	T	Epha2	N	4.73E-01	16.82000472	-0.628385276	NA	4.16611	1969	NA	NA	391.87029	133	NA	NA	NA	NA	NA	NA
chr1	16132227	rs116506614	C	T	PASS	T	structural_interaction_variant	HIGH	EPHA2	ENSG00000142627	interaction	4PDO:B_721-B_872:ENST00000358432	c.2162G>A	NA	13/17	NA	NA	NA	NA	NA	NA	NA	0.000593	0.000399361	0.999601	2503,0	0	0.000199681	5|3	Cataract_6\x2c_age-related_cortical|Age-related_cortical_cataract	C4016349|HP:0011143:CN116874	MedGen|Human_Phenotype_Ontology:MedGen	NA	NA	116600(3)	NA	Cataract~6~multiple~types	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	L	A	0.938	6.07	EPHA2_HUMAN	P	D	6.07	721	35	0.935	T	Epha2	N	4.73E-01	16.82000472	-0.628385276	NA	4.16611	1969	NA	NA	391.87029	133	NA	NA	NA	NA	NA	NA
chr1	16132227	rs116506614	C	T	PASS	T	structural_interaction_variant	HIGH	EPHA2	ENSG00000142627	interaction	4TRL:A_721-A_872:ENST00000358432	c.2162G>A	NA	13/17	NA	NA	NA	NA	NA	NA	NA	0.000593	0.000399361	0.999601	2503,0	0	0.000199681	5|3	Cataract_6\x2c_age-related_cortical|Age-related_cortical_cataract	C4016349|HP:0011143:CN116874	MedGen|Human_Phenotype_Ontology:MedGen	NA	NA	116600(3)	NA	Cataract~6~multiple~types	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	L	A	0.938	6.07	EPHA2_HUMAN	P	D	6.07	721	35	0.935	T	Epha2	N	4.73E-01	16.82000472	-0.628385276	NA	4.16611	1969	NA	NA	391.87029	133	NA	NA	NA	NA	NA	NA
chr1	16132227	rs116506614	C	T	PASS	T	missense_variant	MODERATE	EPHA2	ENSG00000142627	transcript	ENST00000358432.7	c.2162G>A	p.Arg721Gln	13/17	2317/3964	721/976	2162/2931	NA	NA	NA	NA	0.000593	0.000399361	0.999601	2503,0	0	0.000199681	5|3	Cataract_6\x2c_age-related_cortical|Age-related_cortical_cataract	C4016349|HP:0011143:CN116874	MedGen|Human_Phenotype_Ontology:MedGen	NA	NA	116600(3)	NA	Cataract~6~multiple~types	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	607872(4)	NA	IC	NA	NA	L	A	0.938	6.07	EPHA2_HUMAN	P	D	6.07	721	35	0.935	T	Epha2	N	4.73E-01	16.82000472	-0.628385276	NA	4.16611	1969	NA	NA	391.87029	133	NA	NA	NA	NA	NA	NA
chr1	16986334	rs151181674	C	T	PASS	T	missense_variant	MODERATE	ATP13A2	ENSG00000159363	transcript	ENST00000326735.12	c.3430G>A	p.Ala1144Thr	29/29	3464/3840	1144/1180	3430/3543	NA	NA	NA	NA	0.001191	0.0147764	0.984425	2465,2	0.000798722	0.0081869	255	not_specified	CN169374	MedGen	NA	NA	617225(3),606693(3)	NA	Spastic~paraplegia~78~autosomal~recessive,Kufor-Rakeb~syndrome	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	L	N/N/N	0.771	2.49	./AT132_HUMAN	B	B	4.61	1139,1144	18.41	0.796	T	Atp13a2	NA	2.89E-02	6.098136353	-1.159397299	abnormal	3.07383	23400	atp13a2	NA	202.72703	134	NA	NA	NA	NA	NA	NA
chr1	16986334	rs151181674	C	T	PASS	T	intron_variant	MODIFIER	RP1-37C10.3	ENSG00000226526	transcript	ENST00000446261.1	n.187+7222C>T	NA	1/1	NA	NA	NA	NA	NA	NA	NA	0.001191	0.0147764	0.984425	2465,2	0.000798722	0.0081869	255	not_specified	CN169374	MedGen	NA	NA	617225(3),606693(3)	NA	Spastic~paraplegia~78~autosomal~recessive,Kufor-Rakeb~syndrome	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	L	N/N/N	0.771	2.49	./AT132_HUMAN	B	B	4.61	1139,1144	18.41	0.796	T	Atp13a2	NA	2.89E-02	6.098136353	-1.159397299	abnormal	3.07383	23400	atp13a2	NA	202.72703	134	NA	NA	NA	NA	NA	NA
chr1	16988138	rs144557304	C	T	PASS	T	splice_region_variant&synonymous_variant	LOW	ATP13A2	ENSG00000159363	transcript	ENST00000326735.12	c.2859G>A	p.Thr953Thr	25/29	2893/3840	953/1180	2859/3543	NA	NA	NA	NA	0.001071	0.000798722	0.999201	2502,0	0	0.000399361	255|0	not_specified|Parkinson_disease_9	CN169374|C1847640:606693:ORPHA306674	MedGen|MedGen:OMIM:Orphanet	NA	NA	617225(3),606693(3)	NA	Spastic~paraplegia~78~autosomal~recessive,Kufor-Rakeb~syndrome	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Atp13a2	NA	2.89E-02	6.098136353	-1.159397299	abnormal	3.07383	23400	atp13a2	NA	202.72703	134	NA	NA	NA	NA	NA	NA
chr1	16988138	rs144557304	C	T	PASS	T	intron_variant	MODIFIER	RP1-37C10.3	ENSG00000226526	transcript	ENST00000446261.1	n.187+9026C>T	NA	1/1	NA	NA	NA	NA	NA	NA	NA	0.001071	0.000798722	0.999201	2502,0	0	0.000399361	255|0	not_specified|Parkinson_disease_9	CN169374|C1847640:606693:ORPHA306674	MedGen|MedGen:OMIM:Orphanet	NA	NA	617225(3),606693(3)	NA	Spastic~paraplegia~78~autosomal~recessive,Kufor-Rakeb~syndrome	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Atp13a2	NA	2.89E-02	6.098136353	-1.159397299	abnormal	3.07383	23400	atp13a2	NA	202.72703	134	NA	NA	NA	NA	NA	NA
chr1	17005530	rs200816691	T	C	PASS	C	synonymous_variant	LOW	ATP13A2	ENSG00000159363	transcript	ENST00000326735.12	c.132A>G	p.Pro44Pro	3/29	166/3840	44/1180	132/3543	NA	NA	NA	NA	0.004266	0.00119808	0.998802	2501,0	0	0.000599042	255	not_specified	CN169374	MedGen	NA	NA	617225(3),606693(3)	NA	Spastic~paraplegia~78~autosomal~recessive,Kufor-Rakeb~syndrome	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Atp13a2	NA	2.89E-02	6.098136353	-1.159397299	abnormal	3.07383	23400	atp13a2	NA	202.72703	137	NA	NA	NA	NA	NA	NA
chr1	17005530	rs200816691	T	C	PASS	C	downstream_gene_variant	MODIFIER	RP1-37C10.3	ENSG00000226526	transcript	ENST00000446261.1	n.*439T>C	NA	NA	NA	NA	NA	439	NA	NA	NA	0.004266	0.00119808	0.998802	2501,0	0	0.000599042	255	not_specified	CN169374	MedGen	NA	NA	617225(3),606693(3)	NA	Spastic~paraplegia~78~autosomal~recessive,Kufor-Rakeb~syndrome	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Atp13a2	NA	2.89E-02	6.098136353	-1.159397299	abnormal	3.07383	23400	atp13a2	NA	202.72703	137	NA	NA	NA	NA	NA	NA
chr1	17022685	rs138996609	G	A	PASS	A	missense_variant	MODERATE	SDHB	ENSG00000117118	transcript	ENST00000375499.7	c.688C>T	p.Arg230Cys	7/8	839/1153	230/280	688/843	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Hereditary_cancer-predisposing_syndrome	C0027672:699346009	MedGen:SNOMED_CT	NA	3	171300(3),115310(3),606864(3),606764(3),612359(3)	NA	Pheochromocytoma,Paragangliomas~4,Paraganglioma~and~gastric~stromal~sarcoma,Gastrointestinal~stromal~tumor,Cowden~syndrome~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-,AD/IC,AD	607872(4)	NA	IC	NA	NA	H	D	1	5.51	DHSB_HUMAN	D	D	5.51	230	35	1.048	D	Sdhb	NA	1.40E-01	80.73248408	0.527368849	NA	2.67455	6390	NA	etcPathway	150.23642	134	NA	SDHB	KP_EP	AD	185470	NA
chr1	17027802	rs33927012	A	G	PASS	G	missense_variant	MODERATE	SDHB	ENSG00000117118	transcript	ENST00000375499.7	c.487T>C	p.Ser163Pro	5/8	638/1153	163/280	487/843	NA	NA	NA	NA	0.013	0.01877	0.98123	2457,0	0	0.00938498	5|1|255|2|2|2|2|2|2|3	Cowden_syndrome_2|Hereditary_Paraganglioma-Pheochromocytoma_Syndromes|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome|Paragangliomas_4|Gastrointestinal_stromal_tumor|Paragangliomas_4|Pheochromocytoma|Pheochromocytoma	C3552552:612359|C1708353:ORPHA29072|CN221809|CN169374|C0027672:699346009|C1861848:115310|C0238198:606764:ORPHA44890|C1861848:115310|C0031511:171300|C0031511:171300	MedGen:OMIM|MedGen:Orphanet|MedGen|MedGen|MedGen:SNOMED_CT|MedGen:OMIM|MedGen:OMIM:Orphanet|MedGen:OMIM|MedGen:OMIM|MedGen:OMIM	NA	2	171300(3),115310(3),606864(3),606764(3),612359(3)	NA	Pheochromocytoma,Paragangliomas~4,Paraganglioma~and~gastric~stromal~sarcoma,Gastrointestinal~stromal~tumor,Cowden~syndrome~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-,AD/IC,AD	607872(4)	NA	IC	NA	NA	N	A	0.981	5.89	DHSB_HUMAN	B	B	5.89	163	14.04	1.199	T/./.	Sdhb	NA	1.40E-01	80.73248408	0.527368849	NA	2.67455	6390	NA	etcPathway	150.23642	126	NA	SDHB	KP_EP	AD	185470	NA
chr1	17027878	rs386134266	G	GGAA	PASS	GGAA	intron_variant	MODIFIER	SDHB	ENSG00000117118	transcript	ENST00000375499.7	c.424-16_424-14dupTTC	NA	4/7	NA	NA	NA	NA	NA	NA	NA	0.001095	NA	NA	NA	NA	NA	255|0|0,2|2	not_specified|Pheochromocytoma|Paraganglioma_and_gastric_stromal_sarcoma,Pheochromocytoma|not_specified	CN169374|C0031511:171300|C1847319:606864:ORPHA97286,C0031511:171300|CN169374	MedGen|MedGen:OMIM|MedGen:OMIM:Orphanet,MedGen:OMIM|MedGen	NA	NA	171300(3),115310(3),606864(3),606764(3),612359(3)	NA	Pheochromocytoma,Paragangliomas~4,Paraganglioma~and~gastric~stromal~sarcoma,Gastrointestinal~stromal~tumor,Cowden~syndrome~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-,AD/IC,AD	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sdhb	NA	1.40E-01	80.73248408	0.527368849	NA	2.67455	6390	NA	etcPathway	150.23642	136	AAGn|Simple_repeat|Simple_repeat	SDHB	KP_EP	AD	185470	NA
chr1	17027878	rs386134266	G	GGAAGAA	PASS	GGAAGAA	intron_variant	MODIFIER	SDHB	ENSG00000117118	transcript	ENST00000375499.7	c.424-19_424-14dupTTCTTC	NA	4/7	NA	NA	NA	NA	NA	NA	NA	0.003937	NA	NA	NA	NA	NA	255|0|0,2|2	not_specified|Pheochromocytoma|Paraganglioma_and_gastric_stromal_sarcoma,Pheochromocytoma|not_specified	CN169374|C0031511:171300|C1847319:606864:ORPHA97286,C0031511:171300|CN169374	MedGen|MedGen:OMIM|MedGen:OMIM:Orphanet,MedGen:OMIM|MedGen	NA	NA	171300(3),115310(3),606864(3),606764(3),612359(3)	NA	Pheochromocytoma,Paragangliomas~4,Paraganglioma~and~gastric~stromal~sarcoma,Gastrointestinal~stromal~tumor,Cowden~syndrome~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-,AD/IC,AD	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sdhb	NA	1.40E-01	80.73248408	0.527368849	NA	2.67455	6390	NA	etcPathway	150.23642	136	AAGn|Simple_repeat|Simple_repeat	SDHB	KP_EP	AD	185470	NA
chr1	17027878	rs386134266	G	GGAAGAAGAA	PASS	GGAAGAAGAA	intron_variant	MODIFIER	SDHB	ENSG00000117118	transcript	ENST00000375499.7	c.424-22_424-14dupTTCTTCTTC	NA	4/7	NA	NA	NA	NA	NA	NA	NA	6.589e-05	NA	NA	NA	NA	NA	255|0|0,2|2	not_specified|Pheochromocytoma|Paraganglioma_and_gastric_stromal_sarcoma,Pheochromocytoma|not_specified	CN169374|C0031511:171300|C1847319:606864:ORPHA97286,C0031511:171300|CN169374	MedGen|MedGen:OMIM|MedGen:OMIM:Orphanet,MedGen:OMIM|MedGen	NA	NA	171300(3),115310(3),606864(3),606764(3),612359(3)	NA	Pheochromocytoma,Paragangliomas~4,Paraganglioma~and~gastric~stromal~sarcoma,Gastrointestinal~stromal~tumor,Cowden~syndrome~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-,AD/IC,AD	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sdhb	NA	1.40E-01	80.73248408	0.527368849	NA	2.67455	6390	NA	etcPathway	150.23642	136	AAGn|Simple_repeat|Simple_repeat	SDHB	KP_EP	AD	185470	NA
chr1	17028580	rs190139590	A	T	PASS	T	intron_variant	MODIFIER	SDHB	ENSG00000117118	transcript	ENST00000375499.7	c.423+20T>A	NA	4/7	NA	NA	NA	NA	NA	NA	NA	0.003081	0.00239617	0.997604	2498,0	0	0.00119808	4|255|2|2|2	Pheochromocytoma|not_specified|Gastrointestinal_stromal_tumor|Paragangliomas_4|Pheochromocytoma	C0031511:171300|CN169374|C0238198:606764:ORPHA44890|C1861848:115310|C0031511:171300	MedGen:OMIM|MedGen|MedGen:OMIM:Orphanet|MedGen:OMIM|MedGen:OMIM	NA	NA	171300(3),115310(3),606864(3),606764(3),612359(3)	NA	Pheochromocytoma,Paragangliomas~4,Paraganglioma~and~gastric~stromal~sarcoma,Gastrointestinal~stromal~tumor,Cowden~syndrome~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-,AD/IC,AD	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sdhb	NA	1.40E-01	80.73248408	0.527368849	NA	2.67455	6390	NA	etcPathway	150.23642	135	NA	SDHB	KP_EP	AD	185470	NA
chr1	17033077	rs570278423	C	T	PASS	T	missense_variant	MODERATE	SDHB	ENSG00000117118	transcript	ENST00000375499.7	c.269G>A	p.Arg90Gln	3/8	420/1153	90/280	269/843	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	4	not_provided	CN221809	MedGen	NA	NA	171300(3),115310(3),606864(3),606764(3),612359(3)	NA	Pheochromocytoma,Paragangliomas~4,Paraganglioma~and~gastric~stromal~sarcoma,Gastrointestinal~stromal~tumor,Cowden~syndrome~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-,AD/IC,AD	607872(4)	NA	IC	NA	NA	H	D	0.999	5.65	DHSB_HUMAN	D	D	5.65	90	35	0.935	D/./.	Sdhb	NA	1.40E-01	80.73248408	0.527368849	NA	2.67455	6390	NA	etcPathway	150.23642	142	NA	SDHB	KP_EP	AD	185470	NA
chr1	17033078	rs74315366	G	A	PASS	A	stop_gained	HIGH	SDHB	ENSG00000117118	transcript	ENST00000375499.7	c.268C>T	p.Arg90*	3/8	419/1153	90/280	268/843	NA	NA	(SDHB|ENSG00000117118|1|1.00)	(SDHB|ENSG00000117118|1|1.00)	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5|5|5|5,0	Paragangliomas_4|Hereditary_Paraganglioma-Pheochromocytoma_Syndromes|Pheochromocytoma|Hereditary_Paraganglioma-Pheochromocytoma_Syndromes|not_provided|Hereditary_cancer-predisposing_syndrome,Hereditary_cancer-predisposing_syndrome	C1861848:115310|C1708353:ORPHA29072|C0031511:171300|C1708353:ORPHA29072|CN221809|C0027672:699346009,C0027672:699346009	MedGen:OMIM|MedGen:Orphanet|MedGen:OMIM|MedGen:Orphanet|MedGen|MedGen:SNOMED_CT,MedGen:SNOMED_CT	NA	NA	171300(3),115310(3),606864(3),606764(3),612359(3)	NA	Pheochromocytoma,Paragangliomas~4,Paraganglioma~and~gastric~stromal~sarcoma,Gastrointestinal~stromal~tumor,Cowden~syndrome~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-,AD/IC,AD	607872(4)	NA	IC	NA	NA	NA	A	0.998	4.74	NA	NA	NA	5.65	NA	40	0.136	NA	Sdhb	NA	1.40E-01	80.73248408	0.527368849	NA	2.67455	6390	NA	etcPathway	150.23642	133	NA	SDHB	KP_EP	AD	185470	NA
chr1	17053988	rs111430410	C	T	PASS	T	missense_variant	MODERATE	SDHB	ENSG00000117118	transcript	ENST00000375499.7	c.32G>A	p.Arg11His	1/8	183/1153	11/280	32/843	NA	NA	NA	NA	0.0004452	0.00279553	0.997204	2497,0	0	0.00139776	4|0|3|3|3	Pheochromocytoma|Renal_cell_carcinoma|Gastrointestinal_stromal_tumor|Paragangliomas_4|Pheochromocytoma	C0031511:171300|D002292:CN182935|C0238198:606764:ORPHA44890|C1861848:115310|C0031511:171300	MedGen:OMIM|MeSH:MedGen|MedGen:OMIM:Orphanet|MedGen:OMIM|MedGen:OMIM	NA	NA	171300(3),115310(3),606864(3),606764(3),612359(3)	NA	Pheochromocytoma,Paragangliomas~4,Paraganglioma~and~gastric~stromal~sarcoma,Gastrointestinal~stromal~tumor,Cowden~syndrome~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-,AD/IC,AD	607872(4)	NA	IC	NA	NA	L	D	0.083	4.19	DHSB_HUMAN	B	P	5.11	11	22.5	0.044	T	Sdhb	NA	1.40E-01	80.73248408	0.527368849	NA	2.67455	6390	NA	etcPathway	150.23642	132	NA	SDHB	KP_EP	AD	185470	NA
chr1	17053996	rs148738139	G	A	PASS	A	synonymous_variant	LOW	SDHB	ENSG00000117118	transcript	ENST00000375499.7	c.24C>T	p.Ser8Ser	1/8	175/1153	8/280	24/843	NA	NA	NA	NA	0.004132	0.00239617	0.997604	2498,0	0	0.00119808	3|255|2|2|2|3|3	Hereditary_cancer-predisposing_syndrome|not_specified|Gastrointestinal_stromal_tumor|Paragangliomas_4|Pheochromocytoma|Pheochromocytoma|Paraganglioma_and_gastric_stromal_sarcoma	C0027672:699346009|CN169374|C0238198:606764:ORPHA44890|C1861848:115310|C0031511:171300|C0031511:171300|C1847319:606864:ORPHA97286	MedGen:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MedGen:OMIM|MedGen:OMIM|MedGen:OMIM|MedGen:OMIM:Orphanet	NA	1	171300(3),115310(3),606864(3),606764(3),612359(3)	NA	Pheochromocytoma,Paragangliomas~4,Paraganglioma~and~gastric~stromal~sarcoma,Gastrointestinal~stromal~tumor,Cowden~syndrome~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-,AD/IC,AD	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sdhb	NA	1.40E-01	80.73248408	0.527368849	NA	2.67455	6390	NA	etcPathway	150.23642	134	NA	SDHB	KP_EP	AD	185470	NA
chr1	17054012	rs11203289	G	C	PASS	C	missense_variant	MODERATE	SDHB	ENSG00000117118	transcript	ENST00000375499.7	c.8C>G	p.Ala3Gly	1/8	159/1153	3/280	8/843	NA	NA	NA	NA	0.003816	0.0267572	0.973243	2437,0	0	0.0133786	5|0|1|2|2|2|2|3|3	Cowden_syndrome_2|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome|Gastrointestinal_stromal_tumor|Paragangliomas_4|Pheochromocytoma|Pheochromocytoma|Paraganglioma_and_gastric_stromal_sarcoma	C3552552:612359|CN221809|CN169374|C0027672:699346009|C0238198:606764:ORPHA44890|C1861848:115310|C0031511:171300|C0031511:171300|C1847319:606864:ORPHA97286	MedGen:OMIM|MedGen|MedGen|MedGen:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM|MedGen:OMIM|MedGen:OMIM|MedGen:OMIM:Orphanet	NA	NA	171300(3),115310(3),606864(3),606764(3),612359(3)	NA	Pheochromocytoma,Paragangliomas~4,Paraganglioma~and~gastric~stromal~sarcoma,Gastrointestinal~stromal~tumor,Cowden~syndrome~2	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-,AD/IC,AD	607872(4)	NA	IC	NA	NA	L	A	0.948	4.33	DHSB_HUMAN	B	B	5.24	3	22.7	1.03	D	Sdhb	NA	1.40E-01	80.73248408	0.527368849	NA	2.67455	6390	NA	etcPathway	150.23642	120	NA	SDHB	KP_EP	AD	185470	NA
chr1	17697186	rs149908903	G	T	PASS	T	missense_variant	MODERATE	ARHGEF10L	ENSG00000074964	transcript	ENST00000361221.7	c.3646G>T	p.Asp1216Tyr	29/29	3805/4488	1216/1279	3646/3840	NA	NA	NA	NA	5.814e-05	0.000798722	0.999201	2502,0	0	0.000399361	4	Cerebral_visual_impairment_and_intellectual_disability	CN235864	MedGen	NA	NA	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	607872(4)	NA	IC	NA	NA	M	D/D/D/D/D	0.995	4.89	./././././ARGAL_HUMAN	D	D	4.89	989,919,977,1172,1177,1216	32	0.949	D	Arhgef10l	NA	5.69E-01	13.4524652	-0.755258792	NA	5.42207	55160	NA	NA	746.76247	134	NA	NA	NA	NA	NA	NA
chr1	20086199	rs200954922	C	T	PASS	T	stop_gained	HIGH	PLA2G5	ENSG00000127472	transcript	ENST00000375108.3	c.157C>T	p.Arg53*	3/5	425/1161	53/138	157/417	NA	NA	(PLA2G5|ENSG00000127472|1|1.00)	(PLA2G5|ENSG00000127472|1|1.00)	3.295e-05	0.000399361	0.999601	2503,0	0	0.000199681	255	Fleck_retina\x2c_familial_benign	C1856718:228980:ORPHA363989	MedGen:OMIM:Orphanet	NA	NA	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	NA	NA	228980(3)	NA	[Fleck~retina~familial~benign]	AR	NA	NA	607872(4)	NA	IC	NA	NA	NA	A	0.319	1.79	NA	NA	NA	5.26	NA	35	0.935	NA	Pla2g5	N	5.88E-01	31.45789101	-0.317668748	NA	0.82614	5322	NA	NA	25.27033	137	NA	NA	NA	NA	NA	NA
chr1	20639952	rs74315357	C	A	PASS	A	synonymous_variant	LOW	PINK1	ENSG00000158828	transcript	ENST00000321556.4	c.736C>A	p.Arg246Arg	3/8	830/2660	246/581	736/1746	NA	NA	NA	NA	4.118e-05	NA	NA	NA	NA	NA	5	Parkinson_disease_6\x2c_autosomal_recessive_early-onset	C1853833:605909	MedGen:OMIM	NA	NA	605909(3)	NA	Parkinson~disease~6~early~onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pink1	N	7.88E-01	23.62585515	-0.462894052	abnormal	10.22981	65018	pink1	NA	2907.56994	132	NA	NA	NA	NA	NA	NA
chr1	20639952	rs74315357	C	A	PASS	A	downstream_gene_variant	MODIFIER	PINK1-AS	ENSG00000117242	transcript	ENST00000451424.1	n.*2705G>T	NA	NA	NA	NA	NA	2705	NA	NA	NA	4.118e-05	NA	NA	NA	NA	NA	5	Parkinson_disease_6\x2c_autosomal_recessive_early-onset	C1853833:605909	MedGen:OMIM	NA	NA	605909(3)	NA	Parkinson~disease~6~early~onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pink1	N	7.88E-01	23.62585515	-0.462894052	abnormal	10.22981	65018	pink1	NA	2907.56994	132	NA	NA	NA	NA	NA	NA
chr1	20644651	rs74315359	C	T	PASS	T	missense_variant	MODERATE	PINK1	ENSG00000158828	transcript	ENST00000321556.4	c.938C>T	p.Thr313Met	4/8	1032/2660	313/581	938/1746	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Parkinson_disease_6\x2c_autosomal_recessive_early-onset	C1853833:605909	MedGen:OMIM	NA	NA	605909(3)	NA	Parkinson~disease~6~early~onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	M	A	0.926	6.07	PINK1_HUMAN	D	D	6.07	313	34	0.935	D	./Pink1	./N	./7.88E-01	./23.62585515	-0.462894052/.	./abnormal	./10.22981	100861548/65018	./pink1	NA	./2907.56994	132	NA	NA	NA	NA	NA	NA
chr1	20644651	rs74315359	C	T	PASS	T	intron_variant	MODIFIER	PINK1-AS	ENSG00000117242	transcript	ENST00000451424.1	n.3981+934G>A	NA	2/2	NA	NA	NA	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Parkinson_disease_6\x2c_autosomal_recessive_early-onset	C1853833:605909	MedGen:OMIM	NA	NA	605909(3)	NA	Parkinson~disease~6~early~onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	M	A	0.926	6.07	PINK1_HUMAN	D	D	6.07	313	34	0.935	D	./Pink1	./N	./7.88E-01	./23.62585515	-0.462894052/.	./abnormal	./10.22981	100861548/65018	./pink1	NA	./2907.56994	132	NA	NA	NA	NA	NA	NA
chr1	20648577	rs119451946	C	T	PASS	T	missense_variant	MODERATE	PINK1	ENSG00000158828	transcript	ENST00000321556.4	c.1196C>T	p.Pro399Leu	6/8	1290/2660	399/581	1196/1746	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5|0	Parkinson_disease\x2c_autosomal_recessive_early-onset\x2c_digenic\x2c_PINK1/DJ1|Parkinson_Disease\x2c_Recessive	C2751533|CN239372	MedGen|MedGen	NA	NA	605909(3)	NA	Parkinson~disease~6~early~onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	M	A	0.992	6.17	./PINK1_HUMAN	D	D	6.17	92,399	35	0.935	D	./Pink1	./N	./7.88E-01	./23.62585515	-0.462894052/.	./abnormal	./10.22981	100861548/65018	./pink1	NA	./2907.56994	132	NA	NA	NA	NA	NA	NA
chr1	20648577	rs119451946	C	T	PASS	T	downstream_gene_variant	MODIFIER	DDOST	ENSG00000244038	transcript	ENST00000375048.7	c.*3802G>A	NA	NA	NA	NA	NA	3200	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5|0	Parkinson_disease\x2c_autosomal_recessive_early-onset\x2c_digenic\x2c_PINK1/DJ1|Parkinson_Disease\x2c_Recessive	C2751533|CN239372	MedGen|MedGen	NA	NA	605909(3)	NA	Parkinson~disease~6~early~onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	M	A	0.992	6.17	./PINK1_HUMAN	D	D	6.17	92,399	35	0.935	D	./Pink1	./N	./7.88E-01	./23.62585515	-0.462894052/.	./abnormal	./10.22981	100861548/65018	./pink1	NA	./2907.56994	132	NA	NA	NA	NA	NA	NA
chr1	20648577	rs119451946	C	T	PASS	T	non_coding_transcript_exon_variant	MODIFIER	PINK1-AS	ENSG00000117242	transcript	ENST00000451424.1	n.3617G>A	NA	1/3	NA	NA	NA	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5|0	Parkinson_disease\x2c_autosomal_recessive_early-onset\x2c_digenic\x2c_PINK1/DJ1|Parkinson_Disease\x2c_Recessive	C2751533|CN239372	MedGen|MedGen	NA	NA	605909(3)	NA	Parkinson~disease~6~early~onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	M	A	0.992	6.17	./PINK1_HUMAN	D	D	6.17	92,399	35	0.935	D	./Pink1	./N	./7.88E-01	./23.62585515	-0.462894052/.	./abnormal	./10.22981	100861548/65018	./pink1	NA	./2907.56994	132	NA	NA	NA	NA	NA	NA
chr1	20649109	rs45539432	C	T	PASS	T	stop_gained	HIGH	PINK1	ENSG00000158828	transcript	ENST00000321556.4	c.1366C>T	p.Gln456*	7/8	1460/2660	456/581	1366/1746	NA	NA	(PINK1|ENSG00000158828|1|1.00)	(PINK1|ENSG00000158828|1|1.00)	2.471e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Parkinson_disease_6\x2c_autosomal_recessive_early-onset	C1853833:605909	MedGen:OMIM	NA	NA	605909(3)	NA	Parkinson~disease~6~early~onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	A	0.955	5.13	NA	NA	NA	6.05	NA	40	0.935	NA	./Pink1	./N	./7.88E-01	./23.62585515	-0.462894052/.	./abnormal	./10.22981	100861548/65018	./pink1	NA	./2907.56994	127	NA	NA	NA	NA	NA	NA
chr1	20649109	rs45539432	C	T	PASS	T	downstream_gene_variant	MODIFIER	DDOST	ENSG00000244038	transcript	ENST00000375048.7	c.*3270G>A	NA	NA	NA	NA	NA	2668	NA	(PINK1|ENSG00000158828|1|1.00)	(PINK1|ENSG00000158828|1|1.00)	2.471e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Parkinson_disease_6\x2c_autosomal_recessive_early-onset	C1853833:605909	MedGen:OMIM	NA	NA	605909(3)	NA	Parkinson~disease~6~early~onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	A	0.955	5.13	NA	NA	NA	6.05	NA	40	0.935	NA	./Pink1	./N	./7.88E-01	./23.62585515	-0.462894052/.	./abnormal	./10.22981	100861548/65018	./pink1	NA	./2907.56994	127	NA	NA	NA	NA	NA	NA
chr1	20649109	rs45539432	C	T	PASS	T	non_coding_transcript_exon_variant	MODIFIER	PINK1-AS	ENSG00000117242	transcript	ENST00000451424.1	n.3085G>A	NA	1/3	NA	NA	NA	NA	NA	(PINK1|ENSG00000158828|1|1.00)	(PINK1|ENSG00000158828|1|1.00)	2.471e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Parkinson_disease_6\x2c_autosomal_recessive_early-onset	C1853833:605909	MedGen:OMIM	NA	NA	605909(3)	NA	Parkinson~disease~6~early~onset	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	A	0.955	5.13	NA	NA	NA	6.05	NA	40	0.935	NA	./Pink1	./N	./7.88E-01	./23.62585515	-0.462894052/.	./abnormal	./10.22981	100861548/65018	./pink1	NA	./2907.56994	127	NA	NA	NA	NA	NA	NA
chr1	21563267	rs149344982	G	A	PASS	A	missense_variant	MODERATE	ALPL	ENSG00000162551	transcript	ENST00000374832.5	c.455G>A	p.Arg152His	5/12	709/2193	152/524	455/1575	NA	NA	NA	NA	0.011	0.0191693	0.980032	2454,2	0.000798722	0.0103834	255|255|2	not_specified|Hypophosphatasia|not_provided	CN169374|C0020630:ORPHA436|CN221809	MedGen|MedGen:Orphanet|MedGen	NA	NA	146300(3),241500(3),241510(3),146300(3)	NA	Odontohypophosphatasia,Hypophosphatasia~infantile,Hypophosphatasia~childhood,Hypophosphatasia~adult	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR,AR,AR/AD	607872(4)	NA	IC	NA	NA	L	N/N/N/N/N	0.997	2.63	././PPBT_HUMAN	B	B	4.49	75,100,152	22.9	-0.328	T	Alpl	E	4.47E-02	53.98089172	7.61E-05	NA	7.82256	249	NA	NA	1799.01779	134	NA	NA	NA	NA	NA	ALPL
chr1	21564094	rs121918019	G	A	PASS	A	missense_variant	MODERATE	ALPL	ENSG00000162551	transcript	ENST00000374832.5	c.526G>A	p.Ala176Thr	6/12	780/2193	176/524	526/1575	NA	NA	NA	NA	7.413e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Infantile_hypophosphatasia|Childhood_hypophosphatasia	C0268412:241500:ORPHA247651:55236002|C0220743:241510:30174008	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:SNOMED_CT	NA	NA	146300(3),241500(3),241510(3),146300(3)	NA	Odontohypophosphatasia,Hypophosphatasia~infantile,Hypophosphatasia~childhood,Hypophosphatasia~adult	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR,AR,AR/AD	607872(4)	NA	IC	NA	NA	M	A/A/A/A/A	0.103	5.28	././PPBT_HUMAN	D	D	5.28	99,124,176	27.9	0.953	D	Alpl	E	4.47E-02	53.98089172	7.61E-05	NA	7.82256	249	NA	NA	1799.01779	133	NA	NA	NA	NA	NA	ALPL
chr1	21564139	rs121918007	G	A	PASS	A	missense_variant	MODERATE	ALPL	ENSG00000162551	transcript	ENST00000374832.5	c.571G>A	p.Glu191Lys	6/12	825/2193	191/524	571/1575	NA	NA	NA	NA	0.00257	0.00159744	0.998403	2500,0	0	0.000798722	5|5|5|5|5	Infantile_hypophosphatasia|Childhood_hypophosphatasia|Adult_hypophosphatasia|Hypophosphatasia|not_provided	C0268412:241500:ORPHA247651:55236002|C0220743:241510:30174008|C0268413:146300:ORPHA247676:20756002|C0020630:ORPHA436|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:Orphanet|MedGen	NA	NA	146300(3),241500(3),241510(3),146300(3)	NA	Odontohypophosphatasia,Hypophosphatasia~infantile,Hypophosphatasia~childhood,Hypophosphatasia~adult	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR,AR,AR/AD	607872(4)	NA	IC	NA	NA	L	A/A/A/A/A	0.997	5.17	././PPBT_HUMAN	B/B/P	B/P/D	5.17	114,139,191	29.2	0.953	T	Alpl	E	4.47E-02	53.98089172	7.61E-05	NA	7.82256	249	NA	NA	1799.01779	133	NA	NA	NA	NA	NA	ALPL
chr1	21577638	rs34605986	T	C	PASS	C	missense_variant	MODERATE	ALPL	ENSG00000162551	transcript	ENST00000374832.5	c.1565T>C	p.Val522Ala	12/12	1819/2193	522/524	1565/1575	NA	NA	NA	NA	0.094	0.123003	0.866613	2170,26	0.0103834	0.071885	2|255	not_specified|Hypophosphatasia	CN169374|C0020630:ORPHA436	MedGen|MedGen:Orphanet	NA	2	146300(3),241500(3),241510(3),146300(3)	NA	Odontohypophosphatasia,Hypophosphatasia~infantile,Hypophosphatasia~childhood,Hypophosphatasia~adult	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR,AR,AR/AD	607872(4)	NA	IC	NA	NA	N	P/P/P/P/P/P/P	0.029	-5.61	././PPBT_HUMAN	B	B	4.91	445,470,522	0.348	-0.812	T	Alpl	E	4.47E-02	53.98089172	7.61E-05	NA	7.82256	249	NA	NA	1799.01779	126	NA	NA	NA	NA	NA	ALPL
chr1	22863060	rs35882952	G	T	PASS	T	missense_variant	MODERATE	EPHB2	ENSG00000133216	transcript	ENST00000400191.7	c.835G>T	p.Ala279Ser	4/17	853/10816	279/1055	835/3168	NA	NA	NA	NA	0.001161	0.00479233	0.995208	2492,0	0	0.00239617	5	Prostate_cancer/brain_cancer_susceptibility	C1863600:603688	MedGen:OMIM	NA	NA	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603688(3)	NA	607872(4)	NA	IC	NA	{Prostate~cancer/brain~cancer~susceptibility~somatic}	N	A/A/A/A/A	1	3.71	./EPHB2_HUMAN/./.	B	P/B/B/B	4.65	279,279,297,279	12.63	1.048	T	Ephb2	N	1.12E-01	3.862939372	-1.456898556	NA	2.94594	2048	NA	NA	184.17467	126	NA	NA	NA	NA	NA	NA
chr1	22863060	rs35882952	G	T	PASS	T	downstream_gene_variant	MODIFIER	MIR4253	ENSG00000264014	transcript	ENST00000581187.1	n.*99C>A	NA	NA	NA	NA	NA	99	NA	NA	NA	0.001161	0.00479233	0.995208	2492,0	0	0.00239617	5	Prostate_cancer/brain_cancer_susceptibility	C1863600:603688	MedGen:OMIM	NA	NA	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603688(3)	NA	607872(4)	NA	IC	NA	{Prostate~cancer/brain~cancer~susceptibility~somatic}	N	A/A/A/A/A	1	3.71	./EPHB2_HUMAN/./.	B	P/B/B/B	4.65	279,279,297,279	12.63	1.048	T	Ephb2	N	1.12E-01	3.862939372	-1.456898556	NA	2.94594	2048	NA	NA	184.17467	126	NA	NA	NA	NA	NA	NA
chr1	22906853	rs28936395	G	A	PASS	A	structural_interaction_variant	HIGH	EPHB2	ENSG00000133216	interaction	3ZFM:A_678-A_736:ENST00000400191	c.2032G>A	NA	11/17	NA	NA	NA	NA	NA	NA	NA	0.003418	0.00239617	0.997604	2498,0	0	0.00119808	5	Prostate_cancer/brain_cancer_susceptibility	C1863600:603688	MedGen:OMIM	NA	2	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603688(3)	NA	607872(4)	NA	IC	NA	{Prostate~cancer/brain~cancer~susceptibility~somatic}	N	A/A/A/A	0.993	5.43	./EPHB2_HUMAN/./.	B/D/D/P	P/D/D/P	5.43	620,678,696,679	29.1	0.953	D	Ephb2	N	1.12E-01	3.862939372	-1.456898556	NA	2.94594	2048	NA	NA	184.17467	129	NA	NA	NA	NA	NA	NA
chr1	22906853	rs28936395	G	A	PASS	A	missense_variant	MODERATE	EPHB2	ENSG00000133216	transcript	ENST00000400191.7	c.2032G>A	p.Asp678Asn	11/17	2050/10816	678/1055	2032/3168	NA	NA	NA	NA	0.003418	0.00239617	0.997604	2498,0	0	0.00119808	5	Prostate_cancer/brain_cancer_susceptibility	C1863600:603688	MedGen:OMIM	NA	2	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603688(3)	NA	607872(4)	NA	IC	NA	{Prostate~cancer/brain~cancer~susceptibility~somatic}	N	A/A/A/A	0.993	5.43	./EPHB2_HUMAN/./.	B/D/D/P	P/D/D/P	5.43	620,678,696,679	29.1	0.953	D	Ephb2	N	1.12E-01	3.862939372	-1.456898556	NA	2.94594	2048	NA	NA	184.17467	129	NA	NA	NA	NA	NA	NA
chr1	22913757	rs76826147	A	T	PASS	T	stop_gained	HIGH	EPHB2	ENSG00000133216	transcript	ENST00000400191.7	c.3055A>T	p.Lys1019*	17/17	3073/10816	1019/1055	3055/3168	NA	NA	NA	NA	0.003348	0.0239617	0.975639	2443,1	0.000399361	0.0123802	255	Prostate_cancer/brain_cancer_susceptibility	C1863600:603688	MedGen:OMIM	NA	1	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603688(3)	NA	607872(4)	NA	IC	NA	{Prostate~cancer/brain~cancer~susceptibility~somatic}	NA	D/N	0.917	0.896	NA	NA	NA	4.53	NA	0.066	1.197	NA	Ephb2	N	1.12E-01	3.862939372	-1.456898556	NA	2.94594	2048	NA	NA	184.17467	132	NA	NA	NA	NA	NA	NA
chr1	23796183	rs28940885	C	T	PASS	T	missense_variant	MODERATE	GALE	ENSG00000117308	transcript	ENST00000374497.7	c.956G>A	p.Gly319Glu	11/12	1048/1488	319/348	956/1047	NA	NA	NA	NA	0.0004283	0.00399361	0.996006	2494,0	0	0.00199681	5|255	UDPglucose-4-epimerase_deficiency|not_provided	C0751161:230350:ORPHA79238:8849004|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	A	0.98	4.6	././GALE_HUMAN	P	P	5.52	245,319,319	27.1	0.012	./D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	132	NA	NA	NA	NA	NA	NA
chr1	23796183	rs28940885	C	T	PASS	T	downstream_gene_variant	MODIFIER	LYPLA2	ENSG00000011009	transcript	ENST00000374514.7	c.*1451C>T	NA	NA	NA	NA	NA	644	NA	NA	NA	0.0004283	0.00399361	0.996006	2494,0	0	0.00199681	5|255	UDPglucose-4-epimerase_deficiency|not_provided	C0751161:230350:ORPHA79238:8849004|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	A	0.98	4.6	././GALE_HUMAN	P	P	5.52	245,319,319	27.1	0.012	./D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	132	NA	NA	NA	NA	NA	NA
chr1	23796722	rs28940884	T	C	PASS	C	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1EK5:A_257-A_317:ENST00000374497	c.770A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.001754	0.0139776	0.984824	2466,3	0.00119808	0.0081869	5|255	UDPglucose-4-epimerase_deficiency|not_provided	C0751161:230350:ORPHA79238:8849004|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	A	1	5.65	././././GALE_HUMAN	B	B	5.65	193,183,193,257,257	20.6	0.952	./T/T/T/T	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	129	NA	NA	NA	NA	NA	NA
chr1	23796722	rs28940884	T	C	PASS	C	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1EK6:A_257-A_317:ENST00000374497	c.770A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.001754	0.0139776	0.984824	2466,3	0.00119808	0.0081869	5|255	UDPglucose-4-epimerase_deficiency|not_provided	C0751161:230350:ORPHA79238:8849004|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	A	1	5.65	././././GALE_HUMAN	B	B	5.65	193,183,193,257,257	20.6	0.952	./T/T/T/T	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	129	NA	NA	NA	NA	NA	NA
chr1	23796722	rs28940884	T	C	PASS	C	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1HZJ:A_257-A_317:ENST00000374497	c.770A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.001754	0.0139776	0.984824	2466,3	0.00119808	0.0081869	5|255	UDPglucose-4-epimerase_deficiency|not_provided	C0751161:230350:ORPHA79238:8849004|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	A	1	5.65	././././GALE_HUMAN	B	B	5.65	193,183,193,257,257	20.6	0.952	./T/T/T/T	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	129	NA	NA	NA	NA	NA	NA
chr1	23796722	rs28940884	T	C	PASS	C	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1HZJ:B_257-B_317:ENST00000374497	c.770A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.001754	0.0139776	0.984824	2466,3	0.00119808	0.0081869	5|255	UDPglucose-4-epimerase_deficiency|not_provided	C0751161:230350:ORPHA79238:8849004|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	A	1	5.65	././././GALE_HUMAN	B	B	5.65	193,183,193,257,257	20.6	0.952	./T/T/T/T	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	129	NA	NA	NA	NA	NA	NA
chr1	23796722	rs28940884	T	C	PASS	C	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3K:A_257-A_317:ENST00000374497	c.770A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.001754	0.0139776	0.984824	2466,3	0.00119808	0.0081869	5|255	UDPglucose-4-epimerase_deficiency|not_provided	C0751161:230350:ORPHA79238:8849004|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	A	1	5.65	././././GALE_HUMAN	B	B	5.65	193,183,193,257,257	20.6	0.952	./T/T/T/T	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	129	NA	NA	NA	NA	NA	NA
chr1	23796722	rs28940884	T	C	PASS	C	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3L:A_257-A_317:ENST00000374497	c.770A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.001754	0.0139776	0.984824	2466,3	0.00119808	0.0081869	5|255	UDPglucose-4-epimerase_deficiency|not_provided	C0751161:230350:ORPHA79238:8849004|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	A	1	5.65	././././GALE_HUMAN	B	B	5.65	193,183,193,257,257	20.6	0.952	./T/T/T/T	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	129	NA	NA	NA	NA	NA	NA
chr1	23796722	rs28940884	T	C	PASS	C	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3N:A_257-A_317:ENST00000374497	c.770A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.001754	0.0139776	0.984824	2466,3	0.00119808	0.0081869	5|255	UDPglucose-4-epimerase_deficiency|not_provided	C0751161:230350:ORPHA79238:8849004|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	A	1	5.65	././././GALE_HUMAN	B	B	5.65	193,183,193,257,257	20.6	0.952	./T/T/T/T	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	129	NA	NA	NA	NA	NA	NA
chr1	23796722	rs28940884	T	C	PASS	C	missense_variant	MODERATE	GALE	ENSG00000117308	transcript	ENST00000374497.7	c.770A>G	p.Lys257Arg	9/12	862/1488	257/348	770/1047	NA	NA	NA	NA	0.001754	0.0139776	0.984824	2466,3	0.00119808	0.0081869	5|255	UDPglucose-4-epimerase_deficiency|not_provided	C0751161:230350:ORPHA79238:8849004|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	A	1	5.65	././././GALE_HUMAN	B	B	5.65	193,183,193,257,257	20.6	0.952	./T/T/T/T	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	129	NA	NA	NA	NA	NA	NA
chr1	23796722	rs28940884	T	C	PASS	C	downstream_gene_variant	MODIFIER	LYPLA2	ENSG00000011009	transcript	ENST00000374514.7	c.*1990T>C	NA	NA	NA	NA	NA	1183	NA	NA	NA	0.001754	0.0139776	0.984824	2466,3	0.00119808	0.0081869	5|255	UDPglucose-4-epimerase_deficiency|not_provided	C0751161:230350:ORPHA79238:8849004|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	N	A	1	5.65	././././GALE_HUMAN	B	B	5.65	193,183,193,257,257	20.6	0.952	./T/T/T/T	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	129	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1EK5:A_239-A_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1EK5:A_239-A_304:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1EK6:A_239-A_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1EK6:A_239-A_304:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1EK6:B_239-B_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1EK6:B_239-B_304:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1HZJ:A_239-A_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1HZJ:A_239-A_304:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1HZJ:B_239-B_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3K:A_239-A_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3K:A_239-A_304:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3K:B_239-B_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3K:B_239-B_304:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3L:A_239-A_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3L:A_239-A_304:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3L:B_239-B_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3L:B_239-B_304:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3M:A_239-A_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3M:A_239-A_304:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3M:B_239-B_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3M:B_239-B_304:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3N:A_239-A_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3N:B_239-B_275:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	structural_interaction_variant	HIGH	GALE	ENSG00000117308	interaction	1I3N:B_239-B_304:ENST00000374497	c.715C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	missense_variant	MODERATE	GALE	ENSG00000117308	transcript	ENST00000374497.7	c.715C>T	p.Arg239Trp	9/12	807/1488	239/348	715/1047	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23796777	rs137853860	G	A	PASS	A	downstream_gene_variant	MODIFIER	LYPLA2	ENSG00000011009	transcript	ENST00000374514.7	c.*2045G>A	NA	NA	NA	NA	NA	1238	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	UDPglucose-4-epimerase_deficiency	C0751161:230350:ORPHA79238:8849004	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230350(3)	NA	Galactose~epimerase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	H	A	0.743	4.72	././././GALE_HUMAN	D	D	5.65	175,165,175,239,239	34	0.017	./D/D/D/D	Gale	NA	6.21E-02	19.72753008	-0.556537043	NA	2.13484	2582	NA	g1pPathway	97.5207	133	NA	NA	NA	NA	NA	NA
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	frameshift_variant	HIGH	HMGCL	ENSG00000117305	transcript	ENST00000374490.7	c.206_207delCT	p.Ser69fs	3/9	251/1600	69/325	206/978	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	2CW6:A_69-A_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	2CW6:B_69-B_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	2CW6:C_69-C_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	2CW6:D_69-D_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	2CW6:E_69-E_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP3:A_69-A_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP3:B_69-B_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP3:E_69-E_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP4:A_69-A_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP4:B_69-B_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP4:D_69-D_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP4:F_69-F_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP5:A_69-A_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP5:B_69-B_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP5:C_69-C_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP5:D_69-D_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP5:E_69-E_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23817520	rs752137615	CAG	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	HMGCL	ENSG00000117305	interaction	3MP5:F_69-F_102:ENST00000374490	c.206_207delCT	NA	3/9	NA	NA	NA	NA	NA	(HMGCL|ENSG00000117305|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	5|5	Deficiency_of_hydroxymethylglutaryl-CoA_lyase|not_provided	C0268601:246450:124611007|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	246450(3)	NA	HMG-CoA~lyase~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcl	E	2.76E-01	17.74593064	-0.60427181	NA	1.00489	3155	NA	NA	31.95009	144	NA	NA	NA	NA	NA	HMGCL
chr1	23863148	rs80358198	G	A	PASS	A	synonymous_variant	LOW	FUCA1	ENSG00000179163	transcript	ENST00000374479.3	c.648C>T	p.Tyr216Tyr	3/8	656/2047	216/466	648/1401	NA	NA	NA	NA	0.0004612	0.00159744	0.998403	2500,0	0	0.000798722	5	Fucosidosis	C0016788:230000:ORPHA349:64716005	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	230000(3)	NA	Fucosidosis	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Fuca1	NA	8.69E-01	84.55414013	0.663285274	NA	9.82333	2517	NA	NA	2719.65674	132	NA	NA	NA	NA	NA	NA
chr1	25284753	rs121912762	T	C	VQSRTrancheSNP99.80to100.00	C	missense_variant	MODERATE	RHD	ENSG00000187010	transcript	ENST00000342055.9	c.329T>C	p.Leu110Pro	2/9	329/1557	110/493	329/1482	NA	NA	NA	NA	0.001042	0.00159744	0.998403	2500,0	0	0.000798722	5	Rhd_category_d-vii	C4015919	MedGen	NA	NA	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	607872(4)	NA	IC	NA	NA	M	A/A/A/A/A/A/A	0.012	1.78	./././././././RHD_HUMAN	D/D/D/D/D/B/D/D	D/D/D/D/D/B/D/D	3.01	110	22.9	0.709	D/./D/D/D/D/D/D/.	./Rhd	NA	./9.38E-01	89.4373673/99.41613588	0.905808022/3.311471185	NA	./7.06993	57035/6007	NA	NA	./1433.80387	133	NA	NA	NA	NA	NA	NA
chr1	25284753	rs121912762	T	C	VQSRTrancheSNP99.80to100.00	C	intragenic_variant	MODIFIER	RSRP1	ENSG00000117616	gene_variant	ENSG00000117616	n.25284753A>G	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.001042	0.00159744	0.998403	2500,0	0	0.000798722	5	Rhd_category_d-vii	C4015919	MedGen	NA	NA	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	607872(4)	NA	IC	NA	NA	M	A/A/A/A/A/A/A	0.012	1.78	./././././././RHD_HUMAN	D/D/D/D/D/B/D/D	D/D/D/D/D/B/D/D	3.01	110	22.9	0.709	D/./D/D/D/D/D/D/.	./Rhd	NA	./9.38E-01	89.4373673/99.41613588	0.905808022/3.311471185	NA	./7.06993	57035/6007	NA	NA	./1433.80387	133	NA	NA	NA	NA	NA	NA
chr1	25303329	rs121912763	T	G	PASS	G	missense_variant	MODERATE	RHD	ENSG00000187010	transcript	ENST00000342055.9	c.809T>G	p.Val270Gly	6/9	809/1557	270/493	809/1482	NA	NA	NA	NA	0.002702	0	0.998802	2501,3	0.00119808	0.00119808	5	Rhd\x2c_weak_d\x2c_type_I	C4015920	MedGen	NA	NA	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	607872(4)	NA	IC	NA	NA	M	A/A/A/A/A/A/A	0.059	3.19	./././././././RHD_HUMAN	B/P/P/P/B/B/P/P	P/P/P/P/P/B/D/B	3.19	270	23.3	0.781	D/./D/D/D/D/D/D/.	./Rhd	NA	./9.38E-01	89.4373673/99.41613588	0.905808022/3.311471185	NA	./7.06993	57035/6007	NA	NA	./1433.80387	133	NA	NA	NA	NA	NA	NA
chr1	25303329	rs121912763	T	G	PASS	G	intragenic_variant	MODIFIER	RSRP1	ENSG00000117616	gene_variant	ENSG00000117616	n.25303329A>C	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.002702	0	0.998802	2501,3	0.00119808	0.00119808	5	Rhd\x2c_weak_d\x2c_type_I	C4015920	MedGen	NA	NA	NA	NA	NA	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	607872(4)	NA	IC	NA	NA	M	A/A/A/A/A/A/A	0.059	3.19	./././././././RHD_HUMAN	B/P/P/P/B/B/P/P	P/P/P/P/P/B/D/B	3.19	270	23.3	0.781	D/./D/D/D/D/D/D/.	./Rhd	NA	./9.38E-01	89.4373673/99.41613588	0.905808022/3.311471185	NA	./7.06993	57035/6007	NA	NA	./1433.80387	133	NA	NA	NA	NA	NA	NA
chr1	25543763	.	G	C	PASS	C	missense_variant	MODERATE	LDLRAP1	ENSG00000157978	transcript	ENST00000374338.4	c.65G>C	p.Trp22Ser	1/9	184/2940	22/308	65/927	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	5	Hypercholesterolemia\x2c_autosomal_recessive	C1863512:603813	MedGen:OMIM	NA	NA	603813(3)	NA	Hypercholesterolemia~familial~autosomal~recessive	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	-	607872(4)	NA	IC	NA	NA	M	D	0.998	3.03	ARH_HUMAN	P	D	3.95	22	23.3	-0.012	D	Ldlrap1	N	6.99E-01	75.29488087	0.373041938	NA	2.96392	26119	NA	NA	186.26228	NA	NA	NA	NA	NA	NA	NA
chr1	25563142	rs121908326	C	A	PASS	A	missense_variant	MODERATE	LDLRAP1	ENSG00000157978	transcript	ENST00000374338.4	c.605C>A	p.Ser202Tyr	6/9	724/2940	202/308	605/927	NA	NA	NA	NA	0.001161	0.00319489	0.996805	2496,0	0	0.00159744	5	Hypercholesterolemia\x2c_autosomal_recessive	C1863512:603813	MedGen:OMIM	NA	NA	603813(3)	NA	Hypercholesterolemia~familial~autosomal~recessive	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	-	607872(4)	NA	IC	NA	NA	M	A	0.001	3.65	./ARH_HUMAN	P	D	5.51	202	11.90	0.923	D	Ldlrap1	N	6.99E-01	75.29488087	0.373041938	NA	2.96392	26119	NA	NA	186.26228	133	NA	NA	NA	NA	NA	NA
chr1	25800233	rs797044621	G	GGGCCGGGCCC	VQSRTrancheINDEL99.00to100.00	GGGCCGGGCCC	frameshift_variant	HIGH	SEPN1	ENSG00000162430	transcript	ENST00000361547.6	c.13_22dupCGGCCGGGCC	p.Gln8fs	1/13	78/4334	8/590	23/1773	NA	WARNING_TRANSCRIPT_MULTIPLE_STOP_CODONS&INFO_REALIGN_3_PRIME	NA	NA	NA	NA	NA	NA	NA	NA	5	Eichsfeld_type_congenital_muscular_dystrophy	C0410180:602771:240063002	MedGen:OMIM:SNOMED_CT	NA	NA	255310(3),602771(3)	NA	Myopathy~congenital~with~fiber-type~disproportion,Muscular~dystrophy~rigid~spine~1	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sepn1	N	1.22E-01	83.41589998	0.621009802	abnormal	3.65394	57190	sepn1	NA	291.70309	146	CCCCGn|Simple_repeat|Simple_repeat	NA	NA	NA	NA	SEPN1
chr1	25805147	rs35019869	A	G	PASS	G	missense_variant	MODERATE	SEPN1	ENSG00000162430	transcript	ENST00000361547.6	c.409A>G	p.Thr137Ala	4/13	464/4334	137/590	409/1773	NA	WARNING_TRANSCRIPT_MULTIPLE_STOP_CODONS	NA	NA	0.013	0.0147764	0.985224	2467,0	0	0.00738818	255|0	not_specified|SEPN1-Related_Disorders	CN169374|CN239420	MedGen|MedGen	NA	NA	255310(3),602771(3)	NA	Myopathy~congenital~with~fiber-type~disproportion,Muscular~dystrophy~rigid~spine~1	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR	607872(4)	NA	IC	NA	NA	N	N/N/N	0.427	0.598	./SELN_HUMAN	B	B	4.19	103,137	1.957	0.234	T	Sepn1	N	1.22E-01	83.41589998	0.621009802	abnormal	3.65394	57190	sepn1	NA	291.70309	126	NA	NA	NA	NA	NA	SEPN1
chr1	25805164	rs141295085	C	CGAG	PASS	CGAG	conservative_inframe_insertion	MODERATE	SEPN1	ENSG00000162430	transcript	ENST00000361547.6	c.436_438dupGAG	p.Glu146dup	4/13	494/4334	147/590	439/1773	NA	WARNING_TRANSCRIPT_MULTIPLE_STOP_CODONS&INFO_REALIGN_3_PRIME	NA	NA	0.0023	0.0147764	0.985224	2467,0	0	0.00738818	0|255	not_provided|not_specified	CN221809|CN169374	MedGen|MedGen	NA	NA	255310(3),602771(3)	NA	Myopathy~congenital~with~fiber-type~disproportion,Muscular~dystrophy~rigid~spine~1	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sepn1	N	1.22E-01	83.41589998	0.621009802	abnormal	3.65394	57190	sepn1	NA	291.70309	134	NA	NA	NA	NA	NA	SEPN1
chr1	25808625	rs115852080	G	A	PASS	A	missense_variant	MODERATE	SEPN1	ENSG00000162430	transcript	ENST00000361547.6	c.583G>A	p.Ala195Thr	5/13	638/4334	195/590	583/1773	NA	WARNING_TRANSCRIPT_MULTIPLE_STOP_CODONS	NA	NA	0.009986	0.0127796	0.98722	2472,0	0	0.00638978	255	not_specified	CN169374	MedGen	NA	NA	255310(3),602771(3)	NA	Myopathy~congenital~with~fiber-type~disproportion,Muscular~dystrophy~rigid~spine~1	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR	607872(4)	NA	IC	NA	NA	L	D/D/D	0.053	4.02	./SELN_HUMAN	B	D/P	5.97	161,195	14.19	1.036	T	Sepn1	N	1.22E-01	83.41589998	0.621009802	abnormal	3.65394	57190	sepn1	NA	291.70309	132	NA	NA	NA	NA	NA	SEPN1
chr1	25808771	rs139020143	G	A	PASS	A	synonymous_variant	LOW	SEPN1	ENSG00000162430	transcript	ENST00000361547.6	c.729G>A	p.Pro243Pro	5/13	784/4334	243/590	729/1773	NA	WARNING_TRANSCRIPT_MULTIPLE_STOP_CODONS	NA	NA	0.0007687	0.00159744	0.998403	2500,0	0	0.000798722	255|0	not_specified|SEPN1-Related_Disorders	CN169374|CN239420	MedGen|MedGen	NA	1	255310(3),602771(3)	NA	Myopathy~congenital~with~fiber-type~disproportion,Muscular~dystrophy~rigid~spine~1	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sepn1	N	1.22E-01	83.41589998	0.621009802	abnormal	3.65394	57190	sepn1	NA	291.70309	134	NA	NA	NA	NA	NA	SEPN1
chr1	25809791	rs147587542	C	T	PASS	T	synonymous_variant	LOW	SEPN1	ENSG00000162430	transcript	ENST00000361547.6	c.981C>T	p.Arg327Arg	7/13	1036/4334	327/590	981/1773	NA	WARNING_TRANSCRIPT_MULTIPLE_STOP_CODONS	NA	NA	0.025	0.01877	0.980431	2455,2	0.000798722	0.0101837	255|3	not_specified|SEPN1-Related_Disorders	CN169374|CN239420	MedGen|MedGen	NA	1	255310(3),602771(3)	NA	Myopathy~congenital~with~fiber-type~disproportion,Muscular~dystrophy~rigid~spine~1	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sepn1	N	1.22E-01	83.41589998	0.621009802	abnormal	3.65394	57190	sepn1	NA	291.70309	134	NA	NA	NA	NA	NA	SEPN1
chr1	25809791	rs147587542	C	T	PASS	T	upstream_gene_variant	MODIFIER	RP1-317E23.6	ENSG00000255054	transcript	ENST00000527604.1	c.-4182C>T	NA	NA	NA	NA	NA	4182	WARNING_TRANSCRIPT_NO_START_CODON	NA	NA	0.025	0.01877	0.980431	2455,2	0.000798722	0.0101837	255|3	not_specified|SEPN1-Related_Disorders	CN169374|CN239420	MedGen|MedGen	NA	1	255310(3),602771(3)	NA	Myopathy~congenital~with~fiber-type~disproportion,Muscular~dystrophy~rigid~spine~1	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sepn1	N	1.22E-01	83.41589998	0.621009802	abnormal	3.65394	57190	sepn1	NA	291.70309	134	NA	NA	NA	NA	NA	SEPN1
chr1	27373179	rs532781899	AG	A	PASS	A	frameshift_variant	HIGH	FCN3	ENSG00000142748	transcript	ENST00000270879.8	c.349delC	p.Leu117fs	5/8	355/1030	117/299	349/900	NA	NA	(FCN3|ENSG00000142748|1|1.00)	NA	0.017	0.0367412	0.962859	2411,1	0.000399361	0.01877	5	Immunodeficiency_due_to_ficolin_3_deficiency	C3151226:613860:ORPHA331190	MedGen:OMIM:Orphanet	NA	1	613860(3)	NA	Immunodeficiency~due~to~ficolin~3~deficiency	Chromosome~1p36~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	607872(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	6.00E-01	72.59966973	0.308721233	NA	3.01786	8547	NA	NA	193.54891	136	NA	NA	NA	NA	NA	NA
chr1	30874473	rs2282440	G	A	PASS	A	missense_variant	MODERATE	SDC3	ENSG00000162512	transcript	ENST00000339394.6	c.986C>T	p.Thr329Ile	4/5	1161/1580	329/442	986/1329	NA	NA	NA	NA	0.086	0.195288	0.741214	1856,159	0.0634984	0.161142	255	Obesity\x2c_association_with	C4016383	MedGen	NA	NA	NA	NA	NA	NA	NA	AR/AD/Mu	NA	NA	NA	NA	NA	601665(3)	NA	NA	NA	NA	NA	{Obesity~association~with}	N	P/P	0.999	3.85	SDC3_HUMAN/.	B	B	4.84	329,271	21.1	1.048	T	Sdc3	N	2.16E-01	52.25288983	-0.020150552	abnormal	12.65200	9672	sdc3	NA	4069.42538	100	NA	NA	NA	NA	NA	NA
chr1	30876800	rs2491132	C	T	PASS	T	missense_variant	MODERATE	SDC3	ENSG00000162512	transcript	ENST00000339394.6	c.622G>A	p.Val208Ile	3/5	797/1580	208/442	622/1329	NA	NA	NA	NA	0.153	0.127796	0.859824	2153,31	0.0123802	0.076278	255	Obesity\x2c_association_with	C4016383	MedGen	NA	NA	NA	NA	NA	NA	NA	AR/AD/Mu	NA	NA	NA	NA	NA	601665(3)	NA	NA	NA	NA	NA	{Obesity~association~with}	N	P/P	0.517	-8.71	SDC3_HUMAN/.	B	B	4.99	208,150	0.003	-0.265	T	Sdc3	N	2.16E-01	52.25288983	-0.020150552	abnormal	12.65200	9672	sdc3	NA	4069.42538	100	NA	NA	NA	NA	NA	NA
chr1	32204044	rs41263993	C	T	PASS	T	splice_region_variant&synonymous_variant	LOW	CCDC28B	ENSG00000160050	transcript	ENST00000421922.6	c.330C>T	p.Phe110Phe	3/5	430/1415	110/241	330/726	NA	NA	NA	NA	0.011	0.0111821	0.988818	2476,0	0	0.00559105	255	Bardet-Biedl_syndrome_1\x2c_modifier_of	.	.	NA	NA	NA	NA	NA	NA	NA	AR/DR	NA	NA	NA	NA	NA	209900(3)	NA	NA	NA	NA	NA	{Bardet-Biedl~syndrome~1~modifier~of}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ccdc28b	NA	7.83E-01	70.05779665	0.25917371	abnormal	3.91778	79140	ccdc28b	NA	340.90955	127	NA	NA	NA	NA	NA	NA
chr1	32204044	rs41263993	C	T	PASS	T	upstream_gene_variant	MODIFIER	IQCC	ENSG00000160051	transcript	ENST00000537469.2	c.-1638C>T	NA	NA	NA	NA	NA	1627	NA	NA	NA	0.011	0.0111821	0.988818	2476,0	0	0.00559105	255	Bardet-Biedl_syndrome_1\x2c_modifier_of	.	.	NA	NA	NA	NA	NA	NA	NA	AR/DR	NA	NA	NA	NA	NA	209900(3)	NA	NA	NA	NA	NA	{Bardet-Biedl~syndrome~1~modifier~of}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ccdc28b	NA	7.83E-01	70.05779665	0.25917371	abnormal	3.91778	79140	ccdc28b	NA	340.90955	127	NA	NA	NA	NA	NA	NA
chr1	32204044	rs41263993	C	T	PASS	T	downstream_gene_variant	MODIFIER	RP4-622L5.7	ENSG00000224066	transcript	ENST00000421616.1	n.*1454G>A	NA	NA	NA	NA	NA	1454	NA	NA	NA	0.011	0.0111821	0.988818	2476,0	0	0.00559105	255	Bardet-Biedl_syndrome_1\x2c_modifier_of	.	.	NA	NA	NA	NA	NA	NA	NA	AR/DR	NA	NA	NA	NA	NA	209900(3)	NA	NA	NA	NA	NA	{Bardet-Biedl~syndrome~1~modifier~of}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ccdc28b	NA	7.83E-01	70.05779665	0.25917371	abnormal	3.91778	79140	ccdc28b	NA	340.90955	127	NA	NA	NA	NA	NA	NA
chr1	32893848	rs550921485	G	A	PASS	A	missense_variant	MODERATE	HPCA	ENSG00000121905	transcript	ENST00000373467.3	c.568G>A	p.Ala190Thr	4/4	670/1468	190/193	568/582	NA	NA	NA	NA	0.0003449	0.000798722	0.999201	2502,0	0	0.000399361	5	Dystonia_2\x2c_torsion\x2c_autosomal_recessive	1862:C1857093:224500:ORPHA99657	Gene:MedGen:OMIM:Orphanet	NA	NA	224500(3)	NA	Dystonia~2~torsion~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	D	1	3.54	HPCA_HUMAN	B	B	4.55	190	23.7	0.953	T	Hpca	N	1.50E-01	46.20193442	-0.09720619	NA	0.14403	3208	NA	NA	3.85861	142	NA	NA	NA	NA	NA	NA
chr1	32893848	rs550921485	G	A	PASS	A	downstream_gene_variant	MODIFIER	TMEM54	ENSG00000121900	transcript	ENST00000373463.7	c.*957C>T	NA	NA	NA	NA	NA	747	NA	NA	NA	0.0003449	0.000798722	0.999201	2502,0	0	0.000399361	5	Dystonia_2\x2c_torsion\x2c_autosomal_recessive	1862:C1857093:224500:ORPHA99657	Gene:MedGen:OMIM:Orphanet	NA	NA	224500(3)	NA	Dystonia~2~torsion~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	D	1	3.54	HPCA_HUMAN	B	B	4.55	190	23.7	0.953	T	Hpca	N	1.50E-01	46.20193442	-0.09720619	NA	0.14403	3208	NA	NA	3.85861	142	NA	NA	NA	NA	NA	NA
chr1	33036804	rs267606647	C	T	PASS	T	missense_variant	MODERATE	AK2	ENSG00000004455	transcript	ENST00000354858.10	c.25G>A	p.Glu9Lys	1/6	189/1021	9/239	25/720	NA	NA	NA	NA	0.0005961	0.00119808	0.998802	2501,0	0	0.000599042	5	Reticular_dysgenesis	C0272167:267500:ORPHA33355:111584000	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	267500(3)	NA	Reticular~dysgenesis	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	N/N/N/N/N/N	0.37	0.873	././KAD2_HUMAN/.	B	B/P/P/P	4.92	9	11.20	0.935	./T/T/T/T/T/T/.	Ak2	NA	5.55E-01	68.12927577	0.21689899	abnormal	1.93027	204	ak2	NA	82.5936	137	NA	NA	NA	NA	NA	NA
chr1	33036804	rs267606647	C	T	PASS	T	downstream_gene_variant	MODIFIER	RP1-117O3.2	ENSG00000236065	transcript	ENST00000427524.1	n.*4335C>T	NA	NA	NA	NA	NA	4335	NA	NA	NA	0.0005961	0.00119808	0.998802	2501,0	0	0.000599042	5	Reticular_dysgenesis	C0272167:267500:ORPHA33355:111584000	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	267500(3)	NA	Reticular~dysgenesis	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	N/N/N/N/N/N	0.37	0.873	././KAD2_HUMAN/.	B	B/P/P/P	4.92	9	11.20	0.935	./T/T/T/T/T/T/.	Ak2	NA	5.55E-01	68.12927577	0.21689899	abnormal	1.93027	204	ak2	NA	82.5936	137	NA	NA	NA	NA	NA	NA
chr1	34784955	rs777106179	TACG	T	VQSRTrancheINDEL99.00to100.00	T	conservative_inframe_deletion	MODERATE	GJB3	ENSG00000188910	transcript	ENST00000373362.3	c.196_198delGAC	p.Asp66del	2/2	386/1797	66/270	196/813	NA	INFO_REALIGN_3_PRIME	NA	NA	0.0001235	NA	NA	NA	NA	NA	5|0	Deafness\x2c_autosomal_dominant\x2c_with_peripheral_neuropathy|not_specified	C3148751|CN169374	MedGen|MedGen	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	144	NA	NA	NA	NA	NA	NA
chr1	34784955	rs777106179	TACG	T	VQSRTrancheINDEL99.00to100.00	T	intron_variant	MODIFIER	RP1-34M23.5	ENSG00000255811	transcript	ENST00000542839.1	n.110+3030_110+3032delCGT	NA	1/1	NA	NA	NA	NA	NA	NA	NA	0.0001235	NA	NA	NA	NA	NA	5|0	Deafness\x2c_autosomal_dominant\x2c_with_peripheral_neuropathy|not_specified	C3148751|CN169374	MedGen|MedGen	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	144	NA	NA	NA	NA	NA	NA
chr1	34784955	rs777106179	TACG	T	VQSRTrancheINDEL99.00to100.00	T	intragenic_variant	MODIFIER	SMIM12	ENSG00000163866	gene_variant	ENSG00000163866	n.34784958_34784956delCGT	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0001235	NA	NA	NA	NA	NA	5|0	Deafness\x2c_autosomal_dominant\x2c_with_peripheral_neuropathy|not_specified	C3148751|CN169374	MedGen|MedGen	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	144	NA	NA	NA	NA	NA	NA
chr1	34785075	rs150245955	C	A	PASS	A	missense_variant	MODERATE	GJB3	ENSG00000188910	transcript	ENST00000373362.3	c.313C>A	p.His105Asn	2/2	503/1797	105/270	313/813	NA	NA	NA	NA	0.0006589	0.00399361	0.996006	2494,0	0	0.00199681	255	not_specified	CN169374	MedGen	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	L	N/N	0.022	5.85	CXB3_HUMAN	B	B	5.85	105	7.565	0.852	T	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	134	NA	NA	NA	NA	NA	NA
chr1	34785075	rs150245955	C	A	PASS	A	intron_variant	MODIFIER	RP1-34M23.5	ENSG00000255811	transcript	ENST00000542839.1	n.110+2913G>T	NA	1/1	NA	NA	NA	NA	NA	NA	NA	0.0006589	0.00399361	0.996006	2494,0	0	0.00199681	255	not_specified	CN169374	MedGen	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	L	N/N	0.022	5.85	CXB3_HUMAN	B	B	5.85	105	7.565	0.852	T	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	134	NA	NA	NA	NA	NA	NA
chr1	34785075	rs150245955	C	A	PASS	A	intragenic_variant	MODIFIER	SMIM12	ENSG00000163866	gene_variant	ENSG00000163866	n.34785075G>T	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0006589	0.00399361	0.996006	2494,0	0	0.00199681	255	not_specified	CN169374	MedGen	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	L	N/N	0.022	5.85	CXB3_HUMAN	B	B	5.85	105	7.565	0.852	T	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	134	NA	NA	NA	NA	NA	NA
chr1	34785300	rs74315319	C	T	PASS	T	stop_gained	HIGH	GJB3	ENSG00000188910	transcript	ENST00000373362.3	c.538C>T	p.Arg180*	2/2	728/1797	180/270	538/813	NA	NA	NA	NA	8.236e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|0	Deafness\x2c_autosomal_dominant_2b|not_specified	C2675236:612644|CN169374	MedGen:OMIM|MedGen	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	NA	A/A	0.995	2.97	NA	NA	NA	5.07	NA	36	0.85	NA	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	133	NA	NA	NA	NA	NA	NA
chr1	34785300	rs74315319	C	T	PASS	T	intron_variant	MODIFIER	RP1-34M23.5	ENSG00000255811	transcript	ENST00000542839.1	n.110+2688G>A	NA	1/1	NA	NA	NA	NA	NA	NA	NA	8.236e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|0	Deafness\x2c_autosomal_dominant_2b|not_specified	C2675236:612644|CN169374	MedGen:OMIM|MedGen	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	NA	A/A	0.995	2.97	NA	NA	NA	5.07	NA	36	0.85	NA	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	133	NA	NA	NA	NA	NA	NA
chr1	34785300	rs74315319	C	T	PASS	T	intragenic_variant	MODIFIER	SMIM12	ENSG00000163866	gene_variant	ENSG00000163866	n.34785300G>A	NA	NA	NA	NA	NA	NA	NA	NA	NA	8.236e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|0	Deafness\x2c_autosomal_dominant_2b|not_specified	C2675236:612644|CN169374	MedGen:OMIM|MedGen	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	NA	A/A	0.995	2.97	NA	NA	NA	5.07	NA	36	0.85	NA	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	133	NA	NA	NA	NA	NA	NA
chr1	34785309	rs74315318	G	A	PASS	A	missense_variant	MODERATE	GJB3	ENSG00000188910	transcript	ENST00000373362.3	c.547G>A	p.Glu183Lys	2/2	737/1797	183/270	547/813	NA	NA	NA	NA	0.0005107	0.00199681	0.998003	2499,0	0	0.000998403	5|0|3|3	Deafness\x2c_autosomal_dominant_2b|not_specified|Nonsyndromic_Hearing_Loss\x2c_Dominant|Erythrokeratodermia_variabilis	C2675236:612644|CN169374|CN239435|C0265961:133200:ORPHA317:70041004	MedGen:OMIM|MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	2	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	H	A/A	0.994	5.07	CXB3_HUMAN	D	D	5.07	183	26.6	0.951	D	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	133	NA	NA	NA	NA	NA	NA
chr1	34785309	rs74315318	G	A	PASS	A	intron_variant	MODIFIER	RP1-34M23.5	ENSG00000255811	transcript	ENST00000542839.1	n.110+2679C>T	NA	1/1	NA	NA	NA	NA	NA	NA	NA	0.0005107	0.00199681	0.998003	2499,0	0	0.000998403	5|0|3|3	Deafness\x2c_autosomal_dominant_2b|not_specified|Nonsyndromic_Hearing_Loss\x2c_Dominant|Erythrokeratodermia_variabilis	C2675236:612644|CN169374|CN239435|C0265961:133200:ORPHA317:70041004	MedGen:OMIM|MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	2	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	H	A/A	0.994	5.07	CXB3_HUMAN	D	D	5.07	183	26.6	0.951	D	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	133	NA	NA	NA	NA	NA	NA
chr1	34785309	rs74315318	G	A	PASS	A	intragenic_variant	MODIFIER	SMIM12	ENSG00000163866	gene_variant	ENSG00000163866	n.34785309C>T	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0005107	0.00199681	0.998003	2499,0	0	0.000998403	5|0|3|3	Deafness\x2c_autosomal_dominant_2b|not_specified|Nonsyndromic_Hearing_Loss\x2c_Dominant|Erythrokeratodermia_variabilis	C2675236:612644|CN169374|CN239435|C0265961:133200:ORPHA317:70041004	MedGen:OMIM|MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	2	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	H	A/A	0.994	5.07	CXB3_HUMAN	D	D	5.07	183	26.6	0.951	D	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	133	NA	NA	NA	NA	NA	NA
chr1	34785342	rs117385606	G	A	PASS	A	missense_variant	MODERATE	GJB3	ENSG00000188910	transcript	ENST00000373362.3	c.580G>A	p.Ala194Thr	2/2	770/1797	194/270	580/813	NA	NA	NA	NA	0.0008813	0.00279553	0.997204	2497,0	0	0.00139776	5|3|3	Deafness\x2c_digenic\x2c_GJB2/GJB3|Nonsyndromic_Hearing_Loss\x2c_Dominant|Erythrokeratodermia_variabilis	C2673761|CN239435|C0265961:133200:ORPHA317:70041004	MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	L	A/A	0.756	4.16	CXB3_HUMAN	B	B	5.07	194	15.62	0.951	T	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	132	NA	NA	NA	NA	NA	NA
chr1	34785342	rs117385606	G	A	PASS	A	intron_variant	MODIFIER	RP1-34M23.5	ENSG00000255811	transcript	ENST00000542839.1	n.110+2646C>T	NA	1/1	NA	NA	NA	NA	NA	NA	NA	0.0008813	0.00279553	0.997204	2497,0	0	0.00139776	5|3|3	Deafness\x2c_digenic\x2c_GJB2/GJB3|Nonsyndromic_Hearing_Loss\x2c_Dominant|Erythrokeratodermia_variabilis	C2673761|CN239435|C0265961:133200:ORPHA317:70041004	MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	L	A/A	0.756	4.16	CXB3_HUMAN	B	B	5.07	194	15.62	0.951	T	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	132	NA	NA	NA	NA	NA	NA
chr1	34785342	rs117385606	G	A	PASS	A	intragenic_variant	MODIFIER	SMIM12	ENSG00000163866	gene_variant	ENSG00000163866	n.34785342C>T	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0008813	0.00279553	0.997204	2497,0	0	0.00139776	5|3|3	Deafness\x2c_digenic\x2c_GJB2/GJB3|Nonsyndromic_Hearing_Loss\x2c_Dominant|Erythrokeratodermia_variabilis	C2673761|CN239435|C0265961:133200:ORPHA317:70041004	MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	133200(3),220290(3),612644(3)	NA	Erythrokeratodermia~variabilis~et~progressiva,Deafness~autosomal~dominant~with~peripheral~neuropathy~(3)/~Deafness~autosomal~recessive~(3)/~Deafness~digenic~GJB2/GJB3,Deafness~autosomal~dominant~2B	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/DD,AD	NA	NA	NA	NA	NA	L	A/A	0.756	4.16	CXB3_HUMAN	B	B	5.07	194	15.62	0.951	T	Gjb3/Smim12	./E	./1.07E-01	63.81221986/67.30360934	0.145304857/0.198490371	NA	0.07323/3.71358	113444/2707	NA	NA	2.19212/303.93192	132	NA	NA	NA	NA	NA	NA
chr1	36098332	rs80358192	A	G	PASS	G	missense_variant	MODERATE	COL8A2	ENSG00000171812	transcript	ENST00000303143.9	c.1349T>C	p.Leu450Ser	2/2	1356/4447	450/703	1349/2112	NA	NA	NA	NA	9.311e-06	NA	NA	NA	NA	NA	5|5	Corneal_dystrophy\x2c_Fuchs_endothelial_1|Corneal_dystrophy\x2c_posterior_polymorphous\x2c_2	C1850959:136800|C1852795:609140	MedGen:OMIM|MedGen:OMIM	NA	NA	609140(3),136800(3)	NA	Corneal~dystrophy~posterior~polymorphous~2,Corneal~dystrophy~Fuchs~endothelial~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,AD	NA	NA	NA	NA	NA	N	N/N/N	1	4.38	CO8A2_HUMAN	B	B	4.38	450	10.27	1.184	T	Col8a2	N	NA	NA	NA	NA	5.33397	1296	NA	NA	722.29291	133	NA	NA	NA	NA	NA	NA
chr1	36098332	rs80358192	A	G	PASS	G	downstream_gene_variant	MODIFIER	ADPRHL2	ENSG00000116863	transcript	ENST00000373178.4	c.*4946A>G	NA	NA	NA	NA	NA	4400	NA	NA	NA	9.311e-06	NA	NA	NA	NA	NA	5|5	Corneal_dystrophy\x2c_Fuchs_endothelial_1|Corneal_dystrophy\x2c_posterior_polymorphous\x2c_2	C1850959:136800|C1852795:609140	MedGen:OMIM|MedGen:OMIM	NA	NA	609140(3),136800(3)	NA	Corneal~dystrophy~posterior~polymorphous~2,Corneal~dystrophy~Fuchs~endothelial~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,AD	NA	NA	NA	NA	NA	N	N/N/N	1	4.38	CO8A2_HUMAN	B	B	4.38	450	10.27	1.184	T	Col8a2	N	NA	NA	NA	NA	5.33397	1296	NA	NA	722.29291	133	NA	NA	NA	NA	NA	NA
chr1	36467597	rs121918426	G	A	PASS	A	missense_variant	MODERATE	CSF3R	ENSG00000119535	transcript	ENST00000373103.5	c.1919C>T	p.Thr640Ile	15/17	2467/3454	640/863	1919/2592	NA	NA	NA	NA	0.0005354	0.00399361	0.996006	2494,0	0	0.00199681	5	Hereditary_neutrophilia	C0543669:162830:ORPHA279943:129639005	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	617014(3)	NA	Neutropenia~severe~congenital~7~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	N/N/N/N/N/N/N/N	0	-0.531	././CSF3R_HUMAN/.	B	B	4.72	640	0.002	-0.15	T	Csf3r	N	7.86E-01	96.86836518	1.785787059	abnormal	5.09282	1441	csf3r	NA	642.4902	133	NA	NA	NA	NA	NA	NA
chr1	36467597	rs121918426	G	A	PASS	A	upstream_gene_variant	MODIFIER	MRPS15	ENSG00000116898	transcript	ENST00000373116.5	c.-3322C>T	NA	NA	NA	NA	NA	3160	NA	NA	NA	0.0005354	0.00399361	0.996006	2494,0	0	0.00199681	5	Hereditary_neutrophilia	C0543669:162830:ORPHA279943:129639005	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	617014(3)	NA	Neutropenia~severe~congenital~7~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	N/N/N/N/N/N/N/N	0	-0.531	././CSF3R_HUMAN/.	B	B	4.72	640	0.002	-0.15	T	Csf3r	N	7.86E-01	96.86836518	1.785787059	abnormal	5.09282	1441	csf3r	NA	642.4902	133	NA	NA	NA	NA	NA	NA
chr1	40074145	rs72937434	C	G	PASS	G	missense_variant	MODERATE	PPT1	ENSG00000131238	transcript	ENST00000433473.7	c.837G>C	p.Gln279His	9/9	1302/2742	279/306	837/921	NA	NA	NA	NA	0.006762	0.047524	0.950479	2380,5	0.00199681	0.0257588	255|3	not_specified|Neuronal_Ceroid-Lipofuscinosis\x2c_Recessive	CN169374|CN239323	MedGen|MedGen	NA	NA	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	D/D/D	0.999	1.37	././PPT1_HUMAN	B/P/P	P/B/P	5.78	176,205,279	24.9	0.852	D/D/D/D/.	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	130	NA	NA	NA	NA	NA	PPT1
chr1	40074145	rs72937434	C	G	PASS	G	downstream_gene_variant	MODIFIER	CAP1	ENSG00000131236	transcript	ENST00000372792.6	c.*2612C>G	NA	NA	NA	NA	NA	2610	NA	NA	NA	0.006762	0.047524	0.950479	2380,5	0.00199681	0.0257588	255|3	not_specified|Neuronal_Ceroid-Lipofuscinosis\x2c_Recessive	CN169374|CN239323	MedGen|MedGen	NA	NA	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	D/D/D	0.999	1.37	././PPT1_HUMAN	B/P/P	P/B/P	5.78	176,205,279	24.9	0.852	D/D/D/D/.	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	130	NA	NA	NA	NA	NA	PPT1
chr1	40080393	rs572153728	T	C	PASS	C	splice_region_variant&intron_variant	LOW	PPT1	ENSG00000131238	transcript	ENST00000433473.7	c.627+4A>G	NA	6/8	NA	NA	NA	NA	NA	NA	NA	0.002306	0.00758786	0.992412	2485,0	0	0.00379393	255	not_specified	CN169374	MedGen	NA	NA	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	142	NA	NA	NA	NA	NA	PPT1
chr1	40091361	rs1800205	A	G	PASS	G	structural_interaction_variant	HIGH	PPT1	ENSG00000131238	interaction	3GRO:A_109-A_134:ENST00000433473	c.401T>C	NA	4/9	NA	NA	NA	NA	NA	NA	NA	0.066	0.128594	0.861821	2158,24	0.00958466	0.0738818	255|3	not_specified|Neuronal_Ceroid-Lipofuscinosis\x2c_Recessive	CN169374|CN239323	MedGen|MedGen	NA	1	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	P/P	0.891	2.39	./PPT1_HUMAN	B	B	4.82	84,134	15.55	0.192	T/T/./T/T	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	89	NA	NA	NA	NA	NA	PPT1
chr1	40091361	rs1800205	A	G	PASS	G	structural_interaction_variant	HIGH	PPT1	ENSG00000131238	interaction	3GRO:A_134-A_223:ENST00000433473	c.401T>C	NA	4/9	NA	NA	NA	NA	NA	NA	NA	0.066	0.128594	0.861821	2158,24	0.00958466	0.0738818	255|3	not_specified|Neuronal_Ceroid-Lipofuscinosis\x2c_Recessive	CN169374|CN239323	MedGen|MedGen	NA	1	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	P/P	0.891	2.39	./PPT1_HUMAN	B	B	4.82	84,134	15.55	0.192	T/T/./T/T	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	89	NA	NA	NA	NA	NA	PPT1
chr1	40091361	rs1800205	A	G	PASS	G	structural_interaction_variant	HIGH	PPT1	ENSG00000131238	interaction	3GRO:B_109-B_134:ENST00000433473	c.401T>C	NA	4/9	NA	NA	NA	NA	NA	NA	NA	0.066	0.128594	0.861821	2158,24	0.00958466	0.0738818	255|3	not_specified|Neuronal_Ceroid-Lipofuscinosis\x2c_Recessive	CN169374|CN239323	MedGen|MedGen	NA	1	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	P/P	0.891	2.39	./PPT1_HUMAN	B	B	4.82	84,134	15.55	0.192	T/T/./T/T	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	89	NA	NA	NA	NA	NA	PPT1
chr1	40091361	rs1800205	A	G	PASS	G	structural_interaction_variant	HIGH	PPT1	ENSG00000131238	interaction	3GRO:B_134-B_223:ENST00000433473	c.401T>C	NA	4/9	NA	NA	NA	NA	NA	NA	NA	0.066	0.128594	0.861821	2158,24	0.00958466	0.0738818	255|3	not_specified|Neuronal_Ceroid-Lipofuscinosis\x2c_Recessive	CN169374|CN239323	MedGen|MedGen	NA	1	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	P/P	0.891	2.39	./PPT1_HUMAN	B	B	4.82	84,134	15.55	0.192	T/T/./T/T	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	89	NA	NA	NA	NA	NA	PPT1
chr1	40091361	rs1800205	A	G	PASS	G	missense_variant	MODERATE	PPT1	ENSG00000131238	transcript	ENST00000433473.7	c.401T>C	p.Ile134Thr	4/9	866/2742	134/306	401/921	NA	NA	NA	NA	0.066	0.128594	0.861821	2158,24	0.00958466	0.0738818	255|3	not_specified|Neuronal_Ceroid-Lipofuscinosis\x2c_Recessive	CN169374|CN239323	MedGen|MedGen	NA	1	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	P/P	0.891	2.39	./PPT1_HUMAN	B	B	4.82	84,134	15.55	0.192	T/T/./T/T	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	89	NA	NA	NA	NA	NA	PPT1
chr1	40091398	rs137852695	T	A	PASS	A	structural_interaction_variant	HIGH	PPT1	ENSG00000131238	interaction	3GRO:A_122-A_143:ENST00000433473	c.364A>T	NA	4/9	NA	NA	NA	NA	NA	NA	NA	0.0006425	0.00119808	0.998802	2501,0	0	0.000599042	5|5	Ceroid_lipofuscinosis_neuronal_1|not_provided	C1850451:256730:ORPHA228329|CN221809	MedGen:OMIM:Orphanet|MedGen	NA	NA	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	A/A	0.977	3.68	./PPT1_HUMAN	D	D	4.82	72,122	32	1.061	D/D/./D/D	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	133	NA	NA	NA	NA	NA	PPT1
chr1	40091398	rs137852695	T	A	PASS	A	structural_interaction_variant	HIGH	PPT1	ENSG00000131238	interaction	3GRO:A_122-A_206:ENST00000433473	c.364A>T	NA	4/9	NA	NA	NA	NA	NA	NA	NA	0.0006425	0.00119808	0.998802	2501,0	0	0.000599042	5|5	Ceroid_lipofuscinosis_neuronal_1|not_provided	C1850451:256730:ORPHA228329|CN221809	MedGen:OMIM:Orphanet|MedGen	NA	NA	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	A/A	0.977	3.68	./PPT1_HUMAN	D	D	4.82	72,122	32	1.061	D/D/./D/D	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	133	NA	NA	NA	NA	NA	PPT1
chr1	40091398	rs137852695	T	A	PASS	A	structural_interaction_variant	HIGH	PPT1	ENSG00000131238	interaction	3GRO:B_122-B_143:ENST00000433473	c.364A>T	NA	4/9	NA	NA	NA	NA	NA	NA	NA	0.0006425	0.00119808	0.998802	2501,0	0	0.000599042	5|5	Ceroid_lipofuscinosis_neuronal_1|not_provided	C1850451:256730:ORPHA228329|CN221809	MedGen:OMIM:Orphanet|MedGen	NA	NA	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	A/A	0.977	3.68	./PPT1_HUMAN	D	D	4.82	72,122	32	1.061	D/D/./D/D	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	133	NA	NA	NA	NA	NA	PPT1
chr1	40091398	rs137852695	T	A	PASS	A	structural_interaction_variant	HIGH	PPT1	ENSG00000131238	interaction	3GRO:B_122-B_206:ENST00000433473	c.364A>T	NA	4/9	NA	NA	NA	NA	NA	NA	NA	0.0006425	0.00119808	0.998802	2501,0	0	0.000599042	5|5	Ceroid_lipofuscinosis_neuronal_1|not_provided	C1850451:256730:ORPHA228329|CN221809	MedGen:OMIM:Orphanet|MedGen	NA	NA	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	A/A	0.977	3.68	./PPT1_HUMAN	D	D	4.82	72,122	32	1.061	D/D/./D/D	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	133	NA	NA	NA	NA	NA	PPT1
chr1	40091398	rs137852695	T	A	PASS	A	missense_variant&splice_region_variant	MODERATE	PPT1	ENSG00000131238	transcript	ENST00000433473.7	c.364A>T	p.Arg122Trp	4/9	829/2742	122/306	364/921	NA	NA	NA	NA	0.0006425	0.00119808	0.998802	2501,0	0	0.000599042	5|5	Ceroid_lipofuscinosis_neuronal_1|not_provided	C1850451:256730:ORPHA228329|CN221809	MedGen:OMIM:Orphanet|MedGen	NA	NA	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	A/A	0.977	3.68	./PPT1_HUMAN	D	D	4.82	72,122	32	1.061	D/D/./D/D	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	133	NA	NA	NA	NA	NA	PPT1
chr1	40091403	rs117284255	C	T	PASS	T	splice_region_variant&intron_variant	LOW	PPT1	ENSG00000131238	transcript	ENST00000433473.7	c.363-4G>A	NA	3/8	NA	NA	NA	NA	NA	NA	NA	0.008575	0.0183706	0.98123	2457,1	0.000399361	0.00958466	255|2|3	not_specified|Ceroid_lipofuscinosis_neuronal_1|Neuronal_Ceroid-Lipofuscinosis\x2c_Recessive	CN169374|C1850451:256730:ORPHA228329|CN239323	MedGen|MedGen:OMIM:Orphanet|MedGen	NA	1	256730(3)	NA	Ceroid~lipofuscinosis~neuronal~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ppt1	N	2.04E-01	41.90846898	-0.159704656	NA	5.14769	5538	NA	NA	659.10425	132	NA	NA	NA	NA	NA	PPT1
chr1	40271917	rs2076697	T	C	PASS	C	synonymous_variant	LOW	ZMPSTE24	ENSG00000084073	transcript	ENST00000372759.3	c.651T>C	p.Asp217Asp	6/10	816/3108	217/475	651/1428	NA	NA	NA	NA	0.106	0.201278	0.771565	1932,68	0.0271565	0.127796	255|1|2|2	not_specified|not_provided|Lethal_tight_skin_contracture_syndrome|Mandibuloacral_dysplasia	CN169374|CN221809|C0406585:275210:ORPHA1662:400128006|CN118835	MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	1	275210(3),608612(3)	NA	Restrictive~dermopathy~lethal,Mandibuloacral~dysplasia~with~type~B~lipodystrophy	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Zmpste24	E	5.64E-01	16.35999056	-0.648365105	NA	0.96505	10269	NA	NA	30.24713	96	NA	NA	NA	NA	NA	ZMPSTE24
chr1	40301233	rs148008235	C	T	PASS	T	synonymous_variant	LOW	COL9A2	ENSG00000049089	transcript	ENST00000372748.7	c.2019G>A	p.Ser673Ser	32/32	2116/2862	673/689	2019/2070	NA	NA	NA	NA	0.0005024	0.00199681	0.998003	2499,0	0	0.000998403	255	not_specified	CN169374	MedGen	NA	NA	614284(3),600204(3)	NA	?Stickler~syndrome~type~V,Epiphyseal~dysplasia~multiple~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Col9a2	NA	9.69E-02	96.40835103	1.690270544	NA	12.92194	1298	NA	NA	4219.57468	134	NA	NA	NA	NA	NA	NA
chr1	40301270	rs150687987	G	A	PASS	A	missense_variant	MODERATE	COL9A2	ENSG00000049089	transcript	ENST00000372748.7	c.1982C>T	p.Pro661Leu	32/32	2079/2862	661/689	1982/2070	NA	NA	NA	NA	0.002389	0.00119808	0.998802	2501,0	0	0.000599042	255|3|3	not_specified|Stickler_Syndrome\x2c_Recessive|Multiple_Epiphyseal_Dysplasia\x2c_Dominant	CN169374|CN239473|CN043640	MedGen|MedGen|MedGen	NA	NA	614284(3),600204(3)	NA	?Stickler~syndrome~type~V,Epiphyseal~dysplasia~multiple~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	D	0.243	5.6	CO9A2_HUMAN	D	D	5.6	661	34	1.036	D	Col9a2	NA	9.69E-02	96.40835103	1.690270544	NA	12.92194	1298	NA	NA	4219.57468	134	NA	NA	NA	NA	NA	NA
chr1	40301271	rs140041506	G	T	PASS	T	missense_variant	MODERATE	COL9A2	ENSG00000049089	transcript	ENST00000372748.7	c.1981C>A	p.Pro661Thr	32/32	2078/2862	661/689	1981/2070	NA	NA	NA	NA	0.004944	0.0127796	0.986422	2470,2	0.000798722	0.0071885	255|3|3	not_specified|Multiple_Epiphyseal_Dysplasia\x2c_Dominant|Stickler_Syndrome\x2c_Recessive	CN169374|CN043640|CN239473	MedGen|MedGen|MedGen	NA	NA	614284(3),600204(3)	NA	?Stickler~syndrome~type~V,Epiphyseal~dysplasia~multiple~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	L	D	0.26	5.6	CO9A2_HUMAN	D	D	5.6	661	24.7	1.036	D	Col9a2	NA	9.69E-02	96.40835103	1.690270544	NA	12.92194	1298	NA	NA	4219.57468	134	NA	NA	NA	NA	NA	NA
chr1	40818518	rs80358273	C	G	PASS	G	missense_variant	MODERATE	KCNQ4	ENSG00000117013	transcript	ENST00000347132.9	c.546C>G	p.Phe182Leu	4/14	628/4099	182/695	546/2088	NA	NA	NA	NA	0.0003055	0.00119808	0.998802	2501,0	0	0.000599042	5	DFNA_2_Nonsyndromic_Hearing_Loss	C2677637:600101	MedGen:OMIM	NA	NA	600101(3)	NA	Deafness~autosomal~dominant~2A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	N	A/A	1	4.11	./KCNQ4_HUMAN	B	B	5.04	182	19.93	0.92	T	Kcnq4	N	4.24E-02	15.76433121	-0.66859065	NA	5.10359	9132	NA	NA	646.02	132	NA	NA	NA	NA	NA	NA
chr1	42740005	rs118203979	C	T	PASS	T	missense_variant	MODERATE	CLDN19	ENSG00000164007	transcript	ENST00000296387.5	c.59G>A	p.Gly20Asp	1/5	250/2859	20/224	59/675	NA	NA	NA	NA	3.337e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Hypomagnesemia_5\x2c_renal\x2c_with_ocular_involvement	C1855466:248190	MedGen:OMIM	NA	NA	248190(3)	NA	Hypomagnesemia~5~renal~with~ocular~involvement	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	A/A/A	0.998	4.77	././CLD19_HUMAN	D	D	4.77	20	28.8	0.843	D	Cldn19	N	8.54E-02	84.93158764	0.681699246	NA	2.87433	149461	NA	NA	174.5966	132	NA	NA	NA	NA	NA	CLDN19
chr1	42757782	rs72659351	C	A	PASS	A	splice_donor_variant&intron_variant	HIGH	P3H1	ENSG00000117385	transcript	ENST00000236040.8	c.1080+1G>T	NA	5/13	NA	NA	NA	NA	NA	(P3H1|ENSG00000117385|1|1.00)	NA	0.0002224	0.00119808	0.998802	2501,0	0	0.000599042	5|5	Osteogenesis_imperfecta_type_8|not_provided	C1970458:610915|CN221809	MedGen:OMIM|MedGen	NA	NA	610915(3)	NA	Osteogenesis~imperfecta~type~VIII	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	D/D/D	0.933	5.84	NA	NA	NA	5.84	NA	25.9	0.935	NA	P3h1	N	NA	74.68152866	0.360092658	NA	NA	64175	NA	NA	NA	130	NA	NA	NA	NA	NA	LEPRE1
chr1	42759261	rs72659348	AG	A	VQSRTrancheINDEL99.00to100.00	A	frameshift_variant	HIGH	P3H1	ENSG00000117385	transcript	ENST00000236040.8	c.747delC	p.Tyr250fs	3/14	788/2993	249/804	747/2415	NA	NA	(P3H1|ENSG00000117385|1|1.00)	NA	1.647e-05	NA	NA	NA	NA	NA	5	Osteogenesis_imperfecta_type_8	C1970458:610915	MedGen:OMIM	NA	NA	610915(3)	NA	Osteogenesis~imperfecta~type~VIII	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P3h1	N	NA	74.68152866	0.360092658	NA	NA	64175	NA	NA	NA	130	NA	NA	NA	NA	NA	LEPRE1
chr1	42830821	rs56047316	G	A	PASS	A	missense_variant	MODERATE	ERMAP	ENSG00000164010	transcript	ENST00000372514.7	c.139G>A	p.Glu47Lys	3/11	323/3369	47/475	139/1428	NA	NA	NA	NA	0.0002972	0.00119808	0.998802	2501,0	0	0.000599042	255	Antigen_in_Scianna_blood_group_system	C0443842:111750:115720000	MedGen:OMIM:SNOMED_CT	NA	NA	NA	NA	NA	NA	NA	NA	NA	111750(3),111620(3)	NA	[Blood~group~Scianna~system],[Blood~group~Radin]	-,-	NA	NA	NA	NA	NA	NA	NA	L	A/A/A	0.185	-3.72	./ERMAP_HUMAN	B	P/B	4.7	108,47	16.40	-0.232	T	Ermap	NA	9.66E-01	84.64260439	0.666922772	NA	4.74487	114625	NA	NA	543.71214	132	NA	NA	NA	NA	NA	NA
chr1	42830851	rs56025238	G	A	PASS	A	missense_variant	MODERATE	ERMAP	ENSG00000164010	transcript	ENST00000372514.7	c.169G>A	p.Gly57Arg	3/11	353/3369	57/475	169/1428	NA	NA	NA	NA	0.001813	0.00119808	0.998802	2501,0	0	0.000599042	5	SCIANNA_BLOOD_GROUP_SYSTEM\x2c_SC:-1\x2c2	.	.	NA	NA	NA	NA	NA	NA	NA	NA	NA	111750(3),111620(3)	NA	[Blood~group~Scianna~system],[Blood~group~Radin]	-,-	NA	NA	NA	NA	NA	NA	NA	L	A/A/A	0.001	1.5	./ERMAP_HUMAN	P/B	D/P	4.52	118,57	6.793	0.056	T	Ermap	NA	9.66E-01	84.64260439	0.666922772	NA	4.74487	114625	NA	NA	543.71214	132	NA	NA	NA	NA	NA	NA
chr1	42927083	rs146879902	G	A	PASS	A	synonymous_variant	LOW	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.1437C>T	p.Pro479Pro	10/10	1959/3667	479/492	1437/1479	NA	NA	NA	NA	0.0005354	0.00119808	0.998802	2501,0	0	0.000599042	255|3|3	not_specified|Glucose_transporter_type_1_deficiency_syndrome|Dystonia	CN169374|C1847501:ORPHA71277|C0393593	MedGen|MedGen:Orphanet|MedGen	NA	NA	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	134	NA	NA	NA	NA	NA	NA
chr1	42927148	rs13306758	G	T	PASS	T	synonymous_variant	LOW	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.1372C>A	p.Arg458Arg	10/10	1894/3667	458/492	1372/1479	NA	NA	NA	NA	0.002932	0.0111821	0.988019	2474,2	0.000798722	0.00638978	255,2|0|3|3	Epilepsy\x2c_idiopathic_generalized\x2c_susceptibility_to\x2c_12,not_specified|GLUT1_deficiency_syndrome_1|Glucose_transporter_type_1_deficiency_syndrome|Dystonia	C3553859:614847,CN169374|CN030711:606777|C1847501:ORPHA71277|C0393593	MedGen:OMIM,MedGen|MedGen:OMIM|MedGen:Orphanet|MedGen	NA	NA	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	121	NA	NA	NA	NA	NA	NA
chr1	42927224	rs75485205	G	A	PASS	A	synonymous_variant	LOW	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.1296C>T	p.Tyr432Tyr	10/10	1818/3667	432/492	1296/1479	NA	NA	NA	NA	0.0009142	0.00399361	0.996006	2494,0	0	0.00199681	2|0,5	not_specified|GLUT1_deficiency_syndrome_1,GLUT1_deficiency_syndrome_1	CN169374|CN030711:606777,CN030711:606777	MedGen|MedGen:OMIM,MedGen:OMIM	NA	1	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	132	MIRb|SINE|MIR	NA	NA	NA	NA	NA
chr1	42927667	rs148800393	C	T	PASS	T	missense_variant	MODERATE	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.1216G>A	p.Val406Ile	9/10	1738/3667	406/492	1216/1479	NA	NA	NA	NA	0.0001647	0.00119808	0.998802	2501,0	0	0.000599042	4	not_provided	CN221809	MedGen	NA	NA	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	N	D	0.987	5.82	GTR1_HUMAN	B	P	5.82	406	23.7	0.935	T	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	134	NA	NA	NA	NA	NA	NA
chr1	42929202	rs531385270	AG	A	PASS	A	splice_region_variant&intron_variant	LOW	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.972+7delC	NA	7/9	NA	NA	NA	NA	NA	NA	NA	0.0002141	NA	NA	NA	NA	NA	255|0|0	not_specified|Dystonia|Glucose_transporter_type_1_deficiency_syndrome	CN169374|C0393593|C1847501:ORPHA71277	MedGen|MedGen|MedGen:Orphanet	NA	NA	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	142	NA	NA	NA	NA	NA	NA
chr1	42929683	rs78388808	G	A	PASS	A	synonymous_variant	LOW	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.777C>T	p.Ile259Ile	6/10	1299/3667	259/492	777/1479	NA	NA	NA	NA	0.0007578	0.000798722	0.999201	2502,0	0	0.000399361	0|255|3|3	GLUT1_deficiency_syndrome_1|not_specified|Dystonia|Glucose_transporter_type_1_deficiency_syndrome	CN030711:606777|CN169374|C0393593|C1847501:ORPHA71277	MedGen:OMIM|MedGen|MedGen|MedGen:Orphanet	NA	NA	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	131	NA	NA	NA	NA	NA	NA
chr1	42929869	rs139492241	G	A	PASS	A	splice_region_variant&intron_variant	LOW	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.679+4C>T	NA	5/9	NA	NA	NA	NA	NA	NA	NA	0.0001812	0.000399361	0.999601	2503,0	0	0.000199681	255,0|2	not_specified,GLUT1_deficiency_syndrome_1|not_specified	CN169374,CN030711:606777|CN169374	MedGen,MedGen:OMIM|MedGen	NA	NA	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	134	NA	NA	NA	NA	NA	NA
chr1	42930635	rs115541691	G	A	PASS	A	synonymous_variant	LOW	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.507C>T	p.Leu169Leu	4/10	1029/3667	169/492	507/1479	NA	NA	NA	NA	0.0003295	0.00279553	0.997204	2497,0	0	0.00139776	255	not_specified	CN169374	MedGen	NA	NA	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	132	NA	NA	NA	NA	NA	NA
chr1	42930725	rs144538918	G	A	PASS	A	synonymous_variant	LOW	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.417C>T	p.Phe139Phe	4/10	939/3667	139/492	417/1479	NA	NA	NA	NA	0.001581	0.0167732	0.982827	2461,1	0.000399361	0.00878594	255|3|3	not_specified|Dystonia|Glucose_transporter_type_1_deficiency_syndrome	CN169374|C0393593|C1847501:ORPHA71277	MedGen|MedGen|MedGen:Orphanet	NA	NA	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	134	NA	NA	NA	NA	NA	NA
chr1	42930873	rs369273744	A	G	PASS	G	splice_region_variant&intron_variant	LOW	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.276-7T>C	NA	3/9	NA	NA	NA	NA	NA	NA	NA	0.0001647	0.000399361	0.999601	2503,0	0	0.000199681	255	not_specified	CN169374	MedGen	NA	NA	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	138	NA	NA	NA	NA	NA	NA
chr1	42931047	rs202060209	G	T	PASS	T	splice_region_variant&synonymous_variant	LOW	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.274C>A	p.Arg92Arg	3/10	796/3667	92/492	274/1479	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5,2|3|3	GLUT1_deficiency_syndrome_2,not_specified|Glucose_transporter_type_1_deficiency_syndrome|Dystonia	C1842534:612126:ORPHA98811,CN169374|C1847501:ORPHA71277|C0393593	MedGen:OMIM:Orphanet,MedGen|MedGen:Orphanet|MedGen	NA	NA	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	137	NA	NA	NA	NA	NA	NA
chr1	42943313	rs34025424	C	T	PASS	T	synonymous_variant	LOW	SLC2A1	ENSG00000117394	transcript	ENST00000426263.7	c.27G>A	p.Thr9Thr	2/10	549/3667	9/492	27/1479	NA	NA	NA	NA	0.001615	0.00119808	0.998802	2501,0	0	0.000599042	255|3|3	not_specified|Glucose_transporter_type_1_deficiency_syndrome|Dystonia	CN169374|C1847501:ORPHA71277|C0393593	MedGen|MedGen:Orphanet|MedGen	NA	NA	608885(3),612126(3),606777(3),601042(3),601042(3)	NA	Stomatin-deficient~cryohydrocytosis~with~neurologic~defects,GLUT1~deficiency~syndrome~2~childhood~onset,GLUT1~deficiency~syndrome~1~infantile~onset~severe,Dystonia~9,Dystonia~9	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	614847(3),614847(3),614847(3),614847(3)	AD,AD,AR/AD,AD,AD	NA	NA	NA	NA	{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12},{Epilepsy~idiopathic~generalized~susceptibility~to~12}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc2a1	E	9.01E-02	7.661004954	-1.045216355	abnormal	0.56049	6513	slc2a1b	vitCBPathway	15.72909	126	NA	NA	NA	NA	NA	NA
chr1	43338136	rs17292650	G	T	PASS	T	missense_variant	MODERATE	MPL	ENSG00000117400	transcript	ENST00000372470.7	c.117G>T	p.Lys39Asn	2/12	159/1950	39/635	117/1908	NA	NA	NA	NA	0.004406	0.0255591	0.972843	2436,4	0.00159744	0.014377	255|1|3|3	Thrombocytosis\x2c_benign_familial_microcytic|not_specified|Essential_thrombocythemia|Congenital_amegakaryocytic_thrombocytopenia	C1865987:601977|CN169374|C0040028:187950:ORPHA3318|C1327915:604498:ORPHA3319	MedGen:OMIM|MedGen|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet	NA	1	604498(3),601977(3),254450(3)	NA	Thrombocytopenia~congenital~amegakaryocytic,Thrombocythemia~2,Myelofibrosis~with~myeloid~metaplasia~somatic	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD/Smu,-	NA	NA	NA	NA	NA	N	N/N	1	1.65	./TPOR_HUMAN/.	B	B	5.64	32,39,39	13.23	0.072	T/T/.	Mpl	N	3.43E-01	20.82448691	-0.530852121	NA	3.49416	4352	NA	TPOPathway	264.93653	123	NA	NA	NA	NA	NA	MPL
chr1	43338634	rs28928907	G	C	PASS	C	missense_variant	MODERATE	MPL	ENSG00000117400	transcript	ENST00000372470.7	c.305G>C	p.Arg102Pro	3/12	347/1950	102/635	305/1908	NA	NA	NA	NA	0.0004612	0.000399361	0.999601	2503,0	0	0.000199681	5|1	Congenital_amegakaryocytic_thrombocytopenia|not_specified	C1327915:604498:ORPHA3319|CN169374	MedGen:OMIM:Orphanet|MedGen	NA	NA	604498(3),601977(3),254450(3)	NA	Thrombocytopenia~congenital~amegakaryocytic,Thrombocythemia~2,Myelofibrosis~with~myeloid~metaplasia~somatic	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD/Smu,-	NA	NA	NA	NA	NA	M	A/A	0.947	5.56	./TPOR_HUMAN/.	D	D	5.56	95,102,102	25.8	1.048	T/T/.	Mpl	N	3.43E-01	20.82448691	-0.530852121	NA	3.49416	4352	NA	TPOPathway	264.93653	133	NA	NA	NA	NA	NA	MPL
chr1	43338704	rs587778515	CT	C	PASS	C	frameshift_variant	HIGH	MPL	ENSG00000117400	transcript	ENST00000372470.7	c.378delT	p.Phe126fs	3/12	420/1950	126/635	378/1908	NA	INFO_REALIGN_3_PRIME	(MPL|ENSG00000117400|1|1.00)	NA	4.118e-05	NA	NA	NA	NA	NA	1|5	not_specified|not_provided	CN169374|CN221809	MedGen|MedGen	NA	NA	604498(3),601977(3),254450(3)	NA	Thrombocytopenia~congenital~amegakaryocytic,Thrombocythemia~2,Myelofibrosis~with~myeloid~metaplasia~somatic	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD/Smu,-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mpl	N	3.43E-01	20.82448691	-0.530852121	NA	3.49416	4352	NA	TPOPathway	264.93653	142	NA	NA	NA	NA	NA	MPL
chr1	43425193	rs140831372	C	T	PASS	T	synonymous_variant	LOW	SZT2	ENSG00000198198	transcript	ENST00000634258.1	c.2631C>T	p.Thr877Thr	18/72	2631/10299	877/3432	2631/10299	NA	NA	NA	NA	0.006952	0.00838658	0.991613	2483,0	0	0.00419329	255	not_specified	CN169374	MedGen	NA	NA	615476(3)	NA	Epileptic~encephalopathy~early~infantile~18	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Szt2	E	NA	NA	NA	NA	8.52940	23334	NA	NA	2151.43823	134	NA	NA	NA	NA	NA	NA
chr1	43437684	rs149812437	A	T	PASS	T	missense_variant	MODERATE	SZT2	ENSG00000198198	transcript	ENST00000634258.1	c.6380A>T	p.Tyr2127Phe	45/72	6380/10299	2127/3432	6380/10299	NA	NA	NA	NA	0.000593	0.00319489	0.996805	2496,0	0	0.00159744	255	not_specified	CN169374	MedGen	NA	NA	615476(3)	NA	Epileptic~encephalopathy~early~infantile~18	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	N/N	0.996	-2.68	NA	B	B	5.63	2070	5.623	-0.203	T	Szt2	E	NA	NA	NA	NA	8.52940	23334	NA	NA	2151.43823	134	NA	NA	NA	NA	NA	NA
chr1	43824858	rs37458	A	G	PASS	G	missense_variant	MODERATE	ST3GAL3	ENSG00000126091	transcript	ENST00000262915.7	c.382A>G	p.Thr128Ala	5/13	573/2470	128/444	382/1335	NA	NA	NA	NA	0.271	0.348243	0.589457	1476,156	0.0623003	0.236422	255	not_specified	CN169374	MedGen	NA	2	611090(3),615006(3)	NA	Mental~retardation~autosomal~recessive~12,Epileptic~encephalopathy~early~infantile~15	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P/P	0	-0.0277	NA	B	B	2.01	97,113,128	0.001	-0.088	T	St3gal3	NA	5.89E-01	29.16371786	-0.358119787	NA	1.04396	6487	NA	NA	34.04143	76	MER5B|DNA|hAT-Charlie	NA	NA	NA	NA	NA
chr1	43898228	rs114112844	T	C	PASS	C	splice_region_variant&intron_variant	LOW	ST3GAL3	ENSG00000126091	transcript	ENST00000262915.7	c.605-7T>C	NA	7/12	NA	NA	NA	NA	NA	NA	NA	0.003097	0.0171725	0.982827	2461,0	0	0.00858626	255	not_specified	CN169374	MedGen	NA	NA	611090(3),615006(3)	NA	Mental~retardation~autosomal~recessive~12,Epileptic~encephalopathy~early~infantile~15	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	St3gal3	NA	5.89E-01	29.16371786	-0.358119787	NA	1.04396	6487	NA	NA	34.04143	132	NA	NA	NA	NA	NA	NA
chr1	43920773	rs80055718	G	A	PASS	A	intron_variant	MODIFIER	ST3GAL3	ENSG00000126091	transcript	ENST00000262915.7	c.1099-9G>A	NA	11/12	NA	NA	NA	NA	NA	NA	NA	0.046	0.0395367	0.958866	2401,4	0.00159744	0.0213658	255	not_specified	CN169374	MedGen	NA	1	611090(3),615006(3)	NA	Mental~retardation~autosomal~recessive~12,Epileptic~encephalopathy~early~infantile~15	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	St3gal3	NA	5.89E-01	29.16371786	-0.358119787	NA	1.04396	6487	NA	NA	34.04143	132	NA	NA	NA	NA	NA	NA
chr1	44829443	rs56126236	CAG	C	PASS	C	frameshift_variant	HIGH	PTCH2	ENSG00000117425	transcript	ENST00000372192.3	c.1172_1173delCT	p.Ser391fs	9/22	1304/4225	391/1203	1172/3612	NA	NA	(PTCH2|ENSG00000117425|1|1.00)	NA	0.0002389	0.00119808	0.998802	2501,0	0	0.000599042	5	Medulloblastoma	D008527:C0025149:155255:ORPHA616	MeSH:MedGen:OMIM:Orphanet	NA	NA	155255(3),109400(3),605462(3)	NA	Medulloblastoma~somatic,Basal~cell~nevus~syndrome,Basal~cell~carcinoma~somatic	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,AD,-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ptch2	N	2.91E-02	3.467799009	-1.517642441	abnormal	4.57158	8643	ptch2	NA	494.343	129	NA	NA	NA	NA	NA	NA
chr1	44874670	rs77068026	A	C	PASS	C	splice_region_variant&intron_variant	LOW	EIF2B3	ENSG00000070785	transcript	ENST00000360403.6	c.1202+8T>G	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.019	0.0279553	0.970447	2430,4	0.00159744	0.0155751	255|3	not_specified|Leukoencephalopathy_with_vanishing_white_matter	CN169374|C1858991:603896	MedGen|MedGen:OMIM	NA	NA	603896(3)	NA	Leukoencephalopathy~with~vanishing~white~matter	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	N/N	0.627	2.49	NA	B	B	4.79	404	7.246	1.199	T	Eif2b3	NA	1.22E-01	45.12856806	-0.115612493	NA	1.32992	8891	NA	vegfPathway	47.17108	131	NA	NA	NA	NA	NA	NA
chr1	44978366	rs11556200	G	A	PASS	A	synonymous_variant	LOW	EIF2B3	ENSG00000070785	transcript	ENST00000360403.6	c.243C>T	p.Asp81Asp	3/12	370/1659	81/452	243/1359	NA	NA	NA	NA	0.259	0.380591	0.513179	1285,266	0.10623	0.296526	255|2	not_specified|Leukoencephalopathy_with_vanishing_white_matter	CN169374|C1858991:603896	MedGen|MedGen:OMIM	NA	NA	603896(3)	NA	Leukoencephalopathy~with~vanishing~white~matter	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Eif2b3	NA	1.22E-01	45.12856806	-0.115612493	NA	1.32992	8891	NA	vegfPathway	47.17108	120	NA	NA	NA	NA	NA	NA
chr1	44978464	rs72887005	T	C	PASS	C	splice_region_variant&intron_variant	LOW	EIF2B3	ENSG00000070785	transcript	ENST00000360403.6	c.149-4A>G	NA	2/11	NA	NA	NA	NA	NA	NA	NA	0.02	0.100639	0.88139	2207,45	0.0179712	0.0682907	255|2	not_specified|Leukoencephalopathy_with_vanishing_white_matter	CN169374|C1858991:603896	MedGen|MedGen:OMIM	NA	NA	603896(3)	NA	Leukoencephalopathy~with~vanishing~white~matter	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Eif2b3	NA	1.22E-01	45.12856806	-0.115612493	NA	1.32992	8891	NA	vegfPathway	47.17108	130	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3Q:A_292-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3Q:A_297-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3Q:A_301-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3R:A_297-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3R:A_301-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3S:A_292-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3S:A_297-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3S:A_301-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3T:A_292-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3T:A_297-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3T:A_301-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3V:A_292-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3W:A_292-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3W:A_301-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3Y:A_292-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1R3Y:A_297-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	1URO:A_292-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	2Q6Z:A_297-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	2Q71:A_292-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	2Q71:A_297-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	3GVV:A_297-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	3GVV:A_301-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	3GVW:A_292-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	3GVW:A_297-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	structural_interaction_variant	HIGH	UROD	ENSG00000126088	interaction	3GW3:A_292-A_332:ENST00000246337	c.995G>A	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	missense_variant	MODERATE	UROD	ENSG00000126088	transcript	ENST00000246337.8	c.995G>A	p.Arg332His	10/10	1114/1300	332/367	995/1104	NA	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	upstream_gene_variant	MODIFIER	HECTD3	ENSG00000126107	transcript	ENST00000372172.4	c.-4132C>T	NA	NA	NA	NA	NA	4060	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45015389	rs121918066	G	A	PASS	A	downstream_gene_variant	MODIFIER	ZSWIM5	ENSG00000162415	transcript	ENST00000359600.5	c.*3065C>T	NA	NA	NA	NA	NA	1010	NA	NA	NA	0.0003871	0.00119808	0.998802	2501,0	0	0.000599042	5	Familial_porphyria_cutanea_tarda	C0268323:176100:59229005	MedGen:OMIM:SNOMED_CT	NA	NA	176100(3),176100(3)	NA	Porphyria~hepatoerythropoietic,Porphyria~cutanea~tarda	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	A	0.416	5.19	DCUP_HUMAN	B	B	5.19	332	23.4	1.048	T	Urod	E	1.80E-01	61.73036093	0.106667882	abnormal	1.65063	7389	urod	ahspPathway	64.67369	133	NA	NA	NA	NA	NA	NA
chr1	45329371	rs3219496	G	T	PASS	T	missense_variant	MODERATE	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.1585C>A	p.Leu529Met	16/16	1801/1929	529/549	1585/1650	NA	NA	NA	NA	0.002487	0.00399361	0.996006	2494,0	0	0.00199681	2|255|3|2|3	not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|MYH-associated_polyposis|Carcinoma_of_colon	CN221809|C0027672:699346009|CN169374|C1837991:608456:ORPHA247798|C0699790:114500:269533000	MedGen|MedGen:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MedGen:OMIM:SNOMED_CT	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	M	D/D/D/D/D/D/D/D/D/D/D/D/D/N	0.977	4.42	././././MUTYH_HUMAN/././.	D/B/B/P/B/B/B/D	D/P/P/P/P/P/P/D	4.42	210,529,526,516,526,515,409,502	24.2	1.048	T/T/T/T/T/T/T/T/T/T/T/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	106	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45329371	rs3219496	G	T	PASS	T	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*1107G>T	NA	NA	NA	NA	NA	838	NA	NA	NA	0.002487	0.00399361	0.996006	2494,0	0	0.00199681	2|255|3|2|3	not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|MYH-associated_polyposis|Carcinoma_of_colon	CN221809|C0027672:699346009|CN169374|C1837991:608456:ORPHA247798|C0699790:114500:269533000	MedGen|MedGen:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MedGen:OMIM:SNOMED_CT	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	M	D/D/D/D/D/D/D/D/D/D/D/D/D/N	0.977	4.42	././././MUTYH_HUMAN/././.	D/B/B/P/B/B/B/D	D/P/P/P/P/P/P/D	4.42	210,529,526,516,526,515,409,502	24.2	1.048	T/T/T/T/T/T/T/T/T/T/T/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	106	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45329412	rs140118273	G	A	PASS	A	missense_variant	MODERATE	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.1544C>T	p.Ser515Phe	16/16	1760/1929	515/549	1544/1650	NA	NA	NA	NA	0.007874	0.0091853	0.990815	2481,0	0	0.00459265	2|255|2|2	not_provided|MYH-associated_polyposis|not_specified|Hereditary_cancer-predisposing_syndrome	CN221809|C1837991:608456:ORPHA247798|CN169374|C0027672:699346009	MedGen|MedGen:OMIM:Orphanet|MedGen|MedGen:SNOMED_CT	NA	1	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	L	N/N/N/N/N/N/N/N/N/N/N/N/N/N	0.089	0.173	././././MUTYH_HUMAN/././.	B	P/B/B/B/B/B/B/B	4.5	196,515,512,502,512,501,395,488	16.82	-0.253	D/T/D/T/D/T/D/D/D/D/D/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	134	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45329412	rs140118273	G	A	PASS	A	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*1148G>A	NA	NA	NA	NA	NA	879	NA	NA	NA	0.007874	0.0091853	0.990815	2481,0	0	0.00459265	2|255|2|2	not_provided|MYH-associated_polyposis|not_specified|Hereditary_cancer-predisposing_syndrome	CN221809|C1837991:608456:ORPHA247798|CN169374|C0027672:699346009	MedGen|MedGen:OMIM:Orphanet|MedGen|MedGen:SNOMED_CT	NA	1	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	L	N/N/N/N/N/N/N/N/N/N/N/N/N/N	0.089	0.173	././././MUTYH_HUMAN/././.	B	P/B/B/B/B/B/B/B	4.5	196,515,512,502,512,501,395,488	16.82	-0.253	D/T/D/T/D/T/D/D/D/D/D/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	134	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45331220	rs121908381	C	A	PASS	A	stop_gained	HIGH	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.1438G>T	p.Glu480*	14/16	1654/1929	480/549	1438/1650	NA	NA	(MUTYH|ENSG00000132781|1|1.00)	(MUTYH|ENSG00000132781|1|1.00)	9.884e-05	0.00359425	0.996406	2495,0	0	0.00179712	5|5|5	MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome|not_provided	C1837991:608456:ORPHA247798|C0027672:699346009|CN221809	MedGen:OMIM:Orphanet|MedGen:SNOMED_CT|MedGen	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	NA	A/A/A/A/A/A/A/A/A/A/A/A/A/A	0.514	5.16	NA	NA	NA	5.16	NA	38	0.932	NA	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	133	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45331220	rs121908381	C	A	PASS	A	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*2956C>A	NA	NA	NA	NA	NA	2687	NA	(MUTYH|ENSG00000132781|1|1.00)	(MUTYH|ENSG00000132781|1|1.00)	9.884e-05	0.00359425	0.996406	2495,0	0	0.00179712	5|5|5	MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome|not_provided	C1837991:608456:ORPHA247798|C0027672:699346009|CN221809	MedGen:OMIM:Orphanet|MedGen:SNOMED_CT|MedGen	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	NA	A/A/A/A/A/A/A/A/A/A/A/A/A/A	0.514	5.16	NA	NA	NA	5.16	NA	38	0.932	NA	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	133	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45331485	rs144079536	G	T	PASS	T	missense_variant	MODERATE	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.1258C>A	p.Leu420Met	13/16	1474/1929	420/549	1258/1650	NA	NA	NA	NA	0.0005848	0.000399361	0.999601	2503,0	0	0.000199681	0,0|255|0|0	MYH-associated_polyposis,not_provided|Hereditary_cancer-predisposing_syndrome|MYH-associated_polyposis|not_specified	C1837991:608456:ORPHA247798,CN221809|C0027672:699346009|C1837991:608456:ORPHA247798|CN169374	MedGen:OMIM:Orphanet,MedGen|MedGen:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	M	D/D/D/D/D/D/D/D/D/D/D/D/D/D	0.919	4.5	././././MUTYH_HUMAN/././.	D/B/B/P/B/B/B/B	D/B/B/B/B/B/B/B	5.4	101,420,417,407,417,406,300,393	21.6	1.048	D/T/T/T/T/T/D/T/T/D/D/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	134	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45331485	rs144079536	G	T	PASS	T	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*3221G>T	NA	NA	NA	NA	NA	2952	NA	NA	NA	0.0005848	0.000399361	0.999601	2503,0	0	0.000199681	0,0|255|0|0	MYH-associated_polyposis,not_provided|Hereditary_cancer-predisposing_syndrome|MYH-associated_polyposis|not_specified	C1837991:608456:ORPHA247798,CN221809|C0027672:699346009|C1837991:608456:ORPHA247798|CN169374	MedGen:OMIM:Orphanet,MedGen|MedGen:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	M	D/D/D/D/D/D/D/D/D/D/D/D/D/D	0.919	4.5	././././MUTYH_HUMAN/././.	D/B/B/P/B/B/B/B	D/B/B/B/B/B/B/B	5.4	101,420,417,407,417,406,300,393	21.6	1.048	D/T/T/T/T/T/D/T/T/D/D/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	134	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45331529	rs529008617	G	A	PASS	A	missense_variant	MODERATE	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.1214C>T	p.Pro405Leu	13/16	1430/1929	405/549	1214/1650	NA	NA	NA	NA	9.884e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5	Hereditary_cancer-predisposing_syndrome|Carcinoma_of_colon|MYH-associated_polyposis	C0027672:699346009|C0699790:114500:269533000|C1837991:608456:ORPHA247798	MedGen:SNOMED_CT|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	H	D/D/D/D/D/D/D/D/D/D/D/D/D/D	0.998	4.64	././././MUTYH_HUMAN/././.	D	D	5.55	86,405,402,392,402,391,285,378	25.7	1.048	D/D/D/D/D/D/D/D/D/D/D/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	142	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45331529	rs529008617	G	A	PASS	A	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*3265G>A	NA	NA	NA	NA	NA	2996	NA	NA	NA	9.884e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5	Hereditary_cancer-predisposing_syndrome|Carcinoma_of_colon|MYH-associated_polyposis	C0027672:699346009|C0699790:114500:269533000|C1837991:608456:ORPHA247798	MedGen:SNOMED_CT|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	H	D/D/D/D/D/D/D/D/D/D/D/D/D/D	0.998	4.64	././././MUTYH_HUMAN/././.	D	D	5.55	86,405,402,392,402,391,285,378	25.7	1.048	D/D/D/D/D/D/D/D/D/D/D/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	142	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45331556	rs36053993	C	T	PASS	T	missense_variant&splice_region_variant	MODERATE	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.1187G>A	p.Gly396Asp	13/16	1403/1929	396/549	1187/1650	NA	NA	NA	NA	0.002776	0.00479233	0.995208	2492,0	0	0.00239617	5|5|5|5|1|5	MYH-associated_polyposis|Endometrial_carcinoma|not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Carcinoma_of_colon	C1837991:608456:ORPHA247798|C0476089:608089:254878006|CN221809|C0027672:699346009|CN169374|C0699790:114500:269533000	MedGen:OMIM:Orphanet|MedGen:OMIM:SNOMED_CT|MedGen|MedGen:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT	NA	2	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	H	A/A/A/A/A/A/A/A/A/A/A/A/A/A	0.98	5.4	././././MUTYH_HUMAN/././.	D	D	5.4	77,396,393,383,393,382,276,369	29.4	0.935	D/D/D/D/D/D/D/D/D/D/D/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	126	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45331556	rs36053993	C	T	PASS	T	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*3292C>T	NA	NA	NA	NA	NA	3023	NA	NA	NA	0.002776	0.00479233	0.995208	2492,0	0	0.00239617	5|5|5|5|1|5	MYH-associated_polyposis|Endometrial_carcinoma|not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Carcinoma_of_colon	C1837991:608456:ORPHA247798|C0476089:608089:254878006|CN221809|C0027672:699346009|CN169374|C0699790:114500:269533000	MedGen:OMIM:Orphanet|MedGen:OMIM:SNOMED_CT|MedGen|MedGen:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT	NA	2	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	H	A/A/A/A/A/A/A/A/A/A/A/A/A/A	0.98	5.4	././././MUTYH_HUMAN/././.	D	D	5.4	77,396,393,383,393,382,276,369	29.4	0.935	D/D/D/D/D/D/D/D/D/D/D/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	126	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45331729	rs35352891	G	A	PASS	A	missense_variant	MODERATE	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.1118C>T	p.Ala373Val	12/16	1334/1929	373/549	1118/1650	NA	NA	NA	NA	0.0003789	0.00279553	0.997204	2497,0	0	0.00139776	0|255|3	not_provided|MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome	CN221809|C1837991:608456:ORPHA247798|C0027672:699346009	MedGen|MedGen:OMIM:Orphanet|MedGen:SNOMED_CT	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	M	D/D/D/D/D/D/D/D/D/D/D/D/D/D	0.987	5.67	./././MUTYH_HUMAN/././.	B	P/B/P/B/P/P/P	5.67	373,370,360,370,359,253,346	21.1	1.048	T/T/T/D/T/D/T/T/T/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	126	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45331729	rs35352891	G	A	PASS	A	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*3465G>A	NA	NA	NA	NA	NA	3196	NA	NA	NA	0.0003789	0.00279553	0.997204	2497,0	0	0.00139776	0|255|3	not_provided|MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome	CN221809|C1837991:608456:ORPHA247798|C0027672:699346009	MedGen|MedGen:OMIM:Orphanet|MedGen:SNOMED_CT	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	M	D/D/D/D/D/D/D/D/D/D/D/D/D/D	0.987	5.67	./././MUTYH_HUMAN/././.	B	P/B/P/B/P/P/P	5.67	373,370,360,370,359,253,346	21.1	1.048	T/T/T/D/T/D/T/T/T/.	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	126	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45332088	rs77542170	T	C	PASS	C	splice_acceptor_variant&intron_variant	HIGH	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.934-2A>G	NA	10/15	NA	NA	NA	NA	NA	(MUTYH|ENSG00000132781|1|1.00)	NA	0.001021	0.00519169	0.994409	2490,1	0.000399361	0.00299521	4|1|0|5	MYH-associated_polyposis|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided	C1837991:608456:ORPHA247798|CN169374|C0027672:699346009|CN221809	MedGen:OMIM:Orphanet|MedGen|MedGen:SNOMED_CT|MedGen	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	NA	D/D/D/D/D/D/D/D/D/D/D/D/D/D	0.696	5.3	NA	NA	NA	5.3	NA	22.9	1.061	NA	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	131	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45332088	rs77542170	T	C	PASS	C	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*3824T>C	NA	NA	NA	NA	NA	3555	NA	(MUTYH|ENSG00000132781|1|1.00)	NA	0.001021	0.00519169	0.994409	2490,1	0.000399361	0.00299521	4|1|0|5	MYH-associated_polyposis|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided	C1837991:608456:ORPHA247798|CN169374|C0027672:699346009|CN221809	MedGen:OMIM:Orphanet|MedGen|MedGen:SNOMED_CT|MedGen	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	NA	D/D/D/D/D/D/D/D/D/D/D/D/D/D	0.696	5.3	NA	NA	NA	5.3	NA	22.9	1.061	NA	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	131	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45332446	rs200495564	G	A	PASS	A	missense_variant	MODERATE	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.733C>T	p.Arg245Cys	9/16	949/1929	245/549	733/1650	NA	NA	NA	NA	8.237e-05	0.000399361	0.999601	2503,0	0	0.000199681	255|5	MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome	C1837991:608456:ORPHA247798|C0027672:699346009	MedGen:OMIM:Orphanet|MedGen:SNOMED_CT	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	H	D/D/D/D/D/D/D/D/D/D/D/D/D/D	1	4.69	./././MUTYH_HUMAN/././.	D	D	5.6	245,242,232,242,231,125,218	29.5	1.036	D	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	137	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45332446	rs200495564	G	A	PASS	A	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*4182G>A	NA	NA	NA	NA	NA	3913	NA	NA	NA	8.237e-05	0.000399361	0.999601	2503,0	0	0.000199681	255|5	MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome	C1837991:608456:ORPHA247798|C0027672:699346009	MedGen:OMIM:Orphanet|MedGen:SNOMED_CT	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	H	D/D/D/D/D/D/D/D/D/D/D/D/D/D	1	4.69	./././MUTYH_HUMAN/././.	D	D	5.6	245,242,232,242,231,125,218	29.5	1.036	D	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	137	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45332803	rs34612342	T	C	PASS	C	missense_variant	MODERATE	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.536A>G	p.Tyr179Cys	7/16	752/1929	179/549	536/1650	NA	NA	NA	NA	0.001623	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5|5|1|5	MYH-associated_polyposis|Endometrial_carcinoma|not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Carcinoma_of_colon	C1837991:608456:ORPHA247798|C0476089:608089:254878006|CN221809|C0027672:699346009|CN169374|C0699790:114500:269533000	MedGen:OMIM:Orphanet|MedGen:OMIM:SNOMED_CT|MedGen|MedGen:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	H	A/A/A/A/A/A/A/A/A/A/A/A/A/A	1	5.01	././MUTYH_HUMAN/././.	D	D	5.01	179,166,176,165,59,152	24.7	1.061	D	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	126	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45332803	rs34612342	T	C	PASS	C	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*4539T>C	NA	NA	NA	NA	NA	4270	NA	NA	NA	0.001623	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5|5|1|5	MYH-associated_polyposis|Endometrial_carcinoma|not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Carcinoma_of_colon	C1837991:608456:ORPHA247798|C0476089:608089:254878006|CN221809|C0027672:699346009|CN169374|C0699790:114500:269533000	MedGen:OMIM:Orphanet|MedGen:OMIM:SNOMED_CT|MedGen|MedGen:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	H	A/A/A/A/A/A/A/A/A/A/A/A/A/A	1	5.01	././MUTYH_HUMAN/././.	D	D	5.01	179,166,176,165,59,152	24.7	1.061	D	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	126	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45332838	rs201678305	T	C	PASS	C	splice_region_variant&intron_variant	LOW	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.505-4A>G	NA	6/15	NA	NA	NA	NA	NA	NA	NA	0.001573	0.0107827	0.989217	2477,0	0	0.00539137	2|255|2	Hereditary_cancer-predisposing_syndrome|MYH-associated_polyposis|not_specified	C0027672:699346009|C1837991:608456:ORPHA247798|CN169374	MedGen:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	137	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45332838	rs201678305	T	C	PASS	C	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*4574T>C	NA	NA	NA	NA	NA	4305	NA	NA	NA	0.001573	0.0107827	0.989217	2477,0	0	0.00539137	2|255|2	Hereditary_cancer-predisposing_syndrome|MYH-associated_polyposis|not_specified	C0027672:699346009|C1837991:608456:ORPHA247798|CN169374	MedGen:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	137	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45333449	rs121908380	G	A	PASS	A	synonymous_variant	LOW	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.312C>T	p.Tyr104Tyr	3/16	528/1929	104/549	312/1650	NA	NA	NA	NA	0.001326	0.00119808	0.998802	2501,0	0	0.000599042	2|3|2,5|5	MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome|not_specified,MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome	C1837991:608456:ORPHA247798|C0027672:699346009|CN169374,C1837991:608456:ORPHA247798|C0027672:699346009	MedGen:OMIM:Orphanet|MedGen:SNOMED_CT|MedGen,MedGen:OMIM:Orphanet|MedGen:SNOMED_CT	NA	1	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	133	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45333449	rs121908380	G	A	PASS	A	downstream_gene_variant	MODIFIER	HPDL	ENSG00000186603	transcript	ENST00000334815.4	c.*5185G>A	NA	NA	NA	NA	NA	4916	NA	NA	NA	0.001326	0.00119808	0.998802	2501,0	0	0.000599042	2|3|2,5|5	MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome|not_specified,MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome	C1837991:608456:ORPHA247798|C0027672:699346009|CN169374,C1837991:608456:ORPHA247798|C0027672:699346009	MedGen:OMIM:Orphanet|MedGen:SNOMED_CT|MedGen,MedGen:OMIM:Orphanet|MedGen:SNOMED_CT	NA	1	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	133	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45334456	rs587781704	GC	G	VQSRTrancheINDEL99.00to100.00	G	frameshift_variant	HIGH	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.91delG	p.Ala31fs	2/16	307/1929	31/549	91/1650	NA	NA	(MUTYH|ENSG00000132781|1|1.00)	NA	1.647e-05	NA	NA	NA	NA	NA	5	Hereditary_cancer-predisposing_syndrome	C0027672:699346009	MedGen:SNOMED_CT	NA	NA	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	142	CTGCn|Simple_repeat|Simple_repeat	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45334484	rs3219484	C	T	PASS	T	missense_variant	MODERATE	MUTYH	ENSG00000132781	transcript	ENST00000450313.5	c.64G>A	p.Val22Met	2/16	280/1929	22/549	64/1650	NA	NA	NA	NA	0.049	0.0391374	0.960064	2404,2	0.000798722	0.0203674	2|2|255|2	not_provided|not_specified|MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome	CN221809|CN169374|C1837991:608456:ORPHA247798|C0027672:699346009	MedGen|MedGen|MedGen:OMIM:Orphanet|MedGen:SNOMED_CT	NA	5	613659(3),132600(3),608456(3)	NA	Gastric~cancer~somatic,Colorectal~adenomatous~polyposis~autosomal~recessive~with~pilomatricomas,Adenomas~multiple~colorectal	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,Smu,AR	NA	NA	NA	NA	NA	L	N/N/N/N/N/N/N/N/N/N/N/N/N/N	0.394	1.68	././MUTYH_HUMAN/./.	B	B/B/B/P/B	4.52	22,22,22,22,8	17.52	-0.961	D/D/D/D/T/D/D/D/D/D/D/T/D/D/T	Mutyh	NA	2.43E-02	62.09601321	0.112125503	NA	7.69141	4595	NA	NA	1736.8913	106	NA	MUTYH	KP_EP	AR	604933	MUTYH
chr1	45507544	rs543840147	T	TA	PASS	TA	frameshift_variant	HIGH	MMACHC	ENSG00000132763	transcript	ENST00000401061.8	c.271dupA	p.Arg91fs	2/4	552/5296	91/282	272/849	NA	INFO_REALIGN_3_PRIME	(MMACHC|ENSG00000132763|1|1.00)	NA	0.00109	0.00199681	0.998003	2499,0	0	0.000998403	5|5|4|4|5	Methylmalonic_acidemia_with_homocystinuria|not_provided|Bull's_eye_maculopathy|Methylmalonic_acidemia_with_homocystinuria|Disorders_of_Intracellular_Cobalamin_Metabolism	C1848561:277400:ORPHA26|CN221809|CN220153:153870:ORPHA251287:424169002|C1848561:277400:ORPHA26|CN043592	MedGen:OMIM:Orphanet|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45507544	rs543840147	T	TA	PASS	TA	downstream_gene_variant	MODIFIER	PRDX1	ENSG00000117450	transcript	ENST00000262746.5	c.*3784dupT	NA	NA	NA	NA	NA	3491	NA	(MMACHC|ENSG00000132763|1|1.00)	NA	0.00109	0.00199681	0.998003	2499,0	0	0.000998403	5|5|4|4|5	Methylmalonic_acidemia_with_homocystinuria|not_provided|Bull's_eye_maculopathy|Methylmalonic_acidemia_with_homocystinuria|Disorders_of_Intracellular_Cobalamin_Metabolism	C1848561:277400:ORPHA26|CN221809|CN220153:153870:ORPHA251287:424169002|C1848561:277400:ORPHA26|CN043592	MedGen:OMIM:Orphanet|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508805	rs777210603	GGT	G	VQSRTrancheINDEL99.00to100.00	G	frameshift_variant	HIGH	MMACHC	ENSG00000132763	transcript	ENST00000401061.8	c.445_446delTG	p.Cys149fs	4/4	725/5296	149/282	445/849	NA	INFO_REALIGN_3_PRIME	(MMACHC|ENSG00000132763|1|1.00)	NA	1.654e-05	NA	NA	NA	NA	NA	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45508805	rs777210603	GGT	G	VQSRTrancheINDEL99.00to100.00	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_118-A_147:ENST00000401061	c.440_441delGT	NA	4/4	NA	NA	NA	NA	NA	(MMACHC|ENSG00000132763|1|1.00)	NA	1.654e-05	NA	NA	NA	NA	NA	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45508805	rs777210603	GGT	G	VQSRTrancheINDEL99.00to100.00	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_147-A_193:ENST00000401061	c.440_441delGT	NA	4/4	NA	NA	NA	NA	NA	(MMACHC|ENSG00000132763|1|1.00)	NA	1.654e-05	NA	NA	NA	NA	NA	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45508805	rs777210603	GGT	G	VQSRTrancheINDEL99.00to100.00	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_147-A_196:ENST00000401061	c.440_441delGT	NA	4/4	NA	NA	NA	NA	NA	(MMACHC|ENSG00000132763|1|1.00)	NA	1.654e-05	NA	NA	NA	NA	NA	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45508805	rs777210603	GGT	G	VQSRTrancheINDEL99.00to100.00	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:B_147-B_196:ENST00000401061	c.440_441delGT	NA	4/4	NA	NA	NA	NA	NA	(MMACHC|ENSG00000132763|1|1.00)	NA	1.654e-05	NA	NA	NA	NA	NA	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45508805	rs777210603	GGT	G	VQSRTrancheINDEL99.00to100.00	G	downstream_gene_variant	MODIFIER	PRDX1	ENSG00000117450	transcript	ENST00000262746.5	c.*2522_*2523delAC	NA	NA	NA	NA	NA	2230	NA	(MMACHC|ENSG00000132763|1|1.00)	NA	1.654e-05	NA	NA	NA	NA	NA	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45508806	rs140522266	G	C	PASS	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_118-A_147:ENST00000401061	c.440G>C	NA	4/4	NA	NA	NA	NA	NA	NA	NA	0.00043	0.000798722	0.999201	2502,0	0	0.000399361	5,5|4	not_provided,not_provided|Disorders_of_Intracellular_Cobalamin_Metabolism	CN221809,CN221809|CN043592	MedGen,MedGen|MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	0.998	5.57	MMAC_HUMAN	P	D	5.57	147	27.3	1.048	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	134	NA	NA	NA	NA	NA	MMACHC
chr1	45508806	rs140522266	G	C	PASS	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_147-A_193:ENST00000401061	c.440G>C	NA	4/4	NA	NA	NA	NA	NA	NA	NA	0.00043	0.000798722	0.999201	2502,0	0	0.000399361	5,5|4	not_provided,not_provided|Disorders_of_Intracellular_Cobalamin_Metabolism	CN221809,CN221809|CN043592	MedGen,MedGen|MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	0.998	5.57	MMAC_HUMAN	P	D	5.57	147	27.3	1.048	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	134	NA	NA	NA	NA	NA	MMACHC
chr1	45508806	rs140522266	G	C	PASS	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_147-A_196:ENST00000401061	c.440G>C	NA	4/4	NA	NA	NA	NA	NA	NA	NA	0.00043	0.000798722	0.999201	2502,0	0	0.000399361	5,5|4	not_provided,not_provided|Disorders_of_Intracellular_Cobalamin_Metabolism	CN221809,CN221809|CN043592	MedGen,MedGen|MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	0.998	5.57	MMAC_HUMAN	P	D	5.57	147	27.3	1.048	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	134	NA	NA	NA	NA	NA	MMACHC
chr1	45508806	rs140522266	G	C	PASS	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:B_147-B_196:ENST00000401061	c.440G>C	NA	4/4	NA	NA	NA	NA	NA	NA	NA	0.00043	0.000798722	0.999201	2502,0	0	0.000399361	5,5|4	not_provided,not_provided|Disorders_of_Intracellular_Cobalamin_Metabolism	CN221809,CN221809|CN043592	MedGen,MedGen|MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	0.998	5.57	MMAC_HUMAN	P	D	5.57	147	27.3	1.048	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	134	NA	NA	NA	NA	NA	MMACHC
chr1	45508806	rs140522266	G	C	PASS	C	missense_variant	MODERATE	MMACHC	ENSG00000132763	transcript	ENST00000401061.8	c.440G>C	p.Gly147Ala	4/4	720/5296	147/282	440/849	NA	NA	NA	NA	0.00043	0.000798722	0.999201	2502,0	0	0.000399361	5,5|4	not_provided,not_provided|Disorders_of_Intracellular_Cobalamin_Metabolism	CN221809,CN221809|CN043592	MedGen,MedGen|MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	0.998	5.57	MMAC_HUMAN	P	D	5.57	147	27.3	1.048	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	134	NA	NA	NA	NA	NA	MMACHC
chr1	45508806	rs140522266	G	C	PASS	C	downstream_gene_variant	MODIFIER	PRDX1	ENSG00000117450	transcript	ENST00000262746.5	c.*2523C>G	NA	NA	NA	NA	NA	2230	NA	NA	NA	0.00043	0.000798722	0.999201	2502,0	0	0.000399361	5,5|4	not_provided,not_provided|Disorders_of_Intracellular_Cobalamin_Metabolism	CN221809,CN221809|CN043592	MedGen,MedGen|MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	0.998	5.57	MMAC_HUMAN	P	D	5.57	147	27.3	1.048	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	134	NA	NA	NA	NA	NA	MMACHC
chr1	45508975	rs587776889	G	A	PASS	A	stop_gained	HIGH	MMACHC	ENSG00000132763	transcript	ENST00000401061.8	c.609G>A	p.Trp203*	4/4	889/5296	203/282	609/849	NA	NA	NA	NA	3.306e-05	NA	NA	NA	NA	NA	5	Methylmalonic_acidemia_with_homocystinuria	C1848561:277400:ORPHA26	MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	D	1	5.71	NA	NA	NA	5.71	NA	38	1.048	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508975	rs587776889	G	A	PASS	A	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_157-A_203:ENST00000401061	c.609G>A	NA	4/4	NA	NA	NA	NA	NA	NA	NA	3.306e-05	NA	NA	NA	NA	NA	5	Methylmalonic_acidemia_with_homocystinuria	C1848561:277400:ORPHA26	MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	D	1	5.71	NA	NA	NA	5.71	NA	38	1.048	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508975	rs587776889	G	A	PASS	A	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_203-A_223:ENST00000401061	c.609G>A	NA	4/4	NA	NA	NA	NA	NA	NA	NA	3.306e-05	NA	NA	NA	NA	NA	5	Methylmalonic_acidemia_with_homocystinuria	C1848561:277400:ORPHA26	MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	D	1	5.71	NA	NA	NA	5.71	NA	38	1.048	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508975	rs587776889	G	A	PASS	A	downstream_gene_variant	MODIFIER	PRDX1	ENSG00000117450	transcript	ENST00000262746.5	c.*2354C>T	NA	NA	NA	NA	NA	2061	NA	NA	NA	3.306e-05	NA	NA	NA	NA	NA	5	Methylmalonic_acidemia_with_homocystinuria	C1848561:277400:ORPHA26	MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	D	1	5.71	NA	NA	NA	5.71	NA	38	1.048	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SBY:A_156-A_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SBY:B_156-B_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SBZ:A_156-A_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_155-A_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_156-A_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_157-A_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:A_156-A_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:B_156-B_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:C_156-C_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:D_156-D_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:E_156-E_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:F_156-F_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:G_156-G_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:H_156-H_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:I_156-I_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:J_156-J_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:K_156-K_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:L_156-L_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:M_156-M_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:N_156-N_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:O_156-O_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:P_156-P_206:ENST00000401061	c.616C>G	NA	4/4	NA	NA	NA	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	missense_variant	MODERATE	MMACHC	ENSG00000132763	transcript	ENST00000401061.8	c.616C>G	p.Arg206Gly	4/4	896/5296	206/282	616/849	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45508982	rs538023671	C	G	PASS	G	downstream_gene_variant	MODIFIER	PRDX1	ENSG00000117450	transcript	ENST00000262746.5	c.*2347G>C	NA	NA	NA	NA	NA	2054	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D	1	1.4	MMAC_HUMAN	D	D	5.71	206	29.0	0.935	D/.	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	142	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SBZ:A_56-A_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_56-A_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_59-A_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:A_56-A_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:B_56-B_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:C_56-C_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:D_56-D_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:E_56-E_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:F_56-F_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:G_56-G_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:H_56-H_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:I_56-I_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:J_56-J_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:K_56-K_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:L_56-L_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:M_56-M_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:N_56-N_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:O_56-O_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SOM:P_56-P_219:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	structural_interaction_variant	HIGH	MMACHC	ENSG00000132763	interaction	3SC0:A_157-A_220:ENST00000401061	c.656_658delAGA	NA	4/4	NA	NA	NA	NA	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	conservative_inframe_deletion	MODERATE	MMACHC	ENSG00000132763	transcript	ENST00000401061.8	c.658_660delAAG	p.Lys220del	4/4	938/5296	220/282	658/849	NA	INFO_REALIGN_3_PRIME	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	45509021	rs759243577	CAGA	C	VQSRTrancheINDEL99.00to100.00	C	downstream_gene_variant	MODIFIER	PRDX1	ENSG00000117450	transcript	ENST00000262746.5	c.*2305_*2307delTCT	NA	NA	NA	NA	NA	2014	NA	NA	NA	4.134e-05	NA	NA	NA	NA	NA	5|5	not_provided|Methylmalonic_acidemia_with_homocystinuria	CN221809|C1848561:277400:ORPHA26	MedGen|MedGen:OMIM:Orphanet	NA	NA	277400(3)	NA	Methylmalonic~aciduria~and~homocystinuria~cblC~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mmachc	NA	3.18E-01	43.90776126	-0.134019284	NA	4.56840	25974	NA	NA	493.57119	144	NA	NA	NA	NA	NA	MMACHC
chr1	46189973	rs74374973	C	T	PASS	T	missense_variant	MODERATE	POMGNT1	ENSG00000085998	transcript	ENST00000371992.1	c.1666G>A	p.Asp556Asn	20/23	2317/2934	556/748	1666/2247	NA	NA	NA	NA	0.008928	0.0103834	0.989617	2478,0	0	0.00519169	5|255	Limb-girdle_muscular_dystrophy-dystroglycanopathy\x2c_type_C3|not_specified	C3150417:613157:ORPHA206564|CN169374	MedGen:OMIM:Orphanet|MedGen	NA	NA	617123(3),613157(3),613151(3),253280(3)	NA	Retinitis~pigmentosa~76,Muscular~dystrophy-dystroglycanopathy~(limb-girdle)~type~C~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~mental~retardation)~type~B~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~brain~and~eye~anomalies)~type~A~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AR,AR	NA	NA	NA	NA	NA	L	A/A/A/A/A	1	6.06	./././PMGT1_HUMAN	P/P/P/D	D	6.06	534,556,413,556	27.0	0.935	D	Pomgnt1	E	4.59E-01	33.47487615	-0.286522835	NA	2.67332	55624	NA	NA	150.18197	131	NA	NA	NA	NA	NA	POMGNT1
chr1	46189973	rs74374973	C	T	PASS	T	downstream_gene_variant	MODIFIER	TSPAN1	ENSG00000117472	transcript	ENST00000372003.5	c.*4440C>T	NA	NA	NA	NA	NA	4015	NA	NA	NA	0.008928	0.0103834	0.989617	2478,0	0	0.00519169	5|255	Limb-girdle_muscular_dystrophy-dystroglycanopathy\x2c_type_C3|not_specified	C3150417:613157:ORPHA206564|CN169374	MedGen:OMIM:Orphanet|MedGen	NA	NA	617123(3),613157(3),613151(3),253280(3)	NA	Retinitis~pigmentosa~76,Muscular~dystrophy-dystroglycanopathy~(limb-girdle)~type~C~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~mental~retardation)~type~B~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~brain~and~eye~anomalies)~type~A~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AR,AR	NA	NA	NA	NA	NA	L	A/A/A/A/A	1	6.06	./././PMGT1_HUMAN	P/P/P/D	D	6.06	534,556,413,556	27.0	0.935	D	Pomgnt1	E	4.59E-01	33.47487615	-0.286522835	NA	2.67332	55624	NA	NA	150.18197	131	NA	NA	NA	NA	NA	POMGNT1
chr1	46192097	rs138642840	C	T	PASS	T	splice_donor_variant&intron_variant	HIGH	POMGNT1	ENSG00000085998	transcript	ENST00000371992.1	c.1539+1G>A	NA	17/22	NA	NA	NA	NA	NA	(POMGNT1|ENSG00000085998|1|1.00)	NA	0.0008978	0.000798722	0.999201	2502,0	0	0.000399361	5,255|5|5|5|5	Muscle_eye_brain_disease,Muscle_eye_brain_disease|not_provided|Limb-girdle_muscular_dystrophy-dystroglycanopathy\x2c_type_C3|POMGNT1-Related_Disorders|Congenital_muscular_dystrophy-dystroglycanopathy_with_mental_retardation\x2c_type_B3	C0457133:253280:ORPHA588:277950001,C0457133:253280:ORPHA588:277950001|CN221809|C3150417:613157:ORPHA206564|CN239299|C3150412:613151	MedGen:OMIM:Orphanet:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MedGen|MedGen:OMIM	NA	NA	617123(3),613157(3),613151(3),253280(3)	NA	Retinitis~pigmentosa~76,Muscular~dystrophy-dystroglycanopathy~(limb-girdle)~type~C~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~mental~retardation)~type~B~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~brain~and~eye~anomalies)~type~A~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AR,AR	NA	NA	NA	NA	NA	NA	D/D/D/D/D	0.879	6.07	NA	NA	NA	6.07	NA	28.1	0.855	NA	Pomgnt1	E	4.59E-01	33.47487615	-0.286522835	NA	2.67332	55624	NA	NA	150.18197	134	NA	NA	NA	NA	NA	POMGNT1
chr1	46192423	rs146097254	G	A	PASS	A	missense_variant	MODERATE	POMGNT1	ENSG00000085998	transcript	ENST00000371992.1	c.1298C>T	p.Thr433Met	16/23	1949/2934	433/748	1298/2247	NA	NA	NA	NA	0.003171	0.00519169	0.994808	2491,0	0	0.00259585	255|0|0	not_specified|Congenital_Muscular_Dystrophy\x2c_alpha-dystroglycan_related|Limb-Girdle_Muscular_Dystrophy\x2c_Recessive	CN169374|CN239202|CN239352	MedGen|MedGen|MedGen	NA	1	617123(3),613157(3),613151(3),253280(3)	NA	Retinitis~pigmentosa~76,Muscular~dystrophy-dystroglycanopathy~(limb-girdle)~type~C~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~mental~retardation)~type~B~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~brain~and~eye~anomalies)~type~A~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AR,AR	NA	NA	NA	NA	NA	L	D/D/D/D/D	0.977	5.74	./././././PMGT1_HUMAN	D	D	5.74	411,411,411,433,290,433	27.0	1.048	D	Pomgnt1	E	4.59E-01	33.47487615	-0.286522835	NA	2.67332	55624	NA	NA	150.18197	134	NA	NA	NA	NA	NA	POMGNT1
chr1	46192545	rs41292143	C	T	PASS	T	synonymous_variant	LOW	POMGNT1	ENSG00000085998	transcript	ENST00000371992.1	c.1257G>A	p.Leu419Leu	15/23	1908/2934	419/748	1257/2247	NA	NA	NA	NA	0.008994	0.00559105	0.994409	2490,0	0	0.00279553	255	not_specified	CN169374	MedGen	NA	NA	617123(3),613157(3),613151(3),253280(3)	NA	Retinitis~pigmentosa~76,Muscular~dystrophy-dystroglycanopathy~(limb-girdle)~type~C~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~mental~retardation)~type~B~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~brain~and~eye~anomalies)~type~A~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pomgnt1	E	4.59E-01	33.47487615	-0.286522835	NA	2.67332	55624	NA	NA	150.18197	127	NA	NA	NA	NA	NA	POMGNT1
chr1	46194293	rs200863680	A	C	PASS	C	missense_variant	MODERATE	POMGNT1	ENSG00000085998	transcript	ENST00000371992.1	c.860T>G	p.Ile287Ser	9/23	1511/2934	287/748	860/2247	NA	NA	NA	NA	2.471e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	RETINITIS_PIGMENTOSA_76	CN238501:617123	MedGen:OMIM	NA	NA	617123(3),613157(3),613151(3),253280(3)	NA	Retinitis~pigmentosa~76,Muscular~dystrophy-dystroglycanopathy~(limb-girdle)~type~C~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~mental~retardation)~type~B~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~brain~and~eye~anomalies)~type~A~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AR,AR	NA	NA	NA	NA	NA	M	D/D/D/D/D	0.995	5.62	././PMGT1_HUMAN	D/P/P	D	5.62	265,287,287	29.4	1.088	D	Pomgnt1	E	4.59E-01	33.47487615	-0.286522835	NA	2.67332	55624	NA	NA	150.18197	137	NA	NA	NA	NA	NA	POMGNT1
chr1	46194623	rs2292487	T	C	PASS	C	synonymous_variant	LOW	POMGNT1	ENSG00000085998	transcript	ENST00000371992.1	c.681A>G	p.Lys227Lys	8/23	1332/2934	227/748	681/2247	NA	NA	NA	NA	0.355	0.424121	0.454473	1138,304	0.121406	0.333466	255|3|3	not_specified|Limb-Girdle_Muscular_Dystrophy\x2c_Recessive|Congenital_Muscular_Dystrophy\x2c_alpha-dystroglycan_related	CN169374|CN239352|CN239202	MedGen|MedGen|MedGen	NA	2	617123(3),613157(3),613151(3),253280(3)	NA	Retinitis~pigmentosa~76,Muscular~dystrophy-dystroglycanopathy~(limb-girdle)~type~C~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~mental~retardation)~type~B~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~brain~and~eye~anomalies)~type~A~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AR,AR	NA	NA	NA	NA	NA	NA	P/P/P/P/P	0.997	3.73	NA	NA	NA	5.93	NA	6.375	-0.302	D	Pomgnt1	E	4.59E-01	33.47487615	-0.286522835	NA	2.67332	55624	NA	NA	150.18197	100	NA	NA	NA	NA	NA	POMGNT1
chr1	46194860	rs190057175	G	A	PASS	A	synonymous_variant	LOW	POMGNT1	ENSG00000085998	transcript	ENST00000371992.1	c.636C>T	p.Phe212Phe	7/23	1287/2934	212/748	636/2247	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	617123(3),613157(3),613151(3),253280(3)	NA	Retinitis~pigmentosa~76,Muscular~dystrophy-dystroglycanopathy~(limb-girdle)~type~C~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~mental~retardation)~type~B~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~brain~and~eye~anomalies)~type~A~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pomgnt1	E	4.59E-01	33.47487615	-0.286522835	NA	2.67332	55624	NA	NA	150.18197	135	NA	NA	NA	NA	NA	POMGNT1
chr1	46196784	rs150576537	C	T	PASS	T	missense_variant	MODERATE	POMGNT1	ENSG00000085998	transcript	ENST00000371992.1	c.301G>A	p.Val101Ile	4/23	952/2934	101/748	301/2247	NA	NA	NA	NA	0.002949	0.00159744	0.998403	2500,0	0	0.000798722	255|0|0	not_specified|Limb-Girdle_Muscular_Dystrophy\x2c_Recessive|Congenital_Muscular_Dystrophy\x2c_alpha-dystroglycan_related	CN169374|CN239352|CN239202	MedGen|MedGen|MedGen	NA	2	617123(3),613157(3),613151(3),253280(3)	NA	Retinitis~pigmentosa~76,Muscular~dystrophy-dystroglycanopathy~(limb-girdle)~type~C~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~mental~retardation)~type~B~3,Muscular~dystrophy-dystroglycanopathy~(congenital~with~brain~and~eye~anomalies)~type~A~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AR,AR	NA	NA	NA	NA	NA	N	D/D/D/D/D	0.99	5.1	./././PMGT1_HUMAN	B	B	5.1	79,101,101,101	10.79	0.852	T	Pomgnt1	E	4.59E-01	33.47487615	-0.286522835	NA	2.67332	55624	NA	NA	150.18197	134	NA	NA	NA	NA	NA	POMGNT1
chr1	46405089	rs324420	C	A	PASS	A	missense_variant	MODERATE	FAAH	ENSG00000117480	transcript	ENST00000243167.8	c.385C>A	p.Pro129Thr	3/15	469/2094	129/579	385/1740	NA	NA	NA	NA	0.233	0.366613	0.555112	1390,196	0.0782748	0.261581	255	Polysubstance_abuse\x2c_susceptibility_to	C1847831:606581	MedGen:OMIM	NA	1	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	606581(3)	NA	NA	NA	NA	NA	{Drug~addiction~susceptibility~to}	L	P	0.965	3.08	FAAH1_HUMAN	B	B	5.17	129	21.5	0.892	T	Faah	N	8.12E-01	23.42533616	-0.468351206	NA	7.49371	2166	NA	NA	1643.89831	79	NA	NA	NA	NA	NA	NA
chr1	47251217	rs146387723	C	T	PASS	T	synonymous_variant	LOW	STIL	ENSG00000123473	transcript	ENST00000371877.7	c.3786G>A	p.Thr1262Thr	17/17	3934/5009	1262/1288	3786/3867	NA	NA	NA	NA	0.007446	0.00998403	0.990016	2479,0	0	0.00499201	255	not_specified	CN169374	MedGen	NA	NA	612703(3)	NA	Microcephaly~7~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Stil	E	7.54E-01	85.28544468	0.694433477	abnormal	2.61778	6491	stil	NA	144.47167	134	NA	NA	NA	NA	NA	NA
chr1	47302242	rs3125630	G	A	PASS	A	missense_variant	MODERATE	STIL	ENSG00000123473	transcript	ENST00000371877.7	c.257C>T	p.Ala86Val	4/17	405/5009	86/1288	257/3867	NA	NA	NA	NA	0.502	0.392572	0.197284	494,1027	0.410144	0.60643	2|255|2	Primary_autosomal_recessive_microcephaly_7|not_specified|Primary_Microcephaly\x2c_Recessive	C2675187:612703|CN169374|CN239428	MedGen:OMIM|MedGen|MedGen	NA	1	612703(3)	NA	Microcephaly~7~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	P/P/P/P/P	0.994	5.42	./././STIL_HUMAN	B	B	5.42	86	9.328	0.244	T	Stil	E	7.54E-01	85.28544468	0.694433477	abnormal	2.61778	6491	stil	NA	144.47167	103	NA	NA	NA	NA	NA	NA
chr1	52375574	rs387906828	C	T	PASS	T	missense_variant	MODERATE	ORC1	ENSG00000085840	transcript	ENST00000371566.1	c.2159G>A	p.Arg720Gln	15/17	2303/3080	720/861	2159/2586	NA	NA	NA	NA	6.589e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Meier-Gorlin_syndrome_1	CN030358:224690	MedGen:OMIM	NA	NA	224690(3)	NA	Meier-Gorlin~syndrome~1	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	H	D/D	0.949	5.42	./ORC1_HUMAN	D	D	5.42	715,720	35	0.935	D	Orc1	NA	NA	82.93229535	0.606246644	abnormal	4.84738	4998	orc1	mcmPathway	571.04641	137	NA	NA	NA	NA	NA	NA
chr1	52383437	rs201253919	G	A	PASS	A	missense_variant	MODERATE	ORC1	ENSG00000085840	transcript	ENST00000371566.1	c.1996C>T	p.Arg666Trp	13/17	2140/3080	666/861	1996/2586	NA	NA	NA	NA	6.589e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Meier-Gorlin_syndrome_1	CN030358:224690	MedGen:OMIM	NA	NA	224690(3)	NA	Meier-Gorlin~syndrome~1	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	D/D	0.993	4.74	./ORC1_HUMAN	D	D	5.65	661,666	35	1.048	D	Orc1	NA	NA	82.93229535	0.606246644	abnormal	4.84738	4998	orc1	mcmPathway	571.04641	137	NA	NA	NA	NA	NA	NA
chr1	53202427	rs74315294	C	T	PASS	T	missense_variant&splice_region_variant	MODERATE	CPT2	ENSG00000157184	transcript	ENST00000637252.1	c.338C>T	p.Ser113Leu	3/6	482/2739	113/670	338/2013	NA	NA	NA	NA	0.001268	0.00119808	0.998802	2501,0	0	0.000599042	5|5|5|5	Carnitine_palmitoyltransferase_II_deficiency\x2c_late-onset|not_provided|Carnitine_palmitoyltransferase_II_deficiency\x2c_lethal_neonatal|Carnitine_palmitoyltransferase_II_deficiency	C1833508:255110:ORPHA228302|CN221809|C1833518:608836:ORPHA228308|C0342790:ORPHA157:238002005	MedGen:OMIM:Orphanet|MedGen|MedGen:OMIM:Orphanet|MedGen:Orphanet:SNOMED_CT	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	M	A	0.891	5.88	CPT2_HUMAN	D	D	5.88	113	34	0.935	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	133	NA	NA	NA	NA	NA	CPT2
chr1	53210354	rs74315298	C	T	PASS	T	missense_variant	MODERATE	CPT2	ENSG00000157184	transcript	ENST00000637252.1	c.680C>T	p.Pro227Leu	4/6	824/2739	227/670	680/2013	NA	NA	NA	NA	9.06e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5|0	Carnitine_palmitoyltransferase_II_deficiency\x2c_lethal_neonatal|not_provided|Carnitine_palmitoyltransferase_II_deficiency|not_specified	C1833518:608836:ORPHA228308|CN221809|C0342790:ORPHA157:238002005|CN169374	MedGen:OMIM:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	A	0.944	5.5	CPT2_HUMAN	D	D	5.5	227	29.6	0.852	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	133	NA	NA	NA	NA	NA	CPT2
chr1	53210354	rs74315298	C	T	PASS	T	downstream_gene_variant	MODIFIER	C1orf123	ENSG00000162384	transcript	ENST00000294360.4	c.*4305G>A	NA	NA	NA	NA	NA	3745	NA	NA	NA	9.06e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5|0	Carnitine_palmitoyltransferase_II_deficiency\x2c_lethal_neonatal|not_provided|Carnitine_palmitoyltransferase_II_deficiency|not_specified	C1833518:608836:ORPHA228308|CN221809|C0342790:ORPHA157:238002005|CN169374	MedGen:OMIM:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	A	0.944	5.5	CPT2_HUMAN	D	D	5.5	227	29.6	0.852	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	133	NA	NA	NA	NA	NA	CPT2
chr1	53210354	rs74315298	C	T	PASS	T	non_coding_transcript_exon_variant	MODIFIER	RP5-1024G6.2	ENSG00000236723	transcript	ENST00000629810.1	n.341G>A	NA	2/3	NA	NA	NA	NA	NA	NA	NA	9.06e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5|0	Carnitine_palmitoyltransferase_II_deficiency\x2c_lethal_neonatal|not_provided|Carnitine_palmitoyltransferase_II_deficiency|not_specified	C1833518:608836:ORPHA228308|CN221809|C0342790:ORPHA157:238002005|CN169374	MedGen:OMIM:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	A	0.944	5.5	CPT2_HUMAN	D	D	5.5	227	29.6	0.852	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	133	NA	NA	NA	NA	NA	CPT2
chr1	53210722	rs151003641	C	T	PASS	T	missense_variant	MODERATE	CPT2	ENSG00000157184	transcript	ENST00000637252.1	c.1048C>T	p.Arg350Cys	4/6	1192/2739	350/670	1048/2013	NA	NA	NA	NA	0.0002389	0.000798722	0.999201	2502,0	0	0.000399361	4	not_provided	CN221809	MedGen	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	D	1	5.72	CPT2_HUMAN	D	D	5.72	350	34	0.852	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	134	NA	NA	NA	NA	NA	CPT2
chr1	53210722	rs151003641	C	T	PASS	T	downstream_gene_variant	MODIFIER	C1orf123	ENSG00000162384	transcript	ENST00000294360.4	c.*3937G>A	NA	NA	NA	NA	NA	3377	NA	NA	NA	0.0002389	0.000798722	0.999201	2502,0	0	0.000399361	4	not_provided	CN221809	MedGen	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	D	1	5.72	CPT2_HUMAN	D	D	5.72	350	34	0.852	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	134	NA	NA	NA	NA	NA	CPT2
chr1	53210722	rs151003641	C	T	PASS	T	intron_variant	MODIFIER	RP5-1024G6.2	ENSG00000236723	transcript	ENST00000629810.1	n.286-313G>A	NA	1/2	NA	NA	NA	NA	NA	NA	NA	0.0002389	0.000798722	0.999201	2502,0	0	0.000399361	4	not_provided	CN221809	MedGen	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	D	1	5.72	CPT2_HUMAN	D	D	5.72	350	34	0.852	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	134	NA	NA	NA	NA	NA	CPT2
chr1	53210729	rs2229291	T	G	PASS	G	missense_variant	MODERATE	CPT2	ENSG00000157184	transcript	ENST00000637252.1	c.1055T>G	p.Phe352Cys	4/6	1199/2739	352/670	1055/2013	NA	NA	NA	NA	0.022	0.0802716	0.913339	2287,16	0.00638978	0.0465256	255|2|255	Encephalopathy\x2c_acute\x2c_infection-induced\x2c_4\x2c_susceptibility_to|not_specified|Carnitine_palmitoyltransferase_II_deficiency	C3280160:614212:ORPHA263524|CN169374|C0342790:ORPHA157:238002005	MedGen:OMIM:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT	NA	2	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	M	P	1	3.38	CPT2_HUMAN	D	D	5.72	352	24.4	0.964	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	98	NA	NA	NA	NA	NA	CPT2
chr1	53210729	rs2229291	T	G	PASS	G	downstream_gene_variant	MODIFIER	C1orf123	ENSG00000162384	transcript	ENST00000294360.4	c.*3930A>C	NA	NA	NA	NA	NA	3370	NA	NA	NA	0.022	0.0802716	0.913339	2287,16	0.00638978	0.0465256	255|2|255	Encephalopathy\x2c_acute\x2c_infection-induced\x2c_4\x2c_susceptibility_to|not_specified|Carnitine_palmitoyltransferase_II_deficiency	C3280160:614212:ORPHA263524|CN169374|C0342790:ORPHA157:238002005	MedGen:OMIM:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT	NA	2	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	M	P	1	3.38	CPT2_HUMAN	D	D	5.72	352	24.4	0.964	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	98	NA	NA	NA	NA	NA	CPT2
chr1	53210729	rs2229291	T	G	PASS	G	intron_variant	MODIFIER	RP5-1024G6.2	ENSG00000236723	transcript	ENST00000629810.1	n.286-320A>C	NA	1/2	NA	NA	NA	NA	NA	NA	NA	0.022	0.0802716	0.913339	2287,16	0.00638978	0.0465256	255|2|255	Encephalopathy\x2c_acute\x2c_infection-induced\x2c_4\x2c_susceptibility_to|not_specified|Carnitine_palmitoyltransferase_II_deficiency	C3280160:614212:ORPHA263524|CN169374|C0342790:ORPHA157:238002005	MedGen:OMIM:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT	NA	2	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	M	P	1	3.38	CPT2_HUMAN	D	D	5.72	352	24.4	0.964	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	98	NA	NA	NA	NA	NA	CPT2
chr1	53210776	rs1799821	G	A	PASS	A	missense_variant	MODERATE	CPT2	ENSG00000157184	transcript	ENST00000637252.1	c.1102G>A	p.Val368Ile	4/6	1246/2739	368/670	1102/2013	NA	NA	NA	NA	0.483	0.420527	0.376597	943,508	0.202875	0.413139	255|2|2	Encephalopathy\x2c_acute\x2c_infection-induced\x2c_4\x2c_susceptibility_to|not_specified|Carnitine_palmitoyltransferase_II_deficiency	C3280160:614212:ORPHA263524|CN169374|C0342790:ORPHA157:238002005	MedGen:OMIM:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT	NA	2	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	N	P	0.594	-0.261	CPT2_HUMAN	B	B	5.72	368	0.002	0.073	T	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	89	NA	NA	NA	NA	NA	CPT2
chr1	53210776	rs1799821	G	A	PASS	A	downstream_gene_variant	MODIFIER	C1orf123	ENSG00000162384	transcript	ENST00000294360.4	c.*3883C>T	NA	NA	NA	NA	NA	3323	NA	NA	NA	0.483	0.420527	0.376597	943,508	0.202875	0.413139	255|2|2	Encephalopathy\x2c_acute\x2c_infection-induced\x2c_4\x2c_susceptibility_to|not_specified|Carnitine_palmitoyltransferase_II_deficiency	C3280160:614212:ORPHA263524|CN169374|C0342790:ORPHA157:238002005	MedGen:OMIM:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT	NA	2	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	N	P	0.594	-0.261	CPT2_HUMAN	B	B	5.72	368	0.002	0.073	T	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	89	NA	NA	NA	NA	NA	CPT2
chr1	53210776	rs1799821	G	A	PASS	A	intron_variant	MODIFIER	RP5-1024G6.2	ENSG00000236723	transcript	ENST00000629810.1	n.286-367C>T	NA	1/2	NA	NA	NA	NA	NA	NA	NA	0.483	0.420527	0.376597	943,508	0.202875	0.413139	255|2|2	Encephalopathy\x2c_acute\x2c_infection-induced\x2c_4\x2c_susceptibility_to|not_specified|Carnitine_palmitoyltransferase_II_deficiency	C3280160:614212:ORPHA263524|CN169374|C0342790:ORPHA157:238002005	MedGen:OMIM:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT	NA	2	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	N	P	0.594	-0.261	CPT2_HUMAN	B	B	5.72	368	0.002	0.073	T	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	89	NA	NA	NA	NA	NA	CPT2
chr1	53213264	rs186044004	G	A	PASS	A	missense_variant&splice_region_variant	MODERATE	CPT2	ENSG00000157184	transcript	ENST00000637252.1	c.1682G>A	p.Ser561Asn	6/6	1826/2739	561/670	1682/2013	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Carnitine_palmitoyltransferase_II_deficiency	C0342790:ORPHA157:238002005	MedGen:Orphanet:SNOMED_CT	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	D	0.997	5.9	CPT2_HUMAN	D	D	5.9	549	29.2	1.048	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	135	NA	NA	NA	NA	NA	CPT2
chr1	53213264	rs186044004	G	A	PASS	A	downstream_gene_variant	MODIFIER	C1orf123	ENSG00000162384	transcript	ENST00000294360.4	c.*1395C>T	NA	NA	NA	NA	NA	835	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Carnitine_palmitoyltransferase_II_deficiency	C0342790:ORPHA157:238002005	MedGen:Orphanet:SNOMED_CT	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	D	0.997	5.9	CPT2_HUMAN	D	D	5.9	549	29.2	1.048	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	135	NA	NA	NA	NA	NA	CPT2
chr1	53213264	rs186044004	G	A	PASS	A	non_coding_transcript_exon_variant	MODIFIER	RP5-1024G6.2	ENSG00000236723	transcript	ENST00000629810.1	n.209C>T	NA	1/3	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Carnitine_palmitoyltransferase_II_deficiency	C0342790:ORPHA157:238002005	MedGen:Orphanet:SNOMED_CT	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	D	0.997	5.9	CPT2_HUMAN	D	D	5.9	549	29.2	1.048	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	135	NA	NA	NA	NA	NA	CPT2
chr1	53213381	rs1871748	C	G	PASS	G	missense_variant	MODERATE	CPT2	ENSG00000157184	transcript	ENST00000637252.1	c.1799C>G	p.Ser600Cys	6/6	1943/2739	600/670	1799/2013	NA	NA	NA	NA	0.0008978	0.00319489	0.996805	2496,0	0	0.00159744	5	not_provided	CN221809	MedGen	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	D	0.951	5.9	CPT2_HUMAN	D	D	5.9	588	26.9	0.935	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	92	NA	NA	NA	NA	NA	CPT2
chr1	53213381	rs1871748	C	G	PASS	G	downstream_gene_variant	MODIFIER	C1orf123	ENSG00000162384	transcript	ENST00000294360.4	c.*1278G>C	NA	NA	NA	NA	NA	718	NA	NA	NA	0.0008978	0.00319489	0.996805	2496,0	0	0.00159744	5	not_provided	CN221809	MedGen	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	D	0.951	5.9	CPT2_HUMAN	D	D	5.9	588	26.9	0.935	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	92	NA	NA	NA	NA	NA	CPT2
chr1	53213381	rs1871748	C	G	PASS	G	non_coding_transcript_exon_variant	MODIFIER	RP5-1024G6.2	ENSG00000236723	transcript	ENST00000629810.1	n.92G>C	NA	1/3	NA	NA	NA	NA	NA	NA	NA	0.0008978	0.00319489	0.996805	2496,0	0	0.00159744	5	not_provided	CN221809	MedGen	NA	NA	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	H	D	0.951	5.9	CPT2_HUMAN	D	D	5.9	588	26.9	0.935	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	92	NA	NA	NA	NA	NA	CPT2
chr1	53213557	rs1799822	A	G	PASS	G	missense_variant	MODERATE	CPT2	ENSG00000157184	transcript	ENST00000637252.1	c.1975A>G	p.Met659Val	6/6	2119/2739	659/670	1975/2013	NA	NA	NA	NA	0.162	0.169728	0.814696	2040,39	0.0155751	0.100439	2|255	not_specified|Carnitine_palmitoyltransferase_II_deficiency	CN169374|C0342790:ORPHA157:238002005	MedGen|MedGen:Orphanet:SNOMED_CT	NA	3	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	L	P	0.999	5.9	CPT2_HUMAN	B	B	5.9	647	23.0	1.199	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	89	NA	NA	NA	NA	NA	CPT2
chr1	53213557	rs1799822	A	G	PASS	G	upstream_gene_variant	MODIFIER	RP5-1024G6.2	ENSG00000236723	transcript	ENST00000629810.1	n.-85T>C	NA	NA	NA	NA	NA	85	NA	NA	NA	0.162	0.169728	0.814696	2040,39	0.0155751	0.100439	2|255	not_specified|Carnitine_palmitoyltransferase_II_deficiency	CN169374|C0342790:ORPHA157:238002005	MedGen|MedGen:Orphanet:SNOMED_CT	NA	3	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	L	P	0.999	5.9	CPT2_HUMAN	B	B	5.9	647	23.0	1.199	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	89	NA	NA	NA	NA	NA	CPT2
chr1	53213557	rs1799822	A	G	PASS	G	downstream_gene_variant	MODIFIER	C1orf123	ENSG00000162384	transcript	ENST00000294360.4	c.*1102T>C	NA	NA	NA	NA	NA	542	NA	NA	NA	0.162	0.169728	0.814696	2040,39	0.0155751	0.100439	2|255	not_specified|Carnitine_palmitoyltransferase_II_deficiency	CN169374|C0342790:ORPHA157:238002005	MedGen|MedGen:Orphanet:SNOMED_CT	NA	3	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	L	P	0.999	5.9	CPT2_HUMAN	B	B	5.9	647	23.0	1.199	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	89	NA	NA	NA	NA	NA	CPT2
chr1	53213557	rs1799822	A	G	PASS	G	intragenic_variant	MODIFIER	RP5-1024G6.2	ENSG00000236723	gene_variant	ENSG00000236723	n.53213557T>C	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.162	0.169728	0.814696	2040,39	0.0155751	0.100439	2|255	not_specified|Carnitine_palmitoyltransferase_II_deficiency	CN169374|C0342790:ORPHA157:238002005	MedGen|MedGen:Orphanet:SNOMED_CT	NA	3	255110(3),255110(3),608836(3),600649(3)	NA	CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~myopathic~stress-induced,CPT~II~deficiency~lethal~neonatal,CPT~II~deficiency~infantile	Chromosome~1p32-p31~deletion~syndrome	NA	AR/AD	NA	NA	NA	NA	NA	614212(3)	AR,AR,AR,AR	613735(4)	NA	IC	NA	{Encephalopathy~acute~infection-induced~4~susceptibility~to}	L	P	0.999	5.9	CPT2_HUMAN	B	B	5.9	647	23.0	1.199	D	Cpt2	NA	1.31E-01	80.31375324	0.514416907	NA	9.08048	1376	NA	cptPathway	2392.92369	89	NA	NA	NA	NA	NA	CPT2
chr1	53247055	rs5174	C	T	PASS	T	missense_variant&splice_region_variant	MODERATE	LRP8	ENSG00000157193	transcript	ENST00000306052.10	c.2855G>A	p.Arg952Gln	19/19	2957/7648	952/963	2855/2892	NA	NA	NA	NA	0.294	0.207268	0.751997	1883,102	0.0407348	0.144369	255	Myocardial_infarction_1	C1838021:608446	MedGen:OMIM	NA	2	NA	NA	NA	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	608446(3)	NA	613735(4)	NA	IC	NA	{Myocardial~infarction~susceptibility~to}	N	P/P/P/P/P	1	5.43	./././LRP8_HUMAN/.	D/D/B/D/P	D/D/P/D/D	5.43	689,782,893,952,446	34	0.852	D/T/T/T/./D	Lrp8	N	1.13E-02	10.50365652	-0.883608246	NA	7.31657	7804	NA	Lis1Pathway/reelinPathway	1560.30616	52	NA	NA	NA	NA	NA	NA
chr1	53247055	rs5174	C	T	PASS	T	downstream_gene_variant	MODIFIER	RP5-1024G6.5	ENSG00000226754	transcript	ENST00000458151.1	n.*4272C>T	NA	NA	NA	NA	NA	4272	NA	NA	NA	0.294	0.207268	0.751997	1883,102	0.0407348	0.144369	255	Myocardial_infarction_1	C1838021:608446	MedGen:OMIM	NA	2	NA	NA	NA	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	608446(3)	NA	613735(4)	NA	IC	NA	{Myocardial~infarction~susceptibility~to}	N	P/P/P/P/P	1	5.43	./././LRP8_HUMAN/.	D/D/B/D/P	D/D/P/D/D	5.43	689,782,893,952,446	34	0.852	D/T/T/T/./D	Lrp8	N	1.13E-02	10.50365652	-0.883608246	NA	7.31657	7804	NA	Lis1Pathway/reelinPathway	1560.30616	52	NA	NA	NA	NA	NA	NA
chr1	54999196	rs121908145	G	A	PASS	A	missense_variant	MODERATE	BSND	ENSG00000162399	transcript	ENST00000371265.4	c.10G>A	p.Glu4Lys	1/4	264/3472	4/320	10/963	NA	NA	NA	NA	6.589e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Sensorineural_deafness_with_mild_renal_dysfunction	C2748440	MedGen	NA	NA	602522(3),602522(3)	NA	Sensorineural~deafness~with~mild~renal~dysfunction,Bartter~syndrome~type~4a	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	613735(4)	NA	IC	NA	NA	N	D	0.993	4.44	BSND_HUMAN	D	D	4.44	4	27.0	0.975	D	Bsnd	E	3.23E-01	29.16371786	-0.358119787	NA	1.14741	7809	NA	NA	38.75161	132	NA	NA	NA	NA	NA	NA
chr1	54999208	rs74315285	C	T	PASS	T	missense_variant	MODERATE	BSND	ENSG00000162399	transcript	ENST00000371265.4	c.22C>T	p.Arg8Trp	1/4	276/3472	8/320	22/963	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	Bartter_syndrome_type_4	C1865270:602522	MedGen:OMIM	NA	NA	602522(3),602522(3)	NA	Sensorineural~deafness~with~mild~renal~dysfunction,Bartter~syndrome~type~4a	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	613735(4)	NA	IC	NA	NA	L	A	0.996	4.44	BSND_HUMAN	D	D	4.44	8	34	0.872	D	Bsnd	E	3.23E-01	29.16371786	-0.358119787	NA	1.14741	7809	NA	NA	38.75161	132	NA	NA	NA	NA	NA	NA
chr1	54999288	rs141403253	C	T	PASS	T	synonymous_variant	LOW	BSND	ENSG00000162399	transcript	ENST00000371265.4	c.102C>T	p.Tyr34Tyr	1/4	356/3472	34/320	102/963	NA	NA	NA	NA	0.000313	0.000399361	0.999601	2503,0	0	0.000199681	255|0	not_specified|Bartter's_syndrome	CN169374|C0004775:ORPHA112	MedGen|MedGen:Orphanet	NA	NA	602522(3),602522(3)	NA	Sensorineural~deafness~with~mild~renal~dysfunction,Bartter~syndrome~type~4a	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	613735(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Bsnd	E	3.23E-01	29.16371786	-0.358119787	NA	1.14741	7809	NA	NA	38.75161	134	NA	NA	NA	NA	NA	NA
chr1	55039593	rs28362201	G	T	PASS	T	5_prime_UTR_variant	MODIFIER	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.-245G>T	NA	1/12	NA	NA	NA	245	NA	NA	NA	NA	0.047524	0.946885	2371,14	0.00559105	0.029353	0|0,255|3	Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia,Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003,C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55039774	rs45448095	C	T	PASS	T	5_prime_UTR_premature_start_codon_gain_variant	LOW	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.-64C>T	NA	1/12	NA	NA	NA	NA	NA	NA	NA	NA	0.166134	0.823083	2061,27	0.0107827	0.0938498	255|3	Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	127	NA	PCSK9	KP	AD	607786	NA
chr1	55039774	rs45448095	C	T	PASS	T	5_prime_UTR_variant	MODIFIER	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.-64C>T	NA	1/12	NA	NA	NA	64	NA	NA	NA	NA	0.166134	0.823083	2061,27	0.0107827	0.0938498	255|3	Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	127	NA	PCSK9	KP	AD	607786	NA
chr1	55039879	rs371488778	A	ACTG	PASS	ACTG	disruptive_inframe_insertion	MODERATE	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.63_65dupGCT	p.Leu22dup	1/12	356/3637	22/692	66/2079	NA	INFO_REALIGN_3_PRIME	NA	NA	0.077	NA	NA	NA	NA	NA	0,255|2	Familial_hypercholesterolemia,not_specified|Familial_hypercholesterolemia	C0020445:143890:397915002:398036000,CN169374|C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT,MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	17	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	138	GCTn|Simple_repeat|Simple_repeat	PCSK9	KP	AD	607786	NA
chr1	55039879	rs371488778	A	ACTGCTG	PASS	ACTGCTG	disruptive_inframe_insertion	MODERATE	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.60_65dupGCTGCT	p.Leu21_Leu22dup	1/12	356/3637	22/692	66/2079	NA	INFO_REALIGN_3_PRIME	NA	NA	0.001369	NA	NA	NA	NA	NA	0,255|2	Familial_hypercholesterolemia,not_specified|Familial_hypercholesterolemia	C0020445:143890:397915002:398036000,CN169374|C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT,MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	138	GCTn|Simple_repeat|Simple_repeat	PCSK9	KP	AD	607786	NA
chr1	55039931	rs564427867	G	A	PASS	A	missense_variant	MODERATE	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.94G>A	p.Glu32Lys	1/12	384/3637	32/692	94/2079	NA	NA	NA	NA	1.683e-05	0.000798722	0.999201	2502,0	0	0.000399361	4|0	Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	L	N/N	0.162	0.333	PCSK9_HUMAN	B	B	2.53	32	13.91	0.644	T	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	142	NA	PCSK9	KP	AD	607786	NA
chr1	55039974	rs11591147	G	T	PASS	T	missense_variant	MODERATE	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.137G>T	p.Arg46Leu	1/12	427/3637	46/692	137/2079	NA	NA	NA	NA	0.00886	0.0127796	0.98722	2472,0	0	0.00638978	255|2|255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1|Hypercholesterolemia\x2c_autosomal_dominant\x2c_3|Familial_hypercholesterolemia	CN068586|C1863551:603776|C0020445:143890:397915002:398036000	MedGen|MedGen:OMIM|MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	L	N/N	0.001	-0.263	PCSK9_HUMAN	B	B	3.39	46	17.10	-1.272	T	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	120	NA	PCSK9	KP	AD	607786	NA
chr1	55039978	rs28385701	C	T	PASS	T	synonymous_variant	LOW	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.141C>T	p.Ser47Ser	1/12	431/3637	47/692	141/2079	NA	NA	NA	NA	0.008239	0.00798722	0.992013	2484,0	0	0.00399361	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55039995	rs11583680	C	T	PASS	T	missense_variant	MODERATE	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.158C>T	p.Ala53Val	1/12	448/3637	53/692	158/2079	NA	NA	NA	NA	0.094	0.161741	0.827875	2073,26	0.0103834	0.091254	255|2|3	Familial_hypercholesterolemia|not_specified|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|CN169374|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	N	P/P	0.004	2.23	PCSK9_HUMAN	B	B	3.18	53	18.29	0.826	T	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	120	NA	PCSK9	KP	AD	607786	NA
chr1	55040059	rs2495482	A	G	PASS	G	intron_variant	MODIFIER	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.207+15A>G	NA	1/11	NA	NA	NA	NA	NA	NA	NA	0.911	0.158946	0.0119808	30,2076	0.829073	0.908546	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	100	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	stop_gained	HIGH	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.426C>G	p.Tyr142*	3/12	716/3637	142/692	426/2079	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2P4E:P_81-P_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2PMW:A_81-A_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2QTW:A_81-A_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2W2M:P_81-P_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2W2N:P_81-P_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2W2P:P_81-P_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2W2Q:P_81-P_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3BPS:P_81-P_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCW:P_81-P_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCX:P_81-P_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3H42:A_81-A_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3SQO:P_81-P_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:C_81-C_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:P_81-P_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NMX:A_81-A_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4OV6:A_81-A_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55046549	rs67608943	C	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4OV6:D_81-D_142:ENST00000302118	c.426C>G	NA	3/12	NA	NA	NA	NA	NA	(PCSK9|ENSG00000169174|1|1.00)	(PCSK9|ENSG00000169174|1|1.00)	0.0002718	0.00279553	0.997204	2497,0	0	0.00139776	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	A/A/D	0.969	4.73	NA	NA	NA	4.73	NA	37	0.855	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	130	NA	PCSK9	KP	AD	607786	NA
chr1	55052267	rs11800231	G	A	PASS	A	intron_variant	MODIFIER	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.524-11G>A	NA	3/11	NA	NA	NA	NA	NA	NA	NA	0.055	0.146565	0.84385	2113,24	0.00958466	0.0828674	255|2|3	Familial_hypercholesterolemia|not_specified|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|CN169374|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	120	NA	PCSK9	KP	AD	607786	NA
chr1	55052420	rs11800243	G	A	PASS	A	intron_variant	MODIFIER	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.657+9G>A	NA	4/11	NA	NA	NA	NA	NA	NA	NA	0.042	0.0734824	0.924121	2314,6	0.00239617	0.0391374	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	120	NA	PCSK9	KP	AD	607786	NA
chr1	55052643	rs2483205	C	T	PASS	T	splice_region_variant&intron_variant	LOW	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.658-7C>T	NA	4/11	NA	NA	NA	NA	NA	NA	NA	0.425	0.459265	0.376198	942,412	0.164537	0.394169	255|2|3	Familial_hypercholesterolemia|not_specified|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|CN169374|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	100	NA	PCSK9	KP	AD	607786	NA
chr1	55052697	rs7552471	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3BPS:A_199-A_235:ENST00000302118	c.705C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00725	0.0379393	0.959665	2403,6	0.00239617	0.0213658	255|3	Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	116	NA	PCSK9	KP	AD	607786	NA
chr1	55052697	rs7552471	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NMX:B_199-B_235:ENST00000302118	c.705C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00725	0.0379393	0.959665	2403,6	0.00239617	0.0213658	255|3	Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	116	NA	PCSK9	KP	AD	607786	NA
chr1	55052697	rs7552471	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4OV6:B_199-B_235:ENST00000302118	c.705C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00725	0.0379393	0.959665	2403,6	0.00239617	0.0213658	255|3	Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	116	NA	PCSK9	KP	AD	607786	NA
chr1	55052697	rs7552471	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4OV6:E_199-E_235:ENST00000302118	c.705C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00725	0.0379393	0.959665	2403,6	0.00239617	0.0213658	255|3	Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	116	NA	PCSK9	KP	AD	607786	NA
chr1	55052697	rs7552471	C	T	PASS	T	synonymous_variant	LOW	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.705C>T	p.Ser235Ser	5/12	995/3637	235/692	705/2079	NA	NA	NA	NA	0.00725	0.0379393	0.959665	2403,6	0.00239617	0.0213658	255|3	Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	116	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2P4E:A_195-A_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2PMW:B_195-B_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2QTW:B_194-B_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2QTW:B_195-B_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2QTW:B_197-B_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2W2P:A_195-A_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2XTJ:A_195-A_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2XTJ:A_197-A_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3BPS:A_195-A_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCW:A_195-A_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCX:A_195-A_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3H42:B_194-B_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:A_195-A_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:A_197-A_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:B_195-B_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NMX:B_194-B_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NMX:B_195-B_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NMX:B_197-B_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4OV6:B_195-B_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4OV6:E_194-E_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4OV6:E_195-E_237:ENST00000302118	c.709C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052701	rs148195424	C	T	PASS	T	missense_variant	MODERATE	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.709C>T	p.Arg237Trp	5/12	999/3637	237/692	709/2079	NA	NA	NA	NA	0.0005932	0.000399361	0.999601	2503,0	0	0.000199681	255	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	D/D/D	0.968	1.84	PCSK9_HUMAN	D	D	4.02	237	33	-0.044	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55052712	rs41297883	C	T	PASS	T	synonymous_variant	LOW	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.720C>T	p.Gly240Gly	5/12	1010/3637	240/692	720/2079	NA	NA	NA	NA	0.005322	0.0147764	0.985224	2467,0	0	0.00738818	2|255|3	Hypercholesterolemia\x2c_autosomal_dominant\x2c_3|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C1863551:603776|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	127	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2P4E:A_205-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2P4E:A_206-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2P4E:A_207-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2QTW:B_205-B_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2QTW:B_207-B_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2W2M:A_207-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2W2N:A_207-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2W2O:A_206-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2W2P:A_207-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2W2Q:A_206-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2XTJ:A_206-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCW:A_188-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCW:A_211-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3H42:B_206-B_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:A_207-A_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:B_207-B_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NMX:B_206-B_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NMX:B_207-B_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4OV6:B_188-B_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4OV6:B_210-B_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4OV6:E_206-E_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4OV6:E_207-E_251:ENST00000302118	c.753C>T	NA	5/12	NA	NA	NA	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052745	rs28385710	C	T	PASS	T	synonymous_variant	LOW	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.753C>T	p.Arg251Arg	5/12	1043/3637	251/692	753/2079	NA	NA	NA	NA	0.00402	0.0127796	0.98722	2472,0	0	0.00638978	3|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55052794	rs2495477	A	G	PASS	G	splice_region_variant&intron_variant	LOW	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.799+3A>G	NA	5/11	NA	NA	NA	NA	NA	NA	NA	0.429	0.427716	0.319888	801,632	0.252396	0.466254	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	100	NA	PCSK9	KP	AD	607786	NA
chr1	55057360	rs509504	A	G	PASS	G	synonymous_variant	LOW	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.1026A>G	p.Gln342Gln	7/12	1316/3637	342/692	1026/2079	NA	NA	NA	NA	0.995	0.0347444	0.000798722	2,2415	0.964457	0.981829	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058106	rs143275858	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3SQO:A_417-A_454:ENST00000302118	c.1251C>A	NA	8/12	NA	NA	NA	NA	NA	NA	NA	0.0002636	0.00279553	0.997204	2497,0	0	0.00139776	4	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	N	N/N	0.99	0.928	PCSK9_HUMAN	B	B	4.72	417	21.5	-0.337	T	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55058106	rs143275858	C	A	PASS	A	missense_variant	MODERATE	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.1251C>A	p.His417Gln	8/12	1541/3637	417/692	1251/2079	NA	NA	NA	NA	0.0002636	0.00279553	0.997204	2497,0	0	0.00139776	4	Familial_hypercholesterolemia	C0020445:143890:397915002:398036000	MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	N	N/N	0.99	0.928	PCSK9_HUMAN	B	B	4.72	417	21.5	-0.337	T	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55058524	rs540796	A	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2P4E:A_460-A_524:ENST00000302118	c.1380A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.854	0.21845	0.0215655	54,1903	0.759984	0.869209	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058524	rs540796	A	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2PMW:B_460-B_524:ENST00000302118	c.1380A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.854	0.21845	0.0215655	54,1903	0.759984	0.869209	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058524	rs540796	A	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2QTW:B_460-B_524:ENST00000302118	c.1380A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.854	0.21845	0.0215655	54,1903	0.759984	0.869209	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058524	rs540796	A	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3BPS:A_460-A_524:ENST00000302118	c.1380A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.854	0.21845	0.0215655	54,1903	0.759984	0.869209	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058524	rs540796	A	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCW:A_460-A_524:ENST00000302118	c.1380A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.854	0.21845	0.0215655	54,1903	0.759984	0.869209	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058524	rs540796	A	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCX:A_460-A_524:ENST00000302118	c.1380A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.854	0.21845	0.0215655	54,1903	0.759984	0.869209	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058524	rs540796	A	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3H42:B_460-B_524:ENST00000302118	c.1380A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.854	0.21845	0.0215655	54,1903	0.759984	0.869209	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058524	rs540796	A	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3SQO:A_460-A_524:ENST00000302118	c.1380A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.854	0.21845	0.0215655	54,1903	0.759984	0.869209	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058524	rs540796	A	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:A_460-A_524:ENST00000302118	c.1380A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.854	0.21845	0.0215655	54,1903	0.759984	0.869209	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058524	rs540796	A	G	PASS	G	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:B_460-B_524:ENST00000302118	c.1380A>G	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.854	0.21845	0.0215655	54,1903	0.759984	0.869209	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058524	rs540796	A	G	PASS	G	synonymous_variant	LOW	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.1380A>G	p.Val460Val	9/12	1670/3637	460/692	1380/2079	NA	NA	NA	NA	0.854	0.21845	0.0215655	54,1903	0.759984	0.869209	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55058549	rs141502002	C	T	PASS	T	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2PMW:B_469-B_515:ENST00000302118	c.1405C>T	NA	9/12	NA	NA	NA	NA	NA	NA	NA	0.0007001	0.00359425	0.996406	2495,0	0	0.00179712	0|2|4	not_specified|Hypercholesterolemia\x2c_autosomal_dominant\x2c_3|Familial_hypercholesterolemia	CN169374|C1863551:603776|C0020445:143890:397915002:398036000	MedGen|MedGen:OMIM|MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	2	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	N/N	0.003	1.33	PCSK9_HUMAN	P	D	4.47	469	19.93	0.065	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55058549	rs141502002	C	T	PASS	T	missense_variant	MODERATE	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.1405C>T	p.Arg469Trp	9/12	1695/3637	469/692	1405/2079	NA	NA	NA	NA	0.0007001	0.00359425	0.996406	2495,0	0	0.00179712	0|2|4	not_specified|Hypercholesterolemia\x2c_autosomal_dominant\x2c_3|Familial_hypercholesterolemia	CN169374|C1863551:603776|C0020445:143890:397915002:398036000	MedGen|MedGen:OMIM|MedGen:OMIM:SNOMED_CT:SNOMED_CT	NA	2	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	N/N	0.003	1.33	PCSK9_HUMAN	P	D	4.47	469	19.93	0.065	D	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	134	NA	PCSK9	KP	AD	607786	NA
chr1	55058564	rs562556	G	A	PASS	A	missense_variant	MODERATE	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.1420G>A	p.Val474Ile	9/12	1710/3637	474/692	1420/2079	NA	NA	NA	NA	0.854	0.21885	0.0215655	54,1902	0.759585	0.86901	2|255|3	not_specified|Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	CN169374|C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen|MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	2	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	L	P/P	0	-8.95	PCSK9_HUMAN	B	B	4.47	474	0.004	-2.003	T	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55059640	rs28362270	A	G	PASS	G	missense_variant	MODERATE	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.1658A>G	p.His553Arg	10/12	1948/3637	553/692	1658/2079	NA	NA	NA	NA	0.0005316	0.00838658	0.991613	2483,0	0	0.00419329	255	Hypercholesterolemia\x2c_autosomal_dominant\x2c_3	C1863551:603776	MedGen:OMIM	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	M	N/N	0.083	-4.28	PCSK9_HUMAN	B	B	3.59	553	0.009	0.189	T	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063514	rs505151	G	A	PASS	A	missense_variant	MODERATE	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.2009G>A	p.Gly670Glu	12/12	2299/3637	670/692	2009/2079	NA	NA	NA	NA	0.943	0.158147	0.0219649	55,2053	0.819888	0.898962	255|2|3	Familial_hypercholesterolemia|not_specified|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|CN169374|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	N	P	0.001	0.348	PCSK9_HUMAN	B	B	2.82	670	0.003	0.188	T	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55063514	rs505151	G	A	PASS	A	downstream_gene_variant	MODIFIER	USP24	ENSG00000162402	transcript	ENST00000294383.6	c.*5531C>T	NA	NA	NA	NA	NA	2845	NA	NA	NA	0.943	0.158147	0.0219649	55,2053	0.819888	0.898962	255|2|3	Familial_hypercholesterolemia|not_specified|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|CN169374|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	N	P	0.001	0.348	PCSK9_HUMAN	B	B	2.82	670	0.003	0.188	T	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	83	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	stop_gained	HIGH	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.2037C>A	p.Cys679*	12/12	2327/3637	679/692	2037/2079	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2P4E:A_608-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2P4E:A_631-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2PMW:B_607-B_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2PMW:B_608-B_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2PMW:B_631-B_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2QTW:B_607-B_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2QTW:B_608-B_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	2QTW:B_631-B_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3BPS:A_608-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3BPS:A_631-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCW:A_608-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCW:A_631-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCX:A_608-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3GCX:A_631-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3H42:B_608-B_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3H42:B_631-B_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3SQO:A_608-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	3SQO:A_631-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:A_608-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:A_631-A_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:B_608-B_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	structural_interaction_variant	HIGH	PCSK9	ENSG00000169174	interaction	4NE9:B_631-B_679:ENST00000302118	c.2037C>A	NA	12/12	NA	NA	NA	NA	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063542	rs28362286	C	A	PASS	A	downstream_gene_variant	MODIFIER	USP24	ENSG00000162402	transcript	ENST00000294383.6	c.*5503G>T	NA	NA	NA	NA	NA	2817	NA	NA	NA	0.0007666	0.00439297	0.995607	2493,0	0	0.00219649	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_1	CN068586	MedGen	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	D	0.974	3.38	NA	NA	NA	3.38	NA	38	0.935	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063659	rs28362287	C	T	PASS	T	3_prime_UTR_variant	MODIFIER	PCSK9	ENSG00000169174	transcript	ENST00000302118.5	c.*75C>T	NA	12/12	NA	NA	NA	75	NA	NA	NA	NA	0.0471246	0.951677	2383,3	0.00119808	0.0247604	255|3	Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	55063659	rs28362287	C	T	PASS	T	downstream_gene_variant	MODIFIER	USP24	ENSG00000162402	transcript	ENST00000294383.6	c.*5386G>A	NA	NA	NA	NA	NA	2700	NA	NA	NA	NA	0.0471246	0.951677	2383,3	0.00119808	0.0247604	255|3	Familial_hypercholesterolemia|Familial_hypobetalipoproteinemia	C0020445:143890:397915002:398036000|C1862596:ORPHA426:60193003	MedGen:OMIM:SNOMED_CT:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	603776(3),603776(3)	NA	Hypercholesterolemia~familial~3,Hypercholesterolemia~familial~3	Chromosome~1p32-p31~deletion~syndrome	NA	-	NA	NA	NA	NA	NA	603776(3)	-,-	613735(4)	NA	IC	NA	{Low~density~lipoprotein~cholesterol~level~QTL~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Pcsk9	N	4.67E-01	89.89148384	0.942426495	abnormal	5.38585	255738	pcsk9	NA	736.36615	125	NA	PCSK9	KP	AD	607786	NA
chr1	56940965	rs41286844	G	A	PASS	A	stop_gained	HIGH	C8B	ENSG00000021852	transcript	ENST00000371237.8	c.1282C>T	p.Arg428*	9/12	1349/2037	428/591	1282/1776	NA	NA	(C8B|ENSG00000021852|1|1.00)	(C8B|ENSG00000021852|1|1.00)	0.001087	0.00239617	0.997604	2498,0	0	0.00119808	5	Complement_component_8_deficiency_type_2	C3151080:613789	MedGen:OMIM	NA	1	613789(3)	NA	C8~deficiency~type~II	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	NA	A/A/A	0.956	3.45	NA	NA	NA	5.36	NA	41	0.017	NA	C8b	N	4.31E-01	81.67020524	0.558509856	NA	4.94126	732	NA	NA	596.12337	127	NA	NA	NA	NA	NA	NA
chr1	56949599	rs140813121	G	A	PASS	A	stop_gained	HIGH	C8B	ENSG00000021852	transcript	ENST00000371237.8	c.820C>T	p.Arg274*	6/12	887/2037	274/591	820/1776	NA	NA	(C8B|ENSG00000021852|1|1.00)	(C8B|ENSG00000021852|1|1.00)	2.471e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Complement_component_8_deficiency_type_2	C3151080:613789	MedGen:OMIM	NA	1	613789(3)	NA	C8~deficiency~type~II	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	NA	A/A/A	0.004	0.198	NA	NA	NA	5.19	NA	35	-0.402	NA	C8b	N	4.31E-01	81.67020524	0.558509856	NA	4.94126	732	NA	NA	596.12337	134	NA	NA	NA	NA	NA	NA
chr1	62597921	rs569107562	GAACTC	G	VQSRTrancheINDEL99.00to100.00	G	frameshift_variant	HIGH	ANGPTL3	ENSG00000132855	transcript	ENST00000371129.3	c.363_367delCTCAA	p.Asn121fs	1/7	443/2805	121/460	363/1383	NA	INFO_REALIGN_3_PRIME	(ANGPTL3|ENSG00000132855|1|1.00)	NA	0.000206	NA	NA	NA	NA	NA	5	Hypobetalipoproteinemia\x2c_familial\x2c_2	C1857970:605019	MedGen:OMIM	NA	NA	615859(3),605019(3)	NA	Epileptic~encephalopathy~early~infantile~23,Hypobetalipoproteinemia~familial~2	Chromosome~1p32-p31~deletion~syndrome,Omphalocele~due~to~duplication~of~1p31.3	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	613735(4),164750(4)	NA	IC,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Angptl3/Dock7	N	7.76E-01/8.69E-01	0.884642604/45.25831564	-0.113792788/-2.535908408	./abnormal	2.34229/4.41537	27329/85440	./angptl3	NA	115.97808/451.1915	142	NA	NA	NA	NA	NA	NA
chr1	62597921	rs569107562	GAACTC	G	VQSRTrancheINDEL99.00to100.00	G	intron_variant	MODIFIER	DOCK7	ENSG00000116641	transcript	ENST00000635253.1	c.1683-11302_1683-11298delGAGTT	NA	14/49	NA	NA	NA	NA	NA	(ANGPTL3|ENSG00000132855|1|1.00)	NA	0.000206	NA	NA	NA	NA	NA	5	Hypobetalipoproteinemia\x2c_familial\x2c_2	C1857970:605019	MedGen:OMIM	NA	NA	615859(3),605019(3)	NA	Epileptic~encephalopathy~early~infantile~23,Hypobetalipoproteinemia~familial~2	Chromosome~1p32-p31~deletion~syndrome,Omphalocele~due~to~duplication~of~1p31.3	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	613735(4),164750(4)	NA	IC,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Angptl3/Dock7	N	7.76E-01/8.69E-01	0.884642604/45.25831564	-0.113792788/-2.535908408	./abnormal	2.34229/4.41537	27329/85440	./angptl3	NA	115.97808/451.1915	142	NA	NA	NA	NA	NA	NA
chr1	62597996	rs749131121	CAACT	C	VQSRTrancheINDEL99.00to100.00	C	frameshift_variant	HIGH	ANGPTL3	ENSG00000132855	transcript	ENST00000371129.3	c.439_442delAACT	p.Asn147fs	1/7	519/2805	147/460	439/1383	NA	INFO_REALIGN_3_PRIME	(ANGPTL3|ENSG00000132855|1|1.00)	NA	0.000165	NA	NA	NA	NA	NA	5	Hypobetalipoproteinemia\x2c_familial\x2c_2	C1857970:605019	MedGen:OMIM	NA	NA	615859(3),605019(3)	NA	Epileptic~encephalopathy~early~infantile~23,Hypobetalipoproteinemia~familial~2	Chromosome~1p32-p31~deletion~syndrome,Omphalocele~due~to~duplication~of~1p31.3	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	613735(4),164750(4)	NA	IC,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Angptl3/Dock7	N	7.76E-01/8.69E-01	0.884642604/45.25831564	-0.113792788/-2.535908408	./abnormal	2.34229/4.41537	27329/85440	./angptl3	NA	115.97808/451.1915	144	NA	NA	NA	NA	NA	NA
chr1	62597996	rs749131121	CAACT	C	VQSRTrancheINDEL99.00to100.00	C	intron_variant	MODIFIER	DOCK7	ENSG00000116641	transcript	ENST00000635253.1	c.1683-11376_1683-11373delAGTT	NA	14/49	NA	NA	NA	NA	NA	(ANGPTL3|ENSG00000132855|1|1.00)	NA	0.000165	NA	NA	NA	NA	NA	5	Hypobetalipoproteinemia\x2c_familial\x2c_2	C1857970:605019	MedGen:OMIM	NA	NA	615859(3),605019(3)	NA	Epileptic~encephalopathy~early~infantile~23,Hypobetalipoproteinemia~familial~2	Chromosome~1p32-p31~deletion~syndrome,Omphalocele~due~to~duplication~of~1p31.3	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	613735(4),164750(4)	NA	IC,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Angptl3/Dock7	N	7.76E-01/8.69E-01	0.884642604/45.25831564	-0.113792788/-2.535908408	./abnormal	2.34229/4.41537	27329/85440	./angptl3	NA	115.97808/451.1915	144	NA	NA	NA	NA	NA	NA
chr1	63406361	rs35383149	T	C	PASS	C	missense_variant	MODERATE	ALG6	ENSG00000088035	transcript	ENST00000263440.4	c.391T>C	p.Tyr131His	5/14	599/1895	131/509	391/1530	NA	NA	NA	NA	0.029	0.0267572	0.973243	2437,0	0	0.0133786	5|255	Congenital_disorder_of_glycosylation_type_1C|not_specified	C1864178:603147|CN169374	MedGen:OMIM|MedGen	NA	NA	603147(3)	NA	Congenital~disorder~of~glycosylation~type~Ic	Chromosome~1p32-p31~deletion~syndrome,Omphalocele~due~to~duplication~of~1p31.3	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4),164750(4)	NA	IC,AD	NA	NA	M	D/D	0.996	4.75	NA	B	B	5.87	131	18.04	0.993	T	Alg6	NA	2.91E-01	71.49681529	0.286674996	NA	3.53105	29929	NA	NA	271.59069	126	NA	NA	NA	NA	NA	ALG6
chr1	63415881	rs4630153	C	T	PASS	T	missense_variant	MODERATE	ALG6	ENSG00000088035	transcript	ENST00000263440.4	c.917C>T	p.Ser306Phe	10/14	1125/1895	306/509	917/1530	NA	NA	NA	NA	0.75	0.265575	0.0367412	92,1747	0.697684	0.830471	255|2	not_specified|Congenital_disorder_of_glycosylation	CN169374|C0282577:ORPHA137:238049009	MedGen|MedGen:Orphanet:SNOMED_CT	NA	1	603147(3)	NA	Congenital~disorder~of~glycosylation~type~Ic	Chromosome~1p32-p31~deletion~syndrome,Omphalocele~due~to~duplication~of~1p31.3	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4),164750(4)	NA	IC,AD	NA	NA	NA	P/P	0.956	3.91	NA	B	B	5.06	306	14.01	-0.251	T	Alg6	NA	2.91E-01	71.49681529	0.286674996	NA	3.53105	29929	NA	NA	271.59069	111	NA	NA	NA	NA	NA	ALG6
chr1	63429123	rs116660078	T	C	PASS	C	synonymous_variant	LOW	ALG6	ENSG00000088035	transcript	ENST00000263440.4	c.1329T>C	p.Tyr443Tyr	13/14	1537/1895	443/509	1329/1530	NA	NA	NA	NA	0.009291	0.00638978	0.99361	2488,0	0	0.00319489	255|0	not_specified|Congenital_disorder_of_glycosylation	CN169374|C0282577:ORPHA137:238049009	MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	603147(3)	NA	Congenital~disorder~of~glycosylation~type~Ic	Chromosome~1p32-p31~deletion~syndrome,Omphalocele~due~to~duplication~of~1p31.3	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4),164750(4)	NA	IC,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Alg6	NA	2.91E-01	71.49681529	0.286674996	NA	3.53105	29929	NA	NA	271.59069	132	NA	NA	NA	NA	NA	ALG6
chr1	65636397	rs193922650	C	T	PASS	T	synonymous_variant	LOW	LEPR	ENSG00000116678	transcript	ENST00000349533.10	c.2880C>T	p.Asn960Asn	20/20	3065/8227	960/1165	2880/3498	NA	NA	NA	NA	2.471e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	Obesity	C0028754:601665:ORPHA71529:414916001	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	614963(3)	NA	Obesity~morbid~due~to~leptin~receptor~deficiency	Chromosome~1p32-p31~deletion~syndrome,Omphalocele~due~to~duplication~of~1p31.3	NA	NA	NA	NA	NA	NA	NA	NA	-	613735(4),164750(4)	NA	IC,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Lepr	N	6.09E-01	37.69757018	-0.216746887	abnormal	9.99290	3953	lepr	leptinPathway	2800.90586	136	MamRTE1|LINE|RTE-BovB	NA	NA	NA	NA	NA
chr1	67240275	rs11209026	G	A	PASS	A	missense_variant	MODERATE	IL23R	ENSG00000162594	transcript	ENST00000347310.9	c.1142G>A	p.Arg381Gln	9/11	1313/2912	381/629	1142/1890	NA	NA	NA	NA	0.041	0.043131	0.955671	2393,3	0.00119808	0.0227636	255|255	Inflammatory_bowel_disease_17\x2c_protection_against|Psoriasis\x2c_protection_against	C4017090|C4017658	MedGen|MedGen	NA	3	NA	NA	NA	Chromosome~1p32-p31~deletion~syndrome,Omphalocele~due~to~duplication~of~1p31.3	NA	-,-	NA	NA	NA	NA	NA	605606(3),612261(3)	NA	613735(4),164750(4)	NA	IC,AD	NA	{Psoriasis~protection~against},{Inflammatory~bowel~disease~17~protection~against}	M	D/D/N	0.935	5.19	././././././././IL23R_HUMAN	D	D	5.19	127,205,205,139,210,235,288,126,381	32	1.047	D/.	Il23r	N	3.67E-01	87.49115357	0.795569043	NA	3.56826	149233	NA	NA	277.44165	120	NA	NA	NA	NA	NA	NA
chr1	68444632	rs61752878	C	T	PASS	T	missense_variant	MODERATE	RPE65	ENSG00000116745	transcript	ENST00000262340.5	c.394G>A	p.Ala132Thr	5/14	448/2610	132/533	394/1602	NA	NA	NA	NA	0.002866	0.00678914	0.993211	2487,0	0	0.00339457	5|1	Retinitis_pigmentosa_20|not_provided	C3151086:613794|CN221809	MedGen:OMIM|MedGen	NA	NA	613794(3),204100(3)	NA	Retinitis~pigmentosa~20,Leber~congenital~amaurosis~2	Chromosome~1p32-p31~deletion~syndrome,Omphalocele~due~to~duplication~of~1p31.3	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	613735(4),164750(4)	NA	IC,AD	NA	NA	L	A	0.999	5.05	RPE65_HUMAN	B	B	5.05	132	22.2	0.935	T	Rpe65	N	1.14E-01	28.01368247	-0.378346116	NA	3.95184	6121	NA	NA	347.53959	133	NA	NA	NA	NA	NA	NA
chr1	68444858	rs61752871	G	A	PASS	A	missense_variant	MODERATE	RPE65	ENSG00000116745	transcript	ENST00000262340.5	c.271C>T	p.Arg91Trp	4/14	325/2610	91/533	271/1602	NA	NA	NA	NA	8.237e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Retinitis_pigmentosa_20|not_provided	C3151086:613794|CN221809	MedGen:OMIM|MedGen	NA	NA	613794(3),204100(3)	NA	Retinitis~pigmentosa~20,Leber~congenital~amaurosis~2	Chromosome~1p32-p31~deletion~syndrome,Omphalocele~due~to~duplication~of~1p31.3	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	613735(4),164750(4)	NA	IC,AD	NA	NA	M	A	0.987	4.05	RPE65_HUMAN	D	D	5.03	91	33	1.048	D	Rpe65	N	1.14E-01	28.01368247	-0.378346116	NA	3.95184	6121	NA	NA	347.53959	133	NA	NA	NA	NA	NA	NA
chr1	70415987	rs28941785	C	T	PASS	T	structural_interaction_variant	HIGH	CTH	ENSG00000116761	interaction	2NMP:B_42-B_67:ENST00000370938	c.200C>T	NA	2/12	NA	NA	NA	NA	NA	NA	NA	0.006474	0.00519169	0.994808	2491,0	0	0.00259585	5	Cystathioninuria	C0220993:219500:ORPHA212:13003007	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	219500(3)	NA	Cystathioninuria	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	A/A/A	0.995	5.55	././CGL_HUMAN	P/P/D	D	5.55	67	32	0.935	D	Cth	N	2.03E-01	67.03231894	0.194852702	NA	6.69110	1491	NA	methioninepathway	1258.99689	130	NA	NA	NA	NA	NA	NA
chr1	70415987	rs28941785	C	T	PASS	T	structural_interaction_variant	HIGH	CTH	ENSG00000116761	interaction	2NMP:C_40-C_67:ENST00000370938	c.200C>T	NA	2/12	NA	NA	NA	NA	NA	NA	NA	0.006474	0.00519169	0.994808	2491,0	0	0.00259585	5	Cystathioninuria	C0220993:219500:ORPHA212:13003007	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	219500(3)	NA	Cystathioninuria	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	A/A/A	0.995	5.55	././CGL_HUMAN	P/P/D	D	5.55	67	32	0.935	D	Cth	N	2.03E-01	67.03231894	0.194852702	NA	6.69110	1491	NA	methioninepathway	1258.99689	130	NA	NA	NA	NA	NA	NA
chr1	70415987	rs28941785	C	T	PASS	T	structural_interaction_variant	HIGH	CTH	ENSG00000116761	interaction	2NMP:D_40-D_67:ENST00000370938	c.200C>T	NA	2/12	NA	NA	NA	NA	NA	NA	NA	0.006474	0.00519169	0.994808	2491,0	0	0.00259585	5	Cystathioninuria	C0220993:219500:ORPHA212:13003007	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	219500(3)	NA	Cystathioninuria	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	A/A/A	0.995	5.55	././CGL_HUMAN	P/P/D	D	5.55	67	32	0.935	D	Cth	N	2.03E-01	67.03231894	0.194852702	NA	6.69110	1491	NA	methioninepathway	1258.99689	130	NA	NA	NA	NA	NA	NA
chr1	70415987	rs28941785	C	T	PASS	T	structural_interaction_variant	HIGH	CTH	ENSG00000116761	interaction	3COG:B_40-B_67:ENST00000370938	c.200C>T	NA	2/12	NA	NA	NA	NA	NA	NA	NA	0.006474	0.00519169	0.994808	2491,0	0	0.00259585	5	Cystathioninuria	C0220993:219500:ORPHA212:13003007	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	219500(3)	NA	Cystathioninuria	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	A/A/A	0.995	5.55	././CGL_HUMAN	P/P/D	D	5.55	67	32	0.935	D	Cth	N	2.03E-01	67.03231894	0.194852702	NA	6.69110	1491	NA	methioninepathway	1258.99689	130	NA	NA	NA	NA	NA	NA
chr1	70415987	rs28941785	C	T	PASS	T	structural_interaction_variant	HIGH	CTH	ENSG00000116761	interaction	3COG:C_40-C_67:ENST00000370938	c.200C>T	NA	2/12	NA	NA	NA	NA	NA	NA	NA	0.006474	0.00519169	0.994808	2491,0	0	0.00259585	5	Cystathioninuria	C0220993:219500:ORPHA212:13003007	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	219500(3)	NA	Cystathioninuria	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	A/A/A	0.995	5.55	././CGL_HUMAN	P/P/D	D	5.55	67	32	0.935	D	Cth	N	2.03E-01	67.03231894	0.194852702	NA	6.69110	1491	NA	methioninepathway	1258.99689	130	NA	NA	NA	NA	NA	NA
chr1	70415987	rs28941785	C	T	PASS	T	structural_interaction_variant	HIGH	CTH	ENSG00000116761	interaction	3COG:D_40-D_67:ENST00000370938	c.200C>T	NA	2/12	NA	NA	NA	NA	NA	NA	NA	0.006474	0.00519169	0.994808	2491,0	0	0.00259585	5	Cystathioninuria	C0220993:219500:ORPHA212:13003007	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	219500(3)	NA	Cystathioninuria	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	A/A/A	0.995	5.55	././CGL_HUMAN	P/P/D	D	5.55	67	32	0.935	D	Cth	N	2.03E-01	67.03231894	0.194852702	NA	6.69110	1491	NA	methioninepathway	1258.99689	130	NA	NA	NA	NA	NA	NA
chr1	70415987	rs28941785	C	T	PASS	T	structural_interaction_variant	HIGH	CTH	ENSG00000116761	interaction	3COG:D_42-D_67:ENST00000370938	c.200C>T	NA	2/12	NA	NA	NA	NA	NA	NA	NA	0.006474	0.00519169	0.994808	2491,0	0	0.00259585	5	Cystathioninuria	C0220993:219500:ORPHA212:13003007	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	219500(3)	NA	Cystathioninuria	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	A/A/A	0.995	5.55	././CGL_HUMAN	P/P/D	D	5.55	67	32	0.935	D	Cth	N	2.03E-01	67.03231894	0.194852702	NA	6.69110	1491	NA	methioninepathway	1258.99689	130	NA	NA	NA	NA	NA	NA
chr1	70415987	rs28941785	C	T	PASS	T	structural_interaction_variant	HIGH	CTH	ENSG00000116761	interaction	3ELP:B_67-B_249:ENST00000370938	c.200C>T	NA	2/12	NA	NA	NA	NA	NA	NA	NA	0.006474	0.00519169	0.994808	2491,0	0	0.00259585	5	Cystathioninuria	C0220993:219500:ORPHA212:13003007	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	219500(3)	NA	Cystathioninuria	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	A/A/A	0.995	5.55	././CGL_HUMAN	P/P/D	D	5.55	67	32	0.935	D	Cth	N	2.03E-01	67.03231894	0.194852702	NA	6.69110	1491	NA	methioninepathway	1258.99689	130	NA	NA	NA	NA	NA	NA
chr1	70415987	rs28941785	C	T	PASS	T	structural_interaction_variant	HIGH	CTH	ENSG00000116761	interaction	3ELP:C_67-C_249:ENST00000370938	c.200C>T	NA	2/12	NA	NA	NA	NA	NA	NA	NA	0.006474	0.00519169	0.994808	2491,0	0	0.00259585	5	Cystathioninuria	C0220993:219500:ORPHA212:13003007	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	219500(3)	NA	Cystathioninuria	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	A/A/A	0.995	5.55	././CGL_HUMAN	P/P/D	D	5.55	67	32	0.935	D	Cth	N	2.03E-01	67.03231894	0.194852702	NA	6.69110	1491	NA	methioninepathway	1258.99689	130	NA	NA	NA	NA	NA	NA
chr1	70415987	rs28941785	C	T	PASS	T	missense_variant	MODERATE	CTH	ENSG00000116761	transcript	ENST00000370938.7	c.200C>T	p.Thr67Ile	2/12	344/1805	67/405	200/1218	NA	NA	NA	NA	0.006474	0.00519169	0.994808	2491,0	0	0.00259585	5	Cystathioninuria	C0220993:219500:ORPHA212:13003007	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	219500(3)	NA	Cystathioninuria	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	A/A/A	0.995	5.55	././CGL_HUMAN	P/P/D	D	5.55	67	32	0.935	D	Cth	N	2.03E-01	67.03231894	0.194852702	NA	6.69110	1491	NA	methioninepathway	1258.99689	130	NA	NA	NA	NA	NA	NA
chr1	70439117	rs1021737	G	T	PASS	T	missense_variant	MODERATE	CTH	ENSG00000116761	transcript	ENST00000370938.7	c.1208G>T	p.Ser403Ile	12/12	1352/1805	403/405	1208/1218	NA	NA	NA	NA	0.277	0.301118	0.644169	1613,137	0.0547125	0.205272	255|3	Homocysteine\x2c_total_plasma\x2c_elevated|Cystathioninuria	C4017108|C0220993:219500:ORPHA212:13003007	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	2	219500(3)	NA	Cystathioninuria	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	N	P/P/P	0.011	0.838	././CGL_HUMAN	B	B	4.79	371,359,403	14.37	0.127	T	Cth	N	2.03E-01	67.03231894	0.194852702	NA	6.69110	1491	NA	methioninepathway	1258.99689	86	NA	NA	NA	NA	NA	NA
chr1	75732652	rs147559466	G	A	PASS	A	missense_variant	MODERATE	ACADM	ENSG00000117054	transcript	ENST00000370834.9	c.127G>A	p.Glu43Lys	3/13	206/2172	43/454	127/1365	NA	NA	NA	NA	0.00224	0.00399361	0.996006	2494,0	0	0.00199681	5|255|2	not_provided|Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency|not_specified	CN221809|C0220710:201450:ORPHA42:128596003|CN169374	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	D/D/D/D/D	0.889	5.77	././././ACADM_HUMAN	B/P/B/B/B	P/P/P/B/P	5.77	7,43,43,47,43	26.5	0.953	D	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	134	NA	NA	NA	NA	NA	ACADM
chr1	75733592	rs74090726	A	C	PASS	C	synonymous_variant	LOW	ACADM	ENSG00000117054	transcript	ENST00000370834.9	c.450A>C	p.Thr150Thr	6/13	529/2172	150/454	450/1365	NA	NA	NA	NA	0.028	0.0770767	0.921326	2307,4	0.00159744	0.0401358	255|2|255	MCAD_deficiency\x2c_modifier_of|not_specified|Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency	.|CN169374|C0220710:201450:ORPHA42:128596003	.|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	130	NA	NA	NA	NA	NA	ACADM
chr1	75740000	rs78392995	T	G	PASS	G	synonymous_variant	LOW	ACADM	ENSG00000117054	transcript	ENST00000370834.9	c.588T>G	p.Pro196Pro	8/13	667/2172	196/454	588/1365	NA	NA	NA	NA	0.006869	0.0411342	0.955671	2393,8	0.00319489	0.023762	2|255	not_specified|Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency	CN169374|C0220710:201450:ORPHA42:128596003	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	132	NA	NA	NA	NA	NA	ACADM
chr1	75740000	rs78392995	T	G	PASS	G	downstream_gene_variant	MODIFIER	RP4-682C21.2	ENSG00000181227	transcript	ENST00000444241.1	n.*3423A>C	NA	NA	NA	NA	NA	3423	NA	NA	NA	0.006869	0.0411342	0.955671	2393,8	0.00319489	0.023762	2|255	not_specified|Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency	CN169374|C0220710:201450:ORPHA42:128596003	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	132	NA	NA	NA	NA	NA	ACADM
chr1	75745788	rs370523609	G	A	PASS	A	upstream_gene_variant	MODIFIER	RP4-682C21.2	ENSG00000181227	transcript	ENST00000444241.1	n.-1012C>T	NA	NA	NA	NA	NA	1012	NA	NA	NA	0.0001647	0.000798722	0.999201	2502,0	0	0.000399361	4|5	Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency|not_provided	C0220710:201450:ORPHA42:128596003|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	138	NA	NA	NA	NA	NA	ACADM
chr1	75745788	rs370523609	G	A	PASS	A	intron_variant	MODIFIER	ACADM	ENSG00000117054	transcript	ENST00000370834.9	c.699-18G>A	NA	8/12	NA	NA	NA	NA	NA	NA	NA	0.0001647	0.000798722	0.999201	2502,0	0	0.000399361	4|5	Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency|not_provided	C0220710:201450:ORPHA42:128596003|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	138	NA	NA	NA	NA	NA	ACADM
chr1	75745884	rs2229249	A	G	PASS	G	synonymous_variant	LOW	ACADM	ENSG00000117054	transcript	ENST00000370834.9	c.777A>G	p.Ala259Ala	9/13	856/2172	259/454	777/1365	NA	NA	NA	NA	0.003089	0.00678914	0.992812	2486,1	0.000399361	0.00379393	255	Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency	C0220710:201450:ORPHA42:128596003	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	98	NA	NA	NA	NA	NA	ACADM
chr1	75745884	rs2229249	A	G	PASS	G	upstream_gene_variant	MODIFIER	RP4-682C21.2	ENSG00000181227	transcript	ENST00000444241.1	n.-1108T>C	NA	NA	NA	NA	NA	1108	NA	NA	NA	0.003089	0.00678914	0.992812	2486,1	0.000399361	0.00379393	255	Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency	C0220710:201450:ORPHA42:128596003	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	98	NA	NA	NA	NA	NA	ACADM
chr1	75745889	rs149678400	C	A	PASS	A	missense_variant	MODERATE	ACADM	ENSG00000117054	transcript	ENST00000370834.9	c.782C>A	p.Thr261Asn	9/13	861/2172	261/454	782/1365	NA	NA	NA	NA	0.0002389	0.000399361	0.999601	2503,0	0	0.000199681	0|4	not_specified|Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency	CN169374|C0220710:201450:ORPHA42:128596003	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	D/D/D/D/D	0.995	4.9	././././ACADM_HUMAN	B/B/P/B/B	B/B/P/P/B	5.83	192,142,261,232,228	26.4	0.892	D	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	135	NA	NA	NA	NA	NA	ACADM
chr1	75745889	rs149678400	C	A	PASS	A	upstream_gene_variant	MODIFIER	RP4-682C21.2	ENSG00000181227	transcript	ENST00000444241.1	n.-1113G>T	NA	NA	NA	NA	NA	1113	NA	NA	NA	0.0002389	0.000399361	0.999601	2503,0	0	0.000199681	0|4	not_specified|Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency	CN169374|C0220710:201450:ORPHA42:128596003	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	M	D/D/D/D/D	0.995	4.9	././././ACADM_HUMAN	B/B/P/B/B	B/B/P/P/B	5.83	192,142,261,232,228	26.4	0.892	D	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	135	NA	NA	NA	NA	NA	ACADM
chr1	75761161	rs77931234	A	G	PASS	G	missense_variant	MODERATE	ACADM	ENSG00000117054	transcript	ENST00000370834.9	c.1084A>G	p.Lys362Glu	12/13	1163/2172	362/454	1084/1365	NA	NA	NA	NA	0.003311	0.00199681	0.998003	2499,0	0	0.000998403	5,5|5	Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency,Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency|not_provided	C0220710:201450:ORPHA42:128596003,C0220710:201450:ORPHA42:128596003|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	N	D/D/D/D/D	1	5.21	././././ACADM_HUMAN	B	P/B/B/B/B	5.21	293,243,362,333,329	22.1	1.14	T	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	131	NA	NA	NA	NA	NA	ACADM
chr1	75761221	rs148207467	C	T	PASS	T	stop_gained	HIGH	ACADM	ENSG00000117054	transcript	ENST00000370834.9	c.1144C>T	p.Arg382*	12/13	1223/2172	382/454	1144/1365	NA	NA	(ACADM|ENSG00000117054|1|1.00)	(ACADM|ENSG00000117054|1|1.00)	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency	C0220710:201450:ORPHA42:128596003	MedGen:OMIM:Orphanet:SNOMED_CT	NA	2	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	NA	A/A/A/A/A	0.998	4.36	NA	NA	NA	5.3	NA	41	0.935	NA	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	134	NA	NA	NA	NA	NA	ACADM
chr1	75762840	rs143911981	C	T	PASS	T	3_prime_UTR_variant	MODIFIER	ACADM	ENSG00000117054	transcript	ENST00000370834.9	c.*77C>T	NA	13/13	NA	NA	NA	77	NA	NA	NA	NA	0.0163738	0.982827	2461,2	0.000798722	0.00898562	255	Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency	C0220710:201450:ORPHA42:128596003	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	201450(3)	NA	Acyl-CoA~dehydrogenase~medium~chain~deficiency~of	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	613735(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Acadm	E	1.55E-01	35.98726115	-0.247889024	NA	1.25961	34	NA	NA	43.76588	134	NA	NA	NA	NA	NA	ACADM
chr1	77926436	rs372065024	T	C	PASS	C	missense_variant	MODERATE	NEXN	ENSG00000162614	transcript	ENST00000334785.11	c.512T>C	p.Ile171Thr	7/13	696/2607	171/675	512/2028	NA	NA	NA	NA	0.0006791	0.00359425	0.996406	2495,0	0	0.00179712	255	not_specified	CN169374	MedGen	NA	NA	613876(3),613122(3)	NA	Cardiomyopathy~hypertrophic~20,Cardiomyopathy~dilated~1CC	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	613735(4)	NA	IC	NA	NA	N	D/D/D	0.997	5.52	././NEXN_HUMAN/.	B	B	5.52	107,157,171,107	11.50	1.061	D/D/D/T	Nexn	NA	9.29E-01	50.34206181	-0.045835247	abnormal	6.94727	91624	nexn	NA	1371.33421	138	NA	NA	NA	NA	NA	NA
chr1	77926863	rs146245480	C	T	PASS	T	missense_variant	MODERATE	NEXN	ENSG00000162614	transcript	ENST00000334785.11	c.835C>T	p.Arg279Cys	8/13	1019/2607	279/675	835/2028	NA	NA	NA	NA	0.0005878	0.00239617	0.997604	2498,0	0	0.00119808	5|3|0	Familial_hypertrophic_cardiomyopathy_20|not_specified|Primary_familial_hypertrophic_cardiomyopathy	C3151267:613876|CN169374|C0949658:ORPHA155:83978005	MedGen:OMIM|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	613876(3),613122(3)	NA	Cardiomyopathy~hypertrophic~20,Cardiomyopathy~dilated~1CC	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	613735(4)	NA	IC	NA	NA	M	D/D/D	0.986	5.63	././NEXN_HUMAN/.	D	D	5.63	215,265,279,215	32	0.935	D	Nexn	NA	9.29E-01	50.34206181	-0.045835247	abnormal	6.94727	91624	nexn	NA	1371.33421	134	NA	NA	NA	NA	NA	NA
chr1	77926904	rs188416492	T	A	PASS	A	intron_variant	MODIFIER	NEXN	ENSG00000162614	transcript	ENST00000334785.11	c.864+12T>A	NA	8/12	NA	NA	NA	NA	NA	NA	NA	0.001226	0.00159744	0.998403	2500,0	0	0.000798722	255|0|0	not_specified|Hypertrophic_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant	CN169374|HP:0001639:C0007194:ORPHA217569|CN239310	MedGen|Human_Phenotype_Ontology:MedGen:Orphanet|MedGen	NA	NA	613876(3),613122(3)	NA	Cardiomyopathy~hypertrophic~20,Cardiomyopathy~dilated~1CC	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	613735(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nexn	NA	9.29E-01	50.34206181	-0.045835247	abnormal	6.94727	91624	nexn	NA	1371.33421	135	NA	NA	NA	NA	NA	NA
chr1	77929446	rs201763096	A	C	PASS	C	missense_variant	MODERATE	NEXN	ENSG00000162614	transcript	ENST00000334785.11	c.995A>C	p.Glu332Ala	9/13	1179/2607	332/675	995/2028	NA	NA	NA	NA	0.003973	0.00638978	0.99361	2488,0	0	0.00319489	255|2|2|0|0	not_specified|Dilated_cardiomyopathy_1CC|Familial_hypertrophic_cardiomyopathy_20|Hypertrophic_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant	CN169374|C2751084:613122|C3151267:613876|HP:0001639:C0007194:ORPHA217569|CN239310	MedGen|MedGen:OMIM|MedGen:OMIM|Human_Phenotype_Ontology:MedGen:Orphanet|MedGen	NA	NA	613876(3),613122(3)	NA	Cardiomyopathy~hypertrophic~20,Cardiomyopathy~dilated~1CC	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	613735(4)	NA	IC	NA	NA	M	D/D/D	0.742	4.98	././NEXN_HUMAN/.	B	B	4.98	268,318,332,268	23.2	0.202	D	Nexn	NA	9.29E-01	50.34206181	-0.045835247	abnormal	6.94727	91624	nexn	NA	1371.33421	137	GA-rich|Low_complexity|Low_complexity	NA	NA	NA	NA	NA
chr1	77935971	rs762929322	TAGA	T	PASS	T	disruptive_inframe_deletion	MODERATE	NEXN	ENSG00000162614	transcript	ENST00000334785.11	c.1407_1409delAGA	p.Glu470del	11/13	1591/2607	469/675	1407/2028	NA	INFO_REALIGN_3_PRIME	NA	NA	0.0001408	NA	NA	NA	NA	NA	0|4	not_specified|Dilated_cardiomyopathy_1CC	CN169374|C2751084:613122	MedGen|MedGen:OMIM	NA	NA	613876(3),613122(3)	NA	Cardiomyopathy~hypertrophic~20,Cardiomyopathy~dilated~1CC	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	613735(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nexn	NA	9.29E-01	50.34206181	-0.045835247	abnormal	6.94727	91624	nexn	NA	1371.33421	144	NA	NA	NA	NA	NA	NA
chr1	77942167	rs201390657	A	G	PASS	G	missense_variant	MODERATE	NEXN	ENSG00000162614	transcript	ENST00000334785.11	c.1618A>G	p.Met540Val	12/13	1802/2607	540/675	1618/2028	NA	NA	NA	NA	0.0004222	0.00279553	0.997204	2497,0	0	0.00139776	255	not_specified	CN169374	MedGen	NA	NA	613876(3),613122(3)	NA	Cardiomyopathy~hypertrophic~20,Cardiomyopathy~dilated~1CC	Chromosome~1p32-p31~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	613735(4)	NA	IC	NA	NA	M	D/D/D	0.987	5.71	././NEXN_HUMAN/.	B	B	5.71	476,526,540,476	23.2	1.14	D	Nexn	NA	9.29E-01	50.34206181	-0.045835247	abnormal	6.94727	91624	nexn	NA	1371.33421	137	NA	NA	NA	NA	NA	NA
chr1	92478757	rs768494519	CAG	C	PASS	C	splice_region_variant&intron_variant	LOW	GFI1	ENSG00000162676	transcript	ENST00000294702.5	c.925-6_925-5delCT	NA	5/6	NA	NA	NA	NA	NA	NA	NA	0.114	NA	NA	NA	NA	NA	255	Severe_congenital_neutropenia	C1853118:ORPHA42738	MedGen:Orphanet	NA	NA	613107(3),607847(3)	NA	?Neutropenia~severe~congenital~2~autosomal~dominant,?Neutropenia~nonimmune~chronic~idiopathic~of~adults	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Gfi1	N	5.57E-01	73.27199811	0.327131069	abnormal	3.10367	2672	gfi1aa	NA	206.38015	144	AGn|Simple_repeat|Simple_repeat	NA	NA	NA	NA	NA
chr1	92833636	rs58263806	G	A	PASS	A	synonymous_variant	LOW	RPL5	ENSG00000122406	transcript	ENST00000370321.7	c.165G>A	p.Val55Val	3/8	255/1043	55/297	165/894	NA	NA	NA	NA	0.006779	0.0427316	0.954473	2390,7	0.00279553	0.0241613	255	Diamond-Blackfan_anemia	C1260899:ORPHA124:88854002	MedGen:Orphanet:SNOMED_CT	NA	NA	612561(3)	NA	Diamond-Blackfan~anemia~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Fam69a/Rpl5	NA	./6.54E-01	51.40363293/75.87284737	-0.029247611/0.391453969	./abnormal	0.76269/1.33928	388650/6125	./rpl5a	NA	22.85333/47.54737	129	NA	NA	NA	NA	NA	NA
chr1	92833636	rs58263806	G	A	PASS	A	upstream_gene_variant	MODIFIER	SNORD21	ENSG00000206680	transcript	ENST00000383953.1	n.-3653G>A	NA	NA	NA	NA	NA	3653	NA	NA	NA	0.006779	0.0427316	0.954473	2390,7	0.00279553	0.0241613	255	Diamond-Blackfan_anemia	C1260899:ORPHA124:88854002	MedGen:Orphanet:SNOMED_CT	NA	NA	612561(3)	NA	Diamond-Blackfan~anemia~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Fam69a/Rpl5	NA	./6.54E-01	51.40363293/75.87284737	-0.029247611/0.391453969	./abnormal	0.76269/1.33928	388650/6125	./rpl5a	NA	22.85333/47.54737	129	NA	NA	NA	NA	NA	NA
chr1	92833636	rs58263806	G	A	PASS	A	intragenic_variant	MODIFIER	FAM69A	ENSG00000154511	gene_variant	ENSG00000154511	n.92833636C>T	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.006779	0.0427316	0.954473	2390,7	0.00279553	0.0241613	255	Diamond-Blackfan_anemia	C1260899:ORPHA124:88854002	MedGen:Orphanet:SNOMED_CT	NA	NA	612561(3)	NA	Diamond-Blackfan~anemia~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Fam69a/Rpl5	NA	./6.54E-01	51.40363293/75.87284737	-0.029247611/0.391453969	./abnormal	0.76269/1.33928	388650/6125	./rpl5a	NA	22.85333/47.54737	129	NA	NA	NA	NA	NA	NA
chr1	92834847	rs113792800	T	C	PASS	C	synonymous_variant	LOW	RPL5	ENSG00000122406	transcript	ENST00000370321.7	c.258T>C	p.Tyr86Tyr	4/8	348/1043	86/297	258/894	NA	NA	NA	NA	0.005304	0.0275559	0.972045	2434,1	0.000399361	0.0141773	255	Diamond-Blackfan_anemia	C1260899:ORPHA124:88854002	MedGen:Orphanet:SNOMED_CT	NA	NA	612561(3)	NA	Diamond-Blackfan~anemia~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Fam69a/Rpl5	NA	./6.54E-01	51.40363293/75.87284737	-0.029247611/0.391453969	./abnormal	0.76269/1.33928	388650/6125	./rpl5a	NA	22.85333/47.54737	132	NA	NA	NA	NA	NA	NA
chr1	92834847	rs113792800	T	C	PASS	C	upstream_gene_variant	MODIFIER	SNORD21	ENSG00000206680	transcript	ENST00000383953.1	n.-2442T>C	NA	NA	NA	NA	NA	2442	NA	NA	NA	0.005304	0.0275559	0.972045	2434,1	0.000399361	0.0141773	255	Diamond-Blackfan_anemia	C1260899:ORPHA124:88854002	MedGen:Orphanet:SNOMED_CT	NA	NA	612561(3)	NA	Diamond-Blackfan~anemia~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Fam69a/Rpl5	NA	./6.54E-01	51.40363293/75.87284737	-0.029247611/0.391453969	./abnormal	0.76269/1.33928	388650/6125	./rpl5a	NA	22.85333/47.54737	132	NA	NA	NA	NA	NA	NA
chr1	92834847	rs113792800	T	C	PASS	C	intragenic_variant	MODIFIER	FAM69A	ENSG00000154511	gene_variant	ENSG00000154511	n.92834847A>G	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.005304	0.0275559	0.972045	2434,1	0.000399361	0.0141773	255	Diamond-Blackfan_anemia	C1260899:ORPHA124:88854002	MedGen:Orphanet:SNOMED_CT	NA	NA	612561(3)	NA	Diamond-Blackfan~anemia~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Fam69a/Rpl5	NA	./6.54E-01	51.40363293/75.87284737	-0.029247611/0.391453969	./abnormal	0.76269/1.33928	388650/6125	./rpl5a	NA	22.85333/47.54737	132	NA	NA	NA	NA	NA	NA
chr1	92837557	rs11540832	A	G	PASS	G	missense_variant	MODERATE	RPL5	ENSG00000122406	transcript	ENST00000370321.7	c.629A>G	p.Tyr210Cys	6/8	719/1043	210/297	629/894	NA	NA	NA	NA	0.004407	0.00439297	0.995607	2493,0	0	0.00219649	255	Diamond-Blackfan_anemia	C1260899:ORPHA124:88854002	MedGen:Orphanet:SNOMED_CT	NA	NA	612561(3)	NA	Diamond-Blackfan~anemia~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	M	D	0.996	5.2	./RL5_HUMAN	B	B	5.2	210	23.6	1.174	T	Fam69a/Rpl5	NA	./6.54E-01	51.40363293/75.87284737	-0.029247611/0.391453969	./abnormal	0.76269/1.33928	388650/6125	./rpl5a	NA	22.85333/47.54737	120	NA	NA	NA	NA	NA	NA
chr1	92837557	rs11540832	A	G	PASS	G	upstream_gene_variant	MODIFIER	SNORA66	ENSG00000207523	transcript	ENST00000384792.1	n.-3162A>G	NA	NA	NA	NA	NA	3162	NA	NA	NA	0.004407	0.00439297	0.995607	2493,0	0	0.00219649	255	Diamond-Blackfan_anemia	C1260899:ORPHA124:88854002	MedGen:Orphanet:SNOMED_CT	NA	NA	612561(3)	NA	Diamond-Blackfan~anemia~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	M	D	0.996	5.2	./RL5_HUMAN	B	B	5.2	210	23.6	1.174	T	Fam69a/Rpl5	NA	./6.54E-01	51.40363293/75.87284737	-0.029247611/0.391453969	./abnormal	0.76269/1.33928	388650/6125	./rpl5a	NA	22.85333/47.54737	120	NA	NA	NA	NA	NA	NA
chr1	92837557	rs11540832	A	G	PASS	G	downstream_gene_variant	MODIFIER	FAM69A	ENSG00000154511	transcript	ENST00000370310.4	c.*5826T>C	NA	NA	NA	NA	NA	4610	NA	NA	NA	0.004407	0.00439297	0.995607	2493,0	0	0.00219649	255	Diamond-Blackfan_anemia	C1260899:ORPHA124:88854002	MedGen:Orphanet:SNOMED_CT	NA	NA	612561(3)	NA	Diamond-Blackfan~anemia~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	M	D	0.996	5.2	./RL5_HUMAN	B	B	5.2	210	23.6	1.174	T	Fam69a/Rpl5	NA	./6.54E-01	51.40363293/75.87284737	-0.029247611/0.391453969	./abnormal	0.76269/1.33928	388650/6125	./rpl5a	NA	22.85333/47.54737	120	NA	NA	NA	NA	NA	NA
chr1	92837557	rs11540832	A	G	PASS	G	downstream_gene_variant	MODIFIER	SNORD21	ENSG00000206680	transcript	ENST00000383953.1	n.*174A>G	NA	NA	NA	NA	NA	174	NA	NA	NA	0.004407	0.00439297	0.995607	2493,0	0	0.00219649	255	Diamond-Blackfan_anemia	C1260899:ORPHA124:88854002	MedGen:Orphanet:SNOMED_CT	NA	NA	612561(3)	NA	Diamond-Blackfan~anemia~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	M	D	0.996	5.2	./RL5_HUMAN	B	B	5.2	210	23.6	1.174	T	Fam69a/Rpl5	NA	./6.54E-01	51.40363293/75.87284737	-0.029247611/0.391453969	./abnormal	0.76269/1.33928	388650/6125	./rpl5a	NA	22.85333/47.54737	120	NA	NA	NA	NA	NA	NA
chr1	92837557	rs11540832	A	G	PASS	G	intragenic_variant	MODIFIER	FAM69A	ENSG00000154511	gene_variant	ENSG00000154511	n.92837557T>C	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.004407	0.00439297	0.995607	2493,0	0	0.00219649	255	Diamond-Blackfan_anemia	C1260899:ORPHA124:88854002	MedGen:Orphanet:SNOMED_CT	NA	NA	612561(3)	NA	Diamond-Blackfan~anemia~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	M	D	0.996	5.2	./RL5_HUMAN	B	B	5.2	210	23.6	1.174	T	Fam69a/Rpl5	NA	./6.54E-01	51.40363293/75.87284737	-0.029247611/0.391453969	./abnormal	0.76269/1.33928	388650/6125	./rpl5a	NA	22.85333/47.54737	120	NA	NA	NA	NA	NA	NA
chr1	93997932	rs61753046	G	A	PASS	A	stop_gained	HIGH	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.6658C>T	p.Gln2220*	48/50	6745/7309	2220/2273	6658/6822	NA	NA	(ABCA4|ENSG00000198691|1|1.00)	(ABCA4|ENSG00000198691|1|1.00)	4.942e-05	0.000399361	0.999601	2503,0	0	0.000199681	1|5	not_provided|Stargardt_disease_1	CN221809|C1855465:248200	MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	NA	A/A/A	1	5.39	NA	NA	NA	5.39	NA	48	1.045	NA	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	93998061	rs1800555	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.6529G>A	p.Asp2177Asn	48/50	6616/7309	2177/2273	6529/6822	NA	NA	NA	NA	0.01	0.00798722	0.992013	2484,0	0	0.00399361	255|1|3|3|3|3|3	MACULAR_DEGENERATION\x2c_AGE-RELATED\x2c_2\x2c_SUSCEPTIBILITY_TO|not_provided|not_specified|Stargardt_Disease\x2c_Recessive|Cone-Rod_Dystrophy\x2c_Recessive|Macular_degeneration|Retinitis_Pigmentosa\x2c_Recessive	.|CN221809|CN169374|CN239312|CN239309|HP:0000608:C1849131|CN239466	.|MedGen|MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen|MedGen	NA	1	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	L	D/D/D	0.022	5.38	ABCA4_HUMAN	B	B	5.38	2177	23.1	0.065	./T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	89	NA	NA	NA	NA	NA	NA
chr1	94001068	rs62642564	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.6320G>A	p.Arg2107His	46/50	6407/7309	2107/2273	6320/6822	NA	NA	NA	NA	0.00187	0.00838658	0.991214	2482,1	0.000399361	0.00459265	1,1|0|3|3|3|3|4	not_provided,not_provided|not_specified|Retinitis_Pigmentosa\x2c_Recessive|Cone-Rod_Dystrophy\x2c_Recessive|Stargardt_Disease\x2c_Recessive|Macular_degeneration|Stargardt_disease_1	CN221809,CN221809|CN169374|CN239466|CN239309|CN239312|HP:0000608:C1849131|C1855465:248200	MedGen,MedGen|MedGen|MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen|MedGen:OMIM	NA	1	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D/D/D	1	6.08	ABCA4_HUMAN	D	D	6.08	2107	35	0.935	./D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	133	NA	NA	NA	NA	NA	NA
chr1	94001072	rs61750648	G	A	PASS	A	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.6316C>T	p.Arg2106Cys	46/50	6403/7309	2106/2273	6316/6822	NA	NA	NA	NA	0.0001153	0.000399361	0.999601	2503,0	0	0.000199681	1|4	not_provided|Stargardt_disease_1	CN221809|C1855465:248200	MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D/D/D	1	5.14	ABCA4_HUMAN	D	D	6.08	2106	34	1.048	./D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94001992	rs41292677	C	G	PASS	G	missense_variant&splice_region_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.6148G>C	p.Val2050Leu	45/50	6235/7309	2050/2273	6148/6822	NA	NA	NA	NA	0.002751	0.00559105	0.994409	2490,0	0	0.00279553	255|1|0|3|3|3|3|4	Stargardt_disease_1|not_provided|not_specified|Cone-Rod_Dystrophy\x2c_Recessive|Stargardt_Disease\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive|Macular_degeneration|Stargardt_disease_1	C1855465:248200|CN221809|CN169374|CN239309|CN239312|CN239466|HP:0000608:C1849131|C1855465:248200	MedGen:OMIM|MedGen|MedGen|MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	N	A/A/A	0.994	5.65	./ABCA4_HUMAN	B/P	P	5.65	169,2050	33	0.935	./T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	127	NA	NA	NA	NA	NA	NA
chr1	94005499	rs61750641	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.6089G>A	p.Arg2030Gln	44/50	6176/7309	2030/2273	6089/6822	NA	NA	NA	NA	0.0003871	0.000399361	0.999201	2502,1	0.000399361	0.000599042	5|255|5	not_provided|Stargardt_disease_1|Stargardt_disease_1	CN221809|C1855465:248200|C1855465:248200	MedGen|MedGen:OMIM|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	L	D/D/D	0.995	5.02	./ABCA4_HUMAN	P/D	D	5.93	149,2030	34	0.935	./D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	134	NA	NA	NA	NA	NA	NA
chr1	94005509	rs61751408	G	A	PASS	A	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.6079C>T	p.Leu2027Phe	44/50	6166/7309	2027/2273	6079/6822	NA	NA	NA	NA	0.0002141	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5	Stargardt_disease_1|Cone-rod_dystrophy_3|not_provided	C1855465:248200|C1858806:604116|CN221809	MedGen:OMIM|MedGen:OMIM|MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	L	A/A/A	1	5.93	./ABCA4_HUMAN	D	D	5.93	146,2027	29.4	1.048	./D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	133	NA	NA	NA	NA	NA	NA
chr1	94007731	rs28938473	G	A	PASS	A	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.5908C>T	p.Leu1970Phe	43/50	5995/7309	1970/2273	5908/6822	NA	NA	NA	NA	0.002899	0.00479233	0.995208	2492,0	0	0.00239617	5|1|3|4	Stargardt_disease|not_provided|not_specified|Stargardt_disease_1	C0271093:ORPHA827:70099003|CN221809|CN169374|C1855465:248200	MedGen:Orphanet:SNOMED_CT|MedGen|MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	A/A/A	1	5.1	./ABCA4_HUMAN	P/D	D	5.1	89,1970	26.4	0.953	./T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	131	NA	NA	NA	NA	NA	NA
chr1	94008251	rs1800553	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.5882G>A	p.Gly1961Glu	42/50	5969/7309	1961/2273	5882/6822	NA	NA	NA	NA	0.005049	0.00638978	0.99361	2488,0	0	0.00319489	255|255|5|5|5|5	MACULAR_DEGENERATION\x2c_AGE-RELATED\x2c_2\x2c_SUSCEPTIBILITY_TO|Stargardt_disease_1|Cone-rod_dystrophy_3|not_provided|Stargardt_disease_1|ABCA4-Related_Disorders	.|C1855465:248200|C1858806:604116|CN221809|C1855465:248200|CN239167	.|MedGen:OMIM|MedGen:OMIM|MedGen|MedGen:OMIM|MedGen	NA	2	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	N	D/D/D	0.895	5.35	./ABCA4_HUMAN	B/D	P/D	5.35	80,1961	33	0.935	./D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	89	NA	NA	NA	NA	NA	NA
chr1	94008252	rs142253670	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.5881G>A	p.Gly1961Arg	42/50	5968/7309	1961/2273	5881/6822	NA	NA	NA	NA	8.236e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	Stargardt_disease_1	C1855465:248200	MedGen:OMIM	NA	1	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	N	D/D/D	0.882	5.35	./ABCA4_HUMAN	B/D	P/D	5.35	80,1961	35	0.935	./D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	134	NA	NA	NA	NA	NA	NA
chr1	94010821	rs1800552	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.5693G>A	p.Arg1898His	40/50	5780/7309	1898/2273	5693/6822	NA	NA	NA	NA	0.001787	0.000798722	0.999201	2502,0	0	0.000399361	1|4	not_provided|Stargardt_disease_1	CN221809|C1855465:248200	MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	N	N/N/N	0.975	3.62	././ABCA4_HUMAN	B	B	4.74	168,17,1898	22.8	0.09	./T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	89	NA	NA	NA	NA	NA	NA
chr1	94021848	rs113106943	C	T	PASS	T	missense_variant&splice_region_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.4771G>A	p.Gly1591Arg	33/50	4858/7309	1591/2273	4771/6822	NA	NA	NA	NA	0.002611	0.000798722	0.999201	2502,0	0	0.000399361	0|3|3|3|3|4	not_specified|Retinitis_Pigmentosa\x2c_Recessive|Stargardt_Disease\x2c_Recessive|Macular_degeneration|Cone-Rod_Dystrophy\x2c_Recessive|Stargardt_disease_1	CN169374|CN239466|CN239312|HP:0000608:C1849131|CN239309|C1855465:248200	MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen|MedGen|MedGen:OMIM	NA	2	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	L	D	0.998	4.31	ABCA4_HUMAN	B	D	6.16	1591	24.6	0.07	./T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	132	NA	NA	NA	NA	NA	NA
chr1	94021934	rs1762111	A	G	PASS	G	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.4685T>C	p.Ile1562Thr	33/50	4772/7309	1562/2273	4685/6822	NA	NA	NA	NA	0.001301	0.000798722	0.999201	2502,0	0	0.000399361	1|0|0|0|0|5	not_provided|not_specified|ABCA4-Related_Disorders|Cone-Rod_Dystrophy\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive|Stargardt_disease_1	CN221809|CN169374|CN239167|CN239309|CN239466|C1855465:248200	MedGen|MedGen|MedGen|MedGen|MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	L	D	0.634	4.96	ABCA4_HUMAN	B	B	6.07	1562	23.4	1.199	./D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	89	NA	NA	NA	NA	NA	NA
chr1	94024978	rs62642575	G	A	PASS	A	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.4610C>T	p.Thr1537Met	31/50	4697/7309	1537/2273	4610/6822	NA	NA	NA	NA	0.0001153	0.00119808	0.998802	2501,0	0	0.000599042	1|5	not_provided|Stargardt_disease_1	CN221809|C1855465:248200	MedGen|MedGen:OMIM	NA	2	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D	0.989	5.09	ABCA4_HUMAN	D	D	5.09	1537	34	0.953	./D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	134	NA	NA	NA	NA	NA	NA
chr1	94029465	rs568792949	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.4519G>A	p.Gly1507Arg	30/50	4606/7309	1507/2273	4519/6822	NA	NA	NA	NA	5.033e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	Stargardt_disease_1	C1855465:248200	MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D	0.013	5.39	ABCA4_HUMAN	D	D	5.39	1507	34	0.935	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	142	NA	NA	NA	NA	NA	NA
chr1	94030427	rs200967229	C	T	PASS	T	splice_donor_variant&intron_variant	HIGH	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.4352+1G>A	NA	29/49	NA	NA	NA	NA	NA	(ABCA4|ENSG00000198691|1|1.00)	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Stargardt_disease_1	C1855465:248200	MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	NA	D	0.998	4.65	NA	NA	NA	4.65	NA	26.5	0.935	NA	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94030483	rs56357060	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.4297G>A	p.Val1433Ile	29/50	4384/7309	1433/2273	4297/6822	NA	NA	NA	NA	0.001425	0.00119808	0.998802	2501,0	0	0.000599042	1|0|4	not_provided|not_specified|Stargardt_disease_1	CN221809|CN169374|C1855465:248200	MedGen|MedGen|MedGen:OMIM	NA	1	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	N	0.932	2.33	ABCA4_HUMAN	B	P	4.23	1433	20.9	0.935	D/T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	129	NA	NA	NA	NA	NA	NA
chr1	94031046	rs1801666	G	T	PASS	T	synonymous_variant	LOW	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.4203C>A	p.Pro1401Pro	28/50	4290/7309	1401/2273	4203/6822	NA	NA	NA	NA	0.024	NA	NA	2430,1	NA	0.0117812	255|3|3|3|3,1|2|3|3|3|3	not_specified|Cone-Rod_Dystrophy\x2c_Recessive|Stargardt_Disease\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive|Macular_degeneration,not_provided|not_specified|Cone-Rod_Dystrophy\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive|Stargardt_Disease\x2c_Recessive|Macular_degeneration	CN169374|CN239309|CN239312|CN239466|HP:0000608:C1849131,CN221809|CN169374|CN239309|CN239466|CN239312|HP:0000608:C1849131	MedGen|MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen,MedGen|MedGen|MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	89	NA	NA	NA	NA	NA	NA
chr1	94031046	rs1801666	G	A	PASS	A	synonymous_variant	LOW	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.4203C>T	p.Pro1401Pro	28/50	4290/7309	1401/2273	4203/6822	NA	NA	NA	NA	0.00117	NA	NA	2430,0	NA	0.00319489	255|3|3|3|3,1|2|3|3|3|3	not_specified|Cone-Rod_Dystrophy\x2c_Recessive|Stargardt_Disease\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive|Macular_degeneration,not_provided|not_specified|Cone-Rod_Dystrophy\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive|Stargardt_Disease\x2c_Recessive|Macular_degeneration	CN169374|CN239309|CN239312|CN239466|HP:0000608:C1849131,CN221809|CN169374|CN239309|CN239466|CN239312|HP:0000608:C1849131	MedGen|MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen,MedGen|MedGen|MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	89	NA	NA	NA	NA	NA	NA
chr1	94037199	rs147884766	C	T	PASS	T	synonymous_variant	LOW	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.3759G>A	p.Thr1253Thr	25/50	3846/7309	1253/2273	3759/6822	NA	NA	NA	NA	0.0006095	0.00319489	0.996805	2496,0	0	0.00159744	255|3|3|3|3	not_specified|Macular_degeneration|Cone-Rod_Dystrophy\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive|Stargardt_Disease\x2c_Recessive	CN169374|HP:0000608:C1849131|CN239309|CN239466|CN239312	MedGen|Human_Phenotype_Ontology:MedGen|MedGen|MedGen|MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	134	NA	NA	NA	NA	NA	NA
chr1	94040048	rs61750126	A	C	PASS	C	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.3602T>G	p.Leu1201Arg	24/50	3689/7309	1201/2273	3602/6822	NA	NA	NA	NA	0.00808	0.0535144	0.944089	2364,6	0.00239617	0.0291534	5|1|2|3|3|3|3|4	Cone-rod_dystrophy_3|not_provided|not_specified|Stargardt_Disease\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive|Cone-Rod_Dystrophy\x2c_Recessive|Macular_degeneration|Stargardt_disease_1	C1858806:604116|CN221809|CN169374|CN239312|CN239466|CN239309|HP:0000608:C1849131|C1855465:248200	MedGen:OMIM|MedGen|MedGen|MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen|MedGen:OMIM	NA	1	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	L	A	0.862	5.54	ABCA4_HUMAN	B	B	5.54	1201	24.8	1.199	T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	131	NA	NA	NA	NA	NA	NA
chr1	94041345	rs1801269	C	A	PASS	A	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.3386G>T	p.Arg1129Leu	23/50	3473/7309	1129/2273	3386/6822	NA	NA	NA	NA	0.0002471	0.00119808	0.998802	2501,0	0	0.000599042	1|4	not_provided|Stargardt_disease_1	CN221809|C1855465:248200	MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D	1	4.62	ABCA4_HUMAN	D	D	5.54	1129	34	0.852	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	89	NA	NA	NA	NA	NA	NA
chr1	94042767	rs61750120	G	A	PASS	A	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.3322C>T	p.Arg1108Cys	22/50	3409/7309	1108/2273	3322/6822	NA	NA	NA	NA	0.0001153	0.00119808	0.998802	2501,0	0	0.000599042	1|255	not_provided|Stargardt_disease_1	CN221809|C1855465:248200	MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D	0.998	5.76	ABCA4_HUMAN	D	D	5.76	1108	35	0.953	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94043413	rs61751374	G	A	PASS	A	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.3113C>T	p.Ala1038Val	21/50	3200/7309	1038/2273	3113/6822	NA	NA	NA	NA	0.001425	0.00159744	0.998403	2500,0	0	0.000798722	5|5|5|5|1	Stargardt_disease_1|Cone-rod_dystrophy_3|Stargardt_disease_1|Cone-rod_dystrophy_3|not_provided	C1855465:248200|C1858806:604116|C1855465:248200|C1858806:604116|CN221809	MedGen:OMIM|MedGen:OMIM|MedGen:OMIM|MedGen:OMIM|MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	L	A	1	5.92	ABCA4_HUMAN	B	B	5.92	1038	20.5	0.949	T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	133	NA	NA	NA	NA	NA	NA
chr1	94044697	rs61749454	A	G	PASS	G	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.2966T>C	p.Val989Ala	20/50	3053/7309	989/2273	2966/6822	NA	NA	NA	NA	0.0002965	0.00319489	0.996805	2496,0	0	0.00159744	4|0	not_provided|not_specified	CN221809|CN169374	MedGen|MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D	0.958	5.72	ABCA4_HUMAN	B	B	5.72	989	23.7	1.088	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94047009	rs1801581	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.2828G>A	p.Arg943Gln	19/50	2915/7309	943/2273	2828/6822	NA	NA	NA	NA	0.031	0.0283546	0.970447	2430,3	0.00119808	0.0153754	255|5|1|2|3|3|3|3	MACULAR_DEGENERATION\x2c_AGE-RELATED\x2c_2\x2c_SUSCEPTIBILITY_TO|Stargardt_disease_1|not_provided|not_specified|Macular_degeneration|Cone-Rod_Dystrophy\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive|Stargardt_Disease\x2c_Recessive	.|C1855465:248200|CN221809|CN169374|HP:0000608:C1849131|CN239309|CN239466|CN239312	.|MedGen:OMIM|MedGen|MedGen|Human_Phenotype_Ontology:MedGen|MedGen|MedGen|MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	L	N/N	0.505	3.54	./ABCA4_HUMAN	B	P/B	5.62	869,943	22.7	0.935	T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	89	NA	NA	NA	NA	NA	NA
chr1	94047046	rs58331765	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.2791G>A	p.Val931Met	19/50	2878/7309	931/2273	2791/6822	NA	NA	NA	NA	0.0004859	0.00559105	0.994409	2490,0	0	0.00279553	5|1|3|3|3|3	Stargardt_disease_1|not_provided|Retinitis_Pigmentosa\x2c_Recessive|Stargardt_Disease\x2c_Recessive|Macular_degeneration|Cone-Rod_Dystrophy\x2c_Recessive	C1855465:248200|CN221809|CN239466|CN239312|HP:0000608:C1849131|CN239309	MedGen:OMIM|MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen|MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	A/A	0.961	5.62	./ABCA4_HUMAN	D/B	D/P	5.62	857,931	25.5	0.935	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	129	NA	NA	NA	NA	NA	NA
chr1	94048919	rs61749441	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.2692G>A	p.Glu898Lys	18/50	2779/7309	898/2273	2692/6822	NA	NA	NA	NA	9.884e-05	0.000798722	0.999201	2502,0	0	0.000399361	5,1	Stargardt_disease_1,not_provided	C1855465:248200,CN221809	MedGen:OMIM,MedGen	NA	1	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	L	D/N	0.621	5.35	./ABCA4_HUMAN	D/B	D/B	5.35	824,898	22.2	0.935	T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	134	NA	NA	NA	NA	NA	NA
chr1	94048921	rs61749440	G	A	PASS	A	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.2690C>T	p.Thr897Ile	18/50	2777/7309	897/2273	2690/6822	NA	NA	NA	NA	0.001137	0.00319489	0.996805	2496,0	0	0.00159744	1|0|3|3|3|3|4	not_provided|not_specified|Retinitis_Pigmentosa\x2c_Recessive|Stargardt_Disease\x2c_Recessive|Macular_degeneration|Cone-Rod_Dystrophy\x2c_Recessive|Stargardt_disease_1	CN221809|CN169374|CN239466|CN239312|HP:0000608:C1849131|CN239309|C1855465:248200	MedGen|MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen|MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	L	D/N	0.866	5.35	./ABCA4_HUMAN	D/B	D/B	5.35	823,897	23.6	1.048	T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	129	NA	NA	NA	NA	NA	NA
chr1	94051698	rs76157638	C	G	PASS	G	missense_variant&splice_region_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.2588G>C	p.Gly863Ala	17/50	2675/7309	863/2273	2588/6822	NA	NA	NA	NA	0.004967	0.00239617	0.997604	2498,0	0	0.00119808	5|5|5|5|5|5	Stargardt_disease_1|Cone-rod_dystrophy_3|not_provided|Stargardt_disease_1|Stargardt_disease_1|Stargardt_disease_1	C1855465:248200|C1858806:604116|CN221809|C1855465:248200|C1855465:248200|C1855465:248200	MedGen:OMIM|MedGen:OMIM|MedGen|MedGen:OMIM|MedGen:OMIM|MedGen:OMIM	NA	1	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	A/A	0.959	4.9	./ABCA4_HUMAN	P/B	P	5.82	789,863	26.7	0.935	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	134	NA	NA	NA	NA	NA	NA
chr1	94060656	rs61749423	G	T	PASS	T	synonymous_variant	LOW	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.2041C>A	p.Arg681Arg	14/50	2128/7309	681/2273	2041/6822	NA	NA	NA	NA	4.118e-05	0.000399361	0.999601	2503,0	0	0.000199681	1|4|5	not_provided|Bull's_eye_maculopathy|Stargardt_disease_1	CN221809|HP:0011504:C1828210|C1855465:248200	MedGen|Human_Phenotype_Ontology:MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94060674	rs575453437	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.2023G>A	p.Val675Ile	14/50	2110/7309	675/2273	2023/6822	NA	NA	NA	NA	4.942e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	Stargardt_disease_1	C1855465:248200	MedGen:OMIM	NA	1	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	H	D/D	0.994	5.87	./ABCA4_HUMAN	D	D	5.87	675	33	0.935	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	142	NA	NA	NA	NA	NA	NA
chr1	94062586	rs61754024	A	C	PASS	C	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.1928T>G	p.Val643Gly	13/50	2015/7309	643/2273	1928/6822	NA	NA	NA	NA	0.001343	0.00199681	0.998003	2499,0	0	0.000998403	1|0|4	not_provided|not_specified|Stargardt_disease_1	CN221809|CN169374|C1855465:248200	MedGen|MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D/D	1	4.95	./ABCA4_HUMAN	D/B	D/B	4.95	643	27.5	1.199	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94062587	rs61749417	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.1927G>A	p.Val643Met	13/50	2014/7309	643/2273	1927/6822	NA	NA	NA	NA	0.001614	0.0147764	0.985224	2467,0	0	0.00738818	1|255|3|3|3|3	not_provided|not_specified|Macular_degeneration|Cone-Rod_Dystrophy\x2c_Recessive|Stargardt_Disease\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive	CN221809|CN169374|HP:0000608:C1849131|CN239309|CN239312|CN239466	MedGen|MedGen|Human_Phenotype_Ontology:MedGen|MedGen|MedGen|MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D/D	0.999	4.03	./ABCA4_HUMAN	D/P	D	4.95	643	33	0.935	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94063157	rs61748559	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.1715G>A	p.Arg572Gln	12/50	1802/7309	572/2273	1715/6822	NA	NA	NA	NA	4.942e-05	0.000399361	0.999601	2503,0	0	0.000199681	1,255|1|0	not_provided,Stargardt_disease_1|not_provided|not_specified	CN221809,C1855465:248200|CN221809|CN169374	MedGen,MedGen:OMIM|MedGen|MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	H	D/D	0.995	5.04	./ABCA4_HUMAN	D	D	5.04	572	35	0.935	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	133	NA	NA	NA	NA	NA	NA
chr1	94063218	rs145525174	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.1654G>A	p.Val552Ile	12/50	1741/7309	552/2273	1654/6822	NA	NA	NA	NA	0.002636	0.00119808	0.998802	2501,0	0	0.000599042	0|3|3|3|3|4	not_specified|Stargardt_Disease\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive|Cone-Rod_Dystrophy\x2c_Recessive|Macular_degeneration|Stargardt_disease_1	CN169374|CN239312|CN239466|CN239309|HP:0000608:C1849131|C1855465:248200	MedGen|MedGen|MedGen|MedGen|Human_Phenotype_Ontology:MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	L	D/D	0.475	4	./ABCA4_HUMAN	P/B	D/B	4.91	552	15.19	0.935	T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	134	NA	NA	NA	NA	NA	NA
chr1	94098799	rs62645952	G	A	PASS	A	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.763C>T	p.Arg255Cys	6/50	850/7309	255/2273	763/6822	NA	NA	NA	NA	9.884e-05	0.000399361	0.999601	2503,0	0	0.000199681	5,1	Cone-rod_dystrophy_3,not_provided	C1858806:604116,CN221809	MedGen:OMIM,MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D/D	0.746	5.83	./ABCA4_HUMAN	P/B	D/P	5.83	255	29.8	1.048	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94098906	rs61748537	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.656G>A	p.Arg219Lys	6/50	743/7309	219/2273	656/6822	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	4|4	not_provided|Stargardt_disease_1	CN221809|C1855465:248200	MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D/D	0.47	4.92	./ABCA4_HUMAN	P/B	P	5.83	219	15.05	0.935	T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94098944	rs61748536	G	A	PASS	A	synonymous_variant	LOW	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.618C>T	p.Ser206Ser	6/50	705/7309	206/2273	618/6822	NA	NA	NA	NA	0.0008731	NA	NA	2465,0	NA	0.00419329	4|2	not_provided|not_specified	CN221809|CN169374	MedGen|MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	132	NA	NA	NA	NA	NA	NA
chr1	94098944	rs61748536	G	C	PASS	C	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.618C>G	p.Ser206Arg	6/50	705/7309	206/2273	618/6822	NA	NA	NA	NA	0.001343	NA	NA	2465,0	NA	0.00359425	4|2	not_provided|not_specified	CN221809|CN169374	MedGen|MedGen	NA	1	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D/D	0.993	-4.13	./ABCA4_HUMAN	D	D	5.83	206	23.0	-0.241	T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	132	NA	NA	NA	NA	NA	NA
chr1	94103130	rs62646862	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.455G>A	p.Arg152Gln	5/50	542/7309	152/2273	455/6822	NA	NA	NA	NA	0.002389	0.00319489	0.996805	2496,0	0	0.00159744	1|3|4	not_provided|not_specified|Stargardt_disease_1	CN221809|CN169374|C1855465:248200	MedGen|MedGen|MedGen:OMIM	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D/D	0.602	2.6	./ABCA4_HUMAN	B	B	5.27	152	21.5	0.077	T	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94111546	rs62654395	C	A	PASS	A	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.194G>T	p.Gly65Val	3/50	281/7309	65/2273	194/6822	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	1|255	not_provided|Stargardt_disease_1	CN221809|C1855465:248200	MedGen|MedGen:OMIM	NA	1	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D/D	0.997	5.52	./ABCA4_HUMAN	D/B	D/P	5.52	65	31	0.935	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94113062	rs62645958	C	T	PASS	T	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.71G>A	p.Arg24His	2/50	158/7309	24/2273	71/6822	NA	NA	NA	NA	0.0001894	0.000798722	0.999201	2502,0	0	0.000399361	1|3|0|4|0	not_provided|Macular_degeneration|Cone-Rod_Dystrophy\x2c_Recessive|Stargardt_Disease\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive	CN221809|HP:0000608:C1849131|CN239309|CN239312|CN239466	MedGen|Human_Phenotype_Ontology:MedGen|MedGen|MedGen|MedGen	NA	3	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	D/D	0.999	5	./ABCA4_HUMAN	D	D	5.92	24	34	0.935	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	137	NA	NA	NA	NA	NA	NA
chr1	94120994	rs121909205	G	A	PASS	A	missense_variant	MODERATE	ABCA4	ENSG00000198691	transcript	ENST00000370225.3	c.52C>T	p.Arg18Trp	1/50	139/7309	18/2273	52/6822	NA	NA	NA	NA	2.471e-05	0.000798722	0.999201	2502,0	0	0.000399361	255|1	Stargardt_disease_1|not_provided	C1855465:248200|CN221809	MedGen:OMIM|MedGen	NA	NA	248200(3),601718(3),248200(3),248200(3),248200(3),604116(3)	NA	Stargardt~disease~1,Retinitis~pigmentosa~19,Retinal~dystrophy~early-onset~severe,Fundus~flavimaculatus,Fundus~flavimaculatus,Cone-rod~dystrophy~3	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	153800(3),153800(3),153800(3),153800(3)	AR,-,AR,AR,AR,-	NA	NA	NA	NA	{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2},{Macular~degeneration~age-related~2}	M	A/A	0.993	-1.91	./ABCA4_HUMAN	D	D	4.93	18	29.9	-0.661	D	Abca4	N	1.07E-02	86.30573248	0.736662821	NA	12.16874	24	NA	NA	3827.03692	133	NA	NA	NA	NA	NA	NA
chr1	97098598	rs1801267	C	T	PASS	T	missense_variant	MODERATE	DPYD	ENSG00000188641	transcript	ENST00000370192.7	c.2657G>A	p.Arg886His	21/23	2758/4412	886/1025	2657/3078	NA	NA	NA	NA	4.119e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Dihydropyrimidine_dehydrogenase_deficiency	C2720286:274270	MedGen:OMIM	NA	NA	274270(3),274270(3)	NA	5-fluorouracil~toxicity,Dihydropyrimidine~dehydrogenase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	M	A	0.999	4.75	DPYD_HUMAN	D	D	5.66	886	34	0.888	D	./Dpyd	NA	./1.10E-01	./95.02241095	./1.431149089	NA	./8.23273	100873932/1806	NA	NA	./1997.46528	89	NA	NA	NA	NA	NA	DPYD
chr1	97098598	rs1801267	C	T	PASS	T	intragenic_variant	MODIFIER	DPYD-AS1	ENSG00000232878	gene_variant	ENSG00000232878	n.97098598C>T	NA	NA	NA	NA	NA	NA	NA	NA	NA	4.119e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Dihydropyrimidine_dehydrogenase_deficiency	C2720286:274270	MedGen:OMIM	NA	NA	274270(3),274270(3)	NA	5-fluorouracil~toxicity,Dihydropyrimidine~dehydrogenase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	M	A	0.999	4.75	DPYD_HUMAN	D	D	5.66	886	34	0.888	D	./Dpyd	NA	./1.10E-01	./95.02241095	./1.431149089	NA	./8.23273	100873932/1806	NA	NA	./1997.46528	89	NA	NA	NA	NA	NA	DPYD
chr1	97373560	rs773499329	CCTGCCCACAGGCCAGG	C	PASS	C	frameshift_variant&splice_region_variant	HIGH	DPYD	ENSG00000188641	transcript	ENST00000370192.7	c.2043_2058delCCTGGCCTGTGGGCAG	p.Leu682fs	16/23	2159/4412	681/1025	2043/3078	NA	NA	(DPYD|ENSG00000188641|1|1.00)	NA	0.0001318	NA	NA	NA	NA	NA	4	Dihydropyrimidine_dehydrogenase_deficiency	C2720286:274270	MedGen:OMIM	NA	NA	274270(3),274270(3)	NA	5-fluorouracil~toxicity,Dihydropyrimidine~dehydrogenase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Dpyd	NA	1.10E-01	95.02241095	1.431149089	NA	8.23273	1806	NA	NA	1997.46528	136	NA	NA	NA	NA	NA	DPYD
chr1	97450058	rs3918290	C	T	PASS	T	splice_donor_variant&intron_variant	HIGH	DPYD	ENSG00000188641	transcript	ENST00000370192.7	c.1905+1G>A	NA	14/22	NA	NA	NA	NA	NA	(DPYD|ENSG00000188641|1|1.00)	NA	0.005222	0.00519169	0.994409	2490,1	0.000399361	0.00299521	5|5|5|0|6|6|6|6	Dihydropyrimidine_dehydrogenase_deficiency|Fluorouracil_response|not_provided|Hirschsprung_disease_1|Pyrimidine_analogues_response_-_Toxicity/ADR|capecitabine_response_-_Toxicity/ADR|tegafur_response_-_Toxicity/ADR|fluorouracil_response_-_Toxicity/ADR	C2720286:274270|CN077983|CN221809|C2931876:142623|CN236468|CN236492|CN236622|CN236593	MedGen:OMIM|MedGen|MedGen|MedGen:OMIM|MedGen|MedGen|MedGen|MedGen	NA	NA	274270(3),274270(3)	NA	5-fluorouracil~toxicity,Dihydropyrimidine~dehydrogenase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	D	0.979	5.31	NA	NA	NA	5.31	NA	23.7	0.892	NA	Dpyd	NA	1.10E-01	95.02241095	1.431149089	NA	8.23273	1806	NA	NA	1997.46528	108	NA	NA	NA	NA	NA	DPYD
chr1	97515787	rs55886062	A	C	PASS	C	missense_variant	MODERATE	DPYD	ENSG00000188641	transcript	ENST00000370192.7	c.1679T>G	p.Ile560Ser	13/23	1780/4412	560/1025	1679/3078	NA	NA	NA	NA	0.000346	0.000399361	0.999601	2503,0	0	0.000199681	5|6|6|6|6	not_provided|fluorouracil_response_-_Toxicity/ADR|Pyrimidine_analogues_response_-_Toxicity/ADR|capecitabine_response_-_Toxicity/ADR|tegafur_response_-_Toxicity/ADR	CN221809|CN236593|CN236468|CN236492|CN236622	MedGen|MedGen|MedGen|MedGen|MedGen	NA	NA	274270(3),274270(3)	NA	5-fluorouracil~toxicity,Dihydropyrimidine~dehydrogenase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	M	D	1	5.2	DPYD_HUMAN	D	D	5.2	560	31	1.14	D	Dpyd	NA	1.10E-01	95.02241095	1.431149089	NA	8.23273	1806	NA	NA	1997.46528	129	NA	NA	NA	NA	NA	DPYD
chr1	97883329	rs1801265	A	G	PASS	G	missense_variant	MODERATE	DPYD	ENSG00000188641	transcript	ENST00000370192.7	c.85T>C	p.Cys29Arg	2/23	186/4412	29/1025	85/3078	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1,5	not_provided,Dihydropyrimidine_dehydrogenase_deficiency	CN221809,C2720286:274270	MedGen,MedGen:OMIM	NA	NA	274270(3),274270(3)	NA	5-fluorouracil~toxicity,Dihydropyrimidine~dehydrogenase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	0.981	5.84	NA	NA	NA	5.84	NA	NA	0.138	NA	Dpyd	NA	1.10E-01	95.02241095	1.431149089	NA	8.23273	1806	NA	NA	1997.46528	89	NA	NA	NA	NA	NA	DPYD
chr1	97883353	rs72549310	G	A	PASS	A	stop_gained	HIGH	DPYD	ENSG00000188641	transcript	ENST00000370192.7	c.61C>T	p.Arg21*	2/23	162/4412	21/1025	61/3078	NA	NA	(DPYD|ENSG00000188641|1|1.00)	(DPYD|ENSG00000188641|1|1.00)	8.239e-06	0.000399361	0.999601	2503,0	0	0.000199681	4	Dihydropyrimidine_dehydrogenase_deficiency	C2720286:274270	MedGen:OMIM	NA	NA	274270(3),274270(3)	NA	5-fluorouracil~toxicity,Dihydropyrimidine~dehydrogenase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	A/A/D	0.925	5.84	NA	NA	NA	5.84	NA	39	0.108	NA	Dpyd	NA	1.10E-01	95.02241095	1.431149089	NA	8.23273	1806	NA	NA	1997.46528	130	NA	NA	NA	NA	NA	DPYD
chr1	99851058	rs113994127	CAG	C	VQSRTrancheINDEL99.00to100.00	C	frameshift_variant	HIGH	AGL	ENSG00000162688	transcript	ENST00000294724.8	c.18_19delGA	p.Gln6fs	2/34	496/7446	6/1532	18/4599	NA	INFO_REALIGN_3_PRIME	NA	NA	4.942e-05	NA	NA	NA	NA	NA	5|255	Glycogen_storage_disease_IIIb|Glycogen_storage_disease_type_III	C1968740|C0017922:232400:ORPHA308684:66937008	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	232400(3),232400(3)	NA	Glycogen~storage~disease~IIIb,Glycogen~storage~disease~IIIa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Agl	NA	3.57E-02	97.15734843	1.859295831	NA	10.67310	178	NA	NA	3139.05955	132	NA	NA	NA	NA	NA	AGL
chr1	99861532	rs35278779	A	G	PASS	G	missense_variant	MODERATE	AGL	ENSG00000162688	transcript	ENST00000294724.8	c.112A>G	p.Thr38Ala	3/34	590/7446	38/1532	112/4599	NA	NA	NA	NA	0.004711	0.0311502	0.967652	2423,3	0.00119808	0.0167732	255	not_specified	CN169374	MedGen	NA	NA	232400(3),232400(3)	NA	Glycogen~storage~disease~IIIb,Glycogen~storage~disease~IIIa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	M	D/D/D/D/D/D/D	0.997	4.97	././GDE_HUMAN	B	B	4.97	21,22,38	19.82	1.199	D	Agl	NA	3.57E-02	97.15734843	1.859295831	NA	10.67310	178	NA	NA	3139.05955	126	NA	NA	NA	NA	NA	AGL
chr1	99861532	rs35278779	A	G	PASS	G	missense_variant	MODERATE	AC096949.1	ENSG00000283495	transcript	ENST00000361522.5	c.61A>G	p.Thr21Ala	1/32	61/4548	21/1515	61/4548	NA	NA	NA	NA	0.004711	0.0311502	0.967652	2423,3	0.00119808	0.0167732	255	not_specified	CN169374	MedGen	NA	NA	232400(3),232400(3)	NA	Glycogen~storage~disease~IIIb,Glycogen~storage~disease~IIIa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	M	D/D/D/D/D/D/D	0.997	4.97	././GDE_HUMAN	B	B	4.97	21,22,38	19.82	1.199	D	Agl	NA	3.57E-02	97.15734843	1.859295831	NA	10.67310	178	NA	NA	3139.05955	126	NA	NA	NA	NA	NA	AGL
chr1	99861676	rs193186112	C	T	PASS	T	stop_gained	HIGH	AGL	ENSG00000162688	transcript	ENST00000294724.8	c.256C>T	p.Gln86*	3/34	734/7446	86/1532	256/4599	NA	NA	(AC096949.1|ENSG00000283495|1|1.00),(AGL|ENSG00000162688|1|1.00)	(AC096949.1|ENSG00000283495|1|1.00),(AGL|ENSG00000162688|1|1.00)	2.471e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Glycogen_storage_disease_type_III	C0017922:232400:ORPHA308684:66937008	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	232400(3),232400(3)	NA	Glycogen~storage~disease~IIIb,Glycogen~storage~disease~IIIa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	A/A/A/A/A/A/A	0.992	4.15	NA	NA	NA	5.1	NA	36	0.935	NA	Agl	NA	3.57E-02	97.15734843	1.859295831	NA	10.67310	178	NA	NA	3139.05955	135	NA	NA	NA	NA	NA	AGL
chr1	99861676	rs193186112	C	T	PASS	T	stop_gained	HIGH	AC096949.1	ENSG00000283495	transcript	ENST00000361522.5	c.205C>T	p.Gln69*	1/32	205/4548	69/1515	205/4548	NA	NA	(AC096949.1|ENSG00000283495|1|1.00),(AGL|ENSG00000162688|1|1.00)	(AC096949.1|ENSG00000283495|1|1.00),(AGL|ENSG00000162688|1|1.00)	2.471e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Glycogen_storage_disease_type_III	C0017922:232400:ORPHA308684:66937008	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	232400(3),232400(3)	NA	Glycogen~storage~disease~IIIb,Glycogen~storage~disease~IIIa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	A/A/A/A/A/A/A	0.992	4.15	NA	NA	NA	5.1	NA	36	0.935	NA	Agl	NA	3.57E-02	97.15734843	1.859295831	NA	10.67310	178	NA	NA	3139.05955	135	NA	NA	NA	NA	NA	AGL
chr1	99877698	rs141043166	G	A	PASS	A	missense_variant	MODERATE	AGL	ENSG00000162688	transcript	ENST00000294724.8	c.1481G>A	p.Arg494His	12/34	1959/7446	494/1532	1481/4599	NA	NA	NA	NA	0.008879	0.00519169	0.994409	2490,1	0.000399361	0.00299521	255|3	not_specified|Glycogen_storage_disease_type_III	CN169374|C0017922:232400:ORPHA308684:66937008	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	232400(3),232400(3)	NA	Glycogen~storage~disease~IIIb,Glycogen~storage~disease~IIIa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	H	D/D/D/D/D/D/D	0.994	5.07	././GDE_HUMAN	D	D	5.97	477,478,494	33	1.048	D	Agl	NA	3.57E-02	97.15734843	1.859295831	NA	10.67310	178	NA	NA	3139.05955	134	NA	NA	NA	NA	NA	AGL
chr1	99877698	rs141043166	G	A	PASS	A	missense_variant	MODERATE	AC096949.1	ENSG00000283495	transcript	ENST00000361522.5	c.1430G>A	p.Arg477His	10/32	1430/4548	477/1515	1430/4548	NA	NA	NA	NA	0.008879	0.00519169	0.994409	2490,1	0.000399361	0.00299521	255|3	not_specified|Glycogen_storage_disease_type_III	CN169374|C0017922:232400:ORPHA308684:66937008	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	232400(3),232400(3)	NA	Glycogen~storage~disease~IIIb,Glycogen~storage~disease~IIIa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	H	D/D/D/D/D/D/D	0.994	5.07	././GDE_HUMAN	D	D	5.97	477,478,494	33	1.048	D	Agl	NA	3.57E-02	97.15734843	1.859295831	NA	10.67310	178	NA	NA	3139.05955	134	NA	NA	NA	NA	NA	AGL
chr1	99880047	rs199922945	G	T	PASS	T	splice_donor_variant&intron_variant	HIGH	AGL	ENSG00000162688	transcript	ENST00000294724.8	c.1735+1G>T	NA	13/33	NA	NA	NA	NA	NA	(AC096949.1|ENSG00000283495|1|1.00),(AGL|ENSG00000162688|1|1.00)	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|4	Glycogen_storage_disease_IIIa|Glycogen_storage_disease_type_III	C1968739|C0017922:232400:ORPHA308684:66937008	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	232400(3),232400(3)	NA	Glycogen~storage~disease~IIIb,Glycogen~storage~disease~IIIa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	D/D/D/D/D/D/D	1	5.27	NA	NA	NA	5.27	NA	25.3	1.048	NA	Agl	NA	3.57E-02	97.15734843	1.859295831	NA	10.67310	178	NA	NA	3139.05955	137	NA	NA	NA	NA	NA	AGL
chr1	99880047	rs199922945	G	T	PASS	T	splice_donor_variant&intron_variant	HIGH	AC096949.1	ENSG00000283495	transcript	ENST00000361522.5	c.1684+1G>T	NA	11/31	NA	NA	NA	NA	NA	(AC096949.1|ENSG00000283495|1|1.00),(AGL|ENSG00000162688|1|1.00)	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|4	Glycogen_storage_disease_IIIa|Glycogen_storage_disease_type_III	C1968739|C0017922:232400:ORPHA308684:66937008	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	232400(3),232400(3)	NA	Glycogen~storage~disease~IIIb,Glycogen~storage~disease~IIIa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	D/D/D/D/D/D/D	1	5.27	NA	NA	NA	5.27	NA	25.3	1.048	NA	Agl	NA	3.57E-02	97.15734843	1.859295831	NA	10.67310	178	NA	NA	3139.05955	137	NA	NA	NA	NA	NA	AGL
chr1	99884704	rs201201443	G	A	PASS	A	splice_donor_variant&intron_variant	HIGH	AGL	ENSG00000162688	transcript	ENST00000294724.8	c.2681+1G>A	NA	20/33	NA	NA	NA	NA	NA	(AC096949.1|ENSG00000283495|1|1.00),(AGL|ENSG00000162688|1|1.00)	NA	4.119e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Glycogen_storage_disease_type_III	C0017922:232400:ORPHA308684:66937008	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	232400(3),232400(3)	NA	Glycogen~storage~disease~IIIb,Glycogen~storage~disease~IIIa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	D/D/D/D/D/D/D	1	4.74	NA	NA	NA	5.67	NA	24.6	1.048	NA	Agl	NA	3.57E-02	97.15734843	1.859295831	NA	10.67310	178	NA	NA	3139.05955	137	NA	NA	NA	NA	NA	AGL
chr1	99884704	rs201201443	G	A	PASS	A	splice_donor_variant&intron_variant	HIGH	AC096949.1	ENSG00000283495	transcript	ENST00000361522.5	c.2630+1G>A	NA	18/31	NA	NA	NA	NA	NA	(AC096949.1|ENSG00000283495|1|1.00),(AGL|ENSG00000162688|1|1.00)	NA	4.119e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Glycogen_storage_disease_type_III	C0017922:232400:ORPHA308684:66937008	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	232400(3),232400(3)	NA	Glycogen~storage~disease~IIIb,Glycogen~storage~disease~IIIa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	D/D/D/D/D/D/D	1	4.74	NA	NA	NA	5.67	NA	24.6	1.048	NA	Agl	NA	3.57E-02	97.15734843	1.859295831	NA	10.67310	178	NA	NA	3139.05955	137	NA	NA	NA	NA	NA	AGL
chr1	100206199	rs115696850	A	C	PASS	C	intron_variant	MODIFIER	DBT	ENSG00000137992	transcript	ENST00000370132.8	c.1281+31T>G	NA	10/10	NA	NA	NA	NA	NA	NA	NA	0.031	0.0283546	0.970847	2431,2	0.000798722	0.014976	255	not_specified	CN169374	MedGen	NA	NA	248600(3)	NA	Maple~syrup~urine~disease~type~II	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Dbt	E	NA	87.95116773	0.817616644	abnormal	2.87132	1629	dbt	NA	173.95713	132	NA	NA	NA	NA	NA	NA
chr1	100206504	rs12021720	T	C	PASS	C	missense_variant	MODERATE	DBT	ENSG00000137992	transcript	ENST00000370132.8	c.1150A>G	p.Ser384Gly	9/11	1164/10799	384/482	1150/1449	NA	NA	NA	NA	0.914	0.172524	0.0219649	55,2017	0.805511	0.891773	5,255	Intermediate_maple_syrup_urine_disease_type_2,not_specified	CN069615,CN169374	MedGen,MedGen	NA	NA	248600(3)	NA	Maple~syrup~urine~disease~type~II	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	P	0.51	4.4	NA	B	B	5.54	203	1.112	0.069	T	Dbt	E	NA	87.95116773	0.817616644	abnormal	2.87132	1629	dbt	NA	173.95713	120	NA	NA	NA	NA	NA	NA
chr1	100216031	rs146249007	A	G	PASS	G	missense_variant	MODERATE	DBT	ENSG00000137992	transcript	ENST00000370132.8	c.724T>C	p.Ser242Pro	6/11	738/10799	242/482	724/1449	NA	NA	NA	NA	0.009595	0.00678914	0.993211	2487,0	0	0.00339457	255|2	not_specified|not_provided	CN169374|CN221809	MedGen|MedGen	NA	NA	248600(3)	NA	Maple~syrup~urine~disease~type~II	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	N/N	0.005	0.236	./ODB2_HUMAN	B	B	5.66	61,242	1.704	-0.361	T	Dbt	E	NA	87.95116773	0.817616644	abnormal	2.87132	1629	dbt	NA	173.95713	134	NA	NA	NA	NA	NA	NA
chr1	100216031	rs146249007	A	G	PASS	G	downstream_gene_variant	MODIFIER	BRI3P1	ENSG00000225169	transcript	ENST00000440440.1	n.*2361A>G	NA	NA	NA	NA	NA	2361	NA	NA	NA	0.009595	0.00678914	0.993211	2487,0	0	0.00339457	255|2	not_specified|not_provided	CN169374|CN221809	MedGen|MedGen	NA	NA	248600(3)	NA	Maple~syrup~urine~disease~type~II	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	N/N	0.005	0.236	./ODB2_HUMAN	B	B	5.66	61,242	1.704	-0.361	T	Dbt	E	NA	87.95116773	0.817616644	abnormal	2.87132	1629	dbt	NA	173.95713	134	NA	NA	NA	NA	NA	NA
chr1	100216085	rs74103423	C	A	PASS	A	stop_gained	HIGH	DBT	ENSG00000137992	transcript	ENST00000370132.8	c.670G>T	p.Glu224*	6/11	684/10799	224/482	670/1449	NA	NA	(DBT|ENSG00000137992|1|1.00)	(DBT|ENSG00000137992|1|1.00)	9.06e-05	0.00239617	0.997604	2498,0	0	0.00119808	5|5	not_provided|Maple_syrup_urine_disease	CN221809|C0024776:248600:ORPHA268184:27718001	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	248600(3)	NA	Maple~syrup~urine~disease~type~II	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	A/A	0.956	4.75	NA	NA	NA	5.66	NA	39	0.852	NA	Dbt	E	NA	87.95116773	0.817616644	abnormal	2.87132	1629	dbt	NA	173.95713	130	NA	NA	NA	NA	NA	NA
chr1	100216085	rs74103423	C	A	PASS	A	downstream_gene_variant	MODIFIER	BRI3P1	ENSG00000225169	transcript	ENST00000440440.1	n.*2415C>A	NA	NA	NA	NA	NA	2415	NA	(DBT|ENSG00000137992|1|1.00)	(DBT|ENSG00000137992|1|1.00)	9.06e-05	0.00239617	0.997604	2498,0	0	0.00119808	5|5	not_provided|Maple_syrup_urine_disease	CN221809|C0024776:248600:ORPHA268184:27718001	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	248600(3)	NA	Maple~syrup~urine~disease~type~II	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	A/A	0.956	4.75	NA	NA	NA	5.66	NA	39	0.852	NA	Dbt	E	NA	87.95116773	0.817616644	abnormal	2.87132	1629	dbt	NA	173.95713	130	NA	NA	NA	NA	NA	NA
chr1	100235416	rs201469612	C	CT	PASS	CT	intron_variant	MODIFIER	DBT	ENSG00000137992	transcript	ENST00000370132.8	c.251+19dupA	NA	3/10	NA	NA	NA	NA	NA	NA	NA	0.009671	0.00678914	0.993211	2487,0	0	0.00339457	255	not_specified	CN169374	MedGen	NA	NA	248600(3)	NA	Maple~syrup~urine~disease~type~II	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Dbt	E	NA	87.95116773	0.817616644	abnormal	2.87132	1629	dbt	NA	173.95713	137	NA	NA	NA	NA	NA	NA
chr1	102888582	rs1676486	A	G	PASS	G	missense_variant	MODERATE	COL11A1	ENSG00000060718	transcript	ENST00000358392.6	c.4639T>C	p.Ser1547Pro	62/67	4957/7327	1547/1818	4639/5457	NA	NA	NA	NA	0.794	0.319089	0.057508	144,1561	0.623403	0.782947	255|2|2|2|2	Lumbar_disc_herniation\x2c_susceptibility_to|not_specified|Stickler_Syndrome\x2c_Dominant|Fibrochondrogenesis|Marshall_syndrome	C2676840|CN169374|CN239460|C0265282:228520:ORPHA2021:17144009|C0265235:154780:33410002	MedGen|MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:SNOMED_CT	NA	1	604841(3),154780(3),228520(3),228520(3)	NA	Stickler~syndrome~type~II,Marshall~syndrome,Fibrochondrogenesis~1,Fibrochondrogenesis~1	NA	NA	-,-,-	NA	NA	NA	NA	NA	603932(3),603932(3),603932(3)	AD,AD,AR,AR	NA	NA	NA	NA	{Lumbar~disc~herniation~susceptibility~to},{Lumbar~disc~herniation~susceptibility~to},{Lumbar~disc~herniation~susceptibility~to}	N	P/P/P/P	0.963	5.67	./././COBA1_HUMAN/.	B	B	5.67	1419,1496,1547,1535,755	22.0	0.138	T	Col11a1	E	9.44E-03	28.64472753	-0.360177779	NA	18.07025	1301	NA	NA	7076.86232	89	NA	NA	NA	NA	NA	NA
chr1	103005900	rs71752747	CCAT	C	PASS	C	intron_variant	MODIFIER	COL11A1	ENSG00000060718	transcript	ENST00000358392.6	c.1828-12_1828-10delATG	NA	17/66	NA	NA	NA	NA	NA	NA	NA	0.766	NA	NA	NA	NA	NA	255	not_specified	CN169374	MedGen	NA	NA	604841(3),154780(3),228520(3),228520(3)	NA	Stickler~syndrome~type~II,Marshall~syndrome,Fibrochondrogenesis~1,Fibrochondrogenesis~1	NA	NA	-,-,-	NA	NA	NA	NA	NA	603932(3),603932(3),603932(3)	AD,AD,AR,AR	NA	NA	NA	NA	{Lumbar~disc~herniation~susceptibility~to},{Lumbar~disc~herniation~susceptibility~to},{Lumbar~disc~herniation~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Col11a1	E	9.44E-03	28.64472753	-0.360177779	NA	18.07025	1301	NA	NA	7076.86232	137	CATn|Simple_repeat|Simple_repeat	NA	NA	NA	NA	NA
chr1	109274968	rs12740374	G	T	PASS	T	3_prime_UTR_variant	MODIFIER	CELSR2	ENSG00000143126	transcript	ENST00000271332.3	c.*919G>T	NA	34/34	NA	NA	NA	919	NA	NA	NA	NA	0.298323	0.655351	1641,116	0.0463259	0.195487	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_6	C3150834:613589	MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Celsr2	N	2.28E-01	2.176220807	-1.813160269	abnormal	8.08880	1952	celsr2	NA	1933.01574	121	NA	NA	NA	NA	NA	NA
chr1	109274968	rs12740374	G	T	PASS	T	downstream_gene_variant	MODIFIER	PSRC1	ENSG00000134222	transcript	ENST00000409138.6	c.*5185C>A	NA	NA	NA	NA	NA	4597	NA	NA	NA	NA	0.298323	0.655351	1641,116	0.0463259	0.195487	255	Low_density_lipoprotein_cholesterol_level_quantitative_trait_locus_6	C3150834:613589	MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Celsr2	N	2.28E-01	2.176220807	-1.813160269	abnormal	8.08880	1952	celsr2	NA	1933.01574	121	NA	NA	NA	NA	NA	NA
chr1	110064595	rs121908170	G	A	PASS	A	missense_variant	MODERATE	ALX3	ENSG00000156150	transcript	ENST00000369792.4	c.586C>T	p.Arg196Trp	2/4	674/1859	196/343	586/1032	NA	NA	NA	NA	8.237e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Frontonasal_dysplasia_1	C1876203:136760	MedGen:OMIM	NA	NA	136760(3)	NA	Frontonasal~dysplasia~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	A	0.998	1.07	ALX3_HUMAN	D	D	4.32	196	32	0.017	D	Alx3/Strip1	./N	./1.50E-01	35.74545883/4.847841472	-0.249709319/-1.3098007	./abnormal	1.15784/1.22621	257/85369	./strip1	NA	39.05666/42.10694	132	NA	NA	NA	NA	NA	NA
chr1	110064595	rs121908170	G	A	PASS	A	downstream_gene_variant	MODIFIER	RP4-773N10.4	ENSG00000258634	transcript	ENST00000554749.1	n.*2040G>A	NA	NA	NA	NA	NA	2040	NA	NA	NA	8.237e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Frontonasal_dysplasia_1	C1876203:136760	MedGen:OMIM	NA	NA	136760(3)	NA	Frontonasal~dysplasia~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	A	0.998	1.07	ALX3_HUMAN	D	D	4.32	196	32	0.017	D	Alx3/Strip1	./N	./1.50E-01	35.74545883/4.847841472	-0.249709319/-1.3098007	./abnormal	1.15784/1.22621	257/85369	./strip1	NA	39.05666/42.10694	132	NA	NA	NA	NA	NA	NA
chr1	110064595	rs121908170	G	A	PASS	A	intragenic_variant	MODIFIER	STRIP1	ENSG00000143093	gene_variant	ENSG00000143093	n.110064595G>A	NA	NA	NA	NA	NA	NA	NA	NA	NA	8.237e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Frontonasal_dysplasia_1	C1876203:136760	MedGen:OMIM	NA	NA	136760(3)	NA	Frontonasal~dysplasia~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	A	0.998	1.07	ALX3_HUMAN	D	D	4.32	196	32	0.017	D	Alx3/Strip1	./N	./1.50E-01	35.74545883/4.847841472	-0.249709319/-1.3098007	./abnormal	1.15784/1.22621	257/85369	./strip1	NA	39.05666/42.10694	132	NA	NA	NA	NA	NA	NA
chr1	111982463	rs17221819	G	A	PASS	A	synonymous_variant	LOW	KCND3	ENSG00000171385	transcript	ENST00000315987.6	c.264C>T	p.Pro88Pro	2/8	744/2716	88/655	264/1968	NA	NA	NA	NA	0.088	0.0886581	0.908546	2275,7	0.00279553	0.0471246	255	not_specified	CN169374	MedGen	NA	1	607346(3),616399(3)	NA	Spinocerebellar~ataxia~19,Brugada~syndrome~9	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Kcnd3	NA	2.88E-02	12.23755603	-0.80269335	NA	0.57745	3752	NA	NA	16.29843	126	NA	NA	NA	NA	NA	NA
chr1	112913980	rs72552271	C	T	PASS	T	missense_variant	MODERATE	SLC16A1	ENSG00000155380	transcript	ENST00000369626.7	c.1414G>A	p.Gly472Arg	5/5	1777/3910	472/500	1414/1503	NA	NA	NA	NA	0.0001483	0.00119808	0.998802	2501,0	0	0.000599042	5|0	Erythrocyte_lactate_transporter_defect|not_specified	C1855577:245340:ORPHA171690|CN169374	MedGen:OMIM:Orphanet|MedGen	NA	NA	616095(3),610021(3),245340(3)	NA	Monocarboxylate~transporter~1~deficiency,Hyperinsulinemic~hypoglycemia~familial~7,Erythrocyte~lactate~transporter~defect	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AD,AD	NA	NA	NA	NA	NA	N	N/N	0.006	4.87	MOT1_HUMAN	B	B	5.78	472	7.231	0.935	T	Slc16a1	NA	1.73E-01	48.34866714	-0.071520315	NA	0.83286	6566	NA	NA	25.55771	130	NA	NA	NA	NA	NA	NA
chr1	113834946	rs2476601	A	G	PASS	G	missense_variant	MODERATE	PTPN22	ENSG00000134242	transcript	ENST00000359785.9	c.1858T>C	p.Trp620Arg	14/21	1994/3654	620/807	1858/2424	NA	NA	NA	NA	0.933	0.0523163	0.00119808	3,2370	0.946486	0.972644	255|255|255|255|255	Diabetes_mellitus\x2c_insulin-dependent\x2c_susceptibility_to|Rheumatoid_arthritis|Systemic_lupus_erythematosus\x2c_susceptibility_to|Hashimoto_thyroiditis\x2c_susceptibility_to|Addison_disease\x2c_susceptibility_to	.|C0003873:180300:69896004|.|.|.	.|MedGen:OMIM:SNOMED_CT|.|.|.	NA	NA	NA	NA	NA	NA	NA	AD,-,AR	NA	NA	NA	NA	NA	152700(3),180300(3),222100(3)	NA	NA	NA	NA	NA	{Systemic~lupus~erythematosus~susceptibility~to},{Rheumatoid~arthritis~susceptibility~to},{Diabetes~type~1~susceptibility~to}	NA	P/P/P/P/P/P	0.992	2.7	NA	B	B	5.87	376,493,620,565,620	10.78	0.076	T/./T/T/T	Ptpn22	N	6.07E-01	70.64166077	0.268267497	NA	3.55515	26191	NA	NA	275.51599	100	NA	NA	NA	NA	NA	NA
chr1	114677465	rs121912682	C	T	PASS	T	missense_variant	MODERATE	AMPD1	ENSG00000116748	transcript	ENST00000520113.6	c.1373G>A	p.Arg458His	10/16	1389/2375	458/780	1373/2343	NA	NA	NA	NA	0.0007742	0.00439297	0.995607	2493,0	0	0.00219649	5|0	Muscle_AMP_deaminase_deficiency|not_specified	C0268123:615511:9105005|CN169374	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	615511(3)	NA	Myopathy~due~to~myoadenylate~deaminase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	A/A/A	1	5.85	./AMPD1_HUMAN	D	D	5.85	454,425	35	0.852	D	Ampd1	NA	1.26E-01	59.170795	0.073492312	NA	6.22939	270	NA	NA	1051.80051	133	NA	NA	NA	NA	NA	AMPD1
chr1	114677972	rs35859650	G	A	PASS	A	missense_variant	MODERATE	AMPD1	ENSG00000116748	transcript	ENST00000520113.6	c.1261C>T	p.Arg421Trp	9/16	1277/2375	421/780	1261/2343	NA	NA	NA	NA	0.0006754	0.00439297	0.995607	2493,0	0	0.00219649	5	Muscle_AMP_deaminase_deficiency	C0268123:615511:9105005	MedGen:OMIM:SNOMED_CT	NA	NA	615511(3)	NA	Myopathy~due~to~myoadenylate~deaminase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	A/A/A	0.98	1.95	./AMPD1_HUMAN	D	D	5.32	417,388	33	0.031	D	Ampd1	NA	1.26E-01	59.170795	0.073492312	NA	6.22939	270	NA	NA	1051.80051	126	NA	NA	NA	NA	NA	AMPD1
chr1	114678495	rs61752478	C	A	PASS	A	missense_variant	MODERATE	AMPD1	ENSG00000116748	transcript	ENST00000520113.6	c.1029G>T	p.Met343Ile	8/16	1045/2375	343/780	1029/2343	NA	NA	NA	NA	0.00313	0.00519169	0.994808	2491,0	0	0.00259585	5	Muscle_AMP_deaminase_deficiency	C0268123:615511:9105005	MedGen:OMIM:SNOMED_CT	NA	NA	615511(3)	NA	Myopathy~due~to~myoadenylate~deaminase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D/D/D	1	5.1	./AMPD1_HUMAN	P/D	P/D	5.1	339,310	29.2	0.852	D	Ampd1	NA	1.26E-01	59.170795	0.073492312	NA	6.22939	270	NA	NA	1051.80051	129	NA	NA	NA	NA	NA	AMPD1
chr1	114679616	rs34526199	T	A	PASS	A	missense_variant	MODERATE	AMPD1	ENSG00000116748	transcript	ENST00000520113.6	c.959A>T	p.Lys320Ile	7/16	975/2375	320/780	959/2343	NA	NA	NA	NA	0.028	0.0203674	0.978834	2451,2	0.000798722	0.0109824	5	Muscle_AMP_deaminase_deficiency	C0268123:615511:9105005	MedGen:OMIM:SNOMED_CT	NA	1	615511(3)	NA	Myopathy~due~to~myoadenylate~deaminase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	D/D/D	1	5.63	./AMPD1_HUMAN	D	D	5.63	316,287	32	1.061	D	Ampd1	NA	1.26E-01	59.170795	0.073492312	NA	6.22939	270	NA	NA	1051.80051	126	NA	NA	NA	NA	NA	AMPD1
chr1	114688744	rs398123114	AAAAG	A	VQSRTrancheINDEL99.00to100.00	A	splice_region_variant&intron_variant	LOW	AMPD1	ENSG00000116748	transcript	ENST00000520113.6	c.134-7_134-4delCTTT	NA	2/15	NA	NA	NA	NA	NA	NA	NA	0.0006424	NA	NA	NA	NA	NA	5	Muscle_AMP_deaminase_deficiency	C0268123:615511:9105005	MedGen:OMIM:SNOMED_CT	NA	NA	615511(3)	NA	Myopathy~due~to~myoadenylate~deaminase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ampd1	NA	1.26E-01	59.170795	0.073492312	NA	6.22939	270	NA	NA	1051.80051	138	NA	NA	NA	NA	NA	AMPD1
chr1	114693436	rs17602729	G	A	PASS	A	stop_gained&splice_region_variant	HIGH	AMPD1	ENSG00000116748	transcript	ENST00000520113.6	c.133C>T	p.Gln45*	2/16	149/2375	45/780	133/2343	NA	NA	(AMPD1|ENSG00000116748|1|1.00)	(AMPD1|ENSG00000116748|1|1.00)	0.087	0.0698882	0.926917	2321,8	0.00319489	0.038139	5	Muscle_AMP_deaminase_deficiency	C0268123:615511:9105005	MedGen:OMIM:SNOMED_CT	NA	8	615511(3)	NA	Myopathy~due~to~myoadenylate~deaminase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	P/P/P	1	2.84	NA	NA	NA	4.91	NA	36	1.048	NA	Ampd1	NA	1.26E-01	59.170795	0.073492312	NA	6.22939	270	NA	NA	1051.80051	123	NA	NA	NA	NA	NA	AMPD1
chr1	114693436	rs17602729	G	A	PASS	A	downstream_gene_variant	MODIFIER	RN7SL432P	ENSG00000242769	transcript	ENST00000484057.3	n.*4191C>T	NA	NA	NA	NA	NA	4191	NA	(AMPD1|ENSG00000116748|1|1.00)	(AMPD1|ENSG00000116748|1|1.00)	0.087	0.0698882	0.926917	2321,8	0.00319489	0.038139	5	Muscle_AMP_deaminase_deficiency	C0268123:615511:9105005	MedGen:OMIM:SNOMED_CT	NA	8	615511(3)	NA	Myopathy~due~to~myoadenylate~deaminase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	P/P/P	1	2.84	NA	NA	NA	4.91	NA	36	1.048	NA	Ampd1	NA	1.26E-01	59.170795	0.073492312	NA	6.22939	270	NA	NA	1051.80051	123	NA	NA	NA	NA	NA	AMPD1
chr1	114709659	rs143020946	C	T	PASS	T	synonymous_variant	LOW	NRAS	ENSG00000213281	transcript	ENST00000369535.4	c.360G>A	p.Leu120Leu	4/7	614/4449	120/189	360/570	NA	NA	NA	NA	0.0002636	0.000399361	0.999601	2503,0	0	0.000199681	255|3	not_specified|Rasopathy	CN169374|CN166718:ORPHA98733	MedGen|MedGen:Orphanet	NA	NA	188470(3),163200(3),614470(3),613224(3),249400(3),137550(3),162900(3),114500(3)	NA	Thyroid~carcinoma~follicular~somatic,Schimmelpenning-Feuerstein-Mims~syndrome~somatic~mosaic,?RAS-associated~autoimmune~lymphoproliferative~syndrome~type~IV~somatic,Noonan~syndrome~6,Neurocutaneous~melanosis~somatic,Melanocytic~nevus~syndrome~congenital~somatic,Epidermal~nevus~somatic,Colorectal~cancer~somatic	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,-,-,AD,-,-,-,-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nras	N	NA	54.62962963	0.013025609	NA	0.13463	4893	NA	NA	3.64814	134	NA	NA	NA	NA	NA	NA
chr1	115701310	rs148824162	T	A	PASS	A	missense_variant	MODERATE	CASQ2	ENSG00000118729	transcript	ENST00000261448.5	c.1131A>T	p.Glu377Asp	11/11	1371/2674	377/399	1131/1200	NA	NA	NA	NA	0.0001565	0.00319489	0.996805	2496,0	0	0.00159744	255	not_specified	CN169374	MedGen	NA	1	611938(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	N/N	0.008	-10.4	./CASQ2_HUMAN	B	B	5.21	306,377	0.001	-0.638	T	Casq2	N	7.65E-01	42.05590941	-0.157884861	NA	4.91846	845	NA	NA	588.11833	137	TCAn|Simple_repeat|Simple_repeat	NA	NA	NA	NA	NA
chr1	115726998	rs28730716	T	C	PASS	C	missense_variant	MODERATE	CASQ2	ENSG00000118729	transcript	ENST00000261448.5	c.731A>G	p.His244Arg	6/11	971/2674	244/399	731/1200	NA	NA	NA	NA	0.007668	0.0551118	0.944089	2364,2	0.000798722	0.0283546	2|255|0|2|3	Cardiac_arrhythmia|not_specified|not_specified|Cardiovascular_phenotype|Catecholaminergic_polymorphic_ventricular_tachycardia	CN029864:115000|CN169374|CN169374|CN230736|C1631597:ORPHA3286	MedGen:OMIM|MedGen|MedGen|MedGen|MedGen:Orphanet	NA	NA	611938(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D/D	0.988	5.76	./CASQ2_HUMAN	P	P	5.76	173,244	24.8	1.061	D	Casq2	N	7.65E-01	42.05590941	-0.157884861	NA	4.91846	845	NA	NA	588.11833	125	NA	NA	NA	NA	NA	NA
chr1	115732940	rs146664754	G	C	PASS	C	missense_variant	MODERATE	CASQ2	ENSG00000118729	transcript	ENST00000261448.5	c.567C>G	p.Phe189Leu	5/11	807/2674	189/399	567/1200	NA	NA	NA	NA	0.0006919	0.000798722	0.999201	2502,0	0	0.000399361	0|4	not_specified|Ventricular_tachycardia\x2c_polymorphic	CN169374|C0344432	MedGen|MedGen	NA	1	611938(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D/D	1	3.81	./CASQ2_HUMAN	D	D	5.68	118,189	27.7	0.953	D	Casq2	N	7.65E-01	42.05590941	-0.157884861	NA	4.91846	845	NA	NA	588.11833	134	NA	NA	NA	NA	NA	NA
chr1	115738349	rs139281637	C	T	PASS	T	intron_variant	MODIFIER	CASQ2	ENSG00000118729	transcript	ENST00000261448.5	c.421-14G>A	NA	3/10	NA	NA	NA	NA	NA	NA	NA	0.00112	0.000798722	0.999201	2502,0	0	0.000399361	255|0	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia	CN169374|C1631597:ORPHA3286	MedGen|MedGen:Orphanet	NA	NA	611938(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Casq2	N	7.65E-01	42.05590941	-0.157884861	NA	4.91846	845	NA	NA	588.11833	134	NA	NA	NA	NA	NA	NA
chr1	115738350	rs199939582	G	C	PASS	C	intron_variant	MODIFIER	CASQ2	ENSG00000118729	transcript	ENST00000261448.5	c.421-15C>G	NA	3/10	NA	NA	NA	NA	NA	NA	NA	0.0008484	0.000399361	0.999601	2503,0	0	0.000199681	3,255|0	not_specified,not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia	CN169374,CN169374|C1631597:ORPHA3286	MedGen,MedGen|MedGen:Orphanet	NA	NA	611938(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Casq2	N	7.65E-01	42.05590941	-0.157884861	NA	4.91846	845	NA	NA	588.11833	137	NA	NA	NA	NA	NA	NA
chr1	115738350	rs199939582	G	A	PASS	A	intron_variant	MODIFIER	CASQ2	ENSG00000118729	transcript	ENST00000261448.5	c.421-15C>T	NA	3/10	NA	NA	NA	NA	NA	NA	NA	0.0008813	NA	NA	NA	NA	NA	3,255|0	not_specified,not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia	CN169374,CN169374|C1631597:ORPHA3286	MedGen,MedGen|MedGen:Orphanet	NA	NA	611938(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Casq2	N	7.65E-01	42.05590941	-0.157884861	NA	4.91846	845	NA	NA	588.11833	137	NA	NA	NA	NA	NA	NA
chr1	119033203	rs139194636	T	C	PASS	C	missense_variant	MODERATE	WARS2	ENSG00000116874	transcript	ENST00000235521.4	c.791A>G	p.Tyr264Cys	6/6	818/2800	264/360	791/1083	NA	NA	NA	NA	4.942e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	not_provided	CN221809	MedGen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M	D/D/D	0.817	4.71	./SYWM_HUMAN	D	D	5.87	207,264	25.4	1.061	D	Wars2	NA	3.56E-01	69.36777542	0.240763792	NA	5.88205	10352	NA	NA	914.61642	134	NA	NA	NA	NA	NA	NA
chr1	119757427	rs142637231	G	T	PASS	T	synonymous_variant	LOW	HMGCS2	ENSG00000134240	transcript	ENST00000369406.7	c.862C>A	p.Arg288Arg	5/10	912/2428	288/508	862/1527	NA	NA	NA	NA	0.0007907	0.0071885	0.992812	2486,0	0	0.00359425	5,0	not_provided,mitochondrial_3-hydroxy-3-methylglutaryl-CoA_synthase_deficiency	CN221809,C2751532:605911:ORPHA35701	MedGen,MedGen:OMIM:Orphanet	NA	NA	605911(3)	NA	HMG-CoA~synthase-2~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hmgcs2	NA	1.94E-01	10.72776598	-0.867014353	NA	1.69109	3158	NA	NA	66.95673	134	GTGAAGCn|Simple_repeat|Simple_repeat	NA	NA	NA	NA	NA
chr1	119917685	rs312262801	G	C	PASS	C	missense_variant	MODERATE	NOTCH2	ENSG00000134250	transcript	ENST00000256646.6	c.6007C>G	p.Arg2003Gly	33/34	6227/11389	2003/2471	6007/7416	NA	NA	NA	NA	2.471e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Alagille_syndrome_2|Hajdu-Cheney_syndrome	C1857761:610205:ORPHA261629|C0917715:102500:63122002	MedGen:OMIM:Orphanet|MedGen:OMIM:SNOMED_CT	NA	NA	102500(3),610205(3)	NA	Hajdu-Cheney~syndrome,Alagille~syndrome~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	L	D	0.997	3.15	NOTC2_HUMAN	P	D	5.22	2003	29.3	-0.355	D	Notch2	E	1.56E-02	2.14673272	-1.819260363	abnormal	4.40739	4853	notch2	NA	449.73773	137	NA	NA	NA	NA	NA	NA
chr1	119925578	rs41313282	A	T	PASS	T	missense_variant	MODERATE	NOTCH2	ENSG00000134250	transcript	ENST00000256646.6	c.4238T>A	p.Leu1413His	25/34	4458/11389	1413/2471	4238/7416	NA	NA	NA	NA	0.002949	0.00439297	0.995607	2493,0	0	0.00219649	255	not_specified	CN169374	MedGen	NA	NA	102500(3),610205(3)	NA	Hajdu-Cheney~syndrome,Alagille~syndrome~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	N	N	0.961	3.29	NOTC2_HUMAN	B	B	5.72	1413	9.443	1.199	D	Notch2	E	1.56E-02	2.14673272	-1.819260363	abnormal	4.40739	4853	notch2	NA	449.73773	127	NA	NA	NA	NA	NA	NA
chr1	145927328	rs201779890	C	G	PASS	G	downstream_gene_variant	MODIFIER	GNRHR2	ENSG00000211451	transcript	ENST00000312753.9	n.*2014C>G	NA	NA	NA	NA	NA	2014	NA	NA	NA	NA	NA	NA	NA	NA	NA	5|255	Radial_aplasia-thrombocytopenia_syndrome|not_provided	C0175703:274000:85589009|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	274000(3)	NA	Thrombocytopenia-absent~radius~syndrome	Chromosome~1q21.1~deletion~syndrome,Chromosome~1q21.1~duplication~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612474(4),612475(4)	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Rbm8a	NA	NA	47.78839349	-0.075159878	NA	0.08431	9939	NA	NA	2.40691	136	NA	NA	NA	NA	NA	NA
chr1	145927328	rs201779890	C	G	PASS	G	intron_variant	MODIFIER	RBM8A	ENSG00000265241	transcript	ENST00000583313.6	c.67+32G>C	NA	1/5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	5|255	Radial_aplasia-thrombocytopenia_syndrome|not_provided	C0175703:274000:85589009|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	274000(3)	NA	Thrombocytopenia-absent~radius~syndrome	Chromosome~1q21.1~deletion~syndrome,Chromosome~1q21.1~duplication~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612474(4),612475(4)	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Rbm8a	NA	NA	47.78839349	-0.075159878	NA	0.08431	9939	NA	NA	2.40691	136	NA	NA	NA	NA	NA	NA
chr1	145927328	rs201779890	C	G	PASS	G	intron_variant	MODIFIER	CH17-270A2.2	ENSG00000280778	transcript	ENST00000625258.1	c.-30+39C>G	NA	1/3	NA	NA	NA	NA	WARNING_TRANSCRIPT_INCOMPLETE	NA	NA	NA	NA	NA	NA	NA	NA	5|255	Radial_aplasia-thrombocytopenia_syndrome|not_provided	C0175703:274000:85589009|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	274000(3)	NA	Thrombocytopenia-absent~radius~syndrome	Chromosome~1q21.1~deletion~syndrome,Chromosome~1q21.1~duplication~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612474(4),612475(4)	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Rbm8a	NA	NA	47.78839349	-0.075159878	NA	0.08431	9939	NA	NA	2.40691	136	NA	NA	NA	NA	NA	NA
chr1	145927328	rs201779890	C	G	PASS	G	non_coding_transcript_exon_variant	MODIFIER	RP11-315I20.1	ENSG00000234222	transcript	ENST00000598354.5	n.93C>G	NA	1/3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	5|255	Radial_aplasia-thrombocytopenia_syndrome|not_provided	C0175703:274000:85589009|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	274000(3)	NA	Thrombocytopenia-absent~radius~syndrome	Chromosome~1q21.1~deletion~syndrome,Chromosome~1q21.1~duplication~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612474(4),612475(4)	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Rbm8a	NA	NA	47.78839349	-0.075159878	NA	0.08431	9939	NA	NA	2.40691	136	NA	NA	NA	NA	NA	NA
chr1	145927447	rs139428292	C	T	PASS	T	5_prime_UTR_variant	MODIFIER	RBM8A	ENSG00000265241	transcript	ENST00000583313.6	c.-21G>A	NA	1/6	NA	NA	NA	21	NA	NA	NA	8.238e-06	NA	NA	NA	NA	NA	5|5	Radial_aplasia-thrombocytopenia_syndrome|not_provided	C0175703:274000:85589009|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	274000(3)	NA	Thrombocytopenia-absent~radius~syndrome	Chromosome~1q21.1~deletion~syndrome,Chromosome~1q21.1~duplication~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612474(4),612475(4)	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Rbm8a	NA	NA	47.78839349	-0.075159878	NA	0.08431	9939	NA	NA	2.40691	134	NA	NA	NA	NA	NA	NA
chr1	145927447	rs139428292	C	T	PASS	T	downstream_gene_variant	MODIFIER	GNRHR2	ENSG00000211451	transcript	ENST00000312753.9	n.*2133C>T	NA	NA	NA	NA	NA	2133	NA	NA	NA	8.238e-06	NA	NA	NA	NA	NA	5|5	Radial_aplasia-thrombocytopenia_syndrome|not_provided	C0175703:274000:85589009|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	274000(3)	NA	Thrombocytopenia-absent~radius~syndrome	Chromosome~1q21.1~deletion~syndrome,Chromosome~1q21.1~duplication~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612474(4),612475(4)	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Rbm8a	NA	NA	47.78839349	-0.075159878	NA	0.08431	9939	NA	NA	2.40691	134	NA	NA	NA	NA	NA	NA
chr1	145927447	rs139428292	C	T	PASS	T	intron_variant	MODIFIER	CH17-270A2.2	ENSG00000280778	transcript	ENST00000625258.1	c.-30+158C>T	NA	1/3	NA	NA	NA	NA	WARNING_TRANSCRIPT_INCOMPLETE	NA	NA	8.238e-06	NA	NA	NA	NA	NA	5|5	Radial_aplasia-thrombocytopenia_syndrome|not_provided	C0175703:274000:85589009|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	274000(3)	NA	Thrombocytopenia-absent~radius~syndrome	Chromosome~1q21.1~deletion~syndrome,Chromosome~1q21.1~duplication~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612474(4),612475(4)	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Rbm8a	NA	NA	47.78839349	-0.075159878	NA	0.08431	9939	NA	NA	2.40691	134	NA	NA	NA	NA	NA	NA
chr1	145927447	rs139428292	C	T	PASS	T	non_coding_transcript_exon_variant	MODIFIER	RP11-315I20.1	ENSG00000234222	transcript	ENST00000598354.5	n.212C>T	NA	1/3	NA	NA	NA	NA	NA	NA	NA	8.238e-06	NA	NA	NA	NA	NA	5|5	Radial_aplasia-thrombocytopenia_syndrome|not_provided	C0175703:274000:85589009|CN221809	MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	274000(3)	NA	Thrombocytopenia-absent~radius~syndrome	Chromosome~1q21.1~deletion~syndrome,Chromosome~1q21.1~duplication~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612474(4),612475(4)	NA	AD/IC,AD/IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Rbm8a	NA	NA	47.78839349	-0.075159878	NA	0.08431	9939	NA	NA	2.40691	134	NA	NA	NA	NA	NA	NA
chr1	147659496	rs144959805	C	T	PASS	T	missense_variant	MODERATE	ACP6	ENSG00000162836	transcript	ENST00000583509.6	c.379G>A	p.Val127Met	3/10	827/6923	127/428	379/1287	NA	NA	NA	NA	0.0004283	0.000798722	0.999201	2502,0	0	0.000399361	4	Cerebral_visual_impairment_and_intellectual_disability	CN235864	MedGen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M	D/D	0.998	4.72	./PPA6_HUMAN	P/D	D	5.66	127	28.9	0.935	NA	Acp6	NA	8.22E-01	88.74144845	0.863528995	NA	2.61494	51205	NA	NA	144.10699	134	NA	NA	NA	NA	NA	NA
chr1	147758953	rs121434557	C	A	PASS	A	missense_variant	MODERATE	GJA5	ENSG00000265107	transcript	ENST00000579774.2	c.286G>T	p.Ala96Ser	2/2	427/3181	96/358	286/1077	NA	NA	NA	NA	9.884e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Atrial_fibrillation\x2c_familial\x2c_11	C3279693:614049	MedGen:OMIM	NA	NA	108770(3),614049(3)	NA	Atrial~standstill~digenic~(GJA5/SCN5A),Atrial~fibrillation~familial~11	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	L	A/A	1	4.73	CXA5_HUMAN	D	D	5.64	96	28.6	0.935	././D	Gja5	E	1.77E-01	17.03231894	-0.626318434	abnormal	0.49952	2702	cx41.8	NA	13.74549	132	NA	NA	NA	NA	NA	NA
chr1	147758953	rs121434557	C	A	PASS	A	downstream_gene_variant	MODIFIER	RP11-433J22.2	ENSG00000274415	transcript	ENST00000622634.1	n.*544C>A	NA	NA	NA	NA	NA	544	NA	NA	NA	9.884e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Atrial_fibrillation\x2c_familial\x2c_11	C3279693:614049	MedGen:OMIM	NA	NA	108770(3),614049(3)	NA	Atrial~standstill~digenic~(GJA5/SCN5A),Atrial~fibrillation~familial~11	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	L	A/A	1	4.73	CXA5_HUMAN	D	D	5.64	96	28.6	0.935	././D	Gja5	E	1.77E-01	17.03231894	-0.626318434	abnormal	0.49952	2702	cx41.8	NA	13.74549	132	NA	NA	NA	NA	NA	NA
chr1	147908696	rs80358202	T	G	PASS	G	missense_variant	MODERATE	GJA8	ENSG00000121634	transcript	ENST00000369235.1	c.741T>G	p.Ile247Met	1/1	741/1302	247/433	741/1302	NA	NA	NA	NA	0.003163	0.00159744	0.998403	2500,0	0	0.000798722	5|3	Cataract_1|Zonular_Pulverulent_Cataract	C1861828:116200|CN239280	MedGen:OMIM|MedGen	NA	1	116200(3)	NA	Cataract~1~multiple~types	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	N	A/A	0.709	-3.65	CXA8_HUMAN	B	P	4.4	247	0.023	-0.319	T	Gja8	N	1.38E-01	40.35739561	-0.179930907	NA	1.05329	2703	NA	NA	34.49315	132	NA	NA	NA	NA	NA	NA
chr1	149784224	rs74315310	C	T	VQSRTrancheSNP99.80to100.00	T	stop_gained	HIGH	FCGR1A	ENSG00000150337	transcript	ENST00000369168.4	c.274C>T	p.Arg92*	3/6	328/2180	92/374	274/1125	NA	NA	(FCGR1A|ENSG00000150337|1|1.00)	(FCGR1A|ENSG00000150337|1|1.00)	0.00401	0.00758786	0.992412	2485,0	0	0.00379393	5	IGG_receptor_I\x2c_phagocytic\x2c_familial_deficiency_of	C4016211	MedGen	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A/A/A/A	0.025	3.13	NA	NA	NA	3.13	NA	35	-0.024	NA	Fcgr1/Hist2h2bb	./N	./7.83E-01	./65.33380514	./0.169169615	NA	1.00601/1.62893	2209/440689	NA	NA	32.00975/63.31925	132	NA	NA	NA	NA	NA	NA
chr1	149784224	rs74315310	C	T	VQSRTrancheSNP99.80to100.00	T	downstream_gene_variant	MODIFIER	RP11-196G18.3	ENSG00000233030	transcript	ENST00000428289.1	n.*1435G>A	NA	NA	NA	NA	NA	1435	NA	(FCGR1A|ENSG00000150337|1|1.00)	(FCGR1A|ENSG00000150337|1|1.00)	0.00401	0.00758786	0.992412	2485,0	0	0.00379393	5	IGG_receptor_I\x2c_phagocytic\x2c_familial_deficiency_of	C4016211	MedGen	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A/A/A/A	0.025	3.13	NA	NA	NA	3.13	NA	35	-0.024	NA	Fcgr1/Hist2h2bb	./N	./7.83E-01	./65.33380514	./0.169169615	NA	1.00601/1.62893	2209/440689	NA	NA	32.00975/63.31925	132	NA	NA	NA	NA	NA	NA
chr1	149784224	rs74315310	C	T	VQSRTrancheSNP99.80to100.00	T	intron_variant	MODIFIER	HIST2H2BF	ENSG00000203814	transcript	ENST00000545683.1	c.378-964G>A	NA	1/1	NA	NA	NA	NA	NA	(FCGR1A|ENSG00000150337|1|1.00)	(FCGR1A|ENSG00000150337|1|1.00)	0.00401	0.00758786	0.992412	2485,0	0	0.00379393	5	IGG_receptor_I\x2c_phagocytic\x2c_familial_deficiency_of	C4016211	MedGen	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	A/A/A/A	0.025	3.13	NA	NA	NA	3.13	NA	35	-0.024	NA	Fcgr1/Hist2h2bb	./N	./7.83E-01	./65.33380514	./0.169169615	NA	1.00601/1.62893	2209/440689	NA	NA	32.00975/63.31925	132	NA	NA	NA	NA	NA	NA
chr1	149926400	rs115070660	A	G	PASS	G	synonymous_variant	LOW	SF3B4	ENSG00000143368	transcript	ENST00000271628.8	c.682T>C	p.Leu228Leu	3/6	1267/2085	228/424	682/1275	NA	NA	NA	NA	0.017	0.0219649	0.977636	2448,1	0.000399361	0.0113818	255|3	not_specified|Nager_syndrome	CN169374|171:C0265245:154400:35520007	MedGen|Gene:MedGen:OMIM:SNOMED_CT	NA	NA	154400(3)	NA	Acrofacial~dysostosis~1~Nager~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sf3b4	NA	NA	32.61972163	-0.295622497	abnormal	0.08182	10262	sf3b4	NA	2.39611	132	NA	NA	NA	NA	NA	NA
chr1	149926400	rs115070660	A	G	PASS	G	downstream_gene_variant	MODIFIER	MTMR11	ENSG00000014914	transcript	ENST00000439741.2	c.*2729T>C	NA	NA	NA	NA	NA	2254	NA	NA	NA	0.017	0.0219649	0.977636	2448,1	0.000399361	0.0113818	255|3	not_specified|Nager_syndrome	CN169374|171:C0265245:154400:35520007	MedGen|Gene:MedGen:OMIM:SNOMED_CT	NA	NA	154400(3)	NA	Acrofacial~dysostosis~1~Nager~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sf3b4	NA	NA	32.61972163	-0.295622497	abnormal	0.08182	10262	sf3b4	NA	2.39611	132	NA	NA	NA	NA	NA	NA
chr1	150553749	rs587691401	CCAGAGCCCAGGCCTCTGGCA	C	PASS	C	frameshift_variant	HIGH	ADAMTSL4	ENSG00000143382	transcript	ENST00000369039.9	c.767_786delAGGCCTCTGGCACAGAGCCC	p.Gln256fs	6/20	1056/4319	256/1097	767/3294	NA	INFO_REALIGN_3_PRIME	(ADAMTSL4|ENSG00000143382|1|1.00)	NA	0.001408	0.00119808	0.998802	2501,0	0	0.000599042	5|5|5	Ectopia_lentis_et_pupillae|Ectopia_lentis\x2c_isolated_autosomal_recessive|not_provided	C1644196:225200:419237004|C2673634:225100|CN221809	MedGen:OMIM:SNOMED_CT|MedGen:OMIM|MedGen	NA	NA	225100(3),225200(3)	NA	Ectopia~lentis~isolated~autosomal~recessive,Ectopia~lentis~et~pupillae	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Adamtsl4	NA	9.89E-01	53.51497995	-0.00377668	NA	6.35130	54507	NA	NA	1103.99507	142	NA	NA	NA	NA	NA	NA
chr1	150553749	rs587691401	CCAGAGCCCAGGCCTCTGGCA	C	PASS	C	downstream_gene_variant	MODIFIER	MIR4257	ENSG00000264553	transcript	ENST00000581735.1	n.*1736_*1755delCAGAGCCCAGGCCTCTGGCA	NA	NA	NA	NA	NA	1736	NA	(ADAMTSL4|ENSG00000143382|1|1.00)	NA	0.001408	0.00119808	0.998802	2501,0	0	0.000599042	5|5|5	Ectopia_lentis_et_pupillae|Ectopia_lentis\x2c_isolated_autosomal_recessive|not_provided	C1644196:225200:419237004|C2673634:225100|CN221809	MedGen:OMIM:SNOMED_CT|MedGen:OMIM|MedGen	NA	NA	225100(3),225200(3)	NA	Ectopia~lentis~isolated~autosomal~recessive,Ectopia~lentis~et~pupillae	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Adamtsl4	NA	9.89E-01	53.51497995	-0.00377668	NA	6.35130	54507	NA	NA	1103.99507	142	NA	NA	NA	NA	NA	NA
chr1	150553749	rs587691401	CCAGAGCCCAGGCCTCTGGCA	C	PASS	C	intron_variant	MODIFIER	RP11-54A4.2	ENSG00000237781	transcript	ENST00000442435.3	n.476+766_476+785delTGCCAGAGGCCTGGGCTCTG	NA	5/5	NA	NA	NA	NA	NA	(ADAMTSL4|ENSG00000143382|1|1.00)	NA	0.001408	0.00119808	0.998802	2501,0	0	0.000599042	5|5|5	Ectopia_lentis_et_pupillae|Ectopia_lentis\x2c_isolated_autosomal_recessive|not_provided	C1644196:225200:419237004|C2673634:225100|CN221809	MedGen:OMIM:SNOMED_CT|MedGen:OMIM|MedGen	NA	NA	225100(3),225200(3)	NA	Ectopia~lentis~isolated~autosomal~recessive,Ectopia~lentis~et~pupillae	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Adamtsl4	NA	9.89E-01	53.51497995	-0.00377668	NA	6.35130	54507	NA	NA	1103.99507	142	NA	NA	NA	NA	NA	NA
chr1	150558029	rs780264876	T	TG	VQSRTrancheINDEL99.00to100.00	TG	frameshift_variant	HIGH	ADAMTSL4	ENSG00000143382	transcript	ENST00000369039.9	c.2339dupG	p.Gly781fs	15/20	2629/4319	780/1097	2340/3294	NA	INFO_REALIGN_3_PRIME	(ADAMTSL4|ENSG00000143382|1|1.00)	NA	0.001191	NA	NA	NA	NA	NA	5	Ectopia_lentis_et_pupillae	C1644196:225200:419237004	MedGen:OMIM:SNOMED_CT	NA	1	225100(3),225200(3)	NA	Ectopia~lentis~isolated~autosomal~recessive,Ectopia~lentis~et~pupillae	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Adamtsl4	NA	9.89E-01	53.51497995	-0.00377668	NA	6.35130	54507	NA	NA	1103.99507	144	NA	NA	NA	NA	NA	NA
chr1	150558029	rs780264876	T	TG	VQSRTrancheINDEL99.00to100.00	TG	upstream_gene_variant	MODIFIER	RP11-54A4.2	ENSG00000237781	transcript	ENST00000442435.3	n.-306dupC	NA	NA	NA	NA	NA	306	NA	(ADAMTSL4|ENSG00000143382|1|1.00)	NA	0.001191	NA	NA	NA	NA	NA	5	Ectopia_lentis_et_pupillae	C1644196:225200:419237004	MedGen:OMIM:SNOMED_CT	NA	1	225100(3),225200(3)	NA	Ectopia~lentis~isolated~autosomal~recessive,Ectopia~lentis~et~pupillae	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Adamtsl4	NA	9.89E-01	53.51497995	-0.00377668	NA	6.35130	54507	NA	NA	1103.99507	144	NA	NA	NA	NA	NA	NA
chr1	150558029	rs780264876	T	TG	VQSRTrancheINDEL99.00to100.00	TG	downstream_gene_variant	MODIFIER	ADAMTSL4-AS1	ENSG00000203804	transcript	ENST00000615012.1	n.*2172dupC	NA	NA	NA	NA	NA	2172	NA	(ADAMTSL4|ENSG00000143382|1|1.00)	NA	0.001191	NA	NA	NA	NA	NA	5	Ectopia_lentis_et_pupillae	C1644196:225200:419237004	MedGen:OMIM:SNOMED_CT	NA	1	225100(3),225200(3)	NA	Ectopia~lentis~isolated~autosomal~recessive,Ectopia~lentis~et~pupillae	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Adamtsl4	NA	9.89E-01	53.51497995	-0.00377668	NA	6.35130	54507	NA	NA	1103.99507	144	NA	NA	NA	NA	NA	NA
chr1	151289853	rs148402804	C	T	PASS	T	missense_variant	MODERATE	ZNF687	ENSG00000143373	transcript	ENST00000324048.9	c.2810C>T	p.Pro937Leu	7/10	3780/5378	937/1237	2810/3714	NA	NA	NA	NA	6.755e-05	NA	NA	2498,0	NA	0.000599042	5	Paget_disease_of_bone_6	CN235346:616833	MedGen:OMIM	NA	NA	616833(3)	NA	Paget~disease~of~bone~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	N	D/D/D	0.666	2.15	./ZN687_HUMAN	B	B	5.16	937	12.26	0.038	D	Zfp687	NA	3.82E-01	12.08421798	-0.810208867	NA	4.63374	57592	NA	NA	512.33833	134	NA	NA	NA	NA	NA	NA
chr1	151289853	rs148402804	C	T	PASS	T	downstream_gene_variant	MODIFIER	PI4KB	ENSG00000143393	transcript	ENST00000368875.6	c.*2999G>A	NA	NA	NA	NA	NA	2084	NA	NA	NA	6.755e-05	NA	NA	2498,0	NA	0.000599042	5	Paget_disease_of_bone_6	CN235346:616833	MedGen:OMIM	NA	NA	616833(3)	NA	Paget~disease~of~bone~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	N	D/D/D	0.666	2.15	./ZN687_HUMAN	B	B	5.16	937	12.26	0.038	D	Zfp687	NA	3.82E-01	12.08421798	-0.810208867	NA	4.63374	57592	NA	NA	512.33833	134	NA	NA	NA	NA	NA	NA
chr1	151289853	rs148402804	C	G	PASS	G	missense_variant	MODERATE	ZNF687	ENSG00000143373	transcript	ENST00000324048.9	c.2810C>G	p.Pro937Arg	7/10	3780/5378	937/1237	2810/3714	NA	NA	NA	NA	0.0001435	NA	NA	2498,0	NA	0.000599042	5	Paget_disease_of_bone_6	CN235346:616833	MedGen:OMIM	NA	NA	616833(3)	NA	Paget~disease~of~bone~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	N	D/D/D	0.666	2.15	./ZN687_HUMAN	B	B	5.16	937	3.139	0.038	D	Zfp687	NA	3.82E-01	12.08421798	-0.810208867	NA	4.63374	57592	NA	NA	512.33833	134	NA	NA	NA	NA	NA	NA
chr1	151289853	rs148402804	C	G	PASS	G	downstream_gene_variant	MODIFIER	PI4KB	ENSG00000143393	transcript	ENST00000368875.6	c.*2999G>C	NA	NA	NA	NA	NA	2084	NA	NA	NA	0.0001435	NA	NA	2498,0	NA	0.000599042	5	Paget_disease_of_bone_6	CN235346:616833	MedGen:OMIM	NA	NA	616833(3)	NA	Paget~disease~of~bone~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	N	D/D/D	0.666	2.15	./ZN687_HUMAN	B	B	5.16	937	3.139	0.038	D	Zfp687	NA	3.82E-01	12.08421798	-0.810208867	NA	4.63374	57592	NA	NA	512.33833	134	NA	NA	NA	NA	NA	NA
chr1	151289853	rs148402804	C	A	PASS	A	missense_variant	MODERATE	ZNF687	ENSG00000143373	transcript	ENST00000324048.9	c.2810C>A	p.Pro937His	7/10	3780/5378	937/1237	2810/3714	NA	NA	NA	NA	0.0001604	NA	NA	NA	NA	NA	5	Paget_disease_of_bone_6	CN235346:616833	MedGen:OMIM	NA	NA	616833(3)	NA	Paget~disease~of~bone~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	N	D/D/D	0.666	2.15	./ZN687_HUMAN	P	D/P	5.16	937	21.1	0.038	D	Zfp687	NA	3.82E-01	12.08421798	-0.810208867	NA	4.63374	57592	NA	NA	512.33833	134	NA	NA	NA	NA	NA	NA
chr1	151289853	rs148402804	C	A	PASS	A	downstream_gene_variant	MODIFIER	PI4KB	ENSG00000143393	transcript	ENST00000368875.6	c.*2999G>T	NA	NA	NA	NA	NA	2084	NA	NA	NA	0.0001604	NA	NA	NA	NA	NA	5	Paget_disease_of_bone_6	CN235346:616833	MedGen:OMIM	NA	NA	616833(3)	NA	Paget~disease~of~bone~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	N	D/D/D	0.666	2.15	./ZN687_HUMAN	P	D/P	5.16	937	21.1	0.038	D	Zfp687	NA	3.82E-01	12.08421798	-0.810208867	NA	4.63374	57592	NA	NA	512.33833	134	NA	NA	NA	NA	NA	NA
chr1	152303434	rs148606936	G	A	PASS	A	stop_gained	HIGH	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.11452C>T	p.Gln3818*	3/3	11488/12747	3818/4061	11452/12186	NA	NA	NA	NA	5.765e-05	0.000798722	0.999201	2502,0	0	0.000399361	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0.001	2.67	NA	NA	NA	2.67	NA	37	0.897	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	134	NA	NA	NA	NA	NA	NA
chr1	152303434	rs148606936	G	A	PASS	A	intragenic_variant	MODIFIER	FLG-AS1	ENSG00000237975	gene_variant	ENSG00000237975	n.152303434G>A	NA	NA	NA	NA	NA	NA	NA	NA	NA	5.765e-05	0.000798722	0.999201	2502,0	0	0.000399361	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0.001	2.67	NA	NA	NA	2.67	NA	37	0.897	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	134	NA	NA	NA	NA	NA	NA
chr1	152304661	rs201356558	G	C	PASS	C	missense_variant	MODERATE	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.10225C>G	p.Arg3409Gly	3/3	10261/12747	3409/4061	10225/12186	NA	NA	NA	NA	0.0001565	0.00399361	0.996006	2494,0	0	0.00199681	5	not_provided	CN221809	MedGen	NA	1	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	N	N	0	-5.09	FILA_HUMAN	B	B	4.22	3409	1.600	-0.51	T	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	137	CCTGGTn|Simple_repeat|Simple_repeat	NA	NA	NA	NA	NA
chr1	152304661	rs201356558	G	C	PASS	C	intragenic_variant	MODIFIER	FLG-AS1	ENSG00000237975	gene_variant	ENSG00000237975	n.152304661G>C	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0001565	0.00399361	0.996006	2494,0	0	0.00199681	5	not_provided	CN221809	MedGen	NA	1	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	N	N	0	-5.09	FILA_HUMAN	B	B	4.22	3409	1.600	-0.51	T	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	137	CCTGGTn|Simple_repeat|Simple_repeat	NA	NA	NA	NA	NA
chr1	152304939	rs149484917	G	C	PASS	C	stop_gained	HIGH	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.9947C>G	p.Ser3316*	3/3	9983/12747	3316/4061	9947/12186	NA	NA	NA	NA	0.0005519	0.00399361	0.996006	2494,0	0	0.00199681	5	not_provided	CN221809	MedGen	NA	2	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0.002	2.51	NA	NA	NA	3.45	NA	36	0.727	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	134	NA	NA	NA	NA	NA	NA
chr1	152304939	rs149484917	G	C	PASS	C	intragenic_variant	MODIFIER	FLG-AS1	ENSG00000237975	gene_variant	ENSG00000237975	n.152304939G>C	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0005519	0.00399361	0.996006	2494,0	0	0.00199681	5	not_provided	CN221809	MedGen	NA	2	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0.002	2.51	NA	NA	NA	3.45	NA	36	0.727	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	134	NA	NA	NA	NA	NA	NA
chr1	152305146	rs150597413	G	T	PASS	T	stop_gained	HIGH	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.9740C>A	p.Ser3247*	3/3	9776/12747	3247/4061	9740/12186	NA	NA	NA	NA	0.001351	0.000798722	0.999201	2502,0	0	0.000399361	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0.003	-0.0159	NA	NA	NA	3.08	NA	36	0.708	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	134	NA	NA	NA	NA	NA	NA
chr1	152305146	rs150597413	G	T	PASS	T	intragenic_variant	MODIFIER	FLG-AS1	ENSG00000237975	gene_variant	ENSG00000237975	n.152305146G>T	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.001351	0.000798722	0.999201	2502,0	0	0.000399361	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0.003	-0.0159	NA	NA	NA	3.08	NA	36	0.708	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	134	NA	NA	NA	NA	NA	NA
chr1	152307547	rs138726443	G	A	PASS	A	stop_gained	HIGH	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.7339C>T	p.Arg2447*	3/3	7375/12747	2447/4061	7339/12186	NA	NA	NA	NA	0.003047	0.00199681	0.998003	2499,0	0	0.000998403	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-2.88	NA	NA	NA	3.95	NA	35	0.039	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	134	NA	NA	NA	NA	NA	NA
chr1	152307547	rs138726443	G	A	PASS	A	intragenic_variant	MODIFIER	FLG-AS1	ENSG00000237975	gene_variant	ENSG00000237975	n.152307547G>A	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.003047	0.00199681	0.998003	2499,0	0	0.000998403	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-2.88	NA	NA	NA	3.95	NA	35	0.039	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	134	NA	NA	NA	NA	NA	NA
chr1	152307622	rs374588791	C	A	PASS	A	stop_gained	HIGH	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.7264G>T	p.Glu2422*	3/3	7300/12747	2422/4061	7264/12186	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-0.757	NA	NA	NA	3.43	NA	35	0.019	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	138	NA	NA	NA	NA	NA	NA
chr1	152307622	rs374588791	C	A	PASS	A	intragenic_variant	MODIFIER	FLG-AS1	ENSG00000237975	gene_variant	ENSG00000237975	n.152307622C>A	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0001977	0.00199681	0.998003	2499,0	0	0.000998403	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-0.757	NA	NA	NA	3.43	NA	35	0.019	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	138	NA	NA	NA	NA	NA	NA
chr1	152308777	rs200002200	G	A	PASS	A	stop_gained	HIGH	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.6109C>T	p.Arg2037*	3/3	6145/12747	2037/4061	6109/12186	NA	NA	NA	NA	0.0003789	0.000798722	0.999201	2502,0	0	0.000399361	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-3.87	NA	NA	NA	3.16	NA	32	-2.021	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	137	NA	NA	NA	NA	NA	NA
chr1	152308777	rs200002200	G	A	PASS	A	upstream_gene_variant	MODIFIER	FLG-AS1	ENSG00000237975	transcript	ENST00000392688.6	n.-4682G>A	NA	NA	NA	NA	NA	4682	NA	NA	NA	0.0003789	0.000798722	0.999201	2502,0	0	0.000399361	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-3.87	NA	NA	NA	3.16	NA	32	-2.021	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	137	NA	NA	NA	NA	NA	NA
chr1	152308777	rs200002200	G	A	PASS	A	intragenic_variant	MODIFIER	FLG-AS1	ENSG00000237975	gene_variant	ENSG00000237975	n.152308777G>A	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0003789	0.000798722	0.999201	2502,0	0	0.000399361	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-3.87	NA	NA	NA	3.16	NA	32	-2.021	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	137	NA	NA	NA	NA	NA	NA
chr1	152312410	rs115746363	G	A	PASS	A	stop_gained	HIGH	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.2476C>T	p.Arg826*	3/3	2512/12747	826/4061	2476/12186	NA	NA	NA	NA	0.0006754	NA	NA	2491,0	NA	0.00199681	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-7.14	NA	NA	NA	3.57	NA	25.0	-1.016	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	132	NA	NA	NA	NA	NA	NA
chr1	152312410	rs115746363	G	A	PASS	A	upstream_gene_variant	MODIFIER	FLG-AS1	ENSG00000237975	transcript	ENST00000392688.6	n.-1049G>A	NA	NA	NA	NA	NA	1049	NA	NA	NA	0.0006754	NA	NA	2491,0	NA	0.00199681	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-7.14	NA	NA	NA	3.57	NA	25.0	-1.016	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	132	NA	NA	NA	NA	NA	NA
chr1	152312410	rs115746363	G	A	PASS	A	intragenic_variant	MODIFIER	FLG-AS1	ENSG00000237975	gene_variant	ENSG00000237975	n.152312410G>A	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0006754	NA	NA	2491,0	NA	0.00199681	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-7.14	NA	NA	NA	3.57	NA	25.0	-1.016	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	132	NA	NA	NA	NA	NA	NA
chr1	152312600	rs558269137	CACTG	C	PASS	C	frameshift_variant	HIGH	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.2282_2285delCAGT	p.Ser761fs	3/3	2321/12747	761/4061	2282/12186	NA	NA	(FLG|ENSG00000143631|1|1.00)	NA	0.013	0.0107827	0.989217	2477,0	0	0.00539137	5|255|0|0|3|5	Ichthyosis_vulgaris|Dermatitis\x2c_atopic\x2c_2\x2c_susceptibility_to|Dermatitis\x2c_atopic\x2c_2|Ichthyosis_vulgaris|not_specified|not_provided	C0079584:146700|.|C1853965:605803|C0079584:146700|CN169374|CN221809	MedGen:OMIM|.|MedGen:OMIM|MedGen:OMIM|MedGen|MedGen	NA	3	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	142	NA	NA	NA	NA	NA	NA
chr1	152312600	rs558269137	CACTG	C	PASS	C	upstream_gene_variant	MODIFIER	FLG-AS1	ENSG00000237975	transcript	ENST00000392688.6	n.-858_-855delACTG	NA	NA	NA	NA	NA	858	NA	(FLG|ENSG00000143631|1|1.00)	NA	0.013	0.0107827	0.989217	2477,0	0	0.00539137	5|255|0|0|3|5	Ichthyosis_vulgaris|Dermatitis\x2c_atopic\x2c_2\x2c_susceptibility_to|Dermatitis\x2c_atopic\x2c_2|Ichthyosis_vulgaris|not_specified|not_provided	C0079584:146700|.|C1853965:605803|C0079584:146700|CN169374|CN221809	MedGen:OMIM|.|MedGen:OMIM|MedGen:OMIM|MedGen|MedGen	NA	3	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	142	NA	NA	NA	NA	NA	NA
chr1	152312600	rs558269137	CACTG	C	PASS	C	intragenic_variant	MODIFIER	FLG-AS1	ENSG00000237975	gene_variant	ENSG00000237975	n.152312605_152312608delACTG	NA	NA	NA	NA	NA	NA	NA	(FLG|ENSG00000143631|1|1.00)	NA	0.013	0.0107827	0.989217	2477,0	0	0.00539137	5|255|0|0|3|5	Ichthyosis_vulgaris|Dermatitis\x2c_atopic\x2c_2\x2c_susceptibility_to|Dermatitis\x2c_atopic\x2c_2|Ichthyosis_vulgaris|not_specified|not_provided	C0079584:146700|.|C1853965:605803|C0079584:146700|CN169374|CN221809	MedGen:OMIM|.|MedGen:OMIM|MedGen:OMIM|MedGen|MedGen	NA	3	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	142	NA	NA	NA	NA	NA	NA
chr1	152313385	rs61816761	G	A	PASS	A	stop_gained	HIGH	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.1501C>T	p.Arg501*	3/3	1537/12747	501/4061	1501/12186	NA	NA	NA	NA	0.008731	0.00678914	0.993211	2487,0	0	0.00339457	5|255|5	Ichthyosis_vulgaris|Dermatitis\x2c_atopic\x2c_2\x2c_susceptibility_to|not_provided	C0079584:146700|.|CN221809	MedGen:OMIM|.|MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-4.4	NA	NA	NA	3.54	NA	25.7	0.028	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	129	NA	NA	NA	NA	NA	NA
chr1	152313385	rs61816761	G	A	PASS	A	upstream_gene_variant	MODIFIER	FLG-AS1	ENSG00000237975	transcript	ENST00000392688.6	n.-74G>A	NA	NA	NA	NA	NA	74	NA	NA	NA	0.008731	0.00678914	0.993211	2487,0	0	0.00339457	5|255|5	Ichthyosis_vulgaris|Dermatitis\x2c_atopic\x2c_2\x2c_susceptibility_to|not_provided	C0079584:146700|.|CN221809	MedGen:OMIM|.|MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-4.4	NA	NA	NA	3.54	NA	25.7	0.028	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	129	NA	NA	NA	NA	NA	NA
chr1	152313385	rs61816761	G	A	PASS	A	intragenic_variant	MODIFIER	FLG-AS1	ENSG00000237975	gene_variant	ENSG00000237975	n.152313385G>A	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.008731	0.00678914	0.993211	2487,0	0	0.00339457	5|255|5	Ichthyosis_vulgaris|Dermatitis\x2c_atopic\x2c_2\x2c_susceptibility_to|not_provided	C0079584:146700|.|CN221809	MedGen:OMIM|.|MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0	-4.4	NA	NA	NA	3.54	NA	25.7	0.028	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	129	NA	NA	NA	NA	NA	NA
chr1	152313823	rs142991475	G	A	PASS	A	stop_gained	HIGH	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.1063C>T	p.Gln355*	3/3	1099/12747	355/4061	1063/12186	NA	NA	NA	NA	4.942e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0.001	0.744	NA	NA	NA	3	NA	25.6	0.861	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	134	NA	NA	NA	NA	NA	NA
chr1	152313823	rs142991475	G	A	PASS	A	non_coding_transcript_exon_variant	MODIFIER	FLG-AS1	ENSG00000237975	transcript	ENST00000392688.6	n.365G>A	NA	1/7	NA	NA	NA	NA	NA	NA	NA	4.942e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0.001	0.744	NA	NA	NA	3	NA	25.6	0.861	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	134	NA	NA	NA	NA	NA	NA
chr1	152315363	rs114733570	C	A	PASS	A	stop_gained	HIGH	FLG	ENSG00000143631	transcript	ENST00000368799.1	c.94G>T	p.Glu32*	2/3	130/12747	32/4061	94/12186	NA	NA	NA	NA	0.0001812	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0.961	5.2	NA	NA	NA	5.2	NA	36	0.848	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	132	NA	NA	NA	NA	NA	NA
chr1	152315363	rs114733570	C	A	PASS	A	intron_variant	MODIFIER	FLG-AS1	ENSG00000237975	transcript	ENST00000392688.6	n.914+406C>A	NA	2/6	NA	NA	NA	NA	NA	NA	NA	0.0001812	0.000399361	0.999601	2503,0	0	0.000199681	5	not_provided	CN221809	MedGen	NA	NA	146700(3)	NA	Ichthyosis~vulgaris	NA	NA	-,-	NA	NA	NA	NA	NA	605803(3),605803(3)	AD	NA	NA	NA	NA	{Dermatitis~atopic~susceptibility~to~2},{Dermatitis~atopic~susceptibility~to~2}	NA	D	0.961	5.2	NA	NA	NA	5.2	NA	36	0.848	NA	NA	./E	./9.95E-01	./99.98820477	./24.30246465	NA	./27.35022	2312/339400	NA	NA	./16458.42079	132	NA	NA	NA	NA	NA	NA
chr1	154191927	rs62000429	T	G	PASS	G	missense_variant	MODERATE	TPM3	ENSG00000143549	transcript	ENST00000271850.11	c.92A>C	p.Lys31Thr	1/9	132/1219	31/285	92/858	NA	NA	NA	NA	0.001494	0.0103834	0.989617	2478,0	0	0.00519169	255	not_specified	CN169374	MedGen	NA	NA	609284(3),255310(3),609284(3)	NA	Nemaline~myopathy~1~autosomal~dominant~or~recessive,Myopathy~congenital~with~fiber-type~disproportion,CAP~myopathy~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/AD,AR/AD	NA	NA	NA	NA	NA	H	D/D	1	5.75	TPM3_HUMAN	P	P	5.75	30	27.3	0.964	D	Tpm3	E	9.53E-02	72.009908	0.3032669	NA	1.13903	7170	NA	NA	38.39972	129	NA	NA	NA	NA	NA	NA
chr1	154191927	rs62000429	T	G	PASS	G	downstream_gene_variant	MODIFIER	MIR190B	ENSG00000215938	transcript	ENST00000401119.3	n.*1738A>C	NA	NA	NA	NA	NA	1738	NA	NA	NA	0.001494	0.0103834	0.989617	2478,0	0	0.00519169	255	not_specified	CN169374	MedGen	NA	NA	609284(3),255310(3),609284(3)	NA	Nemaline~myopathy~1~autosomal~dominant~or~recessive,Myopathy~congenital~with~fiber-type~disproportion,CAP~myopathy~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR/AD,AR/AD	NA	NA	NA	NA	NA	H	D/D	1	5.75	TPM3_HUMAN	P	P	5.75	30	27.3	0.964	D	Tpm3	E	9.53E-02	72.009908	0.3032669	NA	1.13903	7170	NA	NA	38.39972	129	NA	NA	NA	NA	NA	NA
chr1	154454494	rs2228145	A	C	PASS	C	missense_variant	MODERATE	IL6R	ENSG00000160712	transcript	ENST00000368485.7	c.1073A>C	p.Asp358Ala	9/10	1510/5914	358/468	1073/1407	NA	NA	NA	NA	0.369	0.374601	0.519569	1301,265	0.105831	0.293131	255|255	Soluble_interleukin-6_receptor\x2c_serum_level_of\x2c_quantitative_trait_locus|Interleukin_6\x2c_serum_level_of\x2c_quantitative_trait_locus	C3553493:614689|C3540094:614752	MedGen:OMIM|MedGen:OMIM	NA	1	NA	NA	NA	NA	NA	NA	NA	614689(3),614752(3)	NA	[Interleukin-6~receptor~soluble~serum~level~of~QTL],[Interleukin~6~serum~level~of~QTL]	-,-	NA	NA	NA	NA	NA	NA	NA	NA	P/P	0.642	2.85	IL6RA_HUMAN	B	B	4.03	358	4.955	1.199	T	Il6ra	N	5.30E-01	42.16206653	-0.156065314	NA	7.10856	3570	NA	il6Pathway/her2Pathway	1450.71381	98	NA	NA	NA	NA	NA	NA
chr1	154569616	rs3926124	A	G	PASS	G	intron_variant	MODIFIER	CHRNB2	ENSG00000160716	transcript	ENST00000636034.1	c.210+9A>G	NA	2/8	NA	NA	NA	NA	NA	NA	NA	0.033	0.131789	0.825879	2068,106	0.0423323	0.108227	255	not_specified	CN169374	MedGen	NA	NA	605375(3)	NA	Epilepsy~nocturnal~frontal~lobe~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Chrnb2	N	7.40E-02	14.96815287	-0.692458599	NA	0.82078	1141	NA	NA	25.07801	108	NA	NA	NA	NA	NA	NA
chr1	154572014	rs55685423	G	C	PASS	C	missense_variant	MODERATE	CHRNB2	ENSG00000160716	transcript	ENST00000636034.1	c.1191G>C	p.Gln397His	5/9	1440/3965	397/518	1191/1557	NA	NA	NA	NA	0.002229	0.00359425	0.996406	2495,0	0	0.00179712	0|255|0	Epilepsy\x2c_nocturnal_frontal_lobe\x2c_type_3|not_specified|Autosomal_dominant_nocturnal_frontal_lobe_epilepsy	C1854335:605375|CN169374|CN043647:ORPHA98784	MedGen:OMIM|MedGen|MedGen:Orphanet	NA	1	605375(3)	NA	Epilepsy~nocturnal~frontal~lobe~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	N	N	0.669	2.83	ACHB2_HUMAN	B	B	3.97	397	4.436	0.71	T	Chrnb2	N	7.40E-02	14.96815287	-0.692458599	NA	0.82078	1141	NA	NA	25.07801	129	NA	NA	NA	NA	NA	NA
chr1	154572056	rs55857552	G	A	PASS	A	synonymous_variant	LOW	CHRNB2	ENSG00000160716	transcript	ENST00000636034.1	c.1233G>A	p.Ala411Ala	5/9	1482/3965	411/518	1233/1557	NA	NA	NA	NA	0.001374	0.00159744	0.998403	2500,0	0	0.000798722	255	not_specified	CN169374	MedGen	NA	NA	605375(3)	NA	Epilepsy~nocturnal~frontal~lobe~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Chrnb2	N	7.40E-02	14.96815287	-0.692458599	NA	0.82078	1141	NA	NA	25.07801	129	NA	NA	NA	NA	NA	NA
chr1	154572175	rs4845378	G	T	PASS	T	intron_variant	MODIFIER	CHRNB2	ENSG00000160716	transcript	ENST00000636034.1	c.1338+14G>T	NA	5/8	NA	NA	NA	NA	NA	NA	NA	0.051	0.188099	0.795927	1993,40	0.0159744	0.110024	255	not_specified	CN169374	MedGen	NA	NA	605375(3)	NA	Epilepsy~nocturnal~frontal~lobe~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Chrnb2	N	7.40E-02	14.96815287	-0.692458599	NA	0.82078	1141	NA	NA	25.07801	111	NA	NA	NA	NA	NA	NA
chr1	154575905	rs8192486	A	G	PASS	G	synonymous_variant	LOW	CHRNB2	ENSG00000160716	transcript	ENST00000636034.1	c.1482A>G	p.Ser494Ser	6/9	1731/3965	494/518	1482/1557	NA	NA	NA	NA	0.0007083	0.000399361	0.999601	2503,0	0	0.000199681	255	not_specified	CN169374	MedGen	NA	NA	605375(3)	NA	Epilepsy~nocturnal~frontal~lobe~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Chrnb2	N	7.40E-02	14.96815287	-0.692458599	NA	0.82078	1141	NA	NA	25.07801	117	NA	NA	NA	NA	NA	NA
chr1	154575905	rs8192486	A	G	PASS	G	downstream_gene_variant	MODIFIER	RP11-61L14.6	ENSG00000233875	transcript	ENST00000421866.1	n.*3160T>C	NA	NA	NA	NA	NA	3160	NA	NA	NA	0.0007083	0.000399361	0.999601	2503,0	0	0.000199681	255	not_specified	CN169374	MedGen	NA	NA	605375(3)	NA	Epilepsy~nocturnal~frontal~lobe~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Chrnb2	N	7.40E-02	14.96815287	-0.692458599	NA	0.82078	1141	NA	NA	25.07801	117	NA	NA	NA	NA	NA	NA
chr1	154575908	rs144813907	C	T	PASS	T	synonymous_variant	LOW	CHRNB2	ENSG00000160716	transcript	ENST00000636034.1	c.1485C>T	p.Asp495Asp	6/9	1734/3965	495/518	1485/1557	NA	NA	NA	NA	0.0004612	0.00599042	0.99401	2489,0	0	0.00299521	255	not_specified	CN169374	MedGen	NA	NA	605375(3)	NA	Epilepsy~nocturnal~frontal~lobe~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Chrnb2	N	7.40E-02	14.96815287	-0.692458599	NA	0.82078	1141	NA	NA	25.07801	134	NA	NA	NA	NA	NA	NA
chr1	154575908	rs144813907	C	T	PASS	T	downstream_gene_variant	MODIFIER	RP11-61L14.6	ENSG00000233875	transcript	ENST00000421866.1	n.*3157G>A	NA	NA	NA	NA	NA	3157	NA	NA	NA	0.0004612	0.00599042	0.99401	2489,0	0	0.00299521	255	not_specified	CN169374	MedGen	NA	NA	605375(3)	NA	Epilepsy~nocturnal~frontal~lobe~3	NA	NA	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Chrnb2	N	7.40E-02	14.96815287	-0.692458599	NA	0.82078	1141	NA	NA	25.07801	134	NA	NA	NA	NA	NA	NA
chr1	154602065	rs145588689	G	C	PASS	C	missense_variant	MODERATE	ADAR	ENSG00000160710	transcript	ENST00000368474.8	c.577C>G	p.Pro193Ala	2/15	777/6625	193/1226	577/3681	NA	NA	NA	NA	0.002141	0.00279553	0.997204	2497,0	0	0.00139776	255|5|3|3	Aicardi-goutieres_syndrome_6|not_provided|Symmetrical_dyschromatosis_of_extremities|Aicardi_Goutieres_syndrome	C3539013:615010|CN221809|C0406775:127400:ORPHA41:239085000|C0393591:ORPHA51:230312006	MedGen:OMIM|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	127400(3),615010(3)	NA	Dyschromatosis~symmetrica~hereditaria,Aicardi-Goutieres~syndrome~6	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR	NA	NA	NA	NA	NA	L	D/D/D	0.736	4.52	././DSRAD_HUMAN	D	D	4.52	193	23.9	0.998	D	Adar	E	1.24E-01	16.70794999	-0.639268965	NA	1.87521	103	NA	antisensePathway	78.80238	134	NA	NA	NA	NA	NA	NA
chr1	155235203	rs1135675	C	G	VQSRTrancheSNP99.80to100.00	G	synonymous_variant	LOW	GBA	ENSG00000177628	transcript	ENST00000327247.9	c.1497G>C	p.Val499Val	11/12	1730/2387	499/536	1497/1611	NA	NA	NA	NA	0.0002965	0.00199681	0.998003	2499,0	0	0.000998403	5|5|5|5|2	Gaucher's_disease\x2c_type_1|Acute_neuronopathic_Gaucher's_disease|Subacute_neuronopathic_Gaucher's_disease|Gaucher_disease\x2c_perinatal_lethal|not_specified	C1961835:230800:62201009|C0268250:230900:ORPHA77260:12246008|C0268251:231000:ORPHA77261:5963005|C1842704:608013:ORPHA85212|CN169374	MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	86	NA	NA	NA	NA	NA	GBA
chr1	155235203	rs1135675	C	G	VQSRTrancheSNP99.80to100.00	G	downstream_gene_variant	MODIFIER	MTX1P1	ENSG00000236675	transcript	ENST00000440904.1	n.*878C>G	NA	NA	NA	NA	NA	878	NA	NA	NA	0.0002965	0.00199681	0.998003	2499,0	0	0.000998403	5|5|5|5|2	Gaucher's_disease\x2c_type_1|Acute_neuronopathic_Gaucher's_disease|Subacute_neuronopathic_Gaucher's_disease|Gaucher_disease\x2c_perinatal_lethal|not_specified	C1961835:230800:62201009|C0268250:230900:ORPHA77260:12246008|C0268251:231000:ORPHA77261:5963005|C1842704:608013:ORPHA85212|CN169374	MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	86	NA	NA	NA	NA	NA	GBA
chr1	155235217	rs368060	C	G	PASS	G	missense_variant	MODERATE	GBA	ENSG00000177628	transcript	ENST00000327247.9	c.1483G>C	p.Ala495Pro	11/12	1716/2387	495/536	1483/1611	NA	NA	NA	NA	0.0001153	NA	NA	NA	NA	NA	5|5|5|5|2	Gaucher's_disease\x2c_type_1|Acute_neuronopathic_Gaucher's_disease|Subacute_neuronopathic_Gaucher's_disease|Gaucher_disease\x2c_perinatal_lethal|not_specified	C1961835:230800:62201009|C0268250:230900:ORPHA77260:12246008|C0268251:231000:ORPHA77261:5963005|C1842704:608013:ORPHA85212|CN169374	MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	M	A/A/A/A/A	0.216	2.22	././GLCM_HUMAN	B	B	3.16	446,382,495	23.0	-0.078	T	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	80	NA	NA	NA	NA	NA	GBA
chr1	155235217	rs368060	C	G	PASS	G	downstream_gene_variant	MODIFIER	MTX1P1	ENSG00000236675	transcript	ENST00000440904.1	n.*892C>G	NA	NA	NA	NA	NA	892	NA	NA	NA	0.0001153	NA	NA	NA	NA	NA	5|5|5|5|2	Gaucher's_disease\x2c_type_1|Acute_neuronopathic_Gaucher's_disease|Subacute_neuronopathic_Gaucher's_disease|Gaucher_disease\x2c_perinatal_lethal|not_specified	C1961835:230800:62201009|C0268250:230900:ORPHA77260:12246008|C0268251:231000:ORPHA77261:5963005|C1842704:608013:ORPHA85212|CN169374	MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	M	A/A/A/A/A	0.216	2.22	././GLCM_HUMAN	B	B	3.16	446,382,495	23.0	-0.078	T	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	80	NA	NA	NA	NA	NA	GBA
chr1	155235252	rs421016	A	G	VQSRTrancheSNP99.80to100.00	G	missense_variant	MODERATE	GBA	ENSG00000177628	transcript	ENST00000327247.9	c.1448T>C	p.Leu483Pro	11/12	1681/2387	483/536	1448/1611	NA	NA	NA	NA	0.003155	0.00678914	0.993211	2487,0	0	0.00339457	5|5|5|255|255|5|5|5|5|5|4|4	Acute_neuronopathic_Gaucher's_disease|Subacute_neuronopathic_Gaucher's_disease|Gaucher's_disease\x2c_type_1|Parkinson_disease\x2c_late-onset|Dementia\x2c_Lewy_body\x2c_susceptibility_to|Gaucher's_disease\x2c_type_1|Acute_neuronopathic_Gaucher's_disease|Subacute_neuronopathic_Gaucher's_disease|Gaucher_disease\x2c_perinatal_lethal|Gaucher_disease|Gaucher's_disease\x2c_type_1|Gaucher's_disease\x2c_type_1	C0268250:230900:ORPHA77260:12246008|C0268251:231000:ORPHA77261:5963005|C1961835:230800:62201009|C3160718:168600:49049000|.|C1961835:230800:62201009|C0268250:230900:ORPHA77260:12246008|C0268251:231000:ORPHA77261:5963005|C1842704:608013:ORPHA85212|C0017205:ORPHA355|C1961835:230800:62201009|C1961835:230800:62201009	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:SNOMED_CT|.|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:Orphanet|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:SNOMED_CT	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	M	A/A/A/A/A	0.033	3.16	././GLCM_HUMAN	B/B/P	P	3.16	434,370,483	24.8	0.914	D	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	80	NA	NA	NA	NA	NA	GBA
chr1	155235252	rs421016	A	G	VQSRTrancheSNP99.80to100.00	G	downstream_gene_variant	MODIFIER	MTX1P1	ENSG00000236675	transcript	ENST00000440904.1	n.*927A>G	NA	NA	NA	NA	NA	927	NA	NA	NA	0.003155	0.00678914	0.993211	2487,0	0	0.00339457	5|5|5|255|255|5|5|5|5|5|4|4	Acute_neuronopathic_Gaucher's_disease|Subacute_neuronopathic_Gaucher's_disease|Gaucher's_disease\x2c_type_1|Parkinson_disease\x2c_late-onset|Dementia\x2c_Lewy_body\x2c_susceptibility_to|Gaucher's_disease\x2c_type_1|Acute_neuronopathic_Gaucher's_disease|Subacute_neuronopathic_Gaucher's_disease|Gaucher_disease\x2c_perinatal_lethal|Gaucher_disease|Gaucher's_disease\x2c_type_1|Gaucher's_disease\x2c_type_1	C0268250:230900:ORPHA77260:12246008|C0268251:231000:ORPHA77261:5963005|C1961835:230800:62201009|C3160718:168600:49049000|.|C1961835:230800:62201009|C0268250:230900:ORPHA77260:12246008|C0268251:231000:ORPHA77261:5963005|C1842704:608013:ORPHA85212|C0017205:ORPHA355|C1961835:230800:62201009|C1961835:230800:62201009	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:SNOMED_CT|.|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:Orphanet|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:SNOMED_CT	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	M	A/A/A/A/A	0.033	3.16	././GLCM_HUMAN	B/B/P	P	3.16	434,370,483	24.8	0.914	D	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	80	NA	NA	NA	NA	NA	GBA
chr1	155235256	rs75671029	C	T	VQSRTrancheSNP99.80to100.00	T	missense_variant	MODERATE	GBA	ENSG00000177628	transcript	ENST00000327247.9	c.1444G>A	p.Asp482Asn	11/12	1677/2387	482/536	1444/1611	NA	NA	NA	NA	0.0006919	0.00479233	0.995208	2492,0	0	0.00239617	255	Parkinson_disease\x2c_late-onset	C3160718:168600:49049000	MedGen:OMIM:SNOMED_CT	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	N	N/N/N/N/N	0.004	-1.24	././GLCM_HUMAN	B	B	3.16	433,369,482	6.275	-0.116	T	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	131	NA	NA	NA	NA	NA	GBA
chr1	155235256	rs75671029	C	T	VQSRTrancheSNP99.80to100.00	T	downstream_gene_variant	MODIFIER	MTX1P1	ENSG00000236675	transcript	ENST00000440904.1	n.*931C>T	NA	NA	NA	NA	NA	931	NA	NA	NA	0.0006919	0.00479233	0.995208	2492,0	0	0.00239617	255	Parkinson_disease\x2c_late-onset	C3160718:168600:49049000	MedGen:OMIM:SNOMED_CT	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	N	N/N/N/N/N	0.004	-1.24	././GLCM_HUMAN	B	B	3.16	433,369,482	6.275	-0.116	T	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	131	NA	NA	NA	NA	NA	GBA
chr1	155235843	rs76763715	T	C	PASS	C	missense_variant&splice_region_variant	MODERATE	GBA	ENSG00000177628	transcript	ENST00000327247.9	c.1226A>G	p.Asn409Ser	10/12	1459/2387	409/536	1226/1611	NA	NA	NA	NA	0.002207	0.00119808	0.998802	2501,0	0	0.000599042	5|255|255|5|5|5,5	Gaucher's_disease\x2c_type_1|Parkinson_disease\x2c_late-onset|Dementia\x2c_Lewy_body\x2c_susceptibility_to|not_provided|Susceptibility_to_Parkinson's_Disease|Gaucher_disease,Gaucher_disease	C1961835:230800:62201009|C3160718:168600:49049000|.|CN221809|CN239381|C0017205:ORPHA355,C0017205:ORPHA355	MedGen:OMIM:SNOMED_CT|MedGen:OMIM:SNOMED_CT|.|MedGen|MedGen|MedGen:Orphanet,MedGen:Orphanet	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	L	D/D/D/D/D	0.99	3.53	././GLCM_HUMAN	B	B/P/P	3.53	360,296,409	22.7	0.916	D	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	131	NA	NA	NA	NA	NA	GBA
chr1	155235843	rs76763715	T	C	PASS	C	downstream_gene_variant	MODIFIER	MTX1P1	ENSG00000236675	transcript	ENST00000440904.1	n.*1518T>C	NA	NA	NA	NA	NA	1518	NA	NA	NA	0.002207	0.00119808	0.998802	2501,0	0	0.000599042	5|255|255|5|5|5,5	Gaucher's_disease\x2c_type_1|Parkinson_disease\x2c_late-onset|Dementia\x2c_Lewy_body\x2c_susceptibility_to|not_provided|Susceptibility_to_Parkinson's_Disease|Gaucher_disease,Gaucher_disease	C1961835:230800:62201009|C3160718:168600:49049000|.|CN221809|CN239381|C0017205:ORPHA355,C0017205:ORPHA355	MedGen:OMIM:SNOMED_CT|MedGen:OMIM:SNOMED_CT|.|MedGen|MedGen|MedGen:Orphanet,MedGen:Orphanet	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	L	D/D/D/D/D	0.99	3.53	././GLCM_HUMAN	B	B/P/P	3.53	360,296,409	22.7	0.916	D	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	131	NA	NA	NA	NA	NA	GBA
chr1	155236376	rs2230288	C	T	PASS	T	missense_variant	MODERATE	GBA	ENSG00000177628	transcript	ENST00000327247.9	c.1093G>A	p.Glu365Lys	9/12	1326/2387	365/536	1093/1611	NA	NA	NA	NA	0.009801	0.00998403	0.990016	2479,0	0	0.00499201	5|2|2	Gaucher's_disease\x2c_type_1|Gaucher's_disease\x2c_type_1|not_specified	C1961835:230800:62201009|C1961835:230800:62201009|CN169374	MedGen:OMIM:SNOMED_CT|MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	L	A/A/A/A/A	0.964	3.67	././GLCM_HUMAN	B	B	3.67	316,252,365	17.33	0.818	T	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	98	NA	NA	NA	NA	NA	GBA
chr1	155236376	rs2230288	C	T	PASS	T	downstream_gene_variant	MODIFIER	MTX1P1	ENSG00000236675	transcript	ENST00000440904.1	n.*2051C>T	NA	NA	NA	NA	NA	2051	NA	NA	NA	0.009801	0.00998403	0.990016	2479,0	0	0.00499201	5|2|2	Gaucher's_disease\x2c_type_1|Gaucher's_disease\x2c_type_1|not_specified	C1961835:230800:62201009|C1961835:230800:62201009|CN169374	MedGen:OMIM:SNOMED_CT|MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	L	A/A/A/A/A	0.964	3.67	././GLCM_HUMAN	B	B	3.67	316,252,365	17.33	0.818	T	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	98	NA	NA	NA	NA	NA	GBA
chr1	155238215	rs364897	T	C	PASS	C	missense_variant	MODERATE	GBA	ENSG00000177628	transcript	ENST00000327247.9	c.680A>G	p.Asn227Ser	7/12	913/2387	227/536	680/1611	NA	NA	NA	NA	6.589e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5	Gaucher's_disease\x2c_type_1|Subacute_neuronopathic_Gaucher's_disease|Gaucher_disease	C1961835:230800:62201009|C0268251:231000:ORPHA77261:5963005|C0017205:ORPHA355	MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:Orphanet	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	L	A/A/A/A/A	0.804	1.25	././GLCM_HUMAN	B	B	3.66	178,114,227	0.013	0.935	T	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	80	NA	NA	NA	NA	NA	GBA
chr1	155238215	rs364897	T	C	PASS	C	downstream_gene_variant	MODIFIER	MTX1P1	ENSG00000236675	transcript	ENST00000440904.1	n.*3890T>C	NA	NA	NA	NA	NA	3890	NA	NA	NA	6.589e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5	Gaucher's_disease\x2c_type_1|Subacute_neuronopathic_Gaucher's_disease|Gaucher_disease	C1961835:230800:62201009|C0268251:231000:ORPHA77261:5963005|C0017205:ORPHA355	MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:Orphanet	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	L	A/A/A/A/A	0.804	1.25	././GLCM_HUMAN	B	B	3.66	178,114,227	0.013	0.935	T	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	80	NA	NA	NA	NA	NA	GBA
chr1	155240629	rs104886460	C	T	VQSRTrancheSNP99.80to100.00	T	splice_donor_variant&intron_variant	HIGH	GBA	ENSG00000177628	transcript	ENST00000327247.9	c.115+1G>A	NA	3/11	NA	NA	NA	NA	NA	(GBA|ENSG00000177628|1|1.00)	NA	0.0001153	0.000798722	0.999201	2502,0	0	0.000399361	5|5	not_provided|Gaucher's_disease\x2c_type_1	CN221809|C1961835:230800:62201009	MedGen|MedGen:OMIM:SNOMED_CT	NA	NA	231005(3),231005(3),231005(3),231000(3),230900(3),230800(3),608013(3)	NA	Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~IIIC,Gaucher~disease~type~III,Gaucher~disease~type~II,Gaucher~disease~type~I,Gaucher~disease~perinatal~lethal	NA	NA	IC/Mu,AD	NA	NA	NA	NA	NA	168600(3),127750(3)	AR,AR,AR,AR,AR,AR,AR	NA	NA	NA	NA	{Parkinson~disease~late-onset~susceptibility~to},{Lewy~body~dementia~susceptibility~to}	NA	D/D/D/D/D	0.539	3.62	NA	NA	NA	3.62	NA	25.0	0.818	NA	Gba	E	8.27E-03	66.12998349	0.178263593	abnormal	2.66182	2629	gba	NA	149.04466	132	NA	NA	NA	NA	NA	GBA
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:A_395-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:A_399-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:A_400-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:A_485-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:A_488-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:B_395-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:B_399-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:B_400-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:B_485-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:B_488-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:C_395-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:C_399-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:C_400-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:C_485-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:C_488-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:D_395-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:D_399-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:D_400-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:D_485-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:D_488-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:A_395-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:A_399-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:A_400-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:B_395-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:B_399-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:B_400-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:C_395-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:C_400-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:D_395-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:D_399-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:D_400-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:D_488-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:A_395-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:A_399-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:A_400-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:A_488-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:A_87-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:B_395-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:B_399-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:B_400-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:B_488-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:C_395-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:C_399-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:C_400-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:C_488-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:D_395-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:D_400-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:D_488-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGI:A_395-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGI:A_399-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGI:A_488-A_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGI:B_399-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGI:B_488-B_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGI:C_395-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGI:C_399-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGI:C_400-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGI:C_488-C_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGI:D_399-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGI:D_488-D_510:ENST00000342741	c.1529G>A	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	missense_variant	MODERATE	PKLR	ENSG00000143627	transcript	ENST00000342741.4	c.1529G>A	p.Arg510Gln	10/11	1568/2083	510/574	1529/1725	NA	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291845	rs113403872	C	T	PASS	T	downstream_gene_variant	MODIFIER	HCN3	ENSG00000143630	transcript	ENST00000368358.3	c.*3382C>T	NA	NA	NA	NA	NA	1997	NA	NA	NA	0.0004036	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Pyruvate_kinase_deficiency_of_red_cells|not_provided	C1849472:266200|CN221809	MedGen:OMIM|MedGen	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	H	A/A	1	4.85	KPYR_HUMAN/.	D	D	4.85	510,501	35	0.932	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:A_362-A_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:B_362-B_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:C_362-C_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGB:D_362-D_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:A_362-A_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:B_362-B_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:C_362-C_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGF:D_362-D_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:A_362-A_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:B_362-B_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:C_362-C_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	structural_interaction_variant	HIGH	PKLR	ENSG00000143627	interaction	2VGG:D_362-D_486:ENST00000342741	c.1456C>T	NA	10/11	NA	NA	NA	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	missense_variant	MODERATE	PKLR	ENSG00000143627	transcript	ENST00000342741.4	c.1456C>T	p.Arg486Trp	10/11	1495/2083	486/574	1456/1725	NA	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	155291918	rs116100695	G	A	PASS	A	downstream_gene_variant	MODIFIER	HCN3	ENSG00000143630	transcript	ENST00000368358.3	c.*3455G>A	NA	NA	NA	NA	NA	2070	NA	NA	NA	0.002825	0.00319489	0.996805	2496,0	0	0.00159744	255	Pyruvate_kinase_deficiency_of_red_cells	C1849472:266200	MedGen:OMIM	NA	1	266200(3),102900(3)	NA	Pyruvate~kinase~deficiency,Adenosine~triphosphate~elevated~of~erythrocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD	NA	NA	NA	NA	NA	M	A/A	0.978	4.85	KPYR_HUMAN/.	D	D	4.85	486,477	34	1.045	D	Pklr	N	6.09E-02	53.98089172	7.61E-05	NA	1.91644	5313	NA	glycolysisPathway	81.73871	132	NA	NA	NA	NA	NA	PKLR
chr1	156115247	rs556237236	G	A	PASS	A	missense_variant	MODERATE	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.329G>A	p.Arg110His	1/12	541/3190	110/664	329/1995	NA	NA	NA	NA	4.947e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	not_provided	CN221809	MedGen	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	M	D/D/D/D/D	0.998	4.9	./LMNA_HUMAN/./.	B	P	4.9	110	23.7	0.974	D	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	142	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156130617	rs41313880	C	T	PASS	T	splice_region_variant&synonymous_variant	LOW	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.357C>T	p.Arg119Arg	2/12	569/3190	119/664	357/1995	NA	NA	NA	NA	0.003171	0.00399361	0.996006	2494,0	0	0.00199681	255|3|3|3|2|2	not_specified|not_provided|Emery-Dreifuss_muscular_dystrophy|Dilated_cardiomyopathy|Charcot-Marie-Tooth_disease\x2c_type_2|Cardiovascular_phenotype	CN169374|CN221809|C0410189:ORPHA261:111508004|EFO_0000407:HP:0001644:CN001497|CN043576|CN230736	MedGen|MedGen|MedGen:Orphanet:SNOMED_CT|EFO:Human_Phenotype_Ontology:MedGen|MedGen|MedGen	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	127	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156130698	rs80356805	C	T	PASS	T	synonymous_variant	LOW	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.438C>T	p.Ala146Ala	2/12	650/3190	146/664	438/1995	NA	NA	NA	NA	0.002331	0.0155751	0.984026	2464,1	0.000399361	0.0081869	255	not_specified	CN169374	MedGen	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	132	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156130757	rs267607570	G	A	PASS	A	missense_variant	MODERATE	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.497G>A	p.Arg166Gln	2/12	709/3190	166/664	497/1995	NA	NA	NA	NA	1.661e-05	0.00159744	0.998403	2500,0	0	0.000798722	0,5	not_specified,not_provided	CN169374,CN221809	MedGen,MedGen	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	L	D/D/D/D/D/D/D/D/D	0.932	5.59	././././LMNA_HUMAN/./.	B	B	5.59	54,166,67,85,166,166,166	23.8	1.048	T	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	137	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156134954	rs148557956	G	A	PASS	A	synonymous_variant	LOW	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.789G>A	p.Leu263Leu	4/12	1001/3190	263/664	789/1995	NA	NA	NA	NA	8.236e-05	0.000399361	0.999601	2503,0	0	0.000199681	255	not_specified	CN169374	MedGen	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	134	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156135174	rs80356809	T	A	PASS	A	intron_variant	MODIFIER	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.811-13T>A	NA	4/11	NA	NA	NA	NA	NA	NA	NA	0.002339	0.00439297	0.995607	2493,0	0	0.00219649	255|1|3|3|3|3|3|3|3|3|3|3	not_specified|not_provided|Lethal_tight_skin_contracture_syndrome|Lipoatrophy_with_Diabetes\x2c_Hepatic_Steatosis\x2c_Hypertrophic_Cardiomyopathy\x2c_and_Leukomelanodermic_Papules|Charcot-Marie-Tooth\x2c_Type_2|Hutchinson-Gilford_syndrome|Mandibuloacral_dysplasia|Limb-Girdle_Muscular_Dystrophy\x2c_Recessive|Congenital_muscular_dystrophy\x2c_LMNA-related|Emery-Dreifuss_muscular_dystrophy|Dilated_Cardiomyopathy\x2c_Dominant|Familial_partial_lipodystrophy	CN169374|CN221809|C0406585:275210:ORPHA1662:400128006|CN239184|CN239171|C0033300:176670:ORPHA740:238870004|CN118835|CN239352|C2750785:613205:ORPHA157973|C0410189:ORPHA261:111508004|CN239310|C0271694:ORPHA98306:49292002	MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MedGen:OMIM:Orphanet|MedGen:Orphanet:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	137	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156135237	rs538089	T	C	PASS	C	synonymous_variant	LOW	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.861T>C	p.Ala287Ala	5/12	1073/3190	287/664	861/1995	NA	NA	NA	NA	0.109	0.217652	0.698083	1748,211	0.0842652	0.193091	255|1|2|2|2|2|2|2|2|2|2|2|2	not_specified|not_provided|Cardiovascular_phenotype|Lethal_tight_skin_contracture_syndrome|Hutchinson-Gilford_syndrome|Dilated_Cardiomyopathy\x2c_Dominant|Congenital_muscular_dystrophy\x2c_LMNA-related|Emery-Dreifuss_muscular_dystrophy|Lipoatrophy_with_Diabetes\x2c_Hepatic_Steatosis\x2c_Hypertrophic_Cardiomyopathy\x2c_and_Leukomelanodermic_Papules|Mandibuloacral_dysplasia|Limb-Girdle_Muscular_Dystrophy\x2c_Recessive|Familial_partial_lipodystrophy|Charcot-Marie-Tooth\x2c_Type_2	CN169374|CN221809|CN230736|C0406585:275210:ORPHA1662:400128006|C0033300:176670:ORPHA740:238870004|CN239310|C2750785:613205:ORPHA157973|C0410189:ORPHA261:111508004|CN239184|CN118835|CN239352|C0271694:ORPHA98306:49292002|CN239171	MedGen|MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MedGen:Orphanet:SNOMED_CT|MedGen|MedGen|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	83	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156136137	rs534807	G	A	PASS	A	intron_variant	MODIFIER	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.1157+16G>A	NA	6/11	NA	NA	NA	NA	NA	NA	NA	0.107	0.215256	0.70008	1753,212	0.0846645	0.192292	2|255|1	Primary_dilated_cardiomyopathy|not_specified|not_provided	C0007193:ORPHA217604:195021004|CN169374|CN221809	MedGen:Orphanet:SNOMED_CT|MedGen|MedGen	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	83	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156136394	rs505058	T	C	PASS	C	synonymous_variant	LOW	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.1338T>C	p.Asp446Asp	7/12	1550/3190	446/664	1338/1995	NA	NA	NA	NA	0.124	0.204473	0.648562	1624,368	0.146965	0.249201	255|1|2|2|2|2|2|2|2|2|2|2|2	not_specified|not_provided|Cardiovascular_phenotype|Familial_partial_lipodystrophy|Congenital_muscular_dystrophy\x2c_LMNA-related|Lipoatrophy_with_Diabetes\x2c_Hepatic_Steatosis\x2c_Hypertrophic_Cardiomyopathy\x2c_and_Leukomelanodermic_Papules|Hutchinson-Gilford_syndrome|Dilated_Cardiomyopathy\x2c_Dominant|Emery-Dreifuss_muscular_dystrophy|Charcot-Marie-Tooth\x2c_Type_2|Mandibuloacral_dysplasia|Lethal_tight_skin_contracture_syndrome|Limb-Girdle_Muscular_Dystrophy\x2c_Recessive	CN169374|CN221809|CN230736|C0271694:ORPHA98306:49292002|C2750785:613205:ORPHA157973|CN239184|C0033300:176670:ORPHA740:238870004|CN239310|C0410189:ORPHA261:111508004|CN239171|CN118835|C0406585:275210:ORPHA1662:400128006|CN239352	MedGen|MedGen|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	4	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	83	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156137175	rs41314035	G	A	PASS	A	synonymous_variant	LOW	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.1551G>A	p.Gln517Gln	9/12	1763/3190	517/664	1551/1995	NA	NA	NA	NA	0.0002554	0.000399361	0.999601	2503,0	0	0.000199681	255|3|3|3|3|3|3|3|3|3|3|3	not_specified|Charcot-Marie-Tooth_disease\x2c_type_2|Mandibuloacral_dysplasia|Limb-Girdle_Muscular_Dystrophy\x2c_Recessive|Hutchinson-Gilford_syndrome|Dilated_Cardiomyopathy\x2c_Dominant|Lethal_tight_skin_contracture_syndrome|Familial_partial_lipodystrophy|Charcot-Marie-Tooth\x2c_Type_2|Emery-Dreifuss_muscular_dystrophy|Congenital_muscular_dystrophy\x2c_LMNA-related|Lipoatrophy_with_Diabetes\x2c_Hepatic_Steatosis\x2c_Hypertrophic_Cardiomyopathy\x2c_and_Leukomelanodermic_Papules	CN169374|CN043576|CN118835|CN239352|C0033300:176670:ORPHA740:238870004|CN239310|C0406585:275210:ORPHA1662:400128006|C0271694:ORPHA98306:49292002|CN239171|C0410189:ORPHA261:111508004|C2750785:613205:ORPHA157973|CN239184	MedGen|MedGen|MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	127	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156137190	rs149339264	C	T	PASS	T	synonymous_variant	LOW	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.1566C>T	p.Cys522Cys	9/12	1778/3190	522/664	1566/1995	NA	NA	NA	NA	0.0004286	0.00479233	0.995208	2492,0	0	0.00239617	4,255|2|3|3|3|3|3|3|3|3|3|3|3	Cardiovascular_phenotype,not_specified|Charcot-Marie-Tooth_disease\x2c_type_2|Cardiovascular_phenotype|Dilated_Cardiomyopathy\x2c_Dominant|Hutchinson-Gilford_syndrome|Emery-Dreifuss_muscular_dystrophy|Familial_partial_lipodystrophy|Limb-Girdle_Muscular_Dystrophy\x2c_Recessive|Mandibuloacral_dysplasia|Lipoatrophy_with_Diabetes\x2c_Hepatic_Steatosis\x2c_Hypertrophic_Cardiomyopathy\x2c_and_Leukomelanodermic_Papules|Congenital_muscular_dystrophy\x2c_LMNA-related|Charcot-Marie-Tooth\x2c_Type_2|Lethal_tight_skin_contracture_syndrome	CN230736,CN169374|CN043576|CN230736|CN239310|C0033300:176670:ORPHA740:238870004|C0410189:ORPHA261:111508004|C0271694:ORPHA98306:49292002|CN239352|CN118835|CN239184|C2750785:613205:ORPHA157973|CN239171|C0406585:275210:ORPHA1662:400128006	MedGen,MedGen|MedGen|MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT|MedGen|MedGen|MedGen|MedGen:OMIM:Orphanet|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	NA	D/D/D/D/D/D/D/D/D	0.996	-3.9	NA	NA	NA	5.29	NA	17.87	-0.308	NA	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	134	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156137743	rs4641	C	T	PASS	T	splice_region_variant&synonymous_variant	LOW	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.1698C>T	p.His566His	10/12	1910/3190	566/664	1698/1995	NA	NA	NA	NA	0.162	0.327875	0.615815	1542,141	0.0563099	0.220248	255|1|2|2|2|2|2|2|2|2|2|2|2|2	not_specified|not_provided|Mandibuloacral_dysplasia_with_type_A_lipodystrophy|Cardiovascular_phenotype|Familial_partial_lipodystrophy|Emery-Dreifuss_muscular_dystrophy|Mandibuloacral_dysplasia|Congenital_muscular_dystrophy\x2c_LMNA-related|Hutchinson-Gilford_syndrome|Lethal_tight_skin_contracture_syndrome|Limb-Girdle_Muscular_Dystrophy\x2c_Recessive|Dilated_Cardiomyopathy\x2c_Dominant|Charcot-Marie-Tooth\x2c_Type_2|Lipoatrophy_with_Diabetes\x2c_Hepatic_Steatosis\x2c_Hypertrophic_Cardiomyopathy\x2c_and_Leukomelanodermic_Papules	CN169374|CN221809|CN236772|CN230736|C0271694:ORPHA98306:49292002|C0410189:ORPHA261:111508004|CN118835|C2750785:613205:ORPHA157973|C0033300:176670:ORPHA740:238870004|C0406585:275210:ORPHA1662:400128006|CN239352|CN239310|CN239171|CN239184	MedGen|MedGen|MedGen|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MedGen|MedGen	NA	4	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	52	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156138534	rs57830985	G	A	PASS	A	missense_variant	MODERATE	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.1745G>A	p.Arg582His	11/12	1957/3190	582/664	1745/1995	NA	NA	NA	NA	8.253e-06	0.000399361	0.999601	2503,0	0	0.000199681	5|1	Familial_partial_lipodystrophy_2|not_provided	C1720860:151660:ORPHA2348|CN221809	MedGen:OMIM:Orphanet|MedGen	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	M	A/A/A/A/A	1	5.05	././LMNA_HUMAN/.	D	D	5.05	582,483,582,552	34	0.953	D	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	133	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156138550	rs80356813	G	A	PASS	A	synonymous_variant	LOW	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.1761G>A	p.Leu587Leu	11/12	1973/3190	587/664	1761/1995	NA	NA	NA	NA	0.001898	0.00119808	0.998802	2501,0	0	0.000599042	2|255|2|3	Cardiomyopathy|not_specified|Charcot-Marie-Tooth_disease\x2c_type_2|Cardiovascular_phenotype	C0878544:ORPHA167848:85898001|CN169374|CN043576|CN230736	MedGen:Orphanet:SNOMED_CT|MedGen|MedGen|MedGen	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	134	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156138593	rs60662302	G	A	PASS	A	missense_variant	MODERATE	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.1804G>A	p.Gly602Ser	11/12	2016/3190	602/664	1804/1995	NA	NA	NA	NA	0.0002555	0.00199681	0.998003	2499,0	0	0.000998403	255|1|0	not_specified|not_provided|Insulin_resistance_syndrome\x2c_type_A	CN169374|CN221809|C0342336:ORPHA2297	MedGen|MedGen|MedGen:Orphanet	NA	NA	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	N	N/N/N/N/N	0.195	-2	././LMNA_HUMAN/.	B	B	5.05	602,503,602,572	0.575	-0.855	T	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	134	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156138719	rs142000963	C	T	PASS	T	missense_variant	MODERATE	LMNA	ENSG00000160789	transcript	ENST00000368300.8	c.1930C>T	p.Arg644Cys	11/12	2142/3190	644/664	1930/1995	NA	NA	NA	NA	0.001211	0.000798722	0.999201	2502,0	0	0.000399361	1,0|255|3|4|0|0	not_provided,Variant_of_unknown_significance|not_specified|not_provided|Charcot-Marie-Tooth_disease|Primary_dilated_cardiomyopathy|Cardiovascular_phenotype	CN221809,.|CN169374|CN221809|C0007959:ORPHA166:50548001|C0007193:ORPHA217604:195021004|CN230736	MedGen,.|MedGen|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT|MedGen	NA	1	275210(3),159001(3),613205(3),248370(3),212112(3),151660(3),176670(3),610140(3),616516(3),181350(3),605588(3),115200(3)	NA	Restrictive~dermopathy~lethal,Muscular~dystrophy~limb-girdle~type~1B,Muscular~dystrophy~congenital,Mandibuloacral~dysplasia,Malouf~syndrome,Lipodystrophy~familial~partial~type~2,Hutchinson-Gilford~progeria,Heart-hand~syndrome~Slovenian~type,Emery-Dreifuss~muscular~dystrophy~3~AR,Emery-Dreifuss~muscular~dystrophy~2~AD,Charcot-Marie-Tooth~disease~type~2B1,Cardiomyopathy~dilated~1A	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AD,AR,AD,AD,AR/AD,AD,AR,AD,AR,AD	NA	NA	NA	NA	NA	L	D/D/D/D/D	1	4.69	./LMNA_HUMAN/.	P	D	4.69	545,644,614	34	0.852	D	Lmna	N	1.03E-03	9.961075725	-0.911109353	abnormal	1.00909	4000	lmna	caspasePathway/fasPathway/HivnefPathway/deathPathway/tnfr1Pathway	32.23482	134	NA	LMNA	KP_EP	AD	150330	LMNA
chr1	156154662	rs149711133	G	A	PASS	A	synonymous_variant	LOW	SEMA4A	ENSG00000196189	transcript	ENST00000355014.6	c.84G>A	p.Thr28Thr	2/15	188/3137	28/761	84/2286	NA	NA	NA	NA	0.0005528	0.000399361	0.999601	2503,0	0	0.000199681	255|0|0	not_specified|Retinitis_Pigmentosa\x2c_Recessive|Cone-Rod_Dystrophy\x2c_Recessive	CN169374|CN239466|CN239309	MedGen|MedGen|MedGen	NA	NA	610282(3),610283(3)	NA	Retinitis~pigmentosa~35,Cone-rod~dystrophy~10	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Sema4a	N	8.95E-01	55.75607455	0.023941474	abnormal	4.62858	64218	sema4aa	NA	510.94958	134	NA	NA	NA	NA	NA	NA
chr1	156176849	rs41265017	G	A	PASS	A	missense_variant	MODERATE	SEMA4A	ENSG00000196189	transcript	ENST00000355014.6	c.2138G>A	p.Arg713Gln	15/15	2242/3137	713/761	2138/2286	NA	NA	NA	NA	0.035	0.0379393	0.959265	2402,7	0.00279553	0.0217652	5|2|3|3	Retinitis_pigmentosa_35|not_specified|Cone-Rod_Dystrophy\x2c_Recessive|Retinitis_Pigmentosa\x2c_Recessive	C1853214:610282|CN169374|CN239309|CN239466	MedGen:OMIM|MedGen|MedGen|MedGen	NA	2	610282(3),610283(3)	NA	Retinitis~pigmentosa~35,Cone-rod~dystrophy~10	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AR	NA	NA	NA	NA	NA	M	P/P/P/P/P/P	0.944	4.16	./SEM4A_HUMAN	B	B	5.18	581,713	21.0	0.996	T/T/T/./T	Sema4a	N	8.95E-01	55.75607455	0.023941474	abnormal	4.62858	64218	sema4aa	NA	510.94958	127	NA	NA	NA	NA	NA	NA
chr1	156243466	rs759330	G	A	PASS	A	3_prime_UTR_variant	MODIFIER	PAQR6	ENSG00000160781	transcript	ENST00000340183.9	c.*663C>T	NA	5/5	NA	NA	NA	663	WARNING_TRANSCRIPT_NO_START_CODON	NA	NA	NA	0.335064	0.0595048	149,1516	0.605431	0.772963	255	Calcium_oxalate_urolithiasis	C1833683:167030:444717006	MedGen:OMIM:SNOMED_CT	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Paqr6	NA	8.36E-01	34.59542345	-0.26993514	NA	2.01985	79957	NA	NA	88.63888	86	L4_A_Mam|LINE|RTE-X	NA	NA	NA	NA	NA
chr1	156243466	rs759330	G	A	PASS	A	downstream_gene_variant	MODIFIER	BGLAP	ENSG00000242252	transcript	ENST00000368272.4	c.*304G>A	NA	NA	NA	NA	NA	145	NA	NA	NA	NA	0.335064	0.0595048	149,1516	0.605431	0.772963	255	Calcium_oxalate_urolithiasis	C1833683:167030:444717006	MedGen:OMIM:SNOMED_CT	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Paqr6	NA	8.36E-01	34.59542345	-0.26993514	NA	2.01985	79957	NA	NA	88.63888	86	L4_A_Mam|LINE|RTE-X	NA	NA	NA	NA	NA
chr1	156243466	rs759330	G	A	PASS	A	downstream_gene_variant	MODIFIER	PMF1	ENSG00000160783	transcript	ENST00000368273.8	c.*3865G>A	NA	NA	NA	NA	NA	3615	NA	NA	NA	NA	0.335064	0.0595048	149,1516	0.605431	0.772963	255	Calcium_oxalate_urolithiasis	C1833683:167030:444717006	MedGen:OMIM:SNOMED_CT	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Paqr6	NA	8.36E-01	34.59542345	-0.26993514	NA	2.01985	79957	NA	NA	88.63888	86	L4_A_Mam|LINE|RTE-X	NA	NA	NA	NA	NA
chr1	156243466	rs759330	G	A	PASS	A	downstream_gene_variant	MODIFIER	PMF1-BGLAP	ENSG00000260238	transcript	ENST00000368276.8	c.*383G>A	NA	NA	NA	NA	NA	203	NA	NA	NA	NA	0.335064	0.0595048	149,1516	0.605431	0.772963	255	Calcium_oxalate_urolithiasis	C1833683:167030:444717006	MedGen:OMIM:SNOMED_CT	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Paqr6	NA	8.36E-01	34.59542345	-0.26993514	NA	2.01985	79957	NA	NA	88.63888	86	L4_A_Mam|LINE|RTE-X	NA	NA	NA	NA	NA
chr1	156864395	rs79678945	G	A	PASS	A	missense_variant	MODERATE	NTRK1	ENSG00000198400	transcript	ENST00000524377.5	c.254G>A	p.Arg85His	2/17	295/2432	85/796	254/2391	NA	NA	NA	NA	0.000766	0.00599042	0.99401	2489,0	0	0.00299521	255	not_specified	CN169374	MedGen	NA	NA	155240(3),256800(3)	NA	Medullary~thyroid~carcinoma~familial,Insensitivity~to~pain~congenital~with~anhidrosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR	NA	NA	NA	NA	NA	N	N/N/N/N	0.013	-1.04	././NTRK1_HUMAN/.	B	B	4.61	85,85,85,55	15.71	-0.768	T	Ntrk1	E	3.95E-02	48.90894079	-0.058785319	NA	5.50883	4914	NA	erk5Pathway/trkaPathway/actinYPathway	774.82794	131	NA	NA	NA	NA	NA	NTRK1
chr1	156879126	rs6336	C	T	PASS	T	missense_variant	MODERATE	NTRK1	ENSG00000198400	transcript	ENST00000524377.5	c.1810C>T	p.His604Tyr	15/17	1851/2432	604/796	1810/2391	NA	NA	NA	NA	0.042	0.043131	0.954073	2389,7	0.00279553	0.024361	5|5|255	Familial_medullary_thyroid_carcinoma|Hereditary_insensitivity_to_pain_with_anhidrosis|Hereditary_insensitivity_to_pain_with_anhidrosis	C1833921:155240:ORPHA99361|C0020074:256800:ORPHA642:62985007|C0020074:256800:ORPHA642:62985007	MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT	NA	2	155240(3),256800(3)	NA	Medullary~thyroid~carcinoma~familial,Insensitivity~to~pain~congenital~with~anhidrosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR	NA	NA	NA	NA	NA	L	A/A/A/A	0.994	4.37	././NTRK1_HUMAN/.	D/P/P/D	D	4.37	601,598,604,568	27.8	0.935	D	Ntrk1	E	3.95E-02	48.90894079	-0.058785319	NA	5.50883	4914	NA	erk5Pathway/trkaPathway/actinYPathway	774.82794	52	NA	NA	NA	NA	NA	NTRK1
chr1	156879154	rs6339	G	T	PASS	T	missense_variant	MODERATE	NTRK1	ENSG00000198400	transcript	ENST00000524377.5	c.1838G>T	p.Gly613Val	15/17	1879/2432	613/796	1838/2391	NA	NA	NA	NA	0.042	0.0435304	0.955272	2392,3	0.00119808	0.0229633	5|5|255|2	Familial_medullary_thyroid_carcinoma|Hereditary_insensitivity_to_pain_with_anhidrosis|Hereditary_insensitivity_to_pain_with_anhidrosis|not_specified	C1833921:155240:ORPHA99361|C0020074:256800:ORPHA642:62985007|C0020074:256800:ORPHA642:62985007|CN169374	MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	3	155240(3),256800(3)	NA	Medullary~thyroid~carcinoma~familial,Insensitivity~to~pain~congenital~with~anhidrosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR	NA	NA	NA	NA	NA	L	A/A/A/A	0.755	3.44	././NTRK1_HUMAN/.	B	B/B/B/P	4.37	610,607,613,577	22.0	1.048	D	Ntrk1	E	3.95E-02	48.90894079	-0.058785319	NA	5.50883	4914	NA	erk5Pathway/trkaPathway/actinYPathway	774.82794	52	NA	NA	NA	NA	NA	NTRK1
chr1	156879336	rs80356677	G	T	PASS	T	missense_variant	MODERATE	NTRK1	ENSG00000198400	transcript	ENST00000524377.5	c.2020G>T	p.Asp674Tyr	15/17	2061/2432	674/796	2020/2391	NA	NA	NA	NA	8.237e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Hereditary_insensitivity_to_pain_with_anhidrosis	C0020074:256800:ORPHA642:62985007	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	155240(3),256800(3)	NA	Medullary~thyroid~carcinoma~familial,Insensitivity~to~pain~congenital~with~anhidrosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR	NA	NA	NA	NA	NA	L	A/A/A/A	1	4.13	././NTRK1_HUMAN/.	D/D/P/D	D	4.13	671,668,674,638	29.3	0.974	D	Ntrk1	E	3.95E-02	48.90894079	-0.058785319	NA	5.50883	4914	NA	erk5Pathway/trkaPathway/actinYPathway	774.82794	131	NA	NA	NA	NA	NA	NTRK1
chr1	156881590	rs35669708	G	A	PASS	A	missense_variant	MODERATE	NTRK1	ENSG00000198400	transcript	ENST00000524377.5	c.2339G>A	p.Arg780Gln	17/17	2380/2432	780/796	2339/2391	NA	NA	NA	NA	0.004887	0.00678914	0.992812	2486,1	0.000399361	0.00379393	3|0,5	not_provided|not_specified,Hereditary_insensitivity_to_pain_with_anhidrosis	CN221809|CN169374,C0020074:256800:ORPHA642:62985007	MedGen|MedGen,MedGen:OMIM:Orphanet:SNOMED_CT	NA	1	155240(3),256800(3)	NA	Medullary~thyroid~carcinoma~familial,Insensitivity~to~pain~congenital~with~anhidrosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR	NA	NA	NA	NA	NA	N	N/N/N/N	0.226	4.1	././NTRK1_HUMAN/.	B	B/B/P/B	5.01	777,774,780,744	10.14	1.048	T	Ntrk1	E	3.95E-02	48.90894079	-0.058785319	NA	5.50883	4914	NA	erk5Pathway/trkaPathway/actinYPathway	774.82794	126	NA	NA	NA	NA	NA	NTRK1
chr1	158654738	rs35948326	G	T	PASS	T	missense_variant	MODERATE	SPTA1	ENSG00000163554	transcript	ENST00000368147.8	c.2909C>A	p.Ala970Asp	21/52	3090/7999	970/2419	2909/7260	NA	NA	NA	NA	0.033	0.0259585	0.972843	2436,3	0.00119808	0.0141773	5|3|3	Spherocytosis\x2c_type_3\x2c_autosomal_recessive|not_specified|Spherocytosis\x2c_Recessive	C4016379|CN169374|CN239472	MedGen|MedGen|MedGen	NA	1	270970(3),266140(3),130600(3)	NA	Spherocytosis~type~3,Pyropoikilocytosis,Elliptocytosis-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AD	NA	NA	NA	NA	NA	L	A/A	0.011	5.22	SPTA1_HUMAN	B	B	5.22	970	24.4	0.994	T/.	Spta1	E	8.06E-01	99.79358339	4.849637631	NA	19.05718	6708	NA	NA	7837.04606	126	NA	NA	NA	NA	NA	NA
chr1	158662793	rs7418956	G	T	PASS	T	missense_variant	MODERATE	SPTA1	ENSG00000163554	transcript	ENST00000368147.8	c.2373C>A	p.Asp791Glu	17/52	2554/7999	791/2419	2373/7260	NA	NA	NA	NA	0.004311	0.0259585	0.973642	2438,1	0.000399361	0.0133786	5|3|3|3	Elliptocytosis_2|Elliptocytosis|Hereditary_pyropoikilocytosis|Spherocytosis\x2c_Recessive	C1851741:130600|HP:0004445:C0427480|C0520739:266140:9434008|CN239472	MedGen:OMIM|Human_Phenotype_Ontology:MedGen|MedGen:OMIM:SNOMED_CT|MedGen	NA	NA	270970(3),266140(3),130600(3)	NA	Spherocytosis~type~3,Pyropoikilocytosis,Elliptocytosis-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AD	NA	NA	NA	NA	NA	M	A/A	0.245	1.43	SPTA1_HUMAN	P	P	4.41	791	18.83	0.067	T/.	Spta1	E	8.06E-01	99.79358339	4.849637631	NA	19.05718	6708	NA	NA	7837.04606	116	NA	NA	NA	NA	NA	NA
chr1	158678432	rs121918636	A	G	PASS	G	missense_variant	MODERATE	SPTA1	ENSG00000163554	transcript	ENST00000368147.8	c.781T>C	p.Ser261Pro	6/52	962/7999	261/2419	781/7260	NA	NA	NA	NA	1.655e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Elliptocytosis_2	C1851741:130600	MedGen:OMIM	NA	NA	270970(3),266140(3),130600(3)	NA	Spherocytosis~type~3,Pyropoikilocytosis,Elliptocytosis-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AD	NA	NA	NA	NA	NA	M	A/A	0.049	3.51	SPTA1_HUMAN	P	D	4.66	261	22.9	1.199	T/./.	Spta1	E	8.06E-01	99.79358339	4.849637631	NA	19.05718	6708	NA	NA	7837.04606	133	NA	NA	NA	NA	NA	NA
chr1	158680641	rs121918643	A	G	PASS	G	missense_variant	MODERATE	SPTA1	ENSG00000163554	transcript	ENST00000368147.8	c.620T>C	p.Leu207Pro	5/52	801/7999	207/2419	620/7260	NA	NA	NA	NA	8.276e-05	0.00119808	0.998802	2501,0	0	0.000599042	5|5	Hereditary_pyropoikilocytosis|Elliptocytosis_2	C0520739:266140:9434008|C1851741:130600	MedGen:OMIM:SNOMED_CT|MedGen:OMIM	NA	NA	270970(3),266140(3),130600(3)	NA	Spherocytosis~type~3,Pyropoikilocytosis,Elliptocytosis-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AD	NA	NA	NA	NA	NA	M	A/A	0.582	5.25	SPTA1_HUMAN	D	D	5.25	207	27.2	1.199	D/.	Spta1	E	8.06E-01	99.79358339	4.849637631	NA	19.05718	6708	NA	NA	7837.04606	133	NA	NA	NA	NA	NA	NA
chr1	158681595	rs757679761	G	GCAA	PASS	GCAA	conservative_inframe_insertion	MODERATE	SPTA1	ENSG00000163554	transcript	ENST00000368147.8	c.460_462dupTTG	p.Leu154dup	4/52	643/7999	154/2419	462/7260	NA	NA	NA	NA	8.267e-05	NA	NA	NA	NA	NA	5	Elliptocytosis_2	C1851741:130600	MedGen:OMIM	NA	NA	270970(3),266140(3),130600(3)	NA	Spherocytosis~type~3,Pyropoikilocytosis,Elliptocytosis-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Spta1	E	8.06E-01	99.79358339	4.849637631	NA	19.05718	6708	NA	NA	7837.04606	144	NA	NA	NA	NA	NA	NA
chr1	158685251	rs121918640	G	T	PASS	T	protein_protein_contact	HIGH	SPTA1	ENSG00000163554	interaction	3LBX:A_41-B_2029:ENST00000368147-ENST00000389722	c.121C>A	NA	2/52	NA	NA	NA	NA	NA	NA	NA	0.0001655	0.000798722	0.999201	2502,0	0	0.000399361	5	Elliptocytosis_2	C1851741:130600	MedGen:OMIM	NA	NA	270970(3),266140(3),130600(3)	NA	Spherocytosis~type~3,Pyropoikilocytosis,Elliptocytosis-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Spta1	E	8.06E-01	99.79358339	4.849637631	NA	19.05718	6708	NA	NA	7837.04606	133	NA	NA	NA	NA	NA	NA
chr1	158685251	rs121918640	G	T	PASS	T	synonymous_variant	LOW	SPTA1	ENSG00000163554	transcript	ENST00000368147.8	c.121C>A	p.Arg41Arg	2/52	302/7999	41/2419	121/7260	NA	NA	NA	NA	0.0001655	0.000798722	0.999201	2502,0	0	0.000399361	5	Elliptocytosis_2	C1851741:130600	MedGen:OMIM	NA	NA	270970(3),266140(3),130600(3)	NA	Spherocytosis~type~3,Pyropoikilocytosis,Elliptocytosis-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Spta1	E	8.06E-01	99.79358339	4.849637631	NA	19.05718	6708	NA	NA	7837.04606	133	NA	NA	NA	NA	NA	NA
chr1	158685289	rs121918641	C	T	PASS	T	missense_variant	MODERATE	SPTA1	ENSG00000163554	transcript	ENST00000368147.8	c.83G>A	p.Arg28His	2/52	264/7999	28/2419	83/7260	NA	NA	NA	NA	2.483e-05	0.000798722	0.999201	2502,0	0	0.000399361	5,5|5|5	Elliptocytosis_2,Elliptocytosis_2|Hereditary_pyropoikilocytosis|not_provided	C1851741:130600,C1851741:130600|C0520739:266140:9434008|CN221809	MedGen:OMIM,MedGen:OMIM|MedGen:OMIM:SNOMED_CT|MedGen	NA	2	270970(3),266140(3),130600(3)	NA	Spherocytosis~type~3,Pyropoikilocytosis,Elliptocytosis-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AD	NA	NA	NA	NA	NA	M	D/D	0.683	4.98	SPTA1_HUMAN	D	D	4.98	28	34	0.892	D/./.	Spta1	E	8.06E-01	99.79358339	4.849637631	NA	19.05718	6708	NA	NA	7837.04606	133	NA	NA	NA	NA	NA	NA
chr1	159204893	rs2814778	T	C	PASS	C	upstream_gene_variant	MODIFIER	CADM3-AS1	ENSG00000225670	transcript	ENST00000415675.3	n.-2381A>G	NA	NA	NA	NA	NA	2381	NA	NA	NA	NA	0.0351438	0.716054	1793,623	0.248802	0.266374	5|255|255	DUFFY_BLOOD_GROUP_SYSTEM\x2c_FY(a-b-)_PHENOTYPE|Plasmodium_vivax\x2c_resistance_to|White_blood_cell_count_quantitative_trait_locus_1	.|C1970105|C2676078:611862	.|MedGen|MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	-,-	NA	611862(3),110700(3),110700(3)	NA	[White~blood~cell~count~QTL],[Blood~group~Duffy~system],[Blood~group~Duffy~system]	-,AD,AD	611162(3),611162(3)	NA	NA	NA	NA	NA	{Malaria~vivax~protection~against},{Malaria~vivax~protection~against}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	./Ackr1	./N	NA	./71.40835103	./0.284856336	NA	NA	100131825/2532	NA	NA	NA	100	NA	NA	NA	NA	NA	NA
chr1	159204893	rs2814778	T	C	PASS	C	upstream_gene_variant	MODIFIER	ACKR1	ENSG00000213088	transcript	ENST00000368121.3	c.-541T>C	NA	NA	NA	NA	NA	366	NA	NA	NA	NA	0.0351438	0.716054	1793,623	0.248802	0.266374	5|255|255	DUFFY_BLOOD_GROUP_SYSTEM\x2c_FY(a-b-)_PHENOTYPE|Plasmodium_vivax\x2c_resistance_to|White_blood_cell_count_quantitative_trait_locus_1	.|C1970105|C2676078:611862	.|MedGen|MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	-,-	NA	611862(3),110700(3),110700(3)	NA	[White~blood~cell~count~QTL],[Blood~group~Duffy~system],[Blood~group~Duffy~system]	-,AD,AD	611162(3),611162(3)	NA	NA	NA	NA	NA	{Malaria~vivax~protection~against},{Malaria~vivax~protection~against}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	./Ackr1	./N	NA	./71.40835103	./0.284856336	NA	NA	100131825/2532	NA	NA	NA	100	NA	NA	NA	NA	NA	NA
chr1	159204893	rs2814778	T	C	PASS	C	downstream_gene_variant	MODIFIER	CADM3	ENSG00000162706	transcript	ENST00000368124.8	c.*3971T>C	NA	NA	NA	NA	NA	2881	NA	NA	NA	NA	0.0351438	0.716054	1793,623	0.248802	0.266374	5|255|255	DUFFY_BLOOD_GROUP_SYSTEM\x2c_FY(a-b-)_PHENOTYPE|Plasmodium_vivax\x2c_resistance_to|White_blood_cell_count_quantitative_trait_locus_1	.|C1970105|C2676078:611862	.|MedGen|MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	-,-	NA	611862(3),110700(3),110700(3)	NA	[White~blood~cell~count~QTL],[Blood~group~Duffy~system],[Blood~group~Duffy~system]	-,AD,AD	611162(3),611162(3)	NA	NA	NA	NA	NA	{Malaria~vivax~protection~against},{Malaria~vivax~protection~against}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	./Ackr1	./N	NA	./71.40835103	./0.284856336	NA	NA	100131825/2532	NA	NA	NA	100	NA	NA	NA	NA	NA	NA
chr1	159204893	rs2814778	T	C	PASS	C	intragenic_variant	MODIFIER	CADM3-AS1	ENSG00000225670	gene_variant	ENSG00000225670	n.159204893A>G	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0351438	0.716054	1793,623	0.248802	0.266374	5|255|255	DUFFY_BLOOD_GROUP_SYSTEM\x2c_FY(a-b-)_PHENOTYPE|Plasmodium_vivax\x2c_resistance_to|White_blood_cell_count_quantitative_trait_locus_1	.|C1970105|C2676078:611862	.|MedGen|MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	-,-	NA	611862(3),110700(3),110700(3)	NA	[White~blood~cell~count~QTL],[Blood~group~Duffy~system],[Blood~group~Duffy~system]	-,AD,AD	611162(3),611162(3)	NA	NA	NA	NA	NA	{Malaria~vivax~protection~against},{Malaria~vivax~protection~against}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	./Ackr1	./N	NA	./71.40835103	./0.284856336	NA	NA	100131825/2532	NA	NA	NA	100	NA	NA	NA	NA	NA	NA
chr1	159204893	rs2814778	T	C	PASS	C	intragenic_variant	MODIFIER	ACKR1	ENSG00000213088	gene_variant	ENSG00000213088	n.159204893T>C	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0351438	0.716054	1793,623	0.248802	0.266374	5|255|255	DUFFY_BLOOD_GROUP_SYSTEM\x2c_FY(a-b-)_PHENOTYPE|Plasmodium_vivax\x2c_resistance_to|White_blood_cell_count_quantitative_trait_locus_1	.|C1970105|C2676078:611862	.|MedGen|MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	-,-	NA	611862(3),110700(3),110700(3)	NA	[White~blood~cell~count~QTL],[Blood~group~Duffy~system],[Blood~group~Duffy~system]	-,AD,AD	611162(3),611162(3)	NA	NA	NA	NA	NA	{Malaria~vivax~protection~against},{Malaria~vivax~protection~against}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	./Ackr1	./N	NA	./71.40835103	./0.284856336	NA	NA	100131825/2532	NA	NA	NA	100	NA	NA	NA	NA	NA	NA
chr1	159205704	rs34599082	C	T	PASS	T	missense_variant	MODERATE	ACKR1	ENSG00000213088	transcript	ENST00000368121.3	c.271C>T	p.Arg91Cys	1/1	446/1240	91/338	271/1017	NA	NA	NA	NA	0.011	0.0091853	0.990815	2481,0	0	0.00459265	5	DUFFY_BLOOD_GROUP_SYSTEM\x2c_FY(bwk)_PHENOTYPE	.	.	NA	NA	NA	NA	NA	NA	NA	-,-	NA	611862(3),110700(3),110700(3)	NA	[White~blood~cell~count~QTL],[Blood~group~Duffy~system],[Blood~group~Duffy~system]	-,AD,AD	611162(3),611162(3)	NA	NA	NA	NA	NA	{Malaria~vivax~protection~against},{Malaria~vivax~protection~against}	L	A/A/A/A	0.979	2.98	./DUFFY_HUMAN	P	D	4.96	91,89	24.2	0.935	T	./Ackr1	./N	NA	./71.40835103	./0.284856336	NA	NA	100131825/2532	NA	NA	NA	126	NA	NA	NA	NA	NA	NA
chr1	159205704	rs34599082	C	T	PASS	T	upstream_gene_variant	MODIFIER	CADM3-AS1	ENSG00000225670	transcript	ENST00000415675.3	n.-3192G>A	NA	NA	NA	NA	NA	3192	NA	NA	NA	0.011	0.0091853	0.990815	2481,0	0	0.00459265	5	DUFFY_BLOOD_GROUP_SYSTEM\x2c_FY(bwk)_PHENOTYPE	.	.	NA	NA	NA	NA	NA	NA	NA	-,-	NA	611862(3),110700(3),110700(3)	NA	[White~blood~cell~count~QTL],[Blood~group~Duffy~system],[Blood~group~Duffy~system]	-,AD,AD	611162(3),611162(3)	NA	NA	NA	NA	NA	{Malaria~vivax~protection~against},{Malaria~vivax~protection~against}	L	A/A/A/A	0.979	2.98	./DUFFY_HUMAN	P	D	4.96	91,89	24.2	0.935	T	./Ackr1	./N	NA	./71.40835103	./0.284856336	NA	NA	100131825/2532	NA	NA	NA	126	NA	NA	NA	NA	NA	NA
chr1	159205704	rs34599082	C	T	PASS	T	downstream_gene_variant	MODIFIER	CADM3	ENSG00000162706	transcript	ENST00000368124.8	c.*4782C>T	NA	NA	NA	NA	NA	3692	NA	NA	NA	0.011	0.0091853	0.990815	2481,0	0	0.00459265	5	DUFFY_BLOOD_GROUP_SYSTEM\x2c_FY(bwk)_PHENOTYPE	.	.	NA	NA	NA	NA	NA	NA	NA	-,-	NA	611862(3),110700(3),110700(3)	NA	[White~blood~cell~count~QTL],[Blood~group~Duffy~system],[Blood~group~Duffy~system]	-,AD,AD	611162(3),611162(3)	NA	NA	NA	NA	NA	{Malaria~vivax~protection~against},{Malaria~vivax~protection~against}	L	A/A/A/A	0.979	2.98	./DUFFY_HUMAN	P	D	4.96	91,89	24.2	0.935	T	./Ackr1	./N	NA	./71.40835103	./0.284856336	NA	NA	100131825/2532	NA	NA	NA	126	NA	NA	NA	NA	NA	NA
chr1	159205704	rs34599082	C	T	PASS	T	intragenic_variant	MODIFIER	CADM3-AS1	ENSG00000225670	gene_variant	ENSG00000225670	n.159205704G>A	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.011	0.0091853	0.990815	2481,0	0	0.00459265	5	DUFFY_BLOOD_GROUP_SYSTEM\x2c_FY(bwk)_PHENOTYPE	.	.	NA	NA	NA	NA	NA	NA	NA	-,-	NA	611862(3),110700(3),110700(3)	NA	[White~blood~cell~count~QTL],[Blood~group~Duffy~system],[Blood~group~Duffy~system]	-,AD,AD	611162(3),611162(3)	NA	NA	NA	NA	NA	{Malaria~vivax~protection~against},{Malaria~vivax~protection~against}	L	A/A/A/A	0.979	2.98	./DUFFY_HUMAN	P	D	4.96	91,89	24.2	0.935	T	./Ackr1	./N	NA	./71.40835103	./0.284856336	NA	NA	100131825/2532	NA	NA	NA	126	NA	NA	NA	NA	NA	NA
chr1	160041491	rs137853074	G	A	PASS	A	missense_variant	MODERATE	KCNJ10	ENSG00000177807	transcript	ENST00000368089.3	c.1042C>T	p.Arg348Cys	2/2	1269/5293	348/379	1042/1140	NA	NA	NA	NA	0.0002389	0.00119808	0.998802	2501,0	0	0.000599042	5|0	Enlarged_vestibular_aqueduct_syndrome|not_specified	C1863752:600791|CN169374	MedGen:OMIM|MedGen	NA	1	612780(3),600791(3)	NA	SESAME~syndrome,Enlarged~vestibular~aqueduct~digenic	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	L	A	0.969	4.18	IRK10_HUMAN	P	D	5.09	348	23.6	1.048	D	Kcnj10	E	8.34E-02	64.51403633	0.150760231	abnormal	3.46792	3766	kcnj10b	NA	260.8417	133	NA	NA	NA	NA	NA	NA
chr1	160041722	rs1130183	G	A	PASS	A	missense_variant	MODERATE	KCNJ10	ENSG00000177807	transcript	ENST00000368089.3	c.811C>T	p.Arg271Cys	2/2	1038/5293	271/379	811/1140	NA	NA	NA	NA	0.046	0.0255591	0.972444	2435,5	0.00199681	0.0147764	255	not_specified	CN169374	MedGen	NA	NA	612780(3),600791(3)	NA	SESAME~syndrome,Enlarged~vestibular~aqueduct~digenic	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	L	D	0.988	5.44	IRK10_HUMAN	P	D	5.44	271	29.8	1.048	D	Kcnj10	E	8.34E-02	64.51403633	0.150760231	abnormal	3.46792	3766	kcnj10b	NA	260.8417	86	NA	NA	NA	NA	NA	NA
chr1	160042480	rs115466046	C	T	PASS	T	missense_variant	MODERATE	KCNJ10	ENSG00000177807	transcript	ENST00000368089.3	c.53G>A	p.Arg18Gln	2/2	280/5293	18/379	53/1140	NA	NA	NA	NA	0.013	0.00878594	0.991214	2482,0	0	0.00439297	255|2	not_specified|SeSAME_syndrome	CN169374|C2748572:612780:ORPHA199343	MedGen|MedGen:OMIM:Orphanet	NA	NA	612780(3),600791(3)	NA	SESAME~syndrome,Enlarged~vestibular~aqueduct~digenic	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	L	D	0.996	5.17	IRK10_HUMAN	B	P	5.17	18	22.6	0.807	T	Kcnj10	E	8.34E-02	64.51403633	0.150760231	abnormal	3.46792	3766	kcnj10b	NA	260.8417	132	NA	NA	NA	NA	NA	NA
chr1	160120918	rs55858252	T	A	PASS	A	missense_variant	MODERATE	ATP1A2	ENSG00000018625	transcript	ENST00000361216.7	c.25T>A	p.Tyr9Asn	2/23	114/5421	9/1020	25/3063	NA	NA	NA	NA	0.001362	0.000798722	0.999201	2502,0	0	0.000399361	255|3|3	not_specified|Familial_hemiplegic_migraine|Alternating_hemiplegia_of_childhood	CN169374|C0338484:ORPHA569:95656000|C0338488:ORPHA2131:230466004	MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	602481(3),602481(3),104290(3)	NA	Migraine~familial~hemiplegic~2,Migraine~familial~basilar,Alternating~hemiplegia~of~childhood	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD	NA	NA	NA	NA	NA	L	D/D	0.996	4.46	AT1A2_HUMAN	B	B	4.46	9	18.10	0.964	T	Atp1a2	E	1.05E-01	4.429110639	-1.374132436	abnormal	1.35867	477	atp1a2a	NA	48.50463	129	NA	NA	NA	NA	NA	NA
chr1	160121203	rs61734527	G	A	PASS	A	synonymous_variant	LOW	ATP1A2	ENSG00000018625	transcript	ENST00000361216.7	c.129G>A	p.Lys43Lys	3/23	218/5421	43/1020	129/3063	NA	NA	NA	NA	0.002298	0.0131789	0.986821	2471,0	0	0.00658946	255|2	not_specified|Familial_hemiplegic_migraine	CN169374|C0338484:ORPHA569:95656000	MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	602481(3),602481(3),104290(3)	NA	Migraine~familial~hemiplegic~2,Migraine~familial~basilar,Alternating~hemiplegia~of~childhood	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Atp1a2	E	1.05E-01	4.429110639	-1.374132436	abnormal	1.35867	477	atp1a2a	NA	48.50463	129	NA	NA	NA	NA	NA	NA
chr1	160123375	rs116711766	G	A	PASS	A	missense_variant	MODERATE	ATP1A2	ENSG00000018625	transcript	ENST00000361216.7	c.340G>A	p.Gly114Ser	4/23	429/5421	114/1020	340/3063	NA	NA	NA	NA	0.0007001	0.00199681	0.998003	2499,0	0	0.000998403	255	not_specified	CN169374	MedGen	NA	NA	602481(3),602481(3),104290(3)	NA	Migraine~familial~hemiplegic~2,Migraine~familial~basilar,Alternating~hemiplegia~of~childhood	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD	NA	NA	NA	NA	NA	L	D/D	0.997	5.06	AT1A2_HUMAN	B	B	5.06	114	22.8	0.953	T	Atp1a2	E	1.05E-01	4.429110639	-1.374132436	abnormal	1.35867	477	atp1a2a	NA	48.50463	134	NA	NA	NA	NA	NA	NA
chr1	160127639	rs373178892	G	A	PASS	A	missense_variant	MODERATE	ATP1A2	ENSG00000018625	transcript	ENST00000361216.7	c.836G>A	p.Arg279Gln	8/23	925/5421	279/1020	836/3063	NA	NA	NA	NA	0.0001647	0.000399361	0.999601	2503,0	0	0.000199681	255	not_specified	CN169374	MedGen	NA	1	602481(3),602481(3),104290(3)	NA	Migraine~familial~hemiplegic~2,Migraine~familial~basilar,Alternating~hemiplegia~of~childhood	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD	NA	NA	NA	NA	NA	N	N/N	0.948	2.34	././AT1A2_HUMAN	B	B	4.89	124,179,279	20.6	0.091	T	Atp1a2	E	1.05E-01	4.429110639	-1.374132436	abnormal	1.35867	477	atp1a2a	NA	48.50463	138	NA	NA	NA	NA	NA	NA
chr1	160128753	rs1063125	G	A	PASS	A	synonymous_variant	LOW	ATP1A2	ENSG00000018625	transcript	ENST00000361216.7	c.1119G>A	p.Ser373Ser	9/23	1208/5421	373/1020	1119/3063	NA	NA	NA	NA	0.199	0.306709	0.636981	1595,141	0.0563099	0.209665	255|2|2	not_specified|Alternating_hemiplegia_of_childhood|Familial_hemiplegic_migraine	CN169374|C0338488:ORPHA2131:230466004|C0338484:ORPHA569:95656000	MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	602481(3),602481(3),104290(3)	NA	Migraine~familial~hemiplegic~2,Migraine~familial~basilar,Alternating~hemiplegia~of~childhood	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Atp1a2	E	1.05E-01	4.429110639	-1.374132436	abnormal	1.35867	477	atp1a2a	NA	48.50463	86	NA	NA	NA	NA	NA	NA
chr1	160130474	rs17846714	C	T	PASS	T	synonymous_variant	LOW	ATP1A2	ENSG00000018625	transcript	ENST00000361216.7	c.1704C>T	p.Phe568Phe	13/23	1793/5421	568/1020	1704/3063	NA	NA	NA	NA	0.03	0.053115	0.945687	2368,3	0.00119808	0.0277556	255|3|3	not_specified|Alternating_hemiplegia_of_childhood|Familial_hemiplegic_migraine	CN169374|C0338488:ORPHA2131:230466004|C0338484:ORPHA569:95656000	MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	602481(3),602481(3),104290(3)	NA	Migraine~familial~hemiplegic~2,Migraine~familial~basilar,Alternating~hemiplegia~of~childhood	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Atp1a2	E	1.05E-01	4.429110639	-1.374132436	abnormal	1.35867	477	atp1a2a	NA	48.50463	123	NA	NA	NA	NA	NA	NA
chr1	160135160	rs61734529	C	T	PASS	T	synonymous_variant	LOW	ATP1A2	ENSG00000018625	transcript	ENST00000361216.7	c.1980C>T	p.Cys660Cys	15/23	2069/5421	660/1020	1980/3063	NA	NA	NA	NA	0.006391	0.0399361	0.959265	2402,2	0.000798722	0.0207668	255|3|3	not_specified|Familial_hemiplegic_migraine|Alternating_hemiplegia_of_childhood	CN169374|C0338484:ORPHA569:95656000|C0338488:ORPHA2131:230466004	MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	602481(3),602481(3),104290(3)	NA	Migraine~familial~hemiplegic~2,Migraine~familial~basilar,Alternating~hemiplegia~of~childhood	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Atp1a2	E	1.05E-01	4.429110639	-1.374132436	abnormal	1.35867	477	atp1a2a	NA	48.50463	129	NA	NA	NA	NA	NA	NA
chr1	160135577	rs17846715	C	T	PASS	T	synonymous_variant	LOW	ATP1A2	ENSG00000018625	transcript	ENST00000361216.7	c.2259C>T	p.Ala753Ala	16/23	2348/5421	753/1020	2259/3063	NA	NA	NA	NA	0.108	0.111821	0.88099	2206,18	0.0071885	0.063099	255|3|3	not_specified|Alternating_hemiplegia_of_childhood|Familial_hemiplegic_migraine	CN169374|C0338488:ORPHA2131:230466004|C0338484:ORPHA569:95656000	MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	602481(3),602481(3),104290(3)	NA	Migraine~familial~hemiplegic~2,Migraine~familial~basilar,Alternating~hemiplegia~of~childhood	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Atp1a2	E	1.05E-01	4.429110639	-1.374132436	abnormal	1.35867	477	atp1a2a	NA	48.50463	123	NA	NA	NA	NA	NA	NA
chr1	160136374	rs3747626	C	T	PASS	T	splice_region_variant&intron_variant	LOW	ATP1A2	ENSG00000018625	transcript	ENST00000361216.7	c.2563+4C>T	NA	18/22	NA	NA	NA	NA	NA	NA	NA	0.001408	0.00599042	0.99401	2489,0	0	0.00299521	255|3|3	not_specified|Familial_hemiplegic_migraine|Alternating_hemiplegia_of_childhood	CN169374|C0338484:ORPHA569:95656000|C0338488:ORPHA2131:230466004	MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	1	602481(3),602481(3),104290(3)	NA	Migraine~familial~hemiplegic~2,Migraine~familial~basilar,Alternating~hemiplegia~of~childhood	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Atp1a2	E	1.05E-01	4.429110639	-1.374132436	abnormal	1.35867	477	atp1a2a	NA	48.50463	107	NA	NA	NA	NA	NA	NA
chr1	160136942	rs146839867	G	A	PASS	A	synonymous_variant	LOW	ATP1A2	ENSG00000018625	transcript	ENST00000361216.7	c.2751G>A	p.Thr917Thr	20/23	2840/5421	917/1020	2751/3063	NA	NA	NA	NA	0.0009142	0.000798722	0.999201	2502,0	0	0.000399361	255|0|0	not_specified|Familial_hemiplegic_migraine|Alternating_hemiplegia_of_childhood	CN169374|C0338484:ORPHA569:95656000|C0338488:ORPHA2131:230466004	MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	602481(3),602481(3),104290(3)	NA	Migraine~familial~hemiplegic~2,Migraine~familial~basilar,Alternating~hemiplegia~of~childhood	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Atp1a2	E	1.05E-01	4.429110639	-1.374132436	abnormal	1.35867	477	atp1a2a	NA	48.50463	134	NA	NA	NA	NA	NA	NA
chr1	160837925	rs3766379	T	C	PASS	C	intron_variant	MODIFIER	CD244	ENSG00000122223	transcript	ENST00000368033.7	c.849+526A>G	NA	5/8	NA	NA	NA	NA	NA	NA	NA	NA	0.497604	0.189696	475,783	0.3127	0.561502	255	Rheumatoid_arthritis	C0003873:180300:69896004	MedGen:OMIM:SNOMED_CT	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	180300(3)	NA	NA	NA	NA	NA	{Rheumatoid~arthritis~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Cd244	N	7.27E-01	75.43052607	0.374860183	NA	1.87145	51744	NA	NA	78.66055	107	NA	NA	NA	NA	NA	NA
chr1	161039733	rs3737787	G	A	PASS	A	3_prime_UTR_variant	MODIFIER	USF1	ENSG00000158773	transcript	ENST00000368020.5	c.*187C>T	NA	11/11	NA	NA	NA	187	NA	NA	NA	NA	0.270367	0.694489	1739,88	0.0351438	0.170327	255	Hyperlipidemia\x2c_familial_combined\x2c_susceptibility_to	.	.	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	602491(3)	NA	NA	NA	NA	NA	{Hyperlipidemia~familial~combined~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Usf1	N	2.73E-01	26.23260203	-0.405853867	NA	0.26955	7391	NA	NA	7.16676	107	NA	NA	NA	NA	NA	NA
chr1	161039733	rs3737787	G	A	PASS	A	upstream_gene_variant	MODIFIER	RP11-544M22.13	ENSG00000270149	transcript	ENST00000289779.7	c.-844C>T	NA	NA	NA	NA	NA	789	NA	NA	NA	NA	0.270367	0.694489	1739,88	0.0351438	0.170327	255	Hyperlipidemia\x2c_familial_combined\x2c_susceptibility_to	.	.	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	602491(3)	NA	NA	NA	NA	NA	{Hyperlipidemia~familial~combined~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Usf1	N	2.73E-01	26.23260203	-0.405853867	NA	0.26955	7391	NA	NA	7.16676	107	NA	NA	NA	NA	NA	NA
chr1	161039733	rs3737787	G	A	PASS	A	upstream_gene_variant	MODIFIER	TSTD1	ENSG00000215845	transcript	ENST00000368023.7	c.-844C>T	NA	NA	NA	NA	NA	783	NA	NA	NA	NA	0.270367	0.694489	1739,88	0.0351438	0.170327	255	Hyperlipidemia\x2c_familial_combined\x2c_susceptibility_to	.	.	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	602491(3)	NA	NA	NA	NA	NA	{Hyperlipidemia~familial~combined~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Usf1	N	2.73E-01	26.23260203	-0.405853867	NA	0.26955	7391	NA	NA	7.16676	107	NA	NA	NA	NA	NA	NA
chr1	161039733	rs3737787	G	A	PASS	A	downstream_gene_variant	MODIFIER	RP11-544M22.3	ENSG00000232879	transcript	ENST00000433122.2	n.*4727G>A	NA	NA	NA	NA	NA	4727	NA	NA	NA	NA	0.270367	0.694489	1739,88	0.0351438	0.170327	255	Hyperlipidemia\x2c_familial_combined\x2c_susceptibility_to	.	.	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	602491(3)	NA	NA	NA	NA	NA	{Hyperlipidemia~familial~combined~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Usf1	N	2.73E-01	26.23260203	-0.405853867	NA	0.26955	7391	NA	NA	7.16676	107	NA	NA	NA	NA	NA	NA
chr1	161040972	rs2073658	C	T	PASS	T	upstream_gene_variant	MODIFIER	RP11-544M22.13	ENSG00000270149	transcript	ENST00000289779.7	c.-2083G>A	NA	NA	NA	NA	NA	2028	NA	NA	NA	NA	0.271965	0.692891	1735,88	0.0351438	0.171126	255	Hyperlipidemia\x2c_familial_combined\x2c_susceptibility_to	.	.	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	602491(3)	NA	NA	NA	NA	NA	{Hyperlipidemia~familial~combined~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Usf1	N	2.73E-01	26.23260203	-0.405853867	NA	0.26955	7391	NA	NA	7.16676	96	NA	NA	NA	NA	NA	NA
chr1	161040972	rs2073658	C	T	PASS	T	upstream_gene_variant	MODIFIER	TSTD1	ENSG00000215845	transcript	ENST00000368023.7	c.-2083G>A	NA	NA	NA	NA	NA	2022	NA	NA	NA	NA	0.271965	0.692891	1735,88	0.0351438	0.171126	255	Hyperlipidemia\x2c_familial_combined\x2c_susceptibility_to	.	.	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	602491(3)	NA	NA	NA	NA	NA	{Hyperlipidemia~familial~combined~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Usf1	N	2.73E-01	26.23260203	-0.405853867	NA	0.26955	7391	NA	NA	7.16676	96	NA	NA	NA	NA	NA	NA
chr1	161040972	rs2073658	C	T	PASS	T	intron_variant	MODIFIER	USF1	ENSG00000158773	transcript	ENST00000368020.5	c.561-100G>A	NA	7/10	NA	NA	NA	NA	NA	NA	NA	NA	0.271965	0.692891	1735,88	0.0351438	0.171126	255	Hyperlipidemia\x2c_familial_combined\x2c_susceptibility_to	.	.	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	602491(3)	NA	NA	NA	NA	NA	{Hyperlipidemia~familial~combined~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Usf1	N	2.73E-01	26.23260203	-0.405853867	NA	0.26955	7391	NA	NA	7.16676	96	NA	NA	NA	NA	NA	NA
chr1	161076355	rs267606991	C	T	PASS	T	missense_variant&splice_region_variant	MODERATE	NECTIN4	ENSG00000143217	transcript	ENST00000368012.3	c.851G>A	p.Arg284Gln	4/9	1154/3502	284/510	851/1533	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Ectodermal_dysplasia-syndactyly_syndrome_1	C3150807:613573:ORPHA247820	MedGen:OMIM:Orphanet	NA	NA	613573(3)	NA	Ectodermal~dysplasia-syndactyly~syndrome~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	-	NA	NA	NA	NA	NA	M	D/D	0.967	4.99	./PVRL4_HUMAN	D	D	4.99	18,284	28.7	0.935	D	Pvrl4	NA	NA	30.70299599	-0.334253673	NA	NA	81607	NA	NA	NA	137	NA	NA	NA	NA	NA	NA
chr1	161169143	rs12735723	C	G	PASS	G	missense_variant	MODERATE	PPOX	ENSG00000143224	transcript	ENST00000352210.9	c.767C>G	p.Pro256Arg	7/13	977/1686	256/477	767/1434	NA	NA	NA	NA	0.006647	0.00559105	0.994409	2490,0	0	0.00279553	5	Variegate_porphyria\x2c_homozygous	C0342860	MedGen	NA	1	176200(3)	NA	Porphyria~variegata	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	M	A/A/A/A/A	0.767	5.57	././PPOX_HUMAN	B/P/B	B/D/P	5.57	223,94,256	22.3	0.935	T	Ppox	NA	7.27E-02	35.98726115	-0.247889024	abnormal	3.53606	5498	ppox	NA	272.26655	121	NA	NA	NA	NA	NA	NA
chr1	161169143	rs12735723	C	G	PASS	G	downstream_gene_variant	MODIFIER	USP21	ENSG00000143258	transcript	ENST00000289865.12	c.*3696C>G	NA	NA	NA	NA	NA	3420	NA	NA	NA	0.006647	0.00559105	0.994409	2490,0	0	0.00279553	5	Variegate_porphyria\x2c_homozygous	C0342860	MedGen	NA	1	176200(3)	NA	Porphyria~variegata	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	M	A/A/A/A/A	0.767	5.57	././PPOX_HUMAN	B/P/B	B/D/P	5.57	223,94,256	22.3	0.935	T	Ppox	NA	7.27E-02	35.98726115	-0.247889024	abnormal	3.53606	5498	ppox	NA	272.26655	121	NA	NA	NA	NA	NA	NA
chr1	161169143	rs12735723	C	G	PASS	G	downstream_gene_variant	MODIFIER	B4GALT3	ENSG00000158850	transcript	ENST00000319769.9	c.*2673G>C	NA	NA	NA	NA	NA	2167	NA	NA	NA	0.006647	0.00559105	0.994409	2490,0	0	0.00279553	5	Variegate_porphyria\x2c_homozygous	C0342860	MedGen	NA	1	176200(3)	NA	Porphyria~variegata	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	M	A/A/A/A/A	0.767	5.57	././PPOX_HUMAN	B/P/B	B/D/P	5.57	223,94,256	22.3	0.935	T	Ppox	NA	7.27E-02	35.98726115	-0.247889024	abnormal	3.53606	5498	ppox	NA	272.26655	121	NA	NA	NA	NA	NA	NA
chr1	161210599	rs150667550	T	C	PASS	C	missense_variant	MODERATE	NDUFS2	ENSG00000158864	transcript	ENST00000367993.7	c.875T>C	p.Met292Thr	10/15	1323/2042	292/463	875/1392	NA	NA	NA	NA	0.000313	0.000399361	0.999601	2503,0	0	0.000199681	4	not_provided	CN221809	MedGen	NA	NA	252010(3)	NA	Mitochondrial~complex~I~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/XLD/Mi	NA	NA	NA	NA	NA	M	D/D/D	1	5.06	./././NDUS2_HUMAN	B/P/P/P	B/P/D/D	5.06	241,194,292,292	26.6	1.061	D	Ndufs2	NA	5.24E-02	79.37603208	0.485092724	NA	6.09270	4720	NA	NA	1000.4517	134	NA	NA	NA	NA	NA	NA
chr1	161210599	rs150667550	T	C	PASS	C	upstream_gene_variant	MODIFIER	FCER1G	ENSG00000158869	transcript	ENST00000367992.7	c.-4723T>C	NA	NA	NA	NA	NA	4680	NA	NA	NA	0.000313	0.000399361	0.999601	2503,0	0	0.000199681	4	not_provided	CN221809	MedGen	NA	NA	252010(3)	NA	Mitochondrial~complex~I~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/XLD/Mi	NA	NA	NA	NA	NA	M	D/D/D	1	5.06	./././NDUS2_HUMAN	B/P/P/P	B/P/D/D	5.06	241,194,292,292	26.6	1.061	D	Ndufs2	NA	5.24E-02	79.37603208	0.485092724	NA	6.09270	4720	NA	NA	1000.4517	134	NA	NA	NA	NA	NA	NA
chr1	161305939	rs34307129	G	A	PASS	A	synonymous_variant	LOW	MPZ	ENSG00000158887	transcript	ENST00000463290.5	c.684C>T	p.Ser228Ser	6/7	733/1693	228/248	684/747	NA	NA	NA	NA	0.02	0.0175719	0.981629	2458,2	0.000798722	0.00958466	255|3|3|3|3	not_specified|Congenital_hypomyelinating_neuropathy|Charcot-Marie-Tooth\x2c_Type_1|Charcot-Marie-Tooth\x2c_Intermediate|Roussy-Lévy_syndrome	CN169374|C0393818:605253:ORPHA99951:230562000|CN239158|CN239334|C0205713:180800:ORPHA3115:45853006	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	180800(3),605253(3),145900(3),607736(3),607677(3),118200(3),607791(3)	NA	Roussy-Levy~syndrome,Neuropathy~congenital~hypomyelinating,Dejerine-Sottas~disease,Charcot-Marie-Tooth~disease~type~2J,Charcot-Marie-Tooth~disease~type~2I,Charcot-Marie-Tooth~disease~type~1B,Charcot-Marie-Tooth~disease~dominant~intermediate~D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR/AD,AR/AD,AD,AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mpz	N	1.57E-01	38.2814343	-0.207437529	NA	0.55165	4359	NA	NA	15.36913	126	NA	NA	NA	NA	NA	MPZ
chr1	161509955	rs1801274	A	G	PASS	G	missense_variant	MODERATE	FCGR2A	ENSG00000143226	transcript	ENST00000271450.10	c.500A>G	p.His167Arg	4/7	538/2412	167/317	500/954	NA	NA	NA	NA	0.479	0.478435	0.319089	799,507	0.202476	0.441693	255|255|255|6	Lupus_nephritis\x2c_susceptibility_to|Pseudomonas_aeruginosa\x2c_susceptibility_to_chronic_infection_by\x2c_in_cystic_fibrosis|Malaria\x2c_severe\x2c_susceptibility_to|trastuzumab_response_-_Efficacy	.|.|C1970029|CN236585	.|.|MedGen|MedGen	NA	2	NA	NA	NA	NA	NA	AR,-,AD	NA	NA	NA	NA	NA	219700(3),611162(3),152700(3)	NA	NA	NA	NA	NA	{Pseudomonas~aeruginosa~susceptibility~to~chronic~infection~by~in~cystic~fibrosis},{Malaria~severe~susceptibility~to},{Lupus~nephritis~susceptibility~to}	L	P/P	0	-4.15	FCG2A_HUMAN/.	B	B	2.65	167,166	0.002	-4.176	T	Fcgr3	N	8.71E-01	88.35810333	0.841481379	NA	4.83249	2212	NA	NA	565.82336	89	NA	NA	NA	NA	NA	NA
chr1	161509955	rs1801274	A	G	PASS	G	upstream_gene_variant	MODIFIER	RP11-25K21.6	ENSG00000273112	transcript	ENST00000537821.2	n.-3221A>G	NA	NA	NA	NA	NA	3221	NA	NA	NA	0.479	0.478435	0.319089	799,507	0.202476	0.441693	255|255|255|6	Lupus_nephritis\x2c_susceptibility_to|Pseudomonas_aeruginosa\x2c_susceptibility_to_chronic_infection_by\x2c_in_cystic_fibrosis|Malaria\x2c_severe\x2c_susceptibility_to|trastuzumab_response_-_Efficacy	.|.|C1970029|CN236585	.|.|MedGen|MedGen	NA	2	NA	NA	NA	NA	NA	AR,-,AD	NA	NA	NA	NA	NA	219700(3),611162(3),152700(3)	NA	NA	NA	NA	NA	{Pseudomonas~aeruginosa~susceptibility~to~chronic~infection~by~in~cystic~fibrosis},{Malaria~severe~susceptibility~to},{Lupus~nephritis~susceptibility~to}	L	P/P	0	-4.15	FCG2A_HUMAN/.	B	B	2.65	167,166	0.002	-4.176	T	Fcgr3	N	8.71E-01	88.35810333	0.841481379	NA	4.83249	2212	NA	NA	565.82336	89	NA	NA	NA	NA	NA	NA
chr1	161548543	rs10127939	A	C	VQSRTrancheSNP99.80to100.00	C	missense_variant	MODERATE	FCGR3A	ENSG00000203747	transcript	ENST00000367969.7	c.305T>G	p.Leu102Arg	3/5	489/2310	102/290	305/873	NA	NA	NA	NA	0.046	NA	NA	2180,1	NA	0.0389377	5	Immunodeficiency_20	C3810342:615707:ORPHA437552	MedGen:OMIM:Orphanet	NA	4	615707(3)	NA	Immunodeficiency~20	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	N/N/N/N/N	0.009	0.726	FCG3A_HUMAN/./.	B	B/P/B	4.43	66,101,66	0.518	-0.349	T/./T/T/T	Fcgr4	NA	9.90E-01	77.79547063	0.440999548	NA	2.14247	2214	NA	NA	98.19478	119	NA	NA	NA	NA	NA	NA
chr1	161548543	rs10127939	A	C	VQSRTrancheSNP99.80to100.00	C	intron_variant	MODIFIER	RP11-25K21.6	ENSG00000273112	transcript	ENST00000537821.2	n.271+30406A>C	NA	3/4	NA	NA	NA	NA	NA	NA	NA	0.046	NA	NA	2180,1	NA	0.0389377	5	Immunodeficiency_20	C3810342:615707:ORPHA437552	MedGen:OMIM:Orphanet	NA	4	615707(3)	NA	Immunodeficiency~20	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	N/N/N/N/N	0.009	0.726	FCG3A_HUMAN/./.	B	B/P/B	4.43	66,101,66	0.518	-0.349	T/./T/T/T	Fcgr4	NA	9.90E-01	77.79547063	0.440999548	NA	2.14247	2214	NA	NA	98.19478	119	NA	NA	NA	NA	NA	NA
chr1	161548543	rs10127939	A	T	VQSRTrancheSNP99.80to100.00	T	missense_variant	MODERATE	FCGR3A	ENSG00000203747	transcript	ENST00000367969.7	c.305T>A	p.Leu102His	3/5	489/2310	102/290	305/873	NA	NA	NA	NA	0.054	NA	NA	2180,1	NA	0.0265575	5	Immunodeficiency_20	C3810342:615707:ORPHA437552	MedGen:OMIM:Orphanet	NA	5	615707(3)	NA	Immunodeficiency~20	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	N/N/N/N/N	0.009	0.726	FCG3A_HUMAN/./.	D	D	4.43	66,101,66	0.466	-0.349	T/./T/T/T	Fcgr4	NA	9.90E-01	77.79547063	0.440999548	NA	2.14247	2214	NA	NA	98.19478	119	NA	NA	NA	NA	NA	NA
chr1	161548543	rs10127939	A	T	VQSRTrancheSNP99.80to100.00	T	intron_variant	MODIFIER	RP11-25K21.6	ENSG00000273112	transcript	ENST00000537821.2	n.271+30406A>T	NA	3/4	NA	NA	NA	NA	NA	NA	NA	0.054	NA	NA	2180,1	NA	0.0265575	5	Immunodeficiency_20	C3810342:615707:ORPHA437552	MedGen:OMIM:Orphanet	NA	5	615707(3)	NA	Immunodeficiency~20	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	N/N/N/N/N	0.009	0.726	FCG3A_HUMAN/./.	D	D	4.43	66,101,66	0.466	-0.349	T/./T/T/T	Fcgr4	NA	9.90E-01	77.79547063	0.440999548	NA	2.14247	2214	NA	NA	98.19478	119	NA	NA	NA	NA	NA	NA
chr1	161629781	rs2290834	T	C	VQSRTrancheSNP99.80to100.00	C	missense_variant	MODERATE	FCGR3B	ENSG00000162747	transcript	ENST00000531221.5	c.424A>G	p.Ile142Val	3/5	428/1339	142/269	424/810	NA	NA	NA	NA	0.349	NA	NA	NA	NA	NA	5	Neutrophil-specific_antigens_na1/na2	C4017227	MedGen	NA	13	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N	P/P/P/P/P/P/P/P	0	-5.57	FCG3B_HUMAN	B	B	2.79	106	0.001	0.011	T/T/././T/T	Fcgr4	NA	4.00E-01	45.12856806	-0.115612493	NA	2.77603	2215	NA	NA	161.44959	100	NA	NA	NA	NA	NA	NA
chr1	161629853	rs147574249	T	C	VQSRTrancheSNP99.80to100.00	C	missense_variant	MODERATE	FCGR3B	ENSG00000162747	transcript	ENST00000531221.5	c.352A>G	p.Asn118Asp	3/5	356/1339	118/269	352/810	NA	NA	NA	NA	0.138	0.140575	0.646166	1618,534	0.213259	0.283546	5	Neutrophil-specific_antigens_na1/na2	C4017227	MedGen	NA	5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N	N/N/N/N/N/N/N/N	0	-5.57	FCG3B_HUMAN	B	B	2.79	82	0.002	-1.884	T/T/././T/T	Fcgr4	NA	4.00E-01	45.12856806	-0.115612493	NA	2.77603	2215	NA	NA	161.44959	134	NA	NA	NA	NA	NA	NA
chr1	161629903	rs448740	T	C	VQSRTrancheSNP99.80to100.00	C	missense_variant	MODERATE	FCGR3B	ENSG00000162747	transcript	ENST00000531221.5	c.302A>G	p.Asn101Ser	3/5	306/1339	101/269	302/810	NA	NA	NA	NA	0.588	0.421326	0.25639	642,807	0.322284	0.532947	5	Neutrophil-specific_antigens_na1/na2	C4017227	MedGen	NA	26	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	P/P/P/P/P/P/P/P	0	-2.58	NA	NA	NA	2.79	NA	0.001	-0.53	T/T/././T/T	Fcgr4	NA	4.00E-01	45.12856806	-0.115612493	NA	2.77603	2215	NA	NA	161.44959	80	NA	NA	NA	NA	NA	NA
chr1	161629989	rs200688856	G	C	VQSRTrancheSNP99.80to100.00	C	missense_variant	MODERATE	FCGR3B	ENSG00000162747	transcript	ENST00000531221.5	c.216C>G	p.Ser72Arg	3/5	220/1339	72/269	216/810	NA	NA	NA	NA	0.0003864	0.110623	0.817093	2046,181	0.0722843	0.127596	5	Neutrophil-specific_antigens_na1/na2	C4017227	MedGen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N	P/P/P/P/P/P/P/P	0.001	-5.13	FCG3B_HUMAN	B	B	2.79	36	0.002	-0.573	T/T/././T/T	Fcgr4	NA	4.00E-01	45.12856806	-0.115612493	NA	2.77603	2215	NA	NA	161.44959	137	NA	NA	NA	NA	NA	NA
chr1	161674008	rs1050501	T	C	VQSRTrancheSNP99.80to100.00	C	missense_variant	MODERATE	FCGR2B	ENSG00000072694	transcript	ENST00000358671.9	c.695T>C	p.Ile232Thr	5/8	776/2115	232/310	695/933	NA	NA	NA	NA	0.107	0.295927	0.666134	1668,95	0.0379393	0.185903	255|255	Systemic_lupus_erythematosus\x2c_susceptibility_to|Malaria\x2c_resistance_to	.|C2720293	.|MedGen	NA	9	NA	NA	NA	NA	NA	AD,-	NA	NA	NA	NA	NA	152700(3),611162(3)	NA	NA	NA	NA	NA	{Systemic~lupus~erythematosus~susceptibility~to},{Malaria~resistance~to}	L	P/P/P/P/P/P/P	0.298	2.85	./././FCG2B_HUMAN/.	B	B	3.99	225,232,232,232,232	7.094	-0.216	T/T/T/T/T/.	Fcgr2b	N	8.40E-01	58.52795471	0.060756528	NA	7.58570	2213	NA	blymphocytePathway	1693.68129	86	NA	NA	NA	NA	NA	NA
chr1	161674008	rs1050501	T	C	VQSRTrancheSNP99.80to100.00	C	non_coding_transcript_exon_variant	MODIFIER	RP11-25K21.1	ENSG00000234211	transcript	ENST00000626340.1	n.180A>G	NA	2/2	NA	NA	NA	NA	NA	NA	NA	0.107	0.295927	0.666134	1668,95	0.0379393	0.185903	255|255	Systemic_lupus_erythematosus\x2c_susceptibility_to|Malaria\x2c_resistance_to	.|C2720293	.|MedGen	NA	9	NA	NA	NA	NA	NA	AD,-	NA	NA	NA	NA	NA	152700(3),611162(3)	NA	NA	NA	NA	NA	{Systemic~lupus~erythematosus~susceptibility~to},{Malaria~resistance~to}	L	P/P/P/P/P/P/P	0.298	2.85	./././FCG2B_HUMAN/.	B	B	3.99	225,232,232,232,232	7.094	-0.216	T/T/T/T/T/.	Fcgr2b	N	8.40E-01	58.52795471	0.060756528	NA	7.58570	2213	NA	blymphocytePathway	1693.68129	86	NA	NA	NA	NA	NA	NA
chr1	161984849	rs185436876	C	T	PASS	T	missense_variant	MODERATE	OLFML2B	ENSG00000162745	transcript	ENST00000367940.2	c.1609G>A	p.Gly537Ser	7/8	1819/2685	537/751	1609/2256	NA	NA	NA	NA	0.0001483	0.000399361	0.999601	2503,0	0	0.000199681	4	not_provided	CN221809	MedGen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	L	D/D/D	0.787	4.18	./OLM2B_HUMAN	D	D	4.18	537,536	34	0.768	D	Olfml2b	NA	1.99E-01	93.25902335	1.229050169	NA	5.62241	25903	NA	NA	819.22455	135	NA	NA	NA	NA	NA	NA
chr1	161998241	rs142806829	C	T	PASS	T	missense_variant	MODERATE	OLFML2B	ENSG00000162745	transcript	ENST00000367940.2	c.1061G>A	p.Arg354His	6/8	1271/2685	354/751	1061/2256	NA	NA	NA	NA	0.0001071	0.000399361	0.999601	2503,0	0	0.000199681	4	not_provided	CN221809	MedGen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N	N/N	0.001	-7.83	./OLM2B_HUMAN	B	B	3.92	354,353	1.474	-1.904	T	Olfml2b	NA	1.99E-01	93.25902335	1.229050169	NA	5.62241	25903	NA	NA	819.22455	134	NA	NA	NA	NA	NA	NA
chr1	168104855	rs200635937	A	T	PASS	T	missense_variant	MODERATE	GPR161	ENSG00000143147	transcript	ENST00000537209.5	c.56T>A	p.Leu19Gln	3/7	674/8256	19/549	56/1650	NA	NA	NA	NA	0.003319	0.00878594	0.991214	2482,0	0	0.00439297	0|4	not_provided|Pituitary_stalk_interruption_syndrome	CN221809|CN206776:ORPHA95496	MedGen|MedGen:Orphanet	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	D/D/D/D/D/D/D/N	0.798	2.96	NA	P	D/P	5.24	19	24.2	0.237	D/T	Gpr161	N	5.84E-01	12.33191791	-0.800872469	abnormal	2.08754	23432	gpr161	NA	94.16225	137	NA	NA	NA	NA	NA	NA
chr1	168293210	rs200197424	C	T	PASS	T	stop_gained	HIGH	TBX19	ENSG00000143178	transcript	ENST00000367821.7	c.535C>T	p.Arg179*	3/8	586/2822	179/448	535/1347	NA	NA	(TBX19|ENSG00000143178|1|1.00)	(TBX19|ENSG00000143178|1|1.00)	4.118e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	ACTH_deficiency	C0342388:201400:237692001	MedGen:OMIM:SNOMED_CT	NA	NA	201400(3)	NA	Adrenocorticotropic~hormone~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	A	0.983	4.08	NA	NA	NA	5.02	NA	37	0.852	NA	Tbx19	N	2.78E-01	9.170794999	-0.955204708	NA	1.28223	9095	NA	NA	44.73479	137	NA	NA	NA	NA	NA	NA
chr1	169468787	rs3737682	A	G	PASS	G	synonymous_variant	LOW	SLC19A2	ENSG00000117479	transcript	ENST00000236137.9	c.1080T>C	p.Thr360Thr	4/6	1317/3671	360/497	1080/1494	NA	NA	NA	NA	0.00789	0.043131	0.954872	2391,5	0.00199681	0.0235623	255|3|3	not_specified|Megaloblastic_anemia\x2c_thiamine-responsive\x2c_with_diabetes_mellitus_and_sensorineural_deafness|Thiamine-responsive_megaloblastic_anemia	CN169374|C0342287:249270:ORPHA49827:237617006|HP:0004860:CN004305	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|Human_Phenotype_Ontology:MedGen	NA	NA	249270(3)	NA	Thiamine-responsive~megaloblastic~anemia~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Slc19a2	N	2.58E-01	34.59542345	-0.26993514	NA	2.88209	10560	NA	NA	175.54032	107	NA	NA	NA	NA	NA	NA
chr1	169477212	rs74315374	C	T	PASS	T	stop_gained	HIGH	SLC19A2	ENSG00000117479	transcript	ENST00000236137.9	c.750G>A	p.Trp250*	2/6	987/3671	250/497	750/1494	NA	NA	(SLC19A2|ENSG00000117479|1|1.00)	(SLC19A2|ENSG00000117479|1|1.00)	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Megaloblastic_anemia\x2c_thiamine-responsive\x2c_with_diabetes_mellitus_and_sensorineural_deafness	C0342287:249270:ORPHA49827:237617006	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	249270(3)	NA	Thiamine-responsive~megaloblastic~anemia~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	A/A/A	1	5.34	NA	NA	NA	5.34	NA	39	0.852	NA	Slc19a2	N	2.58E-01	34.59542345	-0.26993514	NA	2.88209	10560	NA	NA	175.54032	133	NA	NA	NA	NA	NA	NA
chr1	169477212	rs74315374	C	T	PASS	T	upstream_gene_variant	MODIFIER	RP1-206D15.5	ENSG00000234604	transcript	ENST00000452472.2	n.-3053G>A	NA	NA	NA	NA	NA	3053	NA	(SLC19A2|ENSG00000117479|1|1.00)	(SLC19A2|ENSG00000117479|1|1.00)	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Megaloblastic_anemia\x2c_thiamine-responsive\x2c_with_diabetes_mellitus_and_sensorineural_deafness	C0342287:249270:ORPHA49827:237617006	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	249270(3)	NA	Thiamine-responsive~megaloblastic~anemia~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	A/A/A	1	5.34	NA	NA	NA	5.34	NA	39	0.852	NA	Slc19a2	N	2.58E-01	34.59542345	-0.26993514	NA	2.88209	10560	NA	NA	175.54032	133	NA	NA	NA	NA	NA	NA
chr1	169549811	rs6025	C	T	PASS	T	missense_variant	MODERATE	F5	ENSG00000198734	transcript	ENST00000367796.3	c.1601G>A	p.Arg534Gln	10/25	1803/7039	534/2229	1601/6690	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	6,5|255|255|255|5	hormonal_contraceptives_for_systemic_use_response_-_Toxicity/ADR,Thrombophilia_due_to_factor_V_Leiden|Ischemic_stroke\x2c_susceptibility_to|Budd-Chiari_syndrome\x2c_susceptibility_to|Recurrent_abortion|Factor_V_deficiency	CN236515,C2674152|.|.|C0000809:614389:102878001|C0015499:227400:ORPHA326:4320005	MedGen,MedGen|.|.|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	188055(3),188055(3),227400(3),227400(3),227400(3)	NA	Thrombophilia~due~to~activated~protein~C~resistance,Thrombophilia~due~to~activated~protein~C~resistance,Factor~V~deficiency,Factor~V~deficiency,Factor~V~deficiency	NA	NA	AD,Mu,Mu,AD,AR,AR	NA	NA	NA	NA	NA	188055(3),601367(3),601367(3),614389(3),600880(3),600880(3)	AD,AD,AR,AR,AR	NA	NA	NA	NA	{Thrombophilia~susceptibility~to~due~to~factor~V~Leiden},{Stroke~ischemic~susceptibility~to},{Stroke~ischemic~susceptibility~to},{Pregnancy~loss~recurrent~susceptibility~to~1},{Budd-Chiari~syndrome},{Budd-Chiari~syndrome}	NA	NA	0.984	5.71	NA	NA	NA	5.71	NA	NA	0.935	NA	F5	E	8.63E-02	99.38075018	3.230985335	NA	18.61572	2153	NA	extrinsicPathway/intrinsicPathway	7503.35737	52	NA	NA	NA	NA	NA	F5
chr1	169555299	rs118203906	C	G	PASS	G	missense_variant	MODERATE	F5	ENSG00000198734	transcript	ENST00000367796.3	c.1001G>C	p.Arg334Thr	7/25	1203/7039	334/2229	1001/6690	NA	NA	NA	NA	0.0001647	0.000399361	0.999601	2503,0	0	0.000199681	5	Thrombophilia_due_to_activated_protein_C_resistance	C1861171:188055	MedGen:OMIM	NA	NA	188055(3),188055(3),227400(3),227400(3),227400(3)	NA	Thrombophilia~due~to~activated~protein~C~resistance,Thrombophilia~due~to~activated~protein~C~resistance,Factor~V~deficiency,Factor~V~deficiency,Factor~V~deficiency	NA	NA	AD,Mu,Mu,AD,AR,AR	NA	NA	NA	NA	NA	188055(3),601367(3),601367(3),614389(3),600880(3),600880(3)	AD,AD,AR,AR,AR	NA	NA	NA	NA	{Thrombophilia~susceptibility~to~due~to~factor~V~Leiden},{Stroke~ischemic~susceptibility~to},{Stroke~ischemic~susceptibility~to},{Pregnancy~loss~recurrent~susceptibility~to~1},{Budd-Chiari~syndrome},{Budd-Chiari~syndrome}	M	A/A/A	0.228	4.77	FA5_HUMAN	P	D	5.69	334	22.9	0.035	T	F5	E	8.63E-02	99.38075018	3.230985335	NA	18.61572	2153	NA	extrinsicPathway/intrinsicPathway	7503.35737	132	NA	NA	NA	NA	NA	F5
chr1	169555300	rs118203905	T	C	PASS	C	missense_variant	MODERATE	F5	ENSG00000198734	transcript	ENST00000367796.3	c.1000A>G	p.Arg334Gly	7/25	1202/7039	334/2229	1000/6690	NA	NA	NA	NA	0.0004859	0.00399361	0.996006	2494,0	0	0.00199681	5	Factor_V_Hong_Kong	CN068435	MedGen	NA	NA	188055(3),188055(3),227400(3),227400(3),227400(3)	NA	Thrombophilia~due~to~activated~protein~C~resistance,Thrombophilia~due~to~activated~protein~C~resistance,Factor~V~deficiency,Factor~V~deficiency,Factor~V~deficiency	NA	NA	AD,Mu,Mu,AD,AR,AR	NA	NA	NA	NA	NA	188055(3),601367(3),601367(3),614389(3),600880(3),600880(3)	AD,AD,AR,AR,AR	NA	NA	NA	NA	{Thrombophilia~susceptibility~to~due~to~factor~V~Leiden},{Stroke~ischemic~susceptibility~to},{Stroke~ischemic~susceptibility~to},{Pregnancy~loss~recurrent~susceptibility~to~1},{Budd-Chiari~syndrome},{Budd-Chiari~syndrome}	M	A/A/A	0.388	0.446	FA5_HUMAN	P	D	5.69	334	23.8	0.143	D	F5	E	8.63E-02	99.38075018	3.230985335	NA	18.61572	2153	NA	extrinsicPathway/intrinsicPathway	7503.35737	132	NA	NA	NA	NA	NA	F5
chr1	169596108	rs6133	C	A	PASS	A	missense_variant	MODERATE	SELP	ENSG00000174175	transcript	ENST00000263686.10	c.1918G>T	p.Val640Leu	12/17	1956/3142	640/830	1918/2493	NA	NA	NA	NA	0.127	0.196086	0.682907	1710,303	0.121006	0.21905	255	Atopy\x2c_susceptibility_to	C1840254	MedGen	NA	1	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	147050(3)	NA	NA	NA	NA	NA	{Atopy~susceptibility~to}	NA	P/P/P/P/P/P/P/P/P/P	0.008	3.22	NA	B	B	4.22	640	10.83	0.852	T/T/T/./T	Selp	N	9.37E-01	90.80561453	1.008569289	abnormal	6.85373	6403	selp	granulocytesPathway/LairPathway/ephA4Pathway/monocytePathway	1329.25055	52	NA	NA	NA	NA	NA	NA
chr1	170544841	rs183596463	G	T	PASS	T	missense_variant	MODERATE	GORAB	ENSG00000120370	transcript	ENST00000367763.7	c.733G>T	p.Ala245Ser	4/5	753/2189	245/394	733/1185	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5	Geroderma_osteodysplastica	C0432255:231070:ORPHA2078:254116003	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	231070(3)	NA	Geroderma~osteodysplasticum	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D/D	0.332	5.81	GORAB_HUMAN	D	D	5.81	245	32	0.998	D	Gorab	NA	8.87E-01	23.42533616	-0.468351206	NA	1.35806	92344	NA	NA	48.46487	135	NA	NA	NA	NA	NA	NA
chr1	171107825	rs2266782	G	A	PASS	A	missense_variant	MODERATE	FMO3	ENSG00000007933	transcript	ENST00000367755.8	c.472G>A	p.Glu158Lys	4/9	583/2087	158/532	472/1599	NA	NA	NA	NA	0.383	0.413738	0.445288	1115,353	0.140974	0.347843	5|4|5|2|2	Trimethylaminuria\x2c_mild|Trimethylaminuria|Trimethylaminuria|not_specified|Trimethylaminuria	C4016101|C0342739:602079:237959005|C0342739:602079:237959005|CN169374|C0342739:602079:237959005	MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT	NA	1	602079(3)	NA	Trimethylaminuria	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	P/P/P/P	0.931	3.78	././FMO3_HUMAN	B	P/B/B	4.7	95,138,158	21.6	0.918	T	Fmo3	NA	9.97E-01	91.30691201	1.043548753	NA	13.99230	2328	NA	NA	4771.19044	100	NA	NA	NA	NA	NA	NA
chr1	171110939	rs1736557	G	A	PASS	A	missense_variant	MODERATE	FMO3	ENSG00000007933	transcript	ENST00000367755.8	c.769G>A	p.Val257Met	6/9	880/2087	257/532	769/1599	NA	NA	NA	NA	0.08	0.160144	0.822284	2059,44	0.0175719	0.0976438	255|2	Trimethylaminuria|not_specified	C0342739:602079:237959005|CN169374	MedGen:OMIM:SNOMED_CT|MedGen	NA	2	602079(3)	NA	Trimethylaminuria	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	P/P/P/P	0.77	-9.22	././FMO3_HUMAN	B	B	4.61	194,237,257	4.624	-1.563	T	Fmo3	NA	9.97E-01	91.30691201	1.043548753	NA	13.99230	2328	NA	NA	4771.19044	89	NA	NA	NA	NA	NA	NA
chr1	171114092	rs61753344	G	T	PASS	T	stop_gained	HIGH	FMO3	ENSG00000007933	transcript	ENST00000367755.8	c.913G>T	p.Glu305*	7/9	1024/2087	305/532	913/1599	NA	NA	(FMO3|ENSG00000007933|1|1.00)	(FMO3|ENSG00000007933|1|1.00)	0.0003048	0.000399361	0.999601	2503,0	0	0.000199681	5	Trimethylaminuria	C0342739:602079:237959005	MedGen:OMIM:SNOMED_CT	NA	1	602079(3)	NA	Trimethylaminuria	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	A/A/A/A	0.877	-0.487	NA	NA	NA	4.73	NA	33	-0.326	NA	Fmo3	NA	9.97E-01	91.30691201	1.043548753	NA	13.99230	2328	NA	NA	4771.19044	129	NA	NA	NA	NA	NA	NA
chr1	171114102	rs2266780	A	G	PASS	G	missense_variant	MODERATE	FMO3	ENSG00000007933	transcript	ENST00000367755.8	c.923A>G	p.Glu308Gly	7/9	1034/2087	308/532	923/1599	NA	NA	NA	NA	0.153	0.15655	0.830272	2079,33	0.0131789	0.0914537	5|4|2|2	Trimethylaminuria\x2c_mild|Trimethylaminuria|not_specified|Trimethylaminuria	C4016101|C0342739:602079:237959005|CN169374|C0342739:602079:237959005	MedGen|MedGen:OMIM:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT	NA	7	602079(3)	NA	Trimethylaminuria	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	P/P/P/P	0.981	3.58	././FMO3_HUMAN	D/P/P	D/P/P	4.73	245,288,308	23.9	1.088	T	Fmo3	NA	9.97E-01	91.30691201	1.043548753	NA	13.99230	2328	NA	NA	4771.19044	100	NA	NA	NA	NA	NA	NA
chr1	171114258	rs28363581	T	C	PASS	C	missense_variant	MODERATE	FMO3	ENSG00000007933	transcript	ENST00000367755.8	c.1079T>C	p.Leu360Pro	7/9	1190/2087	360/532	1079/1599	NA	NA	NA	NA	0.0003871	0.00399361	0.996006	2494,0	0	0.00199681	255	Trimethylaminuria	C0342739:602079:237959005	MedGen:OMIM:SNOMED_CT	NA	NA	602079(3)	NA	Trimethylaminuria	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	A/A/A/A	0.025	-6.37	././FMO3_HUMAN	B	B	4.92	297,340,360	1.639	-0.075	T	Fmo3	NA	9.97E-01	91.30691201	1.043548753	NA	13.99230	2328	NA	NA	4771.19044	125	NA	NA	NA	NA	NA	NA
chr1	171114339	rs72549331	G	A	PASS	A	missense_variant	MODERATE	FMO3	ENSG00000007933	transcript	ENST00000367755.8	c.1160G>A	p.Arg387His	7/9	1271/2087	387/532	1160/1599	NA	NA	NA	NA	0.0001071	0.000798722	0.999201	2502,0	0	0.000399361	5	Trimethylaminuria	C0342739:602079:237959005	MedGen:OMIM:SNOMED_CT	NA	NA	602079(3)	NA	Trimethylaminuria	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D/D/D/D	0.991	2.99	././FMO3_HUMAN	B/P/P	P/D/D	4.92	324,367,387	24.9	0.108	D	Fmo3	NA	9.97E-01	91.30691201	1.043548753	NA	13.99230	2328	NA	NA	4771.19044	130	NA	NA	NA	NA	NA	NA
chr1	171636338	rs74315329	G	A	PASS	A	stop_gained	HIGH	MYOC	ENSG00000034971	transcript	ENST00000037502.10	c.1102C>T	p.Gln368*	3/3	1174/2095	368/504	1102/1515	NA	NA	NA	NA	0.001087	0.00119808	0.998802	2501,0	0	0.000599042	5|4	Primary_open_angle_glaucoma_juvenile_onset_1|Primary_open_angle_glaucoma	C1842028:137750|C0339573:137760:77075001	MedGen:OMIM|MedGen:OMIM:SNOMED_CT	NA	3	137750(3)	NA	Glaucoma~1A~primary~open~angle	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	A	0.286	4.52	NA	NA	NA	5.46	NA	37	1.048	NA	Myoc	N	2.09E-01	43.90776126	-0.134019284	NA	5.67376	4653	NA	NA	839.33434	133	NA	NA	NA	NA	NA	NA
chr1	171636338	rs74315329	G	A	PASS	A	intron_variant	MODIFIER	RP3-454G6.2	ENSG00000283683	transcript	ENST00000637303.1	c.235-2292G>A	NA	3/3	NA	NA	NA	NA	NA	NA	NA	0.001087	0.00119808	0.998802	2501,0	0	0.000599042	5|4	Primary_open_angle_glaucoma_juvenile_onset_1|Primary_open_angle_glaucoma	C1842028:137750|C0339573:137760:77075001	MedGen:OMIM|MedGen:OMIM:SNOMED_CT	NA	3	137750(3)	NA	Glaucoma~1A~primary~open~angle	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	A	0.286	4.52	NA	NA	NA	5.46	NA	37	1.048	NA	Myoc	N	2.09E-01	43.90776126	-0.134019284	NA	5.67376	4653	NA	NA	839.33434	133	NA	NA	NA	NA	NA	NA
chr1	171652468	rs74315339	C	A	PASS	A	missense_variant	MODERATE	MYOC	ENSG00000034971	transcript	ENST00000037502.10	c.144G>T	p.Gln48His	1/3	216/2095	48/504	144/1515	NA	NA	NA	NA	0.001318	0.00519169	0.994808	2491,0	0	0.00259585	5|5|5	Primary_open_angle_glaucoma_juvenile_onset_1|Glaucoma_3\x2c_primary_congenital\x2c_a\x2c_digenic|MYOC-Related_Disorders	C1842028:137750|C1866550|CN239330	MedGen:OMIM|MedGen|MedGen	NA	1	137750(3)	NA	Glaucoma~1A~primary~open~angle	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	L	A	0.437	0.193	./MYOC_HUMAN	B	B	5.72	48	12.62	-0.972	D/.	Myoc	N	2.09E-01	43.90776126	-0.134019284	NA	5.67376	4653	NA	NA	839.33434	133	NA	NA	NA	NA	NA	NA
chr1	171652476	rs74315337	G	A	PASS	A	stop_gained	HIGH	MYOC	ENSG00000034971	transcript	ENST00000037502.10	c.136C>T	p.Arg46*	1/3	208/2095	46/504	136/1515	NA	NA	(MYOC|ENSG00000034971|1|1.00)	(MYOC|ENSG00000034971|1|1.00)	0.0006836	0.00279553	0.997204	2497,0	0	0.00139776	5	Glaucoma_1\x2c_open_angle\x2c_a\x2c_autosomal_recessive	C4016749	MedGen	NA	NA	137750(3)	NA	Glaucoma~1A~primary~open~angle	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	A	0.958	3.69	NA	NA	NA	5.72	NA	36	0.953	NA	Myoc	N	2.09E-01	43.90776126	-0.134019284	NA	5.67376	4653	NA	NA	839.33434	133	NA	NA	NA	NA	NA	NA
chr1	172658358	rs763110	C	T	PASS	T	upstream_gene_variant	MODIFIER	FASLG	ENSG00000117560	transcript	ENST00000367721.2	c.-844C>T	NA	NA	NA	NA	NA	660	NA	NA	NA	NA	0.364217	0.28754	720,872	0.348243	0.530351	255	LUNG_CANCER\x2c_SUSCEPTIBILITY_TO	.	.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	86	NA	NA	NA	NA	NA	NA
chr1	172658358	rs763110	C	T	PASS	T	intergenic_region	MODIFIER	RNU6-693P-FASLG	ENSG00000251943-ENSG00000117560	intergenic_region	ENSG00000251943-ENSG00000117560	n.172658358C>T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.364217	0.28754	720,872	0.348243	0.530351	255	LUNG_CANCER\x2c_SUSCEPTIBILITY_TO	.	.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	86	NA	NA	NA	NA	NA	NA
chr1	173828312	rs367543010	T	TC	PASS	TC	upstream_gene_variant	MODIFIER	CENPL	ENSG00000120334	transcript	ENST00000356198.6	c.-17014_-17013insG	NA	NA	NA	NA	NA	3991	NA	NA	NA	0.008509	0.00199681	0.998003	2499,0	0	0.000998403	5	Leukoencephalopathy_with_Brainstem_and_Spinal_Cord_Involvement_and_Lactate_Elevation	C1970180:611105:ORPHA137898	MedGen:OMIM:Orphanet	NA	NA	611105(3)	NA	Leukoencephalopathy~with~brain~stem~and~spinal~cord~involvement~and~lactate~elevation	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Dars2	NA	4.06E-01	67.19155461	0.196671391	NA	3.94027	55157	NA	NA	345.04556	137	NA	NA	NA	NA	NA	NA
chr1	173828312	rs367543010	T	TC	PASS	TC	intron_variant	MODIFIER	DARS2	ENSG00000117593	transcript	ENST00000361951.4	c.228-21_228-20insC	NA	2/16	NA	NA	NA	NA	NA	NA	NA	0.008509	0.00199681	0.998003	2499,0	0	0.000998403	5	Leukoencephalopathy_with_Brainstem_and_Spinal_Cord_Involvement_and_Lactate_Elevation	C1970180:611105:ORPHA137898	MedGen:OMIM:Orphanet	NA	NA	611105(3)	NA	Leukoencephalopathy~with~brain~stem~and~spinal~cord~involvement~and~lactate~elevation	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Dars2	NA	4.06E-01	67.19155461	0.196671391	NA	3.94027	55157	NA	NA	345.04556	137	NA	NA	NA	NA	NA	NA
chr1	173828312	rs367543010	T	TCC	PASS	TCC	upstream_gene_variant	MODIFIER	CENPL	ENSG00000120334	transcript	ENST00000356198.6	c.-17014_-17013insGG	NA	NA	NA	NA	NA	3991	NA	NA	NA	4.943e-05	NA	NA	NA	NA	NA	5	Leukoencephalopathy_with_Brainstem_and_Spinal_Cord_Involvement_and_Lactate_Elevation	C1970180:611105:ORPHA137898	MedGen:OMIM:Orphanet	NA	NA	611105(3)	NA	Leukoencephalopathy~with~brain~stem~and~spinal~cord~involvement~and~lactate~elevation	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Dars2	NA	4.06E-01	67.19155461	0.196671391	NA	3.94027	55157	NA	NA	345.04556	137	NA	NA	NA	NA	NA	NA
chr1	173828312	rs367543010	T	TCC	PASS	TCC	intron_variant	MODIFIER	DARS2	ENSG00000117593	transcript	ENST00000361951.4	c.228-21_228-20insCC	NA	2/16	NA	NA	NA	NA	NA	NA	NA	4.943e-05	NA	NA	NA	NA	NA	5	Leukoencephalopathy_with_Brainstem_and_Spinal_Cord_Involvement_and_Lactate_Elevation	C1970180:611105:ORPHA137898	MedGen:OMIM:Orphanet	NA	NA	611105(3)	NA	Leukoencephalopathy~with~brain~stem~and~spinal~cord~involvement~and~lactate~elevation	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Dars2	NA	4.06E-01	67.19155461	0.196671391	NA	3.94027	55157	NA	NA	345.04556	137	NA	NA	NA	NA	NA	NA
chr1	173904011	rs121909554	G	A	PASS	A	missense_variant	MODERATE	SERPINC1	ENSG00000117601	transcript	ENST00000367698.3	c.1273C>T	p.Arg425Cys	7/7	1392/1594	425/464	1273/1395	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Antithrombin_III_deficiency	C0272375:613118:ORPHA82:36351005	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	613118(3)	NA	Thrombophilia~due~to~antithrombin~III~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD	NA	NA	NA	NA	NA	M	A	0.998	5.74	ANT3_HUMAN	D	D	5.74	425	35	1.048	./T	Serpinc1	E	NA	50.22410946	-0.047654689	abnormal	1.46750	462	serpinc1	amiPathway/extrinsicPathway/intrinsicPathway	54.14108	133	NA	NA	NA	NA	NA	NA
chr1	173904011	rs121909554	G	A	PASS	A	downstream_gene_variant	MODIFIER	ZBTB37	ENSG00000185278	transcript	ENST00000367701.9	c.*17887G>A	NA	NA	NA	NA	NA	462	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Antithrombin_III_deficiency	C0272375:613118:ORPHA82:36351005	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	613118(3)	NA	Thrombophilia~due~to~antithrombin~III~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD	NA	NA	NA	NA	NA	M	A	0.998	5.74	ANT3_HUMAN	D	D	5.74	425	35	1.048	./T	Serpinc1	E	NA	50.22410946	-0.047654689	abnormal	1.46750	462	serpinc1	amiPathway/extrinsicPathway/intrinsicPathway	54.14108	133	NA	NA	NA	NA	NA	NA
chr1	173904038	rs121909548	C	A	PASS	A	missense_variant	MODERATE	SERPINC1	ENSG00000117601	transcript	ENST00000367698.3	c.1246G>T	p.Ala416Ser	7/7	1365/1594	416/464	1246/1395	NA	NA	NA	NA	0.0007166	0.000399361	0.999601	2503,0	0	0.000199681	255|0|3,5	Antithrombin_III_deficiency|Antithrombin_deficiency|not_specified,Antithrombin_III_deficiency	C0272375:613118:ORPHA82:36351005|CN221564|CN169374,C0272375:613118:ORPHA82:36351005	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen,MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	613118(3)	NA	Thrombophilia~due~to~antithrombin~III~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD	NA	NA	NA	NA	NA	M	D	0.794	5.74	ANT3_HUMAN	D	D	5.74	416	27.0	0.935	./D	Serpinc1	E	NA	50.22410946	-0.047654689	abnormal	1.46750	462	serpinc1	amiPathway/extrinsicPathway/intrinsicPathway	54.14108	133	NA	NA	NA	NA	NA	NA
chr1	173904038	rs121909548	C	A	PASS	A	downstream_gene_variant	MODIFIER	ZBTB37	ENSG00000185278	transcript	ENST00000367701.9	c.*17914C>A	NA	NA	NA	NA	NA	489	NA	NA	NA	0.0007166	0.000399361	0.999601	2503,0	0	0.000199681	255|0|3,5	Antithrombin_III_deficiency|Antithrombin_deficiency|not_specified,Antithrombin_III_deficiency	C0272375:613118:ORPHA82:36351005|CN221564|CN169374,C0272375:613118:ORPHA82:36351005	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen,MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	613118(3)	NA	Thrombophilia~due~to~antithrombin~III~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD	NA	NA	NA	NA	NA	M	D	0.794	5.74	ANT3_HUMAN	D	D	5.74	416	27.0	0.935	./D	Serpinc1	E	NA	50.22410946	-0.047654689	abnormal	1.46750	462	serpinc1	amiPathway/extrinsicPathway/intrinsicPathway	54.14108	133	NA	NA	NA	NA	NA	NA
chr1	173910838	rs2227627	G	A	PASS	A	synonymous_variant	LOW	SERPINC1	ENSG00000117601	transcript	ENST00000367698.3	c.678C>T	p.Thr226Thr	4/7	797/1594	226/464	678/1395	NA	NA	NA	NA	0.0008978	0.000798722	0.999201	2502,0	0	0.000399361	255	Antithrombin_III_deficiency	C0272375:613118:ORPHA82:36351005	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	613118(3)	NA	Thrombophilia~due~to~antithrombin~III~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Serpinc1	E	NA	50.22410946	-0.047654689	abnormal	1.46750	462	serpinc1	amiPathway/extrinsicPathway/intrinsicPathway	54.14108	98	NA	NA	NA	NA	NA	NA
chr1	173914725	rs121909552	C	T	PASS	T	missense_variant	MODERATE	SERPINC1	ENSG00000117601	transcript	ENST00000367698.3	c.236G>A	p.Arg79His	2/7	355/1594	79/464	236/1395	NA	NA	NA	NA	4.942e-05	0.000798722	0.999201	2502,0	0	0.000399361	5|3	Antithrombin_III_deficiency|Antithrombin_deficiency	C0272375:613118:ORPHA82:36351005|CN221564	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	1	613118(3)	NA	Thrombophilia~due~to~antithrombin~III~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD	NA	NA	NA	NA	NA	M	A	0.973	5.67	ANT3_HUMAN	B	D	5.67	79	33	0.935	./D	Serpinc1	E	NA	50.22410946	-0.047654689	abnormal	1.46750	462	serpinc1	amiPathway/extrinsicPathway/intrinsicPathway	54.14108	133	NA	NA	NA	NA	NA	NA
chr1	173914743	rs121909551	G	A	PASS	A	missense_variant	MODERATE	SERPINC1	ENSG00000117601	transcript	ENST00000367698.3	c.218C>T	p.Pro73Leu	2/7	337/1594	73/464	218/1395	NA	NA	NA	NA	0.0007166	0.000399361	0.999601	2503,0	0	0.000199681	255|3	Antithrombin_III_deficiency|Antithrombin_deficiency	C0272375:613118:ORPHA82:36351005|CN221564	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	NA	613118(3)	NA	Thrombophilia~due~to~antithrombin~III~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD	NA	NA	NA	NA	NA	M	A	0.948	5.67	ANT3_HUMAN	D	D	5.67	73	32	1.048	./D	Serpinc1	E	NA	50.22410946	-0.047654689	abnormal	1.46750	462	serpinc1	amiPathway/extrinsicPathway/intrinsicPathway	54.14108	133	NA	NA	NA	NA	NA	NA
chr1	173914872	rs2227624	A	T	PASS	T	missense_variant	MODERATE	SERPINC1	ENSG00000117601	transcript	ENST00000367698.3	c.89T>A	p.Val30Glu	2/7	208/1594	30/464	89/1395	NA	NA	NA	NA	0.001688	0.00239617	0.997604	2498,0	0	0.00119808	255	Antithrombin_III_deficiency	C0272375:613118:ORPHA82:36351005	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	613118(3)	NA	Thrombophilia~due~to~antithrombin~III~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD	NA	NA	NA	NA	NA	L	N	0.143	1.33	ANT3_HUMAN	B	P	5.53	30	14.05	0.237	./D	Serpinc1	E	NA	50.22410946	-0.047654689	abnormal	1.46750	462	serpinc1	amiPathway/extrinsicPathway/intrinsicPathway	54.14108	98	NA	NA	NA	NA	NA	NA
chr1	179552605	rs74315348	G	A	PASS	A	missense_variant&splice_region_variant	MODERATE	NPHS2	ENSG00000116218	transcript	ENST00000367615.8	c.871C>T	p.Arg291Trp	7/8	940/1855	291/383	871/1152	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	255	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant	C1868672:600995	MedGen:OMIM	NA	2	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	A/A/A	1	4.31	./PODO_HUMAN	D	D	5.34	223,291	35	1.048	D	Axdnd1/Nphs2	./E	./2.51E-01	55.21939137/82.93229535	0.016664174/0.606246644	./abnormal	4.02079/6.31028	126859/7827	./nphs2	NA	1082.91305/360.80001	133	NA	NA	NA	NA	NA	NA
chr1	179552605	rs74315348	G	A	PASS	A	upstream_gene_variant	MODIFIER	RP11-545A16.1	ENSG00000261250	transcript	ENST00000569644.1	n.-3683C>T	NA	NA	NA	NA	NA	3683	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	255	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant	C1868672:600995	MedGen:OMIM	NA	2	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	A/A/A	1	4.31	./PODO_HUMAN	D	D	5.34	223,291	35	1.048	D	Axdnd1/Nphs2	./E	./2.51E-01	55.21939137/82.93229535	0.016664174/0.606246644	./abnormal	4.02079/6.31028	126859/7827	./nphs2	NA	1082.91305/360.80001	133	NA	NA	NA	NA	NA	NA
chr1	179552605	rs74315348	G	A	PASS	A	intron_variant	MODIFIER	AXDND1	ENSG00000162779	transcript	ENST00000367618.7	c.3032-1907G>A	NA	25/25	NA	NA	NA	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	255	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant	C1868672:600995	MedGen:OMIM	NA	2	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	A/A/A	1	4.31	./PODO_HUMAN	D	D	5.34	223,291	35	1.048	D	Axdnd1/Nphs2	./E	./2.51E-01	55.21939137/82.93229535	0.016664174/0.606246644	./abnormal	4.02079/6.31028	126859/7827	./nphs2	NA	1082.91305/360.80001	133	NA	NA	NA	NA	NA	NA
chr1	179557079	rs61747728	C	T	PASS	T	missense_variant	MODERATE	NPHS2	ENSG00000116218	transcript	ENST00000367615.8	c.686G>A	p.Arg229Gln	5/8	755/1855	229/383	686/1152	NA	NA	NA	NA	0.029	0.0267572	0.972045	2434,3	0.00119808	0.0145767	255|0	Nephrotic_syndrome\x2c_type_2\x2c_susceptibility_to|Proteinuria	.|HP:0000093:C0033687	.|Human_Phenotype_Ontology:MedGen	NA	3	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	D/D	1	5.93	PODO_HUMAN	B	P	5.93	229	28.2	0.935	T	Nphs2	E	2.51E-01	55.21939137	0.016664174	abnormal	4.02079	7827	nphs2	NA	360.80001	129	NA	NA	NA	NA	NA	NA
chr1	179557079	rs61747728	C	T	PASS	T	downstream_gene_variant	MODIFIER	AXDND1	ENSG00000162779	transcript	ENST00000367618.7	c.*2560C>T	NA	NA	NA	NA	NA	2344	NA	NA	NA	0.029	0.0267572	0.972045	2434,3	0.00119808	0.0145767	255|0	Nephrotic_syndrome\x2c_type_2\x2c_susceptibility_to|Proteinuria	.|HP:0000093:C0033687	.|Human_Phenotype_Ontology:MedGen	NA	3	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	D/D	1	5.93	PODO_HUMAN	B	P	5.93	229	28.2	0.935	T	Nphs2	E	2.51E-01	55.21939137	0.016664174	abnormal	4.02079	7827	nphs2	NA	360.80001	129	NA	NA	NA	NA	NA	NA
chr1	179559710	rs530318579	C	T	PASS	T	missense_variant	MODERATE	NPHS2	ENSG00000116218	transcript	ENST00000367615.8	c.503G>A	p.Arg168His	4/8	572/1855	168/383	503/1152	NA	NA	NA	NA	3.304e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant	C1868672:600995	MedGen:OMIM	NA	NA	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	D/D	1	4.52	./PODO_HUMAN	D	D	5.44	168	34	0.935	D	Nphs2	E	2.51E-01	55.21939137	0.016664174	abnormal	4.02079	7827	nphs2	NA	360.80001	142	NA	NA	NA	NA	NA	NA
chr1	179559710	rs530318579	C	T	PASS	T	downstream_gene_variant	MODIFIER	AXDND1	ENSG00000162779	transcript	ENST00000367618.7	c.*5191C>T	NA	NA	NA	NA	NA	4975	NA	NA	NA	3.304e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant	C1868672:600995	MedGen:OMIM	NA	NA	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	H	D/D	1	4.52	./PODO_HUMAN	D	D	5.44	168	34	0.935	D	Nphs2	E	2.51E-01	55.21939137	0.016664174	abnormal	4.02079	7827	nphs2	NA	360.80001	142	NA	NA	NA	NA	NA	NA
chr1	179575806	rs74315344	G	A	PASS	A	missense_variant	MODERATE	NPHS2	ENSG00000116218	transcript	ENST00000367615.8	c.59C>T	p.Pro20Leu	1/8	128/1855	20/383	59/1152	NA	NA	NA	NA	0.001945	0.00638978	0.99361	2488,0	0	0.00319489	5	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant	C1868672:600995	MedGen:OMIM	NA	NA	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	A/A	0.002	2.83	./PODO_HUMAN	B	B	3.85	20	19.45	0.703	D	Nphs2	E	2.51E-01	55.21939137	0.016664174	abnormal	4.02079	7827	nphs2	NA	360.80001	133	NA	NA	NA	NA	NA	NA
chr1	179575806	rs74315344	G	A	PASS	A	upstream_gene_variant	MODIFIER	RNU5F-2P	ENSG00000251875	transcript	ENST00000516066.1	n.-462G>A	NA	NA	NA	NA	NA	462	NA	NA	NA	0.001945	0.00638978	0.99361	2488,0	0	0.00319489	5	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant	C1868672:600995	MedGen:OMIM	NA	NA	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	A/A	0.002	2.83	./PODO_HUMAN	B	B	3.85	20	19.45	0.703	D	Nphs2	E	2.51E-01	55.21939137	0.016664174	abnormal	4.02079	7827	nphs2	NA	360.80001	133	NA	NA	NA	NA	NA	NA
chr1	179575915	rs12406197	C	A	PASS	A	5_prime_UTR_premature_start_codon_gain_variant	LOW	NPHS2	ENSG00000116218	transcript	ENST00000367615.8	c.-51G>T	NA	1/8	NA	NA	NA	NA	NA	NA	NA	0.179	0.297923	0.667732	1672,86	0.034345	0.183307	5|4|3	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant|Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant|Steroid-resistant_nephrotic_syndrome	C1868672:600995|C1868672:600995|HP:0012588:CN183857	MedGen:OMIM|MedGen:OMIM|Human_Phenotype_Ontology:MedGen	NA	NA	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphs2	E	2.51E-01	55.21939137	0.016664174	abnormal	4.02079	7827	nphs2	NA	360.80001	120	NA	NA	NA	NA	NA	NA
chr1	179575915	rs12406197	C	A	PASS	A	5_prime_UTR_variant	MODIFIER	NPHS2	ENSG00000116218	transcript	ENST00000367615.8	c.-51G>T	NA	1/8	NA	NA	NA	51	NA	NA	NA	0.179	0.297923	0.667732	1672,86	0.034345	0.183307	5|4|3	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant|Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant|Steroid-resistant_nephrotic_syndrome	C1868672:600995|C1868672:600995|HP:0012588:CN183857	MedGen:OMIM|MedGen:OMIM|Human_Phenotype_Ontology:MedGen	NA	NA	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphs2	E	2.51E-01	55.21939137	0.016664174	abnormal	4.02079	7827	nphs2	NA	360.80001	120	NA	NA	NA	NA	NA	NA
chr1	179575915	rs12406197	C	A	PASS	A	upstream_gene_variant	MODIFIER	RNU5F-2P	ENSG00000251875	transcript	ENST00000516066.1	n.-353C>A	NA	NA	NA	NA	NA	353	NA	NA	NA	0.179	0.297923	0.667732	1672,86	0.034345	0.183307	5|4|3	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant|Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant|Steroid-resistant_nephrotic_syndrome	C1868672:600995|C1868672:600995|HP:0012588:CN183857	MedGen:OMIM|MedGen:OMIM|Human_Phenotype_Ontology:MedGen	NA	NA	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphs2	E	2.51E-01	55.21939137	0.016664174	abnormal	4.02079	7827	nphs2	NA	360.80001	120	NA	NA	NA	NA	NA	NA
chr1	179575916	rs78541594	G	C	PASS	C	5_prime_UTR_variant	MODIFIER	NPHS2	ENSG00000116218	transcript	ENST00000367615.8	c.-52C>G	NA	1/8	NA	NA	NA	52	NA	NA	NA	0.009435	0.0966454	0.886581	2220,42	0.0167732	0.0650958	5|3	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant|Steroid-resistant_nephrotic_syndrome	C1868672:600995|HP:0012588:CN183857	MedGen:OMIM|Human_Phenotype_Ontology:MedGen	NA	NA	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphs2	E	2.51E-01	55.21939137	0.016664174	abnormal	4.02079	7827	nphs2	NA	360.80001	132	NA	NA	NA	NA	NA	NA
chr1	179575916	rs78541594	G	C	PASS	C	upstream_gene_variant	MODIFIER	RNU5F-2P	ENSG00000251875	transcript	ENST00000516066.1	n.-352G>C	NA	NA	NA	NA	NA	352	NA	NA	NA	0.009435	0.0966454	0.886581	2220,42	0.0167732	0.0650958	5|3	Nephrotic_syndrome\x2c_idiopathic\x2c_steroid-resistant|Steroid-resistant_nephrotic_syndrome	C1868672:600995|HP:0012588:CN183857	MedGen:OMIM|Human_Phenotype_Ontology:MedGen	NA	NA	600995(3)	NA	Nephrotic~syndrome~type~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nphs2	E	2.51E-01	55.21939137	0.016664174	abnormal	4.02079	7827	nphs2	NA	360.80001	132	NA	NA	NA	NA	NA	NA
chr1	182585422	rs486907	C	T	PASS	T	missense_variant	MODERATE	RNASEL	ENSG00000135828	transcript	ENST00000367559.7	c.1385G>A	p.Arg462Gln	2/7	1639/4238	462/741	1385/2226	NA	NA	NA	NA	0.309	0.323083	0.607827	1522,173	0.0690895	0.230631	255	Prostate_cancer\x2c_susceptibility_to	.	.	NA	2	601518(3)	NA	Prostate~cancer~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	M	P/P/P	0.154	0.0561	././RN5A_HUMAN	P	D	5.95	462	22.9	0.077	D	Rnasel	N	6.85E-01	40.63458363	-0.172654315	NA	8.78025	6041	NA	NA	2257.84547	83	NA	NA	NA	NA	NA	NA
chr1	182586014	rs74315364	C	A	PASS	A	stop_gained	HIGH	RNASEL	ENSG00000135828	transcript	ENST00000367559.7	c.793G>T	p.Glu265*	2/7	1047/4238	265/741	793/2226	NA	NA	(RNASEL|ENSG00000135828|1|1.00)	(RNASEL|ENSG00000135828|1|1.00)	0.003978	0.00359425	0.996406	2495,0	0	0.00179712	5	Prostate_cancer\x2c_hereditary\x2c_1	C2931456:601518:ORPHA1331	MedGen:OMIM:Orphanet	NA	NA	601518(3)	NA	Prostate~cancer~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	A/A/A	0.061	3.2	NA	NA	NA	5.15	NA	35	0.075	NA	Rnasel	N	6.85E-01	40.63458363	-0.172654315	NA	8.78025	6041	NA	NA	2257.84547	133	NA	NA	NA	NA	NA	NA
chr1	182586014	rs74315364	C	A	PASS	A	structural_interaction_variant	HIGH	RNASEL	ENSG00000135828	interaction	4G8L:A_233-A_265:ENST00000367559	c.793G>T	NA	2/7	NA	NA	NA	NA	NA	(RNASEL|ENSG00000135828|1|1.00)	(RNASEL|ENSG00000135828|1|1.00)	0.003978	0.00359425	0.996406	2495,0	0	0.00179712	5	Prostate_cancer\x2c_hereditary\x2c_1	C2931456:601518:ORPHA1331	MedGen:OMIM:Orphanet	NA	NA	601518(3)	NA	Prostate~cancer~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	A/A/A	0.061	3.2	NA	NA	NA	5.15	NA	35	0.075	NA	Rnasel	N	6.85E-01	40.63458363	-0.172654315	NA	8.78025	6041	NA	NA	2257.84547	133	NA	NA	NA	NA	NA	NA
chr1	182586014	rs74315364	C	A	PASS	A	structural_interaction_variant	HIGH	RNASEL	ENSG00000135828	interaction	4G8L:B_233-B_265:ENST00000367559	c.793G>T	NA	2/7	NA	NA	NA	NA	NA	(RNASEL|ENSG00000135828|1|1.00)	(RNASEL|ENSG00000135828|1|1.00)	0.003978	0.00359425	0.996406	2495,0	0	0.00179712	5	Prostate_cancer\x2c_hereditary\x2c_1	C2931456:601518:ORPHA1331	MedGen:OMIM:Orphanet	NA	NA	601518(3)	NA	Prostate~cancer~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	A/A/A	0.061	3.2	NA	NA	NA	5.15	NA	35	0.075	NA	Rnasel	N	6.85E-01	40.63458363	-0.172654315	NA	8.78025	6041	NA	NA	2257.84547	133	NA	NA	NA	NA	NA	NA
chr1	182586014	rs74315364	C	A	PASS	A	structural_interaction_variant	HIGH	RNASEL	ENSG00000135828	interaction	4G8L:C_233-C_265:ENST00000367559	c.793G>T	NA	2/7	NA	NA	NA	NA	NA	(RNASEL|ENSG00000135828|1|1.00)	(RNASEL|ENSG00000135828|1|1.00)	0.003978	0.00359425	0.996406	2495,0	0	0.00179712	5	Prostate_cancer\x2c_hereditary\x2c_1	C2931456:601518:ORPHA1331	MedGen:OMIM:Orphanet	NA	NA	601518(3)	NA	Prostate~cancer~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	A/A/A	0.061	3.2	NA	NA	NA	5.15	NA	35	0.075	NA	Rnasel	N	6.85E-01	40.63458363	-0.172654315	NA	8.78025	6041	NA	NA	2257.84547	133	NA	NA	NA	NA	NA	NA
chr1	182586014	rs74315364	C	A	PASS	A	structural_interaction_variant	HIGH	RNASEL	ENSG00000135828	interaction	4G8L:D_233-D_265:ENST00000367559	c.793G>T	NA	2/7	NA	NA	NA	NA	NA	(RNASEL|ENSG00000135828|1|1.00)	(RNASEL|ENSG00000135828|1|1.00)	0.003978	0.00359425	0.996406	2495,0	0	0.00179712	5	Prostate_cancer\x2c_hereditary\x2c_1	C2931456:601518:ORPHA1331	MedGen:OMIM:Orphanet	NA	NA	601518(3)	NA	Prostate~cancer~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	A/A/A	0.061	3.2	NA	NA	NA	5.15	NA	35	0.075	NA	Rnasel	N	6.85E-01	40.63458363	-0.172654315	NA	8.78025	6041	NA	NA	2257.84547	133	NA	NA	NA	NA	NA	NA
chr1	182586014	rs74315364	C	A	PASS	A	structural_interaction_variant	HIGH	RNASEL	ENSG00000135828	interaction	4OAU:C_233-C_265:ENST00000367559	c.793G>T	NA	2/7	NA	NA	NA	NA	NA	(RNASEL|ENSG00000135828|1|1.00)	(RNASEL|ENSG00000135828|1|1.00)	0.003978	0.00359425	0.996406	2495,0	0	0.00179712	5	Prostate_cancer\x2c_hereditary\x2c_1	C2931456:601518:ORPHA1331	MedGen:OMIM:Orphanet	NA	NA	601518(3)	NA	Prostate~cancer~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	A/A/A	0.061	3.2	NA	NA	NA	5.15	NA	35	0.075	NA	Rnasel	N	6.85E-01	40.63458363	-0.172654315	NA	8.78025	6041	NA	NA	2257.84547	133	NA	NA	NA	NA	NA	NA
chr1	182586014	rs74315364	C	A	PASS	A	structural_interaction_variant	HIGH	RNASEL	ENSG00000135828	interaction	4OAV:B_233-B_265:ENST00000367559	c.793G>T	NA	2/7	NA	NA	NA	NA	NA	(RNASEL|ENSG00000135828|1|1.00)	(RNASEL|ENSG00000135828|1|1.00)	0.003978	0.00359425	0.996406	2495,0	0	0.00179712	5	Prostate_cancer\x2c_hereditary\x2c_1	C2931456:601518:ORPHA1331	MedGen:OMIM:Orphanet	NA	NA	601518(3)	NA	Prostate~cancer~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	A/A/A	0.061	3.2	NA	NA	NA	5.15	NA	35	0.075	NA	Rnasel	N	6.85E-01	40.63458363	-0.172654315	NA	8.78025	6041	NA	NA	2257.84547	133	NA	NA	NA	NA	NA	NA
chr1	182586014	rs74315364	C	A	PASS	A	structural_interaction_variant	HIGH	RNASEL	ENSG00000135828	interaction	4OAV:D_233-D_265:ENST00000367559	c.793G>T	NA	2/7	NA	NA	NA	NA	NA	(RNASEL|ENSG00000135828|1|1.00)	(RNASEL|ENSG00000135828|1|1.00)	0.003978	0.00359425	0.996406	2495,0	0	0.00179712	5	Prostate_cancer\x2c_hereditary\x2c_1	C2931456:601518:ORPHA1331	MedGen:OMIM:Orphanet	NA	NA	601518(3)	NA	Prostate~cancer~1	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	NA	A/A/A	0.061	3.2	NA	NA	NA	5.15	NA	35	0.075	NA	Rnasel	N	6.85E-01	40.63458363	-0.172654315	NA	8.78025	6041	NA	NA	2257.84547	133	NA	NA	NA	NA	NA	NA
chr1	183240176	rs139043074	C	T	PASS	T	missense_variant	MODERATE	LAMC2	ENSG00000058085	transcript	ENST00000264144.4	c.3206C>T	p.Thr1069Met	21/23	3271/5147	1069/1193	3206/3582	NA	NA	NA	NA	0.001878	0.00199681	0.998003	2499,0	0	0.000998403	255|0	not_specified|Epidermolysis_bullosa\x2c_junctional	CN169374|C0079301:ORPHA305	MedGen|MedGen:Orphanet	NA	1	226650(3),226700(3)	NA	Epidermolysis~bullosa~junctional~non-Herlitz~type,Epidermolysis~bullosa~junctional~Herlitz~type	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	NA	NA	NA	NA	NA	N	N/N	0.004	-5.57	./LAMC2_HUMAN/.	B	B	5.69	1069	7.658	-1.665	T	Lamc2	E	7.74E-01	81.3871196	0.551058225	NA	8.10025	3918	NA	NA	1938.54056	134	NA	NA	NA	NA	NA	LAMC2
chr1	183563302	rs13306575	G	A	PASS	A	missense_variant	MODERATE	NCF2	ENSG00000116701	transcript	ENST00000367535.7	c.1183C>T	p.Arg395Trp	13/15	1435/2226	395/526	1183/1581	NA	NA	NA	NA	0.015	0.0311502	0.966454	2420,6	0.00239617	0.0179712	5|3	Chronic_granulomatous_disease\x2c_autosomal_recessive_cytochrome_b-positive\x2c_type_2|Chronic_granulomatous_disease	C1856245:233710|C0018203:ORPHA379	MedGen:OMIM|MedGen:Orphanet	NA	1	233710(3)	NA	Chronic~granulomatous~disease~due~to~deficiency~of~NCF-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	A/A/A/A	0.977	4.78	././NCF2_HUMAN	B/P/P	B/D/D	5.7	314,350,395	34	1.048	D	Ncf2/Smg7	NA	4.13E-01/9.12E-01	32.23047889/94.01391838	-0.306750577/1.308134829	./abnormal	13.42911/8.99331	4688/9887	./smg7	./fMLPpathway/rac1Pathway	2354.2528/4481.78688	121	NA	NA	NA	NA	NA	NA
chr1	183563302	rs13306575	G	A	PASS	A	intragenic_variant	MODIFIER	SMG7	ENSG00000116698	gene_variant	ENSG00000116698	n.183563302G>A	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.015	0.0311502	0.966454	2420,6	0.00239617	0.0179712	5|3	Chronic_granulomatous_disease\x2c_autosomal_recessive_cytochrome_b-positive\x2c_type_2|Chronic_granulomatous_disease	C1856245:233710|C0018203:ORPHA379	MedGen:OMIM|MedGen:Orphanet	NA	1	233710(3)	NA	Chronic~granulomatous~disease~due~to~deficiency~of~NCF-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	A/A/A/A	0.977	4.78	././NCF2_HUMAN	B/P/P	B/D/D	5.7	314,350,395	34	1.048	D	Ncf2/Smg7	NA	4.13E-01/9.12E-01	32.23047889/94.01391838	-0.306750577/1.308134829	./abnormal	13.42911/8.99331	4688/9887	./smg7	./fMLPpathway/rac1Pathway	2354.2528/4481.78688	121	NA	NA	NA	NA	NA	NA
chr1	183577667	rs119103276	G	C	PASS	C	structural_interaction_variant	HIGH	NCF2	ENSG00000116701	interaction	1E96:B_69-B_100:ENST00000367535	c.298C>G	NA	3/15	NA	NA	NA	NA	NA	NA	NA	0.00103	0.00239617	0.997604	2498,0	0	0.00119808	5	Chronic_granulomatous_disease\x2c_autosomal_recessive_cytochrome_b-positive\x2c_type_2	C1856245:233710	MedGen:OMIM	NA	NA	233710(3)	NA	Chronic~granulomatous~disease~due~to~deficiency~of~NCF-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	D/D/D/N	0.975	4.71	././NCF2_HUMAN	B	P/B/B	5.66	100	12.56	0.136	T	Ncf2/Smg7	NA	4.13E-01/9.12E-01	32.23047889/94.01391838	-0.306750577/1.308134829	./abnormal	13.42911/8.99331	4688/9887	./smg7	./fMLPpathway/rac1Pathway	2354.2528/4481.78688	132	NA	NA	NA	NA	NA	NA
chr1	183577667	rs119103276	G	C	PASS	C	structural_interaction_variant	HIGH	NCF2	ENSG00000116701	interaction	1WM5:A_69-A_100:ENST00000367535	c.298C>G	NA	3/15	NA	NA	NA	NA	NA	NA	NA	0.00103	0.00239617	0.997604	2498,0	0	0.00119808	5	Chronic_granulomatous_disease\x2c_autosomal_recessive_cytochrome_b-positive\x2c_type_2	C1856245:233710	MedGen:OMIM	NA	NA	233710(3)	NA	Chronic~granulomatous~disease~due~to~deficiency~of~NCF-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	D/D/D/N	0.975	4.71	././NCF2_HUMAN	B	P/B/B	5.66	100	12.56	0.136	T	Ncf2/Smg7	NA	4.13E-01/9.12E-01	32.23047889/94.01391838	-0.306750577/1.308134829	./abnormal	13.42911/8.99331	4688/9887	./smg7	./fMLPpathway/rac1Pathway	2354.2528/4481.78688	132	NA	NA	NA	NA	NA	NA
chr1	183577667	rs119103276	G	C	PASS	C	missense_variant	MODERATE	NCF2	ENSG00000116701	transcript	ENST00000367535.7	c.298C>G	p.Gln100Glu	3/15	550/2226	100/526	298/1581	NA	NA	NA	NA	0.00103	0.00239617	0.997604	2498,0	0	0.00119808	5	Chronic_granulomatous_disease\x2c_autosomal_recessive_cytochrome_b-positive\x2c_type_2	C1856245:233710	MedGen:OMIM	NA	NA	233710(3)	NA	Chronic~granulomatous~disease~due~to~deficiency~of~NCF-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	D/D/D/N	0.975	4.71	././NCF2_HUMAN	B	P/B/B	5.66	100	12.56	0.136	T	Ncf2/Smg7	NA	4.13E-01/9.12E-01	32.23047889/94.01391838	-0.306750577/1.308134829	./abnormal	13.42911/8.99331	4688/9887	./smg7	./fMLPpathway/rac1Pathway	2354.2528/4481.78688	132	NA	NA	NA	NA	NA	NA
chr1	183577667	rs119103276	G	C	PASS	C	intragenic_variant	MODIFIER	SMG7	ENSG00000116698	gene_variant	ENSG00000116698	n.183577667G>C	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.00103	0.00239617	0.997604	2498,0	0	0.00119808	5	Chronic_granulomatous_disease\x2c_autosomal_recessive_cytochrome_b-positive\x2c_type_2	C1856245:233710	MedGen:OMIM	NA	NA	233710(3)	NA	Chronic~granulomatous~disease~due~to~deficiency~of~NCF-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	D/D/D/N	0.975	4.71	././NCF2_HUMAN	B	P/B/B	5.66	100	12.56	0.136	T	Ncf2/Smg7	NA	4.13E-01/9.12E-01	32.23047889/94.01391838	-0.306750577/1.308134829	./abnormal	13.42911/8.99331	4688/9887	./smg7	./fMLPpathway/rac1Pathway	2354.2528/4481.78688	132	NA	NA	NA	NA	NA	NA
chr1	186178506	rs121434382	A	G	PASS	G	missense_variant	MODERATE	HMCN1	ENSG00000143341	transcript	ENST00000271588.8	c.16034A>G	p.Gln5345Arg	104/107	16263/18208	5345/5635	16034/16908	NA	NA	NA	NA	0.0008484	0.000399361	0.999601	2503,0	0	0.000199681	255	MACULAR_DEGENERATION\x2c_AGE-RELATED\x2c_1\x2c_SUSCEPTIBILITY_TO	.	.	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	603075(3)	NA	NA	NA	NA	NA	{Macular~degeneration~age-related~1}	N	D/N	0.995	4.65	HMCN1_HUMAN	B	B	5.77	5345	12.34	1.199	T	Hmcn1	NA	6.75E-01	0.247699929	-3.689691478	abnormal	19.62945	83872	hmcn1	NA	8270.20936	132	NA	NA	NA	NA	NA	NA
chr1	186178506	rs121434382	A	G	PASS	G	upstream_gene_variant	MODIFIER	GS1-174L6.4	ENSG00000224691	transcript	ENST00000428391.1	n.-1204T>C	NA	NA	NA	NA	NA	1204	NA	NA	NA	0.0008484	0.000399361	0.999601	2503,0	0	0.000199681	255	MACULAR_DEGENERATION\x2c_AGE-RELATED\x2c_1\x2c_SUSCEPTIBILITY_TO	.	.	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	603075(3)	NA	NA	NA	NA	NA	{Macular~degeneration~age-related~1}	N	D/N	0.995	4.65	HMCN1_HUMAN	B	B	5.77	5345	12.34	1.199	T	Hmcn1	NA	6.75E-01	0.247699929	-3.689691478	abnormal	19.62945	83872	hmcn1	NA	8270.20936	132	NA	NA	NA	NA	NA	NA
chr1	193122233	rs150951102	C	T	PASS	T	synonymous_variant	LOW	CDC73	ENSG00000134371	transcript	ENST00000367435.3	c.33C>T	p.Tyr11Tyr	1/17	217/4969	11/531	33/1596	NA	NA	NA	NA	0.0006013	0.000399361	0.999601	2503,0	0	0.000199681	255|3|3	Parathyroid_carcinoma|Hyperparathyroidism_2|Isolated_Hyperparathyroidism	C0687150:608266:ORPHA143:255037004|C1704981:145001:ORPHA99880|CN239442	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen	NA	NA	608266(3),145001(3),145001(3),145000(3)	NA	Parathyroid~carcinoma,Parathyroid~adenoma~with~cystic~changes,Hyperparathyroidism-jaw~tumor~syndrome,Hyperparathyroidism~familial~primary	NA	NA	NA	NA	NA	NA	NA	NA	NA	-,AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Cdc73	E	1.12E-01	27.41802312	-0.383807564	abnormal	0.23098	79577	cdc73	NA	6.11441	134	NA	NA	NA	NA	NA	NA
chr1	196673103	rs800292	G	A	PASS	A	missense_variant	MODERATE	CFH	ENSG00000000971	transcript	ENST00000367429.8	c.184G>A	p.Val62Ile	2/22	424/4127	62/1231	184/3696	NA	NA	NA	NA	0.32	0.401757	0.33107	829,669	0.267173	0.468051	255|1|2|2|2|2	Age-related_macular_degeneration_4|not_provided|Basal_laminar_drusen|Macular_degeneration|Mesangiocapillary_glomerulonephritis\x2c_type_II|Atypical_hemolytic_uremic_syndrome	C1853147:610698|CN221809|C0730295:126700:312926005|HP:0000608:C1849131|C0268743:ORPHA93571:59479006|C2931788:ORPHA2134	MedGen:OMIM|MedGen|MedGen:OMIM:SNOMED_CT|Human_Phenotype_Ontology:MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet	NA	4	609814(3),609814(3),609814(3),126700(3)	NA	Complement~factor~H~deficiency,Complement~factor~H~deficiency,Complement~factor~H~deficiency,Basal~laminar~drusen	NA	NA	-,AR/AD	NA	NA	NA	NA	NA	610698(3),235400(3)	AR/AD,AR/AD,AR/AD,AD	NA	NA	NA	NA	{Macular~degeneration~age-related~4},{Hemolytic~uremic~syndrome~atypical~susceptibility~to~1}	N	P/P/P	0.028	5.12	././CFAH_HUMAN/.	B	B	5.12	62	0.040	0.168	T/./T	Cfh	N	3.58E-01	80.37272942	0.519883383	NA	6.09993	3075	NA	NA	1002.72313	86	NA	NA	NA	NA	NA	NA
chr1	196690107	rs1061170	C	T	PASS	T	missense_variant	MODERATE	CFH	ENSG00000000971	transcript	ENST00000367429.8	c.1204C>T	p.His402Tyr	9/22	1444/4127	402/1231	1204/3696	NA	NA	NA	NA	0.671	0.355831	0.0886581	222,1391	0.555511	0.733427	255|5,2|2|2|2	Age-related_macular_degeneration_4|Basal_laminar_drusen,Basal_laminar_drusen|Macular_degeneration|Mesangiocapillary_glomerulonephritis\x2c_type_II|Atypical_hemolytic_uremic_syndrome	C1853147:610698|C0730295:126700:312926005,C0730295:126700:312926005|HP:0000608:C1849131|C0268743:ORPHA93571:59479006|C2931788:ORPHA2134	MedGen:OMIM|MedGen:OMIM:SNOMED_CT,MedGen:OMIM:SNOMED_CT|Human_Phenotype_Ontology:MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet	NA	2	609814(3),609814(3),609814(3),126700(3)	NA	Complement~factor~H~deficiency,Complement~factor~H~deficiency,Complement~factor~H~deficiency,Basal~laminar~drusen	NA	NA	-,AR/AD	NA	NA	NA	NA	NA	610698(3),235400(3)	AR/AD,AR/AD,AR/AD,AD	NA	NA	NA	NA	{Macular~degeneration~age-related~4},{Hemolytic~uremic~syndrome~atypical~susceptibility~to~1}	NA	P/P/P	0	-9.09	NA	B	B	4.54	338,402	0.001	-5.376	T/./T	Cfh	N	3.58E-01	80.37272942	0.519883383	NA	6.09993	3075	NA	NA	1002.72313	86	NA	NA	NA	NA	NA	NA
chr1	196713817	rs2274700	G	A	PASS	A	synonymous_variant	LOW	CFH	ENSG00000000971	transcript	ENST00000367429.8	c.1419G>A	p.Ala473Ala	10/22	1659/4127	473/1231	1419/3696	NA	NA	NA	NA	0.442	0.490815	0.275559	690,585	0.233626	0.479034	2|2|2|2,255	Macular_degeneration|Mesangiocapillary_glomerulonephritis\x2c_type_II|Atypical_hemolytic_uremic_syndrome|Basal_laminar_drusen,Age-related_macular_degeneration_4	HP:0000608:C1849131|C0268743:ORPHA93571:59479006|C2931788:ORPHA2134|C0730295:126700:312926005,C1853147:610698	Human_Phenotype_Ontology:MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet|MedGen:OMIM:SNOMED_CT,MedGen:OMIM	NA	4	609814(3),609814(3),609814(3),126700(3)	NA	Complement~factor~H~deficiency,Complement~factor~H~deficiency,Complement~factor~H~deficiency,Basal~laminar~drusen	NA	NA	-,AR/AD	NA	NA	NA	NA	NA	610698(3),235400(3)	AR/AD,AR/AD,AR/AD,AD	NA	NA	NA	NA	{Macular~degeneration~age-related~4},{Hemolytic~uremic~syndrome~atypical~susceptibility~to~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Cfh	N	3.58E-01	80.37272942	0.519883383	NA	6.09993	3075	NA	NA	1002.72313	100	NA	NA	NA	NA	NA	NA
chr1	196713905	rs570523689	C	T	PASS	T	missense_variant	MODERATE	CFH	ENSG00000000971	transcript	ENST00000367429.8	c.1507C>T	p.Pro503Ser	10/22	1747/4127	503/1231	1507/3696	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	255	Age-related_macular_degeneration_4	C1853147:610698	MedGen:OMIM	NA	NA	609814(3),609814(3),609814(3),126700(3)	NA	Complement~factor~H~deficiency,Complement~factor~H~deficiency,Complement~factor~H~deficiency,Basal~laminar~drusen	NA	NA	-,AR/AD	NA	NA	NA	NA	NA	610698(3),235400(3)	AR/AD,AR/AD,AR/AD,AD	NA	NA	NA	NA	{Macular~degeneration~age-related~4},{Hemolytic~uremic~syndrome~atypical~susceptibility~to~1}	H	N	0.594	4.28	CFAH_HUMAN	D	D	5.23	503	25.4	0.892	D	Cfh	N	3.58E-01	80.37272942	0.519883383	NA	6.09993	3075	NA	NA	1002.72313	142	NA	NA	NA	NA	NA	NA
chr1	196727803	rs1410996	G	A	PASS	A	intron_variant	MODIFIER	CFH	ENSG00000000971	transcript	ENST00000367429.8	c.2237-543G>A	NA	14/21	NA	NA	NA	NA	NA	NA	NA	NA	0.49401	0.248003	621,646	0.257987	0.504992	255	Age-related_macular_degeneration_4	C1853147:610698	MedGen:OMIM	NA	NA	609814(3),609814(3),609814(3),126700(3)	NA	Complement~factor~H~deficiency,Complement~factor~H~deficiency,Complement~factor~H~deficiency,Basal~laminar~drusen	NA	NA	-,AR/AD	NA	NA	NA	NA	NA	610698(3),235400(3)	AR/AD,AR/AD,AR/AD,AD	NA	NA	NA	NA	{Macular~degeneration~age-related~4},{Hemolytic~uremic~syndrome~atypical~susceptibility~to~1}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Cfh	N	3.58E-01	80.37272942	0.519883383	NA	6.09993	3075	NA	NA	1002.72313	88	NA	NA	NA	NA	NA	NA
chr1	196747131	rs121913060	G	T	PASS	T	stop_gained	HIGH	CFH	ENSG00000000971	transcript	ENST00000367429.8	c.3514G>T	p.Glu1172*	22/22	3754/4127	1172/1231	3514/3696	NA	NA	NA	NA	8.237e-06	0.000399361	0.999601	2503,0	0	0.000199681	255	Atypical_hemolytic-uremic_syndrome_1	C2749604:235400	MedGen:OMIM	NA	NA	609814(3),609814(3),609814(3),126700(3)	NA	Complement~factor~H~deficiency,Complement~factor~H~deficiency,Complement~factor~H~deficiency,Basal~laminar~drusen	NA	NA	-,AR/AD	NA	NA	NA	NA	NA	610698(3),235400(3)	AR/AD,AR/AD,AR/AD,AD	NA	NA	NA	NA	{Macular~degeneration~age-related~4},{Hemolytic~uremic~syndrome~atypical~susceptibility~to~1}	NA	D	0.006	2.56	NA	NA	NA	4.48	NA	39	0.15	NA	Cfh	N	3.58E-01	80.37272942	0.519883383	NA	6.09993	3075	NA	NA	1002.72313	133	NA	NA	NA	NA	NA	NA
chr1	197061891	rs6003	C	T	PASS	T	missense_variant	MODERATE	F13B	ENSG00000143278	transcript	ENST00000367412.1	c.344G>A	p.Arg115His	3/12	388/2217	115/661	344/1986	NA	NA	NA	NA	0.872	0.214457	0.13099	328,1639	0.654553	0.761781	255|2|2	Venous_thrombosis\x2c_susceptibility_to|not_specified|Factor_xiii\x2c_b_subunit\x2c_deficiency_of	CN068878|CN169374|C2750481:613235	MedGen|MedGen|MedGen:OMIM	NA	NA	613235(3)	NA	Factor~XIIIB~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	P	0	-0.818	F13B_HUMAN	B	B	5.85	115	5.616	-1.615	T	F13b	NA	5.08E-01	86.21137061	0.731244617	NA	2.48552	2165	NA	NA	130.2596	52	NA	NA	NA	NA	NA	NA
chr1	197086795	rs10754213	T	C	PASS	C	splice_region_variant&intron_variant	LOW	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.10331+8A>G	NA	27/27	NA	NA	NA	NA	NA	NA	NA	0.878	0.217252	0.108626	272,1688	0.674121	0.782748	255|2	not_specified|Primary_Microcephaly\x2c_Recessive	CN169374|CN239428	MedGen|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	120	NA	NA	NA	NA	NA	NA
chr1	197090947	rs193251130	T	G	PASS	G	missense_variant	MODERATE	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.9539A>C	p.Gln3180Pro	23/28	9796/10887	3180/3477	9539/10434	NA	NA	NA	NA	0.005024	0.0211661	0.978035	2449,2	0.000798722	0.0113818	255|0|3	Primary_autosomal_recessive_microcephaly_5|not_specified|Primary_Microcephaly\x2c_Recessive	C1837501:608716|CN169374|CN239428	MedGen:OMIM|MedGen|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	A/A/A	0.251	2.61	././ASPM_HUMAN	P	D	4.93	1166,1595,3180	22.7	1.011	T/D/D/.	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	135	NA	NA	NA	NA	NA	NA
chr1	197090994	rs143931757	A	G	PASS	G	synonymous_variant	LOW	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.9492T>C	p.Tyr3164Tyr	23/28	9749/10887	3164/3477	9492/10434	NA	NA	NA	NA	0.002306	0.00439297	0.995607	2493,0	0	0.00219649	5,0	Primary_autosomal_recessive_microcephaly_5,Primary_autosomal_recessive_microcephaly_5	C1837501:608716,C1837501:608716	MedGen:OMIM,MedGen:OMIM	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	134	NA	NA	NA	NA	NA	NA
chr1	197093070	rs151142538	A	G	PASS	G	synonymous_variant	LOW	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.9276T>C	p.Gly3092Gly	21/28	9533/10887	3092/3477	9276/10434	NA	NA	NA	NA	0.0003377	0.00279553	0.997204	2497,0	0	0.00139776	255	not_specified	CN169374	MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	134	NA	NA	NA	NA	NA	NA
chr1	197093168	rs137852994	G	A	PASS	A	stop_gained	HIGH	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.9178C>T	p.Gln3060*	21/28	9435/10887	3060/3477	9178/10434	NA	NA	(ASPM|ENSG00000066279|1|1.00)	(ASPM|ENSG00000066279|1|1.00)	3.295e-05	0.000798722	0.999201	2502,0	0	0.000399361	5|5	Primary_autosomal_recessive_microcephaly_5|not_provided	C1837501:608716|CN221809	MedGen:OMIM|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	A/A/A	0.996	3.22	NA	NA	NA	5.18	NA	44	0.998	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	133	NA	NA	NA	NA	NA	NA
chr1	197101467	rs199422173	TTC	T	PASS	T	frameshift_variant	HIGH	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.7782_7783delGA	p.Lys2595fs	18/28	8040/10887	2594/3477	7782/10434	NA	NA	(ASPM|ENSG00000066279|1|1.00)	NA	0.000297	NA	NA	NA	NA	NA	5|5	Primary_autosomal_recessive_microcephaly_5|not_provided	C1837501:608716|CN221809	MedGen:OMIM|MedGen	NA	1	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	136	TTTCTTn|Simple_repeat|Simple_repeat	NA	NA	NA	NA	NA
chr1	197101490	rs189678019	A	G	PASS	G	synonymous_variant	LOW	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.7761T>C	p.Tyr2587Tyr	18/28	8018/10887	2587/3477	7761/10434	NA	NA	NA	NA	2.473e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Primary_autosomal_recessive_microcephaly_5	C1837501:608716	MedGen:OMIM	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	135	TTTCTTn|Simple_repeat|Simple_repeat	NA	NA	NA	NA	NA
chr1	197101685	rs1412640	T	C	PASS	C	synonymous_variant	LOW	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.7566A>G	p.Leu2522Leu	18/28	7823/10887	2522/3477	7566/10434	NA	NA	NA	NA	0.887	0.22524	0.0714856	179,1761	0.703275	0.815895	2|255|2	Primary_autosomal_recessive_microcephaly_5|not_specified|Primary_Microcephaly\x2c_Recessive	C1837501:608716|CN169374|CN239428	MedGen:OMIM|MedGen|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	88	NA	NA	NA	NA	NA	NA
chr1	197101776	rs118010078	C	T	PASS	T	missense_variant	MODERATE	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.7475G>A	p.Arg2492Lys	18/28	7732/10887	2492/3477	7475/10434	NA	NA	NA	NA	0.0008731	0.00279553	0.997204	2497,0	0	0.00139776	255|0	not_specified|Primary_Microcephaly\x2c_Recessive	CN169374|CN239428	MedGen|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	D/D/D	0.946	4.83	./ASPM_HUMAN	P	P/D	4.83	478,2492	19.53	0.85	T/.	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	132	NA	NA	NA	NA	NA	NA
chr1	197102476	rs140922974	A	G	PASS	G	synonymous_variant	LOW	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.6775T>C	p.Leu2259Leu	18/28	7032/10887	2259/3477	6775/10434	NA	NA	NA	NA	0.000865	0.00599042	0.99401	2489,0	0	0.00299521	255	not_specified	CN169374	MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	134	NA	NA	NA	NA	NA	NA
chr1	197103126	rs150327858	T	C	PASS	C	missense_variant	MODERATE	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.6125A>G	p.Asp2042Gly	18/28	6382/10887	2042/3477	6125/10434	NA	NA	NA	NA	0.0004201	0.000399361	0.999601	2503,0	0	0.000199681	0|255	Primary_autosomal_recessive_microcephaly_5|not_specified	C1837501:608716|CN169374	MedGen:OMIM|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	N/N/N	0.743	3.15	ASPM_HUMAN	B	P	5.57	2042	13.59	0.113	T	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	134	NA	NA	NA	NA	NA	NA
chr1	197103311	rs150642468	G	A	PASS	A	synonymous_variant	LOW	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.5940C>T	p.Tyr1980Tyr	18/28	6197/10887	1980/3477	5940/10434	NA	NA	NA	NA	0.0005024	0.00279553	0.997204	2497,0	0	0.00139776	255	not_specified	CN169374	MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	134	NA	NA	NA	NA	NA	NA
chr1	197104027	rs143733126	A	G	PASS	G	missense_variant	MODERATE	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.5224T>C	p.Tyr1742His	18/28	5481/10887	1742/3477	5224/10434	NA	NA	NA	NA	0.001557	0.00119808	0.998802	2501,0	0	0.000599042	0|255	Primary_autosomal_recessive_microcephaly_5|not_specified	C1837501:608716|CN169374	MedGen:OMIM|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	N/N/N	0.176	-1.25	ASPM_HUMAN	B	B	5.98	1742	0.012	-0.183	T	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	134	NA	NA	NA	NA	NA	NA
chr1	197105038	rs139367209	G	A	PASS	A	missense_variant	MODERATE	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.4213C>T	p.Arg1405Cys	18/28	4470/10887	1405/3477	4213/10434	NA	NA	NA	NA	0.005495	0.00678914	0.992412	2485,2	0.000798722	0.00419329	255|0	not_specified|Primary_Microcephaly\x2c_Recessive	CN169374|CN239428	MedGen|MedGen	NA	1	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	M	D/D/D	0.998	4.33	ASPM_HUMAN	D	D	5.24	1405	29.8	0.953	D	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	134	NA	NA	NA	NA	NA	NA
chr1	197122053	rs41299587	A	C	PASS	C	intron_variant	MODIFIER	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.3742-10T>G	NA	15/27	NA	NA	NA	NA	NA	NA	NA	0.00676	0.0071885	0.992812	2486,0	0	0.00359425	255|0	not_specified|Primary_Microcephaly\x2c_Recessive	CN169374|CN239428	MedGen|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	127	NA	NA	NA	NA	NA	NA
chr1	197122156	rs138558822	T	C	PASS	C	splice_region_variant&intron_variant	LOW	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.3741+3A>G	NA	15/27	NA	NA	NA	NA	NA	NA	NA	0.00183	0.00958466	0.990415	2480,0	0	0.00479233	255|0	not_specified|Primary_Microcephaly\x2c_Recessive	CN169374|CN239428	MedGen|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	134	NA	NA	NA	NA	NA	NA
chr1	197122305	rs149303254	T	C	PASS	C	splice_region_variant&intron_variant	LOW	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.3599-4A>G	NA	14/27	NA	NA	NA	NA	NA	NA	NA	0.0007496	0.00638978	0.99361	2488,0	0	0.00319489	0|255	Primary_autosomal_recessive_microcephaly_5|not_specified	C1837501:608716|CN169374	MedGen:OMIM|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	134	NA	NA	NA	NA	NA	NA
chr1	197122407	rs4915337	A	T	PASS	T	synonymous_variant	LOW	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.3579T>A	p.Ser1193Ser	14/28	3836/10887	1193/3477	3579/10434	NA	NA	NA	NA	0.878	0.217652	0.108626	272,1687	0.673722	0.782548	2|255|2	Primary_autosomal_recessive_microcephaly_5|not_specified|Primary_Microcephaly\x2c_Recessive	C1837501:608716|CN169374|CN239428	MedGen:OMIM|MedGen|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	111	NA	NA	NA	NA	NA	NA
chr1	197133615	rs4915344	A	G	PASS	G	intron_variant	MODIFIER	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.2174-20T>C	NA	5/27	NA	NA	NA	NA	NA	NA	NA	0.241	0.279952	0.560304	1403,400	0.159744	0.29972	255	not_specified	CN169374	MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	111	NA	NA	NA	NA	NA	NA
chr1	197142867	rs143294539	T	C	PASS	C	missense_variant	MODERATE	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.1385A>G	p.Tyr462Cys	3/28	1642/10887	462/3477	1385/10434	NA	NA	NA	NA	0.0004614	0.00678914	0.993211	2487,0	0	0.00339457	255	not_specified	CN169374	MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	N/N	0.001	1.6	./ASPM_HUMAN	B	B	5.44	462	0.012	0.128	T	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	134	NA	NA	NA	NA	NA	NA
chr1	197142867	rs143294539	T	C	PASS	C	upstream_gene_variant	MODIFIER	SEPT14P12	ENSG00000235748	transcript	ENST00000442280.1	n.-3560A>G	NA	NA	NA	NA	NA	3560	NA	NA	NA	0.0004614	0.00678914	0.993211	2487,0	0	0.00339457	255	not_specified	CN169374	MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	N/N	0.001	1.6	./ASPM_HUMAN	B	B	5.44	462	0.012	0.128	T	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	134	NA	NA	NA	NA	NA	NA
chr1	197143096	rs753424199	ACT	A	PASS	A	frameshift_variant	HIGH	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.1154_1155delAG	p.Glu385fs	3/28	1412/10887	385/3477	1154/10434	NA	NA	(ASPM|ENSG00000066279|1|1.00)	NA	1.649e-05	NA	NA	NA	NA	NA	5	not_provided	CN221809	MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	144	NA	NA	NA	NA	NA	NA
chr1	197143096	rs753424199	ACT	A	PASS	A	upstream_gene_variant	MODIFIER	SEPT14P12	ENSG00000235748	transcript	ENST00000442280.1	n.-3791_-3790delAG	NA	NA	NA	NA	NA	3790	NA	(ASPM|ENSG00000066279|1|1.00)	NA	1.649e-05	NA	NA	NA	NA	NA	5	not_provided	CN221809	MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	144	NA	NA	NA	NA	NA	NA
chr1	197143315	rs12025066	T	C	PASS	C	missense_variant	MODERATE	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.937A>G	p.Ile313Val	3/28	1194/10887	313/3477	937/10434	NA	NA	NA	NA	0.000939	0.00359425	0.996406	2495,0	0	0.00179712	255	Primary_autosomal_recessive_microcephaly_5	C1837501:608716	MedGen:OMIM	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	N/N	0.02	0.0921	./ASPM_HUMAN	B	B	5.49	313	0.004	-0.814	T	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	120	NA	NA	NA	NA	NA	NA
chr1	197143315	rs12025066	T	C	PASS	C	upstream_gene_variant	MODIFIER	SEPT14P12	ENSG00000235748	transcript	ENST00000442280.1	n.-4008A>G	NA	NA	NA	NA	NA	4008	NA	NA	NA	0.000939	0.00359425	0.996406	2495,0	0	0.00179712	255	Primary_autosomal_recessive_microcephaly_5	C1837501:608716	MedGen:OMIM	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	N/N	0.02	0.0921	./ASPM_HUMAN	B	B	5.49	313	0.004	-0.814	T	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	120	NA	NA	NA	NA	NA	NA
chr1	197143319	rs563858170	G	C	PASS	C	missense_variant	MODERATE	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.933C>G	p.Ser311Arg	3/28	1190/10887	311/3477	933/10434	NA	NA	NA	NA	0.0007578	0.00119808	0.998802	2501,0	0	0.000599042	255	not_specified	CN169374	MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	N/N	0.783	1.65	./ASPM_HUMAN	B	B	5.49	311	23.6	1.038	D	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	142	NA	NA	NA	NA	NA	NA
chr1	197143319	rs563858170	G	C	PASS	C	upstream_gene_variant	MODIFIER	SEPT14P12	ENSG00000235748	transcript	ENST00000442280.1	n.-4012C>G	NA	NA	NA	NA	NA	4012	NA	NA	NA	0.0007578	0.00119808	0.998802	2501,0	0	0.000599042	255	not_specified	CN169374	MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	L	N/N	0.783	1.65	./ASPM_HUMAN	B	B	5.49	311	23.6	1.038	D	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	142	NA	NA	NA	NA	NA	NA
chr1	197143403	rs6677082	G	A	PASS	A	synonymous_variant	LOW	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.849C>T	p.Ser283Ser	3/28	1106/10887	283/3477	849/10434	NA	NA	NA	NA	0.869	0.211661	0.138578	347,1627	0.64976	0.755591	255|2	not_specified|Primary_Microcephaly\x2c_Recessive	CN169374|CN239428	MedGen|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	116	NA	NA	NA	NA	NA	NA
chr1	197143403	rs6677082	G	A	PASS	A	upstream_gene_variant	MODIFIER	SEPT14P12	ENSG00000235748	transcript	ENST00000442280.1	n.-4096C>T	NA	NA	NA	NA	NA	4096	NA	NA	NA	0.869	0.211661	0.138578	347,1627	0.64976	0.755591	255|2	not_specified|Primary_Microcephaly\x2c_Recessive	CN169374|CN239428	MedGen|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	116	NA	NA	NA	NA	NA	NA
chr1	197143943	rs1571964	G	A	PASS	A	upstream_gene_variant	MODIFIER	SEPT14P12	ENSG00000235748	transcript	ENST00000442280.1	n.-4636C>T	NA	NA	NA	NA	NA	4636	NA	NA	NA	0.868	0.211661	0.138578	347,1627	0.64976	0.755591	255|2	not_specified|Primary_Microcephaly\x2c_Recessive	CN169374|CN239428	MedGen|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	88	NA	NA	NA	NA	NA	NA
chr1	197143943	rs1571964	G	A	PASS	A	intron_variant	MODIFIER	ASPM	ENSG00000066279	transcript	ENST00000367409.8	c.441+14C>T	NA	2/27	NA	NA	NA	NA	NA	NA	NA	0.868	0.211661	0.138578	347,1627	0.64976	0.755591	255|2	not_specified|Primary_Microcephaly\x2c_Recessive	CN169374|CN239428	MedGen|MedGen	NA	NA	608716(3)	NA	Microcephaly~5~primary~autosomal~recessive	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Aspm	N	9.84E-01	96.74451522	1.76062236	abnormal	14.00345	259266	aspm	NA	4776.21455	88	NA	NA	NA	NA	NA	NA
chr1	197328835	rs137853138	G	A	PASS	A	missense_variant	MODERATE	CRB1	ENSG00000134376	transcript	ENST00000367400.7	c.484G>A	p.Val162Met	2/12	619/4932	162/1406	484/4221	NA	NA	NA	NA	0.001186	0.00319489	0.996805	2496,0	0	0.00159744	255|0|3|3	Pigmented_paravenous_chorioretinal_atrophy|not_specified|Leber_congenital_amaurosis|Retinitis_Pigmentosa\x2c_Recessive	C1868310:172870:ORPHA251295|CN169374|C0339527:ORPHA65:193413001|CN239466	MedGen:OMIM:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen	NA	NA	600105(3),172870(3),613835(3)	NA	Retinitis~pigmentosa-12~autosomal~recessive,Pigmented~paravenous~chorioretinal~atrophy,Leber~congenital~amaurosis~8	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,-	NA	NA	NA	NA	NA	L	A/A/A/A	0.762	-8.36	./././CRUM1_HUMAN/.	B	B/B/B/B/P	5.41	162,93,162,162,187	0.011	-1.265	T	Crb1	E	4.01E-02	0.843359283	-2.563327215	NA	2.55575	23418	NA	NA	137.7212	133	NA	NA	NA	NA	NA	NA
chr1	197421010	rs115352681	C	T	PASS	T	synonymous_variant	LOW	CRB1	ENSG00000134376	transcript	ENST00000367400.7	c.1182C>T	p.Cys394Cys	6/12	1317/4932	394/1406	1182/4221	NA	NA	NA	NA	6.589e-05	0.000399361	0.999601	2503,0	0	0.000199681	5	Leber_congenital_amaurosis_8	C3151202:613835	MedGen:OMIM	NA	1	600105(3),172870(3),613835(3)	NA	Retinitis~pigmentosa-12~autosomal~recessive,Pigmented~paravenous~chorioretinal~atrophy,Leber~congenital~amaurosis~8	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Crb1	E	4.01E-02	0.843359283	-2.563327215	NA	2.55575	23418	NA	NA	137.7212	132	NA	NA	NA	NA	NA	NA
chr1	197427631	rs62636287	G	A	PASS	A	missense_variant	MODERATE	CRB1	ENSG00000134376	transcript	ENST00000367400.7	c.2306G>A	p.Arg769His	7/12	2441/4932	769/1406	2306/4221	NA	NA	NA	NA	0.004456	0.0155751	0.984026	2464,1	0.000399361	0.0081869	1|255|3|3|3	not_provided|not_specified|Retinitis_Pigmentosa\x2c_Recessive|Pigmented_paravenous_chorioretinal_atrophy|Leber_congenital_amaurosis	CN221809|CN169374|CN239466|C1868310:172870:ORPHA251295|C0339527:ORPHA65:193413001	MedGen|MedGen|MedGen|MedGen:OMIM:Orphanet|MedGen:Orphanet:SNOMED_CT	NA	2	600105(3),172870(3),613835(3)	NA	Retinitis~pigmentosa-12~autosomal~recessive,Pigmented~paravenous~chorioretinal~atrophy,Leber~congenital~amaurosis~8	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,-	NA	NA	NA	NA	NA	N	N/N/N/N/N/N/N	0.335	0.558	./././CRUM1_HUMAN	B	B	5.56	700,657,418,769	3.556	0.239	T	Crb1	E	4.01E-02	0.843359283	-2.563327215	NA	2.55575	23418	NA	NA	137.7212	131	NA	NA	NA	NA	NA	NA
chr1	197434985	rs62635656	T	C	PASS	C	missense_variant	MODERATE	CRB1	ENSG00000134376	transcript	ENST00000367400.7	c.3122T>C	p.Met1041Thr	9/12	3257/4932	1041/1406	3122/4221	NA	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5|1	Retinitis_pigmentosa_12|not_provided	C1838647:600105|CN221809	MedGen:OMIM|MedGen	NA	NA	600105(3),172870(3),613835(3)	NA	Retinitis~pigmentosa-12~autosomal~recessive,Pigmented~paravenous~chorioretinal~atrophy,Leber~congenital~amaurosis~8	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,-	NA	NA	NA	NA	NA	M	A/A/A/A/A/A	0.99	5.7	./././CRUM1_HUMAN	D/D/D/B	D/D/D/P	5.7	1017,929,690,1041	16.73	1.061	D	Crb1	E	4.01E-02	0.843359283	-2.563327215	NA	2.55575	23418	NA	NA	137.7212	133	NA	NA	NA	NA	NA	NA
chr1	197434985	rs62635656	T	C	PASS	C	downstream_gene_variant	MODIFIER	RP11-75C23.1	ENSG00000230260	transcript	ENST00000422250.1	n.*2991A>G	NA	NA	NA	NA	NA	2991	NA	NA	NA	NA	0.000399361	0.999601	2503,0	0	0.000199681	5|1	Retinitis_pigmentosa_12|not_provided	C1838647:600105|CN221809	MedGen:OMIM|MedGen	NA	NA	600105(3),172870(3),613835(3)	NA	Retinitis~pigmentosa-12~autosomal~recessive,Pigmented~paravenous~chorioretinal~atrophy,Leber~congenital~amaurosis~8	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,-	NA	NA	NA	NA	NA	M	A/A/A/A/A/A	0.99	5.7	./././CRUM1_HUMAN	D/D/D/B	D/D/D/P	5.7	1017,929,690,1041	16.73	1.061	D	Crb1	E	4.01E-02	0.843359283	-2.563327215	NA	2.55575	23418	NA	NA	137.7212	133	NA	NA	NA	NA	NA	NA
chr1	198754304	rs114970039	T	C	PASS	C	missense_variant	MODERATE	PTPRC	ENSG00000081237	transcript	ENST00000442510.6	c.3545T>C	p.Leu1182Ser	32/33	3686/5164	1182/1306	3545/3921	NA	NA	NA	NA	0.0002636	0.00159744	0.998403	2500,0	0	0.000798722	4	not_provided	CN221809	MedGen	NA	NA	608971(3)	NA	Severe~combined~immunodeficiency~T~cell-negative~B-cell/natural~killer-cell~positive	NA	NA	-,-	NA	NA	NA	NA	NA	609532(3),609532(3)	AR	NA	NA	NA	NA	{Hepatitic~C~virus~susceptibility~to},{Hepatitic~C~virus~susceptibility~to}	M	D/D/D/D	0.999	5.8	././PTPRC_HUMAN	D	D	5.8	1021,1132,1180	29.3	1.057	NA	Ptprc	E	NA	68.57159707	0.231457213	NA	1.75714	5788	NA	CSKPathway/blymphocytePathway/tcraPathway/tcytotoxicPathway/thelperPathway	71.3304	132	NA	NA	NA	NA	NA	NA
chr1	201062005	rs116347156	C	T	PASS	T	missense_variant	MODERATE	CACNA1S	ENSG00000081248	transcript	ENST00000362061.3	c.2992G>A	p.Asp998Asn	24/44	3219/6166	998/1873	2992/5622	NA	NA	NA	NA	0.0005601	0.00399361	0.996006	2494,0	0	0.00199681	255|3	Malignant_hyperthermia_susceptibility|Hypokalemic_periodic_paralysis	C0024591:ORPHA423|C0238358:ORPHA681	MedGen:Orphanet|MedGen:Orphanet	NA	1	170400(3),170400(3),170400(3)	NA	Hypokalemic~periodic~paralysis~type~1,Hypokalemic~periodic~paralysis~type~1,Hypokalemic~periodic~paralysis~type~1	NA	NA	IC,AD	NA	NA	NA	NA	NA	188580(3),601887(3)	AD,AD,AD	NA	NA	NA	NA	{Thyrotoxic~periodic~paralysis~susceptibility~to~1},{Malignant~hyperthermia~susceptibility~5}	M	D/D	1	5.17	CAC1S_HUMAN	B	P	5.17	998	34	0.935	D	Cacna1s	E	3.00E-02	5.714791224	-1.20942002	NA	17.17293	779	NA	NA	6599.51391	132	NA	CACNA1S	KP	AD	114208	NA
chr1	201065943	rs2297902	G	A	PASS	A	splice_region_variant&synonymous_variant	LOW	CACNA1S	ENSG00000081248	transcript	ENST00000362061.3	c.2748C>T	p.His916His	22/44	2975/6166	916/1873	2748/5622	NA	NA	NA	NA	0.036	0.0910543	0.900559	2255,21	0.00838658	0.0539137	2|2,5	not_specified|Hypokalemic_periodic_paralysis,Hypokalemic_periodic_paralysis_1	CN169374|C0238358:ORPHA681,C3714580:170400	MedGen|MedGen:Orphanet,MedGen:OMIM	NA	NA	170400(3),170400(3),170400(3)	NA	Hypokalemic~periodic~paralysis~type~1,Hypokalemic~periodic~paralysis~type~1,Hypokalemic~periodic~paralysis~type~1	NA	NA	IC,AD	NA	NA	NA	NA	NA	188580(3),601887(3)	AD,AD,AD	NA	NA	NA	NA	{Thyrotoxic~periodic~paralysis~susceptibility~to~1},{Malignant~hyperthermia~susceptibility~5}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Cacna1s	E	3.00E-02	5.714791224	-1.20942002	NA	17.17293	779	NA	NA	6599.51391	100	NA	CACNA1S	KP	AD	114208	NA
chr1	201091983	rs141204958	G	A	PASS	A	missense_variant	MODERATE	CACNA1S	ENSG00000081248	transcript	ENST00000362061.3	c.530C>T	p.Ser177Leu	4/44	757/6166	177/1873	530/5622	NA	NA	NA	NA	0.0004448	0.000798722	0.999201	2502,0	0	0.000399361	4|255|3	not_provided|Malignant_hyperthermia_susceptibility|Hypokalemic_periodic_paralysis	CN221809|C0024591:ORPHA423|C0238358:ORPHA681	MedGen|MedGen:Orphanet|MedGen:Orphanet	NA	NA	170400(3),170400(3),170400(3)	NA	Hypokalemic~periodic~paralysis~type~1,Hypokalemic~periodic~paralysis~type~1,Hypokalemic~periodic~paralysis~type~1	NA	NA	IC,AD	NA	NA	NA	NA	NA	188580(3),601887(3)	AD,AD,AD	NA	NA	NA	NA	{Thyrotoxic~periodic~paralysis~susceptibility~to~1},{Malignant~hyperthermia~susceptibility~5}	H	D/D	0.98	4.48	CAC1S_HUMAN	P	D	4.48	177	34	1.048	D	Cacna1s	E	3.00E-02	5.714791224	-1.20942002	NA	17.17293	779	NA	NA	6599.51391	134	NA	CACNA1S	KP	AD	114208	NA
chr1	201110107	rs1325310	C	T	PASS	T	downstream_gene_variant	MODIFIER	ASCL5	ENSG00000232237	transcript	ENST00000449188.2	c.*4645G>A	NA	NA	NA	NA	NA	3846	NA	NA	NA	NA	0.438498	0.376997	944,462	0.184505	0.403754	255	Thyrotoxic_periodic_paralysis	C0268446:188580:ORPHA79102:30967002	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	170400(3),170400(3),170400(3)	NA	Hypokalemic~periodic~paralysis~type~1,Hypokalemic~periodic~paralysis~type~1,Hypokalemic~periodic~paralysis~type~1	NA	NA	IC,AD	NA	NA	NA	NA	NA	188580(3),601887(3)	AD,AD,AD	NA	NA	NA	NA	{Thyrotoxic~periodic~paralysis~susceptibility~to~1},{Malignant~hyperthermia~susceptibility~5}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Cacna1s	E	3.00E-02	5.714791224	-1.20942002	NA	17.17293	779	NA	NA	6599.51391	88	NA	CACNA1S	KP	AD	114208	NA
chr1	201110107	rs1325310	C	T	PASS	T	intron_variant	MODIFIER	CACNA1S	ENSG00000081248	transcript	ENST00000362061.3	c.258+57G>A	NA	2/43	NA	NA	NA	NA	NA	NA	NA	NA	0.438498	0.376997	944,462	0.184505	0.403754	255	Thyrotoxic_periodic_paralysis	C0268446:188580:ORPHA79102:30967002	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	170400(3),170400(3),170400(3)	NA	Hypokalemic~periodic~paralysis~type~1,Hypokalemic~periodic~paralysis~type~1,Hypokalemic~periodic~paralysis~type~1	NA	NA	IC,AD	NA	NA	NA	NA	NA	188580(3),601887(3)	AD,AD,AD	NA	NA	NA	NA	{Thyrotoxic~periodic~paralysis~susceptibility~to~1},{Malignant~hyperthermia~susceptibility~5}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Cacna1s	E	3.00E-02	5.714791224	-1.20942002	NA	17.17293	779	NA	NA	6599.51391	88	NA	CACNA1S	KP	AD	114208	NA
chr1	201112815	rs2281845	C	T	PASS	T	upstream_gene_variant	MODIFIER	CACNA1S	ENSG00000081248	transcript	ENST00000362061.3	c.-476G>A	NA	NA	NA	NA	NA	249	NA	NA	NA	NA	0.438898	0.191693	480,925	0.369409	0.588858	255	Thyrotoxic_periodic_paralysis	C0268446:188580:ORPHA79102:30967002	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	100	NA	NA	NA	NA	NA	NA
chr1	201112815	rs2281845	C	T	PASS	T	downstream_gene_variant	MODIFIER	ASCL5	ENSG00000232237	transcript	ENST00000449188.2	c.*1937G>A	NA	NA	NA	NA	NA	1138	NA	NA	NA	NA	0.438898	0.191693	480,925	0.369409	0.588858	255	Thyrotoxic_periodic_paralysis	C0268446:188580:ORPHA79102:30967002	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	100	NA	NA	NA	NA	NA	NA
chr1	201112815	rs2281845	C	T	PASS	T	intergenic_region	MODIFIER	CACNA1S-ASCL5	ENSG00000081248-ENSG00000232237	intergenic_region	ENSG00000081248-ENSG00000232237	n.201112815C>T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.438898	0.191693	480,925	0.369409	0.588858	255	Thyrotoxic_periodic_paralysis	C0268446:188580:ORPHA79102:30967002	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	100	NA	NA	NA	NA	NA	NA
chr1	201359244	rs397516484	C	T	PASS	T	missense_variant	MODERATE	TNNT2	ENSG00000118194	transcript	ENST00000236918.11	c.863G>A	p.Arg288His	16/16	863/1098	288/298	863/897	NA	NA	NA	NA	1.648e-05	0.000399361	0.999601	2503,0	0	0.000199681	0|5,0|0	not_specified|not_provided,not_specified|Familial_hypertrophic_cardiomyopathy_1	CN169374|CN221809,CN169374|C3495498:192600	MedGen|MedGen,MedGen|MedGen:OMIM	NA	1	601494(3),115195(3),612422(3),601494(3)	NA	Left~ventricular~noncompaction~6,Cardiomyopathy~hypertrophic~2,Cardiomyopathy~familial~restrictive~3,Cardiomyopathy~dilated~1D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	L	D/D/D/D/D/D/D/N/N/N	0.938	3.98	././TNNT2_HUMAN/./.	D/D/P/P/D	D	3.98	287,287,288,275,285	28.0	0.888	T/T/././././././T/T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	TNNT2	KP_EP	AD	191045	NA
chr1	201359601	rs45495692	G	A	PASS	A	intron_variant	MODIFIER	TNNT2	ENSG00000118194	transcript	ENST00000236918.11	c.851+22C>T	NA	15/15	NA	NA	NA	NA	NA	NA	NA	0.003388	0.0291534	0.970847	2431,0	0	0.0145767	255	not_specified	CN169374	MedGen	NA	NA	601494(3),115195(3),612422(3),601494(3)	NA	Left~ventricular~noncompaction~6,Cardiomyopathy~hypertrophic~2,Cardiomyopathy~familial~restrictive~3,Cardiomyopathy~dilated~1D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	TNNT2	KP_EP	AD	191045	NA
chr1	201359637	rs376923877	G	A	PASS	A	synonymous_variant	LOW	TNNT2	ENSG00000118194	transcript	ENST00000236918.11	c.837C>T	p.Asn279Asn	15/16	837/1098	279/298	837/897	NA	NA	NA	NA	0.0001072	0.000399361	0.999601	2503,0	0	0.000199681	255,4	not_specified,Primary_familial_hypertrophic_cardiomyopathy	CN169374,C0949658:ORPHA155:83978005	MedGen,MedGen:Orphanet:SNOMED_CT	NA	1	601494(3),115195(3),612422(3),601494(3)	NA	Left~ventricular~noncompaction~6,Cardiomyopathy~hypertrophic~2,Cardiomyopathy~familial~restrictive~3,Cardiomyopathy~dilated~1D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	TNNT2	KP_EP	AD	191045	NA
chr1	201361314	rs141805127	C	T	PASS	T	missense_variant	MODERATE	TNNT2	ENSG00000118194	transcript	ENST00000236918.11	c.775G>A	p.Asp259Asn	14/16	775/1098	259/298	775/897	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	255	not_provided	CN221809	MedGen	NA	NA	601494(3),115195(3),612422(3),601494(3)	NA	Left~ventricular~noncompaction~6,Cardiomyopathy~hypertrophic~2,Cardiomyopathy~familial~restrictive~3,Cardiomyopathy~dilated~1D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	M	D/D/D/D/D/D/D/D/D/D	0.999	3.73	././TNNT2_HUMAN/./.	P	D	3.73	258,258,259,246,256	27.0	0.932	D/D/././././././D/D/D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	TNNT2	KP_EP	AD	191045	NA
chr1	201361940	rs45520032	A	G	PASS	G	missense_variant	MODERATE	TNNT2	ENSG00000118194	transcript	ENST00000236918.11	c.692T>C	p.Ile231Thr	13/16	692/1098	231/298	692/897	NA	NA	NA	NA	0.0001235	0.000399361	0.999601	2503,0	0	0.000199681	255|0|0|0|0|0|0	not_specified|Familial_hypertrophic_cardiomyopathy_2|Left_ventricular_noncompaction_6|Left_ventricular_noncompaction_cardiomyopathy|Hypertrophic_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant|Familial_restrictive_cardiomyopathy	CN169374|C1861864:115195|C1832243:601494|HP:0011664:CN167392|HP:0001639:C0007194:ORPHA217569|CN239310|C0340429:ORPHA217635:233878008	MedGen|MedGen:OMIM|MedGen:OMIM|Human_Phenotype_Ontology:MedGen|Human_Phenotype_Ontology:MedGen:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	601494(3),115195(3),612422(3),601494(3)	NA	Left~ventricular~noncompaction~6,Cardiomyopathy~hypertrophic~2,Cardiomyopathy~familial~restrictive~3,Cardiomyopathy~dilated~1D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	M	D/D/D/D/D/D/D/D/D/D	0.987	4.44	././TNNT2_HUMAN/./.	P/P/D/P/P	D/D/D/P/P	4.44	230,230,231,218,228	27.8	0.242	D/D/././././././D/D/D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	TNNT2	KP_EP	AD	191045	NA
chr1	201364313	rs35914325	C	G	PASS	G	synonymous_variant	LOW	TNNT2	ENSG00000118194	transcript	ENST00000236918.11	c.474G>C	p.Arg158Arg	10/16	474/1098	158/298	474/897	NA	NA	NA	NA	0.002306	0.0123802	0.98762	2473,0	0	0.0061901	255|2|2|2|2|2|2|3|3|3|3	not_specified|Familial_hypertrophic_cardiomyopathy_2|Familial_restrictive_cardiomyopathy_3|Left_ventricular_noncompaction_6|Familial_hypertrophic_cardiomyopathy_2|Left_ventricular_noncompaction_6|Cardiovascular_phenotype|Hypertrophic_cardiomyopathy|Left_ventricular_noncompaction_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant|Familial_restrictive_cardiomyopathy	CN169374|C1861864:115195|C2676271:612422|C1832243:601494|C1861864:115195|C1832243:601494|CN230736|HP:0001639:C0007194:ORPHA217569|HP:0011664:CN167392|CN239310|C0340429:ORPHA217635:233878008	MedGen|MedGen:OMIM|MedGen:OMIM|MedGen:OMIM|MedGen:OMIM|MedGen:OMIM|MedGen|Human_Phenotype_Ontology:MedGen:Orphanet|Human_Phenotype_Ontology:MedGen|MedGen|MedGen:Orphanet:SNOMED_CT	NA	NA	601494(3),115195(3),612422(3),601494(3)	NA	Left~ventricular~noncompaction~6,Cardiomyopathy~hypertrophic~2,Cardiomyopathy~familial~restrictive~3,Cardiomyopathy~dilated~1D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	126	NA	TNNT2	KP_EP	AD	191045	NA
chr1	201364327	rs483352832	G	A	PASS	A	missense_variant	MODERATE	TNNT2	ENSG00000118194	transcript	ENST00000236918.11	c.460C>T	p.Arg154Trp	10/16	460/1098	154/298	460/897	NA	NA	NA	NA	3.295e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|0	Dilated_cardiomyopathy_1DD|Cardiomyopathy	C2750995:613172|HP:0001638:CN001491	MedGen:OMIM|Human_Phenotype_Ontology:MedGen	NA	NA	601494(3),115195(3),612422(3),601494(3)	NA	Left~ventricular~noncompaction~6,Cardiomyopathy~hypertrophic~2,Cardiomyopathy~familial~restrictive~3,Cardiomyopathy~dilated~1D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	M	D/D/D/D/D/D/D/D/D/D	0.378	3.32	./././TNNT2_HUMAN/./.	D	D	4.28	139,156,153,154,144,154	34	0.038	D/D/D/./././././D/D/D/D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	142	NA	TNNT2	KP_EP	AD	191045	NA
chr1	201364336	rs74315379	G	T	PASS	T	synonymous_variant	LOW	TNNT2	ENSG00000118194	transcript	ENST00000236918.11	c.451C>A	p.Arg151Arg	10/16	451/1098	151/298	451/897	NA	NA	NA	NA	0.0001647	0.00119808	0.998802	2501,0	0	0.000599042	5|5|5|5|5|4,3	Left_ventricular_noncompaction_6|Primary_dilated_cardiomyopathy|not_provided|Familial_hypertrophic_cardiomyopathy_2|Cardiomyopathy|Primary_familial_hypertrophic_cardiomyopathy,not_specified	C1832243:601494|C0007193:ORPHA217604:195021004|CN221809|C1861864:115195|C0878544:ORPHA167848:85898001|C0949658:ORPHA155:83978005,CN169374	MedGen:OMIM|MedGen:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT,MedGen	NA	NA	601494(3),115195(3),612422(3),601494(3)	NA	Left~ventricular~noncompaction~6,Cardiomyopathy~hypertrophic~2,Cardiomyopathy~familial~restrictive~3,Cardiomyopathy~dilated~1D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	133	NA	TNNT2	KP_EP	AD	191045	NA
chr1	201365603	rs45490292	C	T	PASS	T	splice_region_variant&intron_variant	LOW	TNNT2	ENSG00000118194	transcript	ENST00000236918.11	c.294+7G>A	NA	8/15	NA	NA	NA	NA	NA	NA	NA	0.003113	0.0191693	0.980431	2455,1	0.000399361	0.00998403	2|255|2|2|3|3|3|3	Primary_familial_hypertrophic_cardiomyopathy|not_specified|Familial_hypertrophic_cardiomyopathy_2|Left_ventricular_noncompaction_6|Familial_restrictive_cardiomyopathy|Hypertrophic_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant|Left_ventricular_noncompaction_cardiomyopathy	C0949658:ORPHA155:83978005|CN169374|C1861864:115195|C1832243:601494|C0340429:ORPHA217635:233878008|HP:0001639:C0007194:ORPHA217569|CN239310|HP:0011664:CN167392	MedGen:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM|MedGen:OMIM|MedGen:Orphanet:SNOMED_CT|Human_Phenotype_Ontology:MedGen:Orphanet|MedGen|Human_Phenotype_Ontology:MedGen	NA	NA	601494(3),115195(3),612422(3),601494(3)	NA	Left~ventricular~noncompaction~6,Cardiomyopathy~hypertrophic~2,Cardiomyopathy~familial~restrictive~3,Cardiomyopathy~dilated~1D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	TNNT2	KP_EP	AD	191045	NA
chr1	201366900	rs45449197	G	C	PASS	C	intron_variant	MODIFIER	TNNT2	ENSG00000118194	transcript	ENST00000236918.11	c.200-29C>G	NA	6/15	NA	NA	NA	NA	NA	NA	NA	0.008862	0.0519169	0.945288	2367,7	0.00279553	0.028754	255	not_specified	CN169374	MedGen	NA	NA	601494(3),115195(3),612422(3),601494(3)	NA	Left~ventricular~noncompaction~6,Cardiomyopathy~hypertrophic~2,Cardiomyopathy~familial~restrictive~3,Cardiomyopathy~dilated~1D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	TNNT2	KP_EP	AD	191045	NA
chr1	201368150	rs45580032	C	T	PASS	T	intron_variant	MODIFIER	TNNT2	ENSG00000118194	transcript	ENST00000236918.11	c.163+12G>A	NA	5/15	NA	NA	NA	NA	NA	NA	NA	0.004934	0.0295527	0.96885	2426,4	0.00159744	0.0163738	255|3|3|3|3	not_specified|Left_ventricular_noncompaction_cardiomyopathy|Familial_restrictive_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant|Hypertrophic_cardiomyopathy	CN169374|HP:0011664:CN167392|C0340429:ORPHA217635:233878008|CN239310|HP:0001639:C0007194:ORPHA217569	MedGen|Human_Phenotype_Ontology:MedGen|MedGen:Orphanet:SNOMED_CT|MedGen|Human_Phenotype_Ontology:MedGen:Orphanet	NA	NA	601494(3),115195(3),612422(3),601494(3)	NA	Left~ventricular~noncompaction~6,Cardiomyopathy~hypertrophic~2,Cardiomyopathy~familial~restrictive~3,Cardiomyopathy~dilated~1D	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	TNNT2	KP_EP	AD	191045	NA
chr1	203186754	rs4950928	G	C	PASS	C	upstream_gene_variant	MODIFIER	CHI3L1	ENSG00000133048	transcript	ENST00000255409.7	c.-131C>G	NA	NA	NA	NA	NA	5	NA	NA	NA	NA	0.324281	0.0523163	131,1561	0.623403	0.785543	255	Asthma-related_traits\x2c_susceptibility_to\x2c_7	C2677770:611960	MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	AD,-	NA	NA	NA	NA	NA	181500(3),611960(3)	NA	NA	NA	NA	NA	{Schizophrenia~susceptibility~to},{Asthma-related~traits~susceptibility~to~7}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	111	NA	NA	NA	NA	NA	NA
chr1	203186754	rs4950928	G	C	PASS	C	intergenic_region	MODIFIER	CHI3L1-CHIT1	ENSG00000133048-ENSG00000133063	intergenic_region	ENSG00000133048-ENSG00000133063	n.203186754G>C	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.324281	0.0523163	131,1561	0.623403	0.785543	255	Asthma-related_traits\x2c_susceptibility_to\x2c_7	C2677770:611960	MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	AD,-	NA	NA	NA	NA	NA	181500(3),611960(3)	NA	NA	NA	NA	NA	{Schizophrenia~susceptibility~to},{Asthma-related~traits~susceptibility~to~7}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	111	NA	NA	NA	NA	NA	NA
chr1	203225058	rs2297950	C	T	PASS	T	missense_variant	MODERATE	CHIT1	ENSG00000133063	transcript	ENST00000367229.5	c.304G>A	p.Gly102Ser	4/11	339/2246	102/466	304/1401	NA	NA	NA	NA	0.303	0.410144	0.503994	1262,215	0.0858626	0.290935	255	Chitotriosidase_deficiency	C3279902:614122	MedGen:OMIM	NA	8	NA	NA	NA	NA	NA	NA	NA	614122(3)	NA	[Chitotriosidase~deficiency]	AR	NA	NA	NA	NA	NA	NA	NA	L	P/P/P	0.981	2.59	CHIT1_HUMAN	D	D	4.5	102	31	0.855	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	100	NA	NA	NA	NA	NA	NA
chr1	203225706	rs137852607	C	T	PASS	T	structural_interaction_variant	HIGH	CHIT1	ENSG00000133063	interaction	1HKJ:A_74-A_130:ENST00000367229	c.220G>A	NA	3/11	NA	NA	NA	NA	NA	NA	NA	0.003204	0.00479233	0.995208	2492,0	0	0.00239617	255	Chitotriosidase_deficiency	C3279902:614122	MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	NA	NA	614122(3)	NA	[Chitotriosidase~deficiency]	AR	NA	NA	NA	NA	NA	NA	NA	L	A/A/A	0.092	0.788	./CHIT1_HUMAN	B	B	4.98	84,74	12.76	0.855	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	133	NA	NA	NA	NA	NA	NA
chr1	203225706	rs137852607	C	T	PASS	T	structural_interaction_variant	HIGH	CHIT1	ENSG00000133063	interaction	1HKK:A_74-A_130:ENST00000367229	c.220G>A	NA	3/11	NA	NA	NA	NA	NA	NA	NA	0.003204	0.00479233	0.995208	2492,0	0	0.00239617	255	Chitotriosidase_deficiency	C3279902:614122	MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	NA	NA	614122(3)	NA	[Chitotriosidase~deficiency]	AR	NA	NA	NA	NA	NA	NA	NA	L	A/A/A	0.092	0.788	./CHIT1_HUMAN	B	B	4.98	84,74	12.76	0.855	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	133	NA	NA	NA	NA	NA	NA
chr1	203225706	rs137852607	C	T	PASS	T	structural_interaction_variant	HIGH	CHIT1	ENSG00000133063	interaction	1HKM:A_74-A_130:ENST00000367229	c.220G>A	NA	3/11	NA	NA	NA	NA	NA	NA	NA	0.003204	0.00479233	0.995208	2492,0	0	0.00239617	255	Chitotriosidase_deficiency	C3279902:614122	MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	NA	NA	614122(3)	NA	[Chitotriosidase~deficiency]	AR	NA	NA	NA	NA	NA	NA	NA	L	A/A/A	0.092	0.788	./CHIT1_HUMAN	B	B	4.98	84,74	12.76	0.855	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	133	NA	NA	NA	NA	NA	NA
chr1	203225706	rs137852607	C	T	PASS	T	missense_variant	MODERATE	CHIT1	ENSG00000133063	transcript	ENST00000367229.5	c.220G>A	p.Glu74Lys	3/11	255/2246	74/466	220/1401	NA	NA	NA	NA	0.003204	0.00479233	0.995208	2492,0	0	0.00239617	255	Chitotriosidase_deficiency	C3279902:614122	MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	NA	NA	614122(3)	NA	[Chitotriosidase~deficiency]	AR	NA	NA	NA	NA	NA	NA	NA	L	A/A/A	0.092	0.788	./CHIT1_HUMAN	B	B	4.98	84,74	12.76	0.855	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	133	NA	NA	NA	NA	NA	NA
chr1	205169835	rs554197975	G	A	PASS	A	splice_region_variant&intron_variant	LOW	DSTYK	ENSG00000133059	transcript	ENST00000367162.7	c.655-3C>T	NA	2/12	NA	NA	NA	NA	NA	NA	NA	0.0005272	0.00199681	0.998003	2499,0	0	0.000998403	255	Congenital_anomalies_of_kidney_and_urinary_tract_1\x2c_susceptibility_to	100034704:C1835826:610805	Gene:MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	610805(3)	NA	NA	NA	NA	NA	{Congenital~anomalies~of~kidney~and~urinary~tract~susceptibility~to}	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	142	NA	NA	NA	NA	NA	NA
chr1	205187417	rs201091809	C	T	PASS	T	splice_donor_variant&intron_variant	HIGH	DSTYK	ENSG00000133059	transcript	ENST00000367162.7	c.654+1G>A	NA	2/12	NA	NA	NA	NA	NA	(DSTYK|ENSG00000133059|1|1.00)	NA	0.0002389	0.000399361	0.999601	2503,0	0	0.000199681	255	Congenital_anomalies_of_kidney_and_urinary_tract_1\x2c_susceptibility_to	100034704:C1835826:610805	Gene:MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	610805(3)	NA	NA	NA	NA	NA	{Congenital~anomalies~of~kidney~and~urinary~tract~susceptibility~to}	NA	D/D/D	0.994	5.39	NA	NA	NA	5.39	NA	26.3	0.935	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	NA	NA	NA	NA	NA
chr1	205211450	rs200780796	C	T	PASS	T	missense_variant	MODERATE	DSTYK	ENSG00000133059	transcript	ENST00000367162.7	c.86G>A	p.Arg29Gln	1/13	117/7874	29/929	86/2790	NA	NA	NA	NA	0.0006687	0.00159744	0.998403	2500,0	0	0.000798722	255	Congenital_anomalies_of_kidney_and_urinary_tract_1\x2c_susceptibility_to	100034704:C1835826:610805	Gene:MedGen:OMIM	NA	NA	NA	NA	NA	NA	NA	AD	NA	NA	NA	NA	NA	610805(3)	NA	NA	NA	NA	NA	{Congenital~anomalies~of~kidney~and~urinary~tract~susceptibility~to}	L	D/D/D	1	5.24	./DUSTY_HUMAN	D	D	5.24	29	24.3	0.87	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	NA	NA	NA	NA	NA
chr1	209623999	rs146794392	G	A	PASS	A	stop_gained&splice_region_variant	HIGH	LAMB3	ENSG00000196878	transcript	ENST00000356082.8	c.1978C>T	p.Arg660*	15/23	2113/4055	660/1172	1978/3519	NA	NA	(LAMB3|ENSG00000196878|1|1.00)	(LAMB3|ENSG00000196878|1|1.00)	2.471e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	Junctional_epidermolysis_bullosa_gravis_of_Herlitz	C0079683:226700:ORPHA79404:400140006	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	226650(3),226700(3),104530(3)	NA	Epidermolysis~bullosa~junctional~non-Herlitz~type,Epidermolysis~bullosa~junctional~Herlitz~type,Amelogenesis~imperfecta~type~IA	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR,AD	NA	NA	NA	NA	NA	NA	A/A/A	0.234	-0.687	NA	NA	NA	4.1	NA	35	0.045	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	LAMB3
chr1	209801280	rs121434229	C	T	PASS	T	missense_variant	MODERATE	IRF6	ENSG00000117595	transcript	ENST00000367021.7	c.134G>A	p.Arg45Gln	3/9	307/4306	45/467	134/1404	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5	Van_der_Woude_syndrome	C0175697:119300:79261008	MedGen:OMIM:SNOMED_CT	NA	NA	119300(3),119500(3)	NA	van~der~Woude~syndrome,Popliteal~pterygium~syndrome~1	NA	NA	IC,IC,IC	NA	NA	NA	NA	NA	608864(3),608864(3),608864(3)	AD,AD	NA	NA	NA	NA	{Orofacial~cleft~6},{Orofacial~cleft~6},{Orofacial~cleft~6}	M	A/A	1	6.17	IRF6_HUMAN	D	D	6.17	45	34	0.935	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	NA	NA	NA	NA	NA
chr1	212858606	rs11120047	G	C	PASS	C	missense_variant	MODERATE	FLVCR1	ENSG00000162769	transcript	ENST00000366971.8	c.154G>C	p.Ala52Pro	1/10	352/5939	52/555	154/1668	NA	NA	NA	NA	0.372	0.445687	0.332668	833,555	0.221645	0.444489	255|2	not_specified|Posterior_column_ataxia_with_retinitis_pigmentosa	CN169374|C1836916:609033:ORPHA88628	MedGen|MedGen:OMIM:Orphanet	NA	11	609033(3)	NA	Ataxia~posterior~column~with~retinitis~pigmentosa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	P	0	3.17	FLVC1_HUMAN	B	B	5.04	52	5.091	-0.264	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	120	NA	NA	NA	NA	NA	NA
chr1	212858606	rs11120047	G	C	PASS	C	upstream_gene_variant	MODIFIER	FLVCR1-AS1	ENSG00000198468	transcript	ENST00000356684.7	n.-518C>G	NA	NA	NA	NA	NA	518	NA	NA	NA	0.372	0.445687	0.332668	833,555	0.221645	0.444489	255|2	not_specified|Posterior_column_ataxia_with_retinitis_pigmentosa	CN169374|C1836916:609033:ORPHA88628	MedGen|MedGen:OMIM:Orphanet	NA	11	609033(3)	NA	Ataxia~posterior~column~with~retinitis~pigmentosa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	P	0	3.17	FLVC1_HUMAN	B	B	5.04	52	5.091	-0.264	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	120	NA	NA	NA	NA	NA	NA
chr1	212858606	rs11120047	G	C	PASS	C	upstream_gene_variant	MODIFIER	RP11-348H3.5	ENSG00000236317	transcript	ENST00000422630.1	n.-3240C>G	NA	NA	NA	NA	NA	3240	NA	NA	NA	0.372	0.445687	0.332668	833,555	0.221645	0.444489	255|2	not_specified|Posterior_column_ataxia_with_retinitis_pigmentosa	CN169374|C1836916:609033:ORPHA88628	MedGen|MedGen:OMIM:Orphanet	NA	11	609033(3)	NA	Ataxia~posterior~column~with~retinitis~pigmentosa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	N	P	0	3.17	FLVC1_HUMAN	B	B	5.04	52	5.091	-0.264	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	120	NA	NA	NA	NA	NA	NA
chr1	212897349	rs139242973	T	TACAC	PASS	TACAC	3_prime_UTR_variant	MODIFIER	FLVCR1	ENSG00000162769	transcript	ENST00000366971.8	c.*2077_*2080dupCACA	NA	10/10	NA	NA	NA	2081	INFO_REALIGN_3_PRIME	NA	NA	NA	NA	NA	1309,186	NA	0.255591	0,3,255,0	Posterior_column_ataxia_with_retinitis_pigmentosa,Posterior_column_ataxia_with_retinitis_pigmentosa,Posterior_column_ataxia_with_retinitis_pigmentosa,Posterior_column_ataxia_with_retinitis_pigmentosa	C1836916:609033:ORPHA88628,C1836916:609033:ORPHA88628,C1836916:609033:ORPHA88628,C1836916:609033:ORPHA88628	MedGen:OMIM:Orphanet,MedGen:OMIM:Orphanet,MedGen:OMIM:Orphanet,MedGen:OMIM:Orphanet	NA	NA	609033(3)	NA	Ataxia~posterior~column~with~retinitis~pigmentosa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	NA
chr1	212897349	rs139242973	T	TACACAC	PASS	TACACAC	3_prime_UTR_variant	MODIFIER	FLVCR1	ENSG00000162769	transcript	ENST00000366971.8	c.*2075_*2080dupCACACA	NA	10/10	NA	NA	NA	2081	INFO_REALIGN_3_PRIME	NA	NA	NA	NA	NA	1309,6	NA	0.0311502	0,3,255,0	Posterior_column_ataxia_with_retinitis_pigmentosa,Posterior_column_ataxia_with_retinitis_pigmentosa,Posterior_column_ataxia_with_retinitis_pigmentosa,Posterior_column_ataxia_with_retinitis_pigmentosa	C1836916:609033:ORPHA88628,C1836916:609033:ORPHA88628,C1836916:609033:ORPHA88628,C1836916:609033:ORPHA88628	MedGen:OMIM:Orphanet,MedGen:OMIM:Orphanet,MedGen:OMIM:Orphanet,MedGen:OMIM:Orphanet	NA	NA	609033(3)	NA	Ataxia~posterior~column~with~retinitis~pigmentosa	NA	NA	NA	NA	NA	NA	NA	NA	NA	AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	NA
chr1	215628906	rs145771342	G	A	PASS	A	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.15427C>T	p.Arg5143Cys	71/72	15814/18883	5143/5202	15427/15609	NA	NA	NA	NA	0.0007825	0.00519169	0.994808	2491,0	0	0.00259585	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	D/D	0.993	3.8	USH2A_HUMAN	B	B	5.67	5143	25.0	0.1	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	215628906	rs145771342	G	A	PASS	A	downstream_gene_variant	MODIFIER	SNORD116	ENSG00000202498	transcript	ENST00000365628.1	n.*1120C>T	NA	NA	NA	NA	NA	1120	NA	NA	NA	0.0007825	0.00519169	0.994808	2491,0	0	0.00259585	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	D/D	0.993	3.8	USH2A_HUMAN	B	B	5.67	5143	25.0	0.1	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	215647560	rs56136489	G	A	PASS	A	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.14753C>T	p.Thr4918Met	67/72	15140/18883	4918/5202	14753/15609	NA	NA	NA	NA	0.001203	0.00119808	0.998802	2501,0	0	0.000599042	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	N/N	0.966	3.7	USH2A_HUMAN	P	D	5.62	4918	24.2	1.048	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	129	NA	NA	NA	NA	NA	USH2A
chr1	215674202	rs730254	C	T	PASS	T	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.13709G>A	p.Arg4570His	63/72	14096/18883	4570/5202	13709/15609	NA	NA	NA	NA	0.001598	0.00399361	0.996006	2494,0	0	0.00199681	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	L	D/D	0.6	3.6	USH2A_HUMAN	B	B	4.52	4570	23.4	0.852	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	86	NA	NA	NA	NA	NA	USH2A
chr1	215674433	rs138879998	C	T	PASS	T	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.13478G>A	p.Arg4493His	63/72	13865/18883	4493/5202	13478/15609	NA	NA	NA	NA	0.0005271	0.00279553	0.997204	2497,0	0	0.00139776	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	L	D/D	0.957	-1.6	USH2A_HUMAN	B	B	4.22	4493	10.23	-0.506	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	215675211	rs577938494	T	C	PASS	C	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.12700A>G	p.Thr4234Ala	63/72	13087/18883	4234/5202	12700/15609	NA	NA	NA	NA	1.647e-05	0.000399361	0.999601	2503,0	0	0.000199681	4	Usher_syndrome\x2c_type_2A	C1848634:276901	MedGen:OMIM	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	D/D	0.74	4.1	USH2A_HUMAN	B	B	5.26	4234	23.3	1.061	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	142	NA	NA	NA	NA	NA	USH2A
chr1	215675313	rs114116572	A	C	PASS	C	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.12598T>G	p.Trp4200Gly	63/72	12985/18883	4200/5202	12598/15609	NA	NA	NA	NA	0.0002059	0.00119808	0.998802	2501,0	0	0.000599042	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	L	N/N	0.132	-1.14	USH2A_HUMAN	B	B	4.96	4200	1.067	0.23	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	135	NA	NA	NA	NA	NA	USH2A
chr1	215675336	rs199605265	C	T	PASS	T	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.12575G>A	p.Arg4192His	63/72	12962/18883	4192/5202	12575/15609	NA	NA	NA	NA	0.0004777	0.000399361	0.999601	2503,0	0	0.000199681	0|5|5	not_specified|Retinitis_pigmentosa_39|Usher_syndrome\x2c_type_2A	CN169374|C3151138:613809|C1848634:276901	MedGen|MedGen:OMIM|MedGen:OMIM	NA	1	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	L	N/N	0.993	4.22	USH2A_HUMAN	B	B	5.25	4192	24.0	0.935	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	NA	NA	NA	NA	USH2A
chr1	215680350	rs55921307	G	A	PASS	A	synonymous_variant	LOW	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.12093C>T	p.Tyr4031Tyr	62/72	12480/18883	4031/5202	12093/15609	NA	NA	NA	NA	0.00294	0.00159744	0.998403	2500,0	0	0.000798722	255	not_specified	CN169374	MedGen	NA	1	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	129	NA	NA	NA	NA	NA	USH2A
chr1	215780013	rs115403785	G	A	PASS	A	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.10769C>T	p.Pro3590Leu	55/72	11156/18883	3590/5202	10769/15609	NA	NA	NA	NA	0.0007578	0.000798722	0.998802	2501,1	0.000399361	0.000798722	255	not_specified	CN169374	MedGen	NA	1	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	H	D/D	0.966	4.87	USH2A_HUMAN	B	B	5.79	3590	26.5	1.048	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	215817108	rs73090721	G	A	PASS	A	synonymous_variant	LOW	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.9459C>T	p.Cys3153Cys	48/72	9846/18883	3153/5202	9459/15609	NA	NA	NA	NA	0.001343	0.0107827	0.988818	2476,1	0.000399361	0.00579073	2,5	not_specified,Usher_syndrome\x2c_type_2A	CN169374,C1848634:276901	MedGen,MedGen:OMIM	NA	1	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	130	NA	NA	NA	NA	NA	USH2A
chr1	215877882	rs397518039	T	C	PASS	C	splice_acceptor_variant&intron_variant	HIGH	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.8559-2A>G	NA	42/71	NA	NA	NA	NA	NA	(USH2A|ENSG00000042781|1|1.00)	NA	2.471e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5	Usher_syndrome\x2c_type_2A|Retinitis_pigmentosa	C1848634:276901|C0035334:268000:ORPHA791:28835009	MedGen:OMIM|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	D/D	1	5.9	NA	NA	NA	5.9	NA	25.0	1.061	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	NA	NA	NA	NA	USH2A
chr1	215879007	rs150807452	G	A	PASS	A	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.8315C>T	p.Thr2772Ile	42/72	8702/18883	2772/5202	8315/15609	NA	NA	NA	NA	0.0004448	0.00239617	0.997604	2498,0	0	0.00119808	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	N/N	0.051	3.88	USH2A_HUMAN	B	P	5.94	2772	16.42	0.079	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	215900911	rs375499259	G	A	PASS	A	splice_region_variant&intron_variant	LOW	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.7301-6C>T	NA	38/71	NA	NA	NA	NA	NA	NA	NA	0.0004613	0.000399361	0.999601	2503,0	0	0.000199681	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	NA	NA	NA	NA	USH2A
chr1	215900911	rs375499259	G	A	PASS	A	non_coding_transcript_exon_variant	MODIFIER	RP5-1111A8.3	ENSG00000229242	transcript	ENST00000414995.1	n.247G>A	NA	2/2	NA	NA	NA	NA	NA	NA	NA	0.0004613	0.000399361	0.999601	2503,0	0	0.000199681	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	NA	NA	NA	NA	USH2A
chr1	215965399	rs145718407	G	A	PASS	A	synonymous_variant	LOW	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.7038C>T	p.His2346His	37/72	7425/18883	2346/5202	7038/15609	NA	NA	NA	NA	8.237e-05	0.000399361	0.999601	2503,0	0	0.000199681	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	215999034	rs373604102	A	C	PASS	C	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.6510T>G	p.Ser2170Arg	34/72	6897/18883	2170/5202	6510/15609	NA	NA	NA	NA	0.0009802	0.00359425	0.996406	2495,0	0	0.00179712	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	N	N/N	0.82	2.23	USH2A_HUMAN	B	B	5.77	2170	21.9	1.088	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	NA	NA	NA	NA	USH2A
chr1	216000524	rs142786231	C	A	PASS	A	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.6364G>T	p.Ala2122Ser	33/72	6751/18883	2122/5202	6364/15609	NA	NA	NA	NA	0.0003624	0.00199681	0.998003	2499,0	0	0.000998403	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	D/D	0.643	5.9	USH2A_HUMAN	D	D	5.9	2122	28.4	0.935	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	216070175	rs41303287	T	C	PASS	C	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.5975A>G	p.Tyr1992Cys	30/72	6362/18883	1992/5202	5975/15609	NA	NA	NA	NA	0.003492	0.00239617	0.997604	2498,0	0	0.00119808	255	not_specified	CN169374	MedGen	NA	1	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	N/N	0.765	2.05	USH2A_HUMAN	B	B	5.63	1992	23.2	1.061	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	NA	NA	NA	NA	USH2A
chr1	216070175	rs41303287	T	C	PASS	C	upstream_gene_variant	MODIFIER	RP11-22M7.2	ENSG00000233620	transcript	ENST00000446411.5	n.-2290T>C	NA	NA	NA	NA	NA	2290	NA	NA	NA	0.003492	0.00239617	0.997604	2498,0	0	0.00119808	255	not_specified	CN169374	MedGen	NA	1	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	N/N	0.765	2.05	USH2A_HUMAN	B	B	5.63	1992	23.2	1.061	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	NA	NA	NA	NA	USH2A
chr1	216070218	rs75698489	G	A	PASS	A	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.5932C>T	p.Pro1978Ser	30/72	6319/18883	1978/5202	5932/15609	NA	NA	NA	NA	0.0005765	0.00319489	0.996805	2496,0	0	0.00159744	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	H	D/D	0.998	3.69	USH2A_HUMAN	D	D	5.63	1978	25.9	1.048	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	131	NA	NA	NA	NA	NA	USH2A
chr1	216070218	rs75698489	G	A	PASS	A	upstream_gene_variant	MODIFIER	RP11-22M7.2	ENSG00000233620	transcript	ENST00000446411.5	n.-2247G>A	NA	NA	NA	NA	NA	2247	NA	NA	NA	0.0005765	0.00319489	0.996805	2496,0	0	0.00159744	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	H	D/D	0.998	3.69	USH2A_HUMAN	D	D	5.63	1978	25.9	1.048	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	131	NA	NA	NA	NA	NA	USH2A
chr1	216073261	rs140895792	C	T	PASS	T	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.5612G>A	p.Gly1871Asp	28/72	5999/18883	1871/5202	5612/15609	NA	NA	NA	NA	0.0003625	0.00319489	0.996805	2496,0	0	0.00159744	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	D/D	1	5.93	USH2A_HUMAN	D	D	5.93	1871	26.7	0.935	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	216073261	rs140895792	C	T	PASS	T	intron_variant	MODIFIER	RP11-22M7.2	ENSG00000233620	transcript	ENST00000446411.5	n.136+661C>T	NA	1/2	NA	NA	NA	NA	NA	NA	NA	0.0003625	0.00319489	0.996805	2496,0	0	0.00159744	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	D/D	1	5.93	USH2A_HUMAN	D	D	5.93	1871	26.7	0.935	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	216084817	rs140080678	T	C	PASS	C	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.5048A>G	p.Asn1683Ser	25/72	5435/18883	1683/5202	5048/15609	NA	NA	NA	NA	0.0002059	0.000798722	0.999201	2502,0	0	0.000399361	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	L	N/N	0.03	1.22	USH2A_HUMAN	B	B	4.93	1683	0.155	-1.292	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	216084817	rs140080678	T	C	PASS	C	intron_variant	MODIFIER	RP11-22M7.2	ENSG00000233620	transcript	ENST00000446411.5	n.266-1905T>C	NA	2/2	NA	NA	NA	NA	NA	NA	NA	0.0002059	0.000798722	0.999201	2502,0	0	0.000399361	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	L	N/N	0.03	1.22	USH2A_HUMAN	B	B	4.93	1683	0.155	-1.292	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	216175293	rs41303255	T	A	PASS	A	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.4586A>T	p.Lys1529Ile	21/72	4973/18883	1529/5202	4586/15609	NA	NA	NA	NA	0.0005602	0.00439297	0.995607	2493,0	0	0.00219649	255|0|0	not_specified|Retinitis_Pigmentosa\x2c_Recessive|Retinitis_pigmentosa-deafness_syndrome	CN169374|CN239466|C0271097:500004:ORPHA886:57838006	MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	L	N/N/N	0.724	-0.626	./USH2A_HUMAN	P/B	P	5.89	1529	22.3	0.134	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	NA	NA	NA	NA	USH2A
chr1	216175301	rs147560504	C	A	PASS	A	synonymous_variant	LOW	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.4578G>T	p.Gly1526Gly	21/72	4965/18883	1526/5202	4578/15609	NA	NA	NA	NA	0.0002719	0.00239617	0.997604	2498,0	0	0.00119808	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	216175319	rs148000219	G	A	PASS	A	synonymous_variant	LOW	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.4560C>T	p.Ile1520Ile	21/72	4947/18883	1520/5202	4560/15609	NA	NA	NA	NA	0.002397	0.00319489	0.996805	2496,0	0	0.00159744	255	not_specified	CN169374	MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	216198494	rs111033524	C	A	PASS	A	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.3902G>T	p.Gly1301Val	18/72	4289/18883	1301/5202	3902/15609	NA	NA	NA	NA	0.0009472	0.00159744	0.998403	2500,0	0	0.000798722	3|4	not_specified|Usher_syndrome\x2c_type_1	CN169374|C1568247:276900:ORPHA231169	MedGen|MedGen:OMIM:Orphanet	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	D/D/D	0.944	4.89	./USH2A_HUMAN	D	D	5.81	1301	32	0.935	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	NA	NA	NA	NA	USH2A
chr1	216198494	rs111033524	C	A	PASS	A	downstream_gene_variant	MODIFIER	MRPS18BP1	ENSG00000226013	transcript	ENST00000414228.1	n.*3141G>T	NA	NA	NA	NA	NA	3141	NA	NA	NA	0.0009472	0.00159744	0.998403	2500,0	0	0.000798722	3|4	not_specified|Usher_syndrome\x2c_type_1	CN169374|C1568247:276900:ORPHA231169	MedGen|MedGen:OMIM:Orphanet	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	D/D/D	0.944	4.89	./USH2A_HUMAN	D	D	5.81	1301	32	0.935	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	NA	NA	NA	NA	USH2A
chr1	216198494	rs111033524	C	A	PASS	A	intron_variant	MODIFIER	RP5-1099E6.3	ENSG00000236292	transcript	ENST00000420867.1	n.362+2569C>A	NA	2/2	NA	NA	NA	NA	NA	NA	NA	0.0009472	0.00159744	0.998403	2500,0	0	0.000798722	3|4	not_specified|Usher_syndrome\x2c_type_1	CN169374|C1568247:276900:ORPHA231169	MedGen|MedGen:OMIM:Orphanet	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	M	D/D/D	0.944	4.89	./USH2A_HUMAN	D	D	5.81	1301	32	0.935	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	NA	NA	NA	NA	USH2A
chr1	216199817	rs146462407	G	A	PASS	A	synonymous_variant	LOW	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.3621C>T	p.Ile1207Ile	17/72	4008/18883	1207/5202	3621/15609	NA	NA	NA	NA	0.0006095	0.00319489	0.996805	2496,0	0	0.00159744	255|0|0	not_specified|Retinitis_Pigmentosa\x2c_Recessive|Retinitis_pigmentosa-deafness_syndrome	CN169374|CN239466|C0271097:500004:ORPHA886:57838006	MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	216199817	rs146462407	G	A	PASS	A	downstream_gene_variant	MODIFIER	MRPS18BP1	ENSG00000226013	transcript	ENST00000414228.1	n.*1818C>T	NA	NA	NA	NA	NA	1818	NA	NA	NA	0.0006095	0.00319489	0.996805	2496,0	0	0.00159744	255|0|0	not_specified|Retinitis_Pigmentosa\x2c_Recessive|Retinitis_pigmentosa-deafness_syndrome	CN169374|CN239466|C0271097:500004:ORPHA886:57838006	MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	216199817	rs146462407	G	A	PASS	A	intron_variant	MODIFIER	RP5-1099E6.3	ENSG00000236292	transcript	ENST00000420867.1	n.362+3892G>A	NA	2/2	NA	NA	NA	NA	NA	NA	NA	0.0006095	0.00319489	0.996805	2496,0	0	0.00159744	255|0|0	not_specified|Retinitis_Pigmentosa\x2c_Recessive|Retinitis_pigmentosa-deafness_syndrome	CN169374|CN239466|C0271097:500004:ORPHA886:57838006	MedGen|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	USH2A
chr1	216246592	rs201527662	A	C	PASS	C	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.2802T>G	p.Cys934Trp	13/72	3189/18883	934/5202	2802/15609	NA	NA	NA	NA	0.0002141	0.00159744	0.998403	2500,0	0	0.000798722	5	Retinitis_pigmentosa	C0035334:268000:ORPHA791:28835009	MedGen:OMIM:Orphanet:SNOMED_CT	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	H	D/D/D	1	3.74	./USH2A_HUMAN	D	D	6.03	934	26.6	1.199	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	NA	NA	NA	NA	USH2A
chr1	216246872	rs111033282	G	T	PASS	T	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.2522C>A	p.Ser841Tyr	13/72	2909/18883	841/5202	2522/15609	NA	NA	NA	NA	0.006284	0.00319489	0.996805	2496,0	0	0.00159744	255	not_specified	CN169374	MedGen	NA	1	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	L	D/D/D	0.222	6.03	./USH2A_HUMAN	D	D	6.03	841	24.5	1.048	D/T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	NA	NA	NA	NA	USH2A
chr1	216247118	rs80338902	C	A	PASS	A	missense_variant	MODERATE	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.2276G>T	p.Cys759Phe	13/72	2663/18883	759/5202	2276/15609	NA	NA	NA	NA	0.0007825	0.000399361	0.999601	2503,0	0	0.000199681	255|5|5|5|5|5|5	Retinitis_pigmentosa_39|Retinitis_pigmentosa|Retinitis_pigmentosa_39|Usher_syndrome\x2c_type_2A|Usher_syndrome\x2c_type_2A|not_provided|USH2A-Related_Disorders	C3151138:613809|C0035334:268000:ORPHA791:28835009|C3151138:613809|C1848634:276901|C1848634:276901|CN221809|CN239332	MedGen:OMIM|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM|MedGen:OMIM|MedGen:OMIM|MedGen|MedGen	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	H	A/A/A	0.998	5.79	./USH2A_HUMAN	D	D	5.79	759	33	0.935	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	131	NA	NA	NA	NA	NA	USH2A
chr1	216325524	rs397518043	G	GTGGC	VQSRTrancheINDEL99.00to100.00	GTGGC	frameshift_variant	HIGH	USH2A	ENSG00000042781	transcript	ENST00000307340.7	c.920_923dupGCCA	p.His308fs	6/72	1310/18883	308/5202	923/15609	NA	NA	(USH2A|ENSG00000042781|1|1.00)	NA	0.0001071	NA	NA	NA	NA	NA	5	Usher_syndrome\x2c_type_2A	C1848634:276901	MedGen:OMIM	NA	NA	276901(3),613809(3)	NA	Usher~syndrome~type~2A,Retinitis~pigmentosa~39	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,-	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	NA	NA	NA	NA	USH2A
chr1	218346973	rs10482721	G	A	PASS	A	missense_variant	MODERATE	TGFB2	ENSG00000092969	transcript	ENST00000366929.4	c.272G>A	p.Arg91His	1/8	739/5053	91/442	272/1329	NA	NA	NA	NA	0.004366	0.00159744	0.998403	2500,0	0	0.000798722	255|2|3	not_specified|Holt-Oram_syndrome|Loeys-Dietz_syndrome	CN169374|C0265264:142900:19092004|C2697932:ORPHA60030:446263001	MedGen|MedGen:OMIM:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	614816(3)	NA	Loeys-Dietz~syndrome~4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	612530(4)	NA	IC	NA	NA	M	D/D	0.999	5.45	./TGFB2_HUMAN/.	P/P/D	D	5.45	91,91,92	29.2	0.998	T/D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	119	NA	NA	NA	NA	NA	NA
chr1	218346973	rs10482721	G	A	PASS	A	upstream_gene_variant	MODIFIER	TGFB2-AS1	ENSG00000232480	transcript	ENST00000414452.1	n.-1295C>T	NA	NA	NA	NA	NA	1295	NA	NA	NA	0.004366	0.00159744	0.998403	2500,0	0	0.000798722	255|2|3	not_specified|Holt-Oram_syndrome|Loeys-Dietz_syndrome	CN169374|C0265264:142900:19092004|C2697932:ORPHA60030:446263001	MedGen|MedGen:OMIM:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	614816(3)	NA	Loeys-Dietz~syndrome~4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	612530(4)	NA	IC	NA	NA	M	D/D	0.999	5.45	./TGFB2_HUMAN/.	P/P/D	D	5.45	91,91,92	29.2	0.998	T/D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	119	NA	NA	NA	NA	NA	NA
chr1	218434190	rs10482810	G	C	PASS	C	missense_variant	MODERATE	TGFB2	ENSG00000092969	transcript	ENST00000366929.4	c.703G>C	p.Val235Leu	4/8	1170/5053	235/442	703/1329	NA	NA	NA	NA	0.003336	0.00119808	0.998802	2501,0	0	0.000599042	255|255|2|3	Thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Holt-Oram_syndrome|Loeys-Dietz_syndrome	CN118826:ORPHA91387|CN169374|C0265264:142900:19092004|C2697932:ORPHA60030:446263001	MedGen:Orphanet|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	NA	NA	614816(3)	NA	Loeys-Dietz~syndrome~4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD	612530(4)	NA	IC	NA	NA	L	D/D	0.895	5.91	./TGFB2_HUMAN	P/B	P/B	5.91	235,207	24.3	1.048	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	119	NA	NA	NA	NA	NA	NA
chr1	220137990	rs143722284	G	A	PASS	A	missense_variant	MODERATE	IARS2	ENSG00000067704	transcript	ENST00000366922.2	c.2122G>A	p.Glu708Lys	17/23	2237/3560	708/1012	2122/3039	NA	NA	NA	NA	0.001235	0.00159744	0.998003	2499,1	0.000399361	0.00119808	5|0	Leigh_syndrome|not_provided	C0023264:256000:ORPHA506:29570005|CN221809	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	NA	2	616007(3)	NA	?Cataracts~growth~hormone~deficiency~sensory~neuropathy~sensorineural~hearing~loss~and~skeletal~dysplasia	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	M	D/D	0.725	6	SYIM_HUMAN	B	P	6	708	33	1.048	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	NA
chr1	220151373	rs59190330	T	C	PASS	C	missense_variant	MODERATE	RAB3GAP2	ENSG00000118873	transcript	ENST00000358951.6	c.4060A>G	p.Ile1354Val	35/35	4177/7257	1354/1393	4060/4182	NA	NA	NA	NA	0.0007248	0.00599042	0.99401	2489,0	0	0.00299521	255	not_specified	CN169374	MedGen	NA	NA	614225(3),212720(3)	NA	Warburg~micro~syndrome~2,Martsolf~syndrome	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	612530(4)	NA	IC	NA	NA	M	D	0.996	3.45	RBGPR_HUMAN	B	B	5.83	1354	6.539	0.964	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	129	NA	NA	NA	NA	NA	RAB3GAP2
chr1	220151373	rs59190330	T	C	PASS	C	downstream_gene_variant	MODIFIER	IARS2	ENSG00000067704	transcript	ENST00000366922.2	c.*3738T>C	NA	NA	NA	NA	NA	3332	NA	NA	NA	0.0007248	0.00599042	0.99401	2489,0	0	0.00299521	255	not_specified	CN169374	MedGen	NA	NA	614225(3),212720(3)	NA	Warburg~micro~syndrome~2,Martsolf~syndrome	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	612530(4)	NA	IC	NA	NA	M	D	0.996	3.45	RBGPR_HUMAN	B	B	5.83	1354	6.539	0.964	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	129	NA	NA	NA	NA	NA	RAB3GAP2
chr1	220157330	rs11547779	C	T	PASS	T	synonymous_variant	LOW	RAB3GAP2	ENSG00000118873	transcript	ENST00000358951.6	c.3495G>A	p.Leu1165Leu	31/35	3612/7257	1165/1393	3495/4182	NA	NA	NA	NA	0.088	0.110623	0.884185	2214,13	0.00519169	0.0605032	255|3|3	not_specified|Warburg_micro_syndrome|Martsolf_syndrome	CN169374|CN158709:ORPHA2510|C0796037:212720:ORPHA1387	MedGen|MedGen:Orphanet|MedGen:OMIM:Orphanet	NA	1	614225(3),212720(3)	NA	Warburg~micro~syndrome~2,Martsolf~syndrome	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	120	NA	NA	NA	NA	NA	RAB3GAP2
chr1	220157863	rs2289189	C	G	PASS	G	missense_variant	MODERATE	RAB3GAP2	ENSG00000118873	transcript	ENST00000358951.6	c.3275G>C	p.Ser1092Thr	30/35	3392/7257	1092/1393	3275/4182	NA	NA	NA	NA	0.087	0.110224	0.884585	2215,13	0.00519169	0.0603035	255|3|3	not_specified|Martsolf_syndrome|Warburg_micro_syndrome	CN169374|C0796037:212720:ORPHA1387|CN158709:ORPHA2510	MedGen|MedGen:OMIM:Orphanet|MedGen:Orphanet	NA	1	614225(3),212720(3)	NA	Warburg~micro~syndrome~2,Martsolf~syndrome	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	612530(4)	NA	IC	NA	NA	M	P	0.998	5.59	RBGPR_HUMAN/.	P	D	5.59	1092	26.8	0.876	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	100	NA	NA	NA	NA	NA	RAB3GAP2
chr1	220171111	rs12045447	T	C	PASS	C	missense_variant	MODERATE	RAB3GAP2	ENSG00000118873	transcript	ENST00000358951.6	c.2587A>G	p.Thr863Ala	24/35	2704/7257	863/1393	2587/4182	NA	NA	NA	NA	0.04	0.0938498	0.900559	2255,14	0.00559105	0.052516	255|3|3	not_specified|Warburg_micro_syndrome|Martsolf_syndrome	CN169374|CN158709:ORPHA2510|C0796037:212720:ORPHA1387	MedGen|MedGen:Orphanet|MedGen:OMIM:Orphanet	NA	NA	614225(3),212720(3)	NA	Warburg~micro~syndrome~2,Martsolf~syndrome	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	612530(4)	NA	IC	NA	NA	L	P	0.913	0.657	RBGPR_HUMAN	B	B	5.86	863	0.027	1.061	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	120	NA	NA	NA	NA	NA	RAB3GAP2
chr1	220182842	rs2577126	T	C	PASS	C	synonymous_variant	LOW	RAB3GAP2	ENSG00000118873	transcript	ENST00000358951.6	c.2088A>G	p.Thr696Thr	20/35	2205/7257	696/1393	2088/4182	NA	NA	NA	NA	0.012	0.071885	0.922125	2309,15	0.00599042	0.0419329	255|3|3	not_specified|Warburg_micro_syndrome|Martsolf_syndrome	CN169374|CN158709:ORPHA2510|C0796037:212720:ORPHA1387	MedGen|MedGen:Orphanet|MedGen:OMIM:Orphanet	NA	NA	614225(3),212720(3)	NA	Warburg~micro~syndrome~2,Martsolf~syndrome	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AR	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	100	NA	NA	NA	NA	NA	RAB3GAP2
chr1	223111257	rs2072493	T	C	PASS	C	missense_variant	MODERATE	TLR5	ENSG00000187554	transcript	ENST00000366881.5	c.1775A>G	p.Asn592Ser	6/6	2416/3368	592/858	1775/2577	NA	NA	NA	NA	0.149	0.221246	0.749201	1876,74	0.0295527	0.140176	255	Legionellosis	C1837872:608556	MedGen:OMIM	NA	5	NA	NA	NA	Chromosome~1q41-q42~deletion~syndrome	NA	-,-,-,-	NA	NA	NA	NA	NA	601744(3),601744(3),615557(3),608556(3)	NA	612530(4)	NA	IC	NA	{Systemic~lupus~erythematosus~susceptibility~to~1},{Systemic~lupus~erythematosus~resistance~to},{Melioidosis~susceptibility~to},{Legionaire~disease~susceptibility~to}	N	P/P/P	0	-10	TLR5_HUMAN	B	B	5.49	592	0.001	-1.921	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	96	NA	NA	NA	NA	NA	NA
chr1	223111858	rs5744168	G	A	PASS	A	stop_gained	HIGH	TLR5	ENSG00000187554	transcript	ENST00000366881.5	c.1174C>T	p.Arg392*	6/6	1815/3368	392/858	1174/2577	NA	NA	NA	NA	0.056	0.0942492	0.902556	2260,8	0.00319489	0.0503195	255|255|255	Legionellosis|Systemic_lupus_erythematosus\x2c_resistance_to\x2c_1|Melioidosis\x2c_resistance_to	C1837872:608556|C1864265|CN182252	MedGen:OMIM|MedGen|MedGen	NA	2	NA	NA	NA	Chromosome~1q41-q42~deletion~syndrome	NA	-,-,-,-	NA	NA	NA	NA	NA	601744(3),601744(3),615557(3),608556(3)	NA	612530(4)	NA	IC	NA	{Systemic~lupus~erythematosus~susceptibility~to~1},{Systemic~lupus~erythematosus~resistance~to},{Melioidosis~susceptibility~to},{Legionaire~disease~susceptibility~to}	NA	D/D/D	0.657	4.67	NA	NA	NA	5.59	NA	38	1.048	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	114	NA	NA	NA	NA	NA	NA
chr1	225831932	rs1051740	T	C	PASS	C	missense_variant	MODERATE	EPHX1	ENSG00000143819	transcript	ENST00000272167.9	c.337T>C	p.Tyr113His	3/9	417/1660	113/455	337/1368	NA	NA	NA	NA	0.313	0.393371	0.490016	1227,292	0.116613	0.313299	255|255|255|255|6	Lymphoproliferative_disorders\x2c_susceptibility_to|Preeclampsia\x2c_susceptibility_to|Emphysema\x2c_susceptibility_to|Pulmonary_disease\x2c_chronic_obstructive\x2c_susceptibility_to|carbamazepine_response_-_Dosage	C1851509|.|.|.|CN236494	MedGen|.|.|.|MedGen	NA	3	607748(3),607748(3)	NA	Diphenylhydantoin~toxicity~(1)/~?Fetal~hydantoin~syndrome~(1)/~Hypercholanemia~familial,Diphenylhydantoin~toxicity~(1)/~?Fetal~hydantoin~syndrome~(1)/~Hypercholanemia~familial	Chromosome~1q41-q42~deletion~syndrome	NA	AD	NA	NA	NA	NA	NA	189800(3)	-,-	612530(4)	NA	IC	NA	{Preeclampsia~susceptibility~to}	L	P/P	0.997	5.58	HYEP_HUMAN	D	D	5.58	113	29.6	0.989	D/D/D/./D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	86	NA	NA	NA	NA	NA	NA
chr1	225939929	rs199979438	C	T	VQSRTrancheSNP99.80to100.00	T	synonymous_variant	LOW	LEFTY2	ENSG00000143768	transcript	ENST00000366820.9	c.324G>A	p.Pro108Pro	2/4	673/2287	108/366	324/1101	NA	NA	NA	NA	0.002737	0.00199681	0.998003	2499,0	0	0.000998403	255|3	not_specified|Heterotaxy_syndrome	CN169374|C3178805	MedGen|MedGen	NA	NA	NA	NA	NA	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	NA	NA	NA	NA	NA
chr1	225939929	rs199979438	C	T	VQSRTrancheSNP99.80to100.00	T	upstream_gene_variant	MODIFIER	RP4-559A3.6	ENSG00000248322	transcript	ENST00000513672.1	n.-2372G>A	NA	NA	NA	NA	NA	2372	NA	NA	NA	0.002737	0.00199681	0.998003	2499,0	0	0.000998403	255|3	not_specified|Heterotaxy_syndrome	CN169374|C3178805	MedGen|MedGen	NA	NA	NA	NA	NA	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	NA	NA	NA	NA	NA
chr1	226885546	rs28936380	C	T	PASS	T	missense_variant	MODERATE	PSEN2	ENSG00000143801	transcript	ENST00000366782.5	c.464C>T	p.Thr155Met	6/13	964/2465	155/481	464/1446	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	5|1	Alzheimer_disease\x2c_type_4|not_provided	C1847200:606889|CN221809	MedGen:OMIM|MedGen	NA	NA	613697(3),606889(3)	NA	Cardiomyopathy~dilated~1V,Alzheimer~disease-4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	612530(4)	NA	IC	NA	NA	M	D/D/D/D/D/D	0.961	5.08	./PSN2_HUMAN	B/P	P/D	5.08	122	33	0.919	D/D/D/D/.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	136	NA	NA	NA	NA	NA	NA
chr1	226885570	rs63750197	C	T	PASS	T	missense_variant	MODERATE	PSEN2	ENSG00000143801	transcript	ENST00000366782.5	c.488C>T	p.Ser163Leu	6/13	988/2465	163/481	488/1446	NA	NA	NA	NA	0.0006342	0.00199681	0.998003	2499,0	0	0.000998403	5|5|1|3	Dilated_cardiomyopathy_1V|Alzheimer_disease\x2c_type_4|not_provided|Alzheimer's_disease	C3150958:613697|C1847200:606889|CN221809|C0002395:104300:26929004	MedGen:OMIM|MedGen:OMIM|MedGen|MedGen:OMIM:SNOMED_CT	NA	NA	613697(3),606889(3)	NA	Cardiomyopathy~dilated~1V,Alzheimer~disease-4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	612530(4)	NA	IC	NA	NA	M	A/A/A/A/A/A	0.931	5.14	./PSN2_HUMAN	P	P	5.14	130	31	0.935	D/D/D/.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	133	NA	NA	NA	NA	NA	NA
chr1	226961502	rs11549708	G	A	PASS	A	synonymous_variant	LOW	COQ8A	ENSG00000163050	transcript	ENST00000366777.3	c.117G>A	p.Ala39Ala	2/15	238/2872	39/647	117/1944	NA	NA	NA	NA	0.164	0.140575	0.849042	2126,26	0.0103834	0.0806709	255|2|2	not_specified|Coenzyme_Q10_deficiency\x2c_Spinocerebellar_Ataxia_Type|Spinocerebellar_Ataxia\x2c_Recessive	CN169374|CN239204|CN239195	MedGen|MedGen|MedGen	NA	1	612016(3)	NA	Coenzyme~Q10~deficiency~primary~4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	120	NA	NA	NA	NA	NA	NA
chr1	226961502	rs11549708	G	A	PASS	A	upstream_gene_variant	MODIFIER	RP5-1087E8.2	ENSG00000228525	transcript	ENST00000438895.1	n.-3235C>T	NA	NA	NA	NA	NA	3235	NA	NA	NA	0.164	0.140575	0.849042	2126,26	0.0103834	0.0806709	255|2|2	not_specified|Coenzyme_Q10_deficiency\x2c_Spinocerebellar_Ataxia_Type|Spinocerebellar_Ataxia\x2c_Recessive	CN169374|CN239204|CN239195	MedGen|MedGen|MedGen	NA	1	612016(3)	NA	Coenzyme~Q10~deficiency~primary~4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	120	NA	NA	NA	NA	NA	NA
chr1	226982947	rs41303129	C	T	PASS	T	structural_interaction_variant	HIGH	COQ8A	ENSG00000163050	interaction	4PED:A_331-A_359:ENST00000366777	c.993C>T	NA	8/15	NA	NA	NA	NA	NA	NA	NA	0.016	0.0111821	0.988818	2476,0	0	0.00559105	5|2|3	Coenzyme_Q10_deficiency\x2c_primary\x2c_4|not_specified|Spinocerebellar_Ataxia\x2c_Recessive	C2677589:612016:ORPHA139485|CN169374|CN239195	MedGen:OMIM:Orphanet|MedGen|MedGen	NA	1	612016(3)	NA	Coenzyme~Q10~deficiency~primary~4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	NA	NA	NA	NA	NA
chr1	226982947	rs41303129	C	T	PASS	T	synonymous_variant	LOW	COQ8A	ENSG00000163050	transcript	ENST00000366777.3	c.993C>T	p.Phe331Phe	8/15	1114/2872	331/647	993/1944	NA	NA	NA	NA	0.016	0.0111821	0.988818	2476,0	0	0.00559105	5|2|3	Coenzyme_Q10_deficiency\x2c_primary\x2c_4|not_specified|Spinocerebellar_Ataxia\x2c_Recessive	C2677589:612016:ORPHA139485|CN169374|CN239195	MedGen:OMIM:Orphanet|MedGen|MedGen	NA	1	612016(3)	NA	Coenzyme~Q10~deficiency~primary~4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	NA	NA	NA	NA	NA
chr1	226986631	rs761498232	T	TG	VQSRTrancheINDEL99.00to100.00	TG	frameshift_variant	HIGH	COQ8A	ENSG00000163050	transcript	ENST00000366777.3	c.1844dupG	p.Ser616fs	15/15	1966/2872	615/647	1845/1944	NA	INFO_REALIGN_3_PRIME	(COQ8A|ENSG00000163050|1|1.00)	NA	8.236e-05	NA	NA	NA	NA	NA	5	not_provided	CN221809	MedGen	NA	NA	612016(3)	NA	Coenzyme~Q10~deficiency~primary~4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	144	NA	NA	NA	NA	NA	NA
chr1	226986631	rs761498232	T	TG	VQSRTrancheINDEL99.00to100.00	TG	structural_interaction_variant	HIGH	COQ8A	ENSG00000163050	interaction	4PED:A_475-A_613:ENST00000366777	c.1838_1839insG	NA	15/15	NA	NA	NA	NA	NA	(COQ8A|ENSG00000163050|1|1.00)	NA	8.236e-05	NA	NA	NA	NA	NA	5	not_provided	CN221809	MedGen	NA	NA	612016(3)	NA	Coenzyme~Q10~deficiency~primary~4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	144	NA	NA	NA	NA	NA	NA
chr1	226986631	rs761498232	T	TG	VQSRTrancheINDEL99.00to100.00	TG	downstream_gene_variant	MODIFIER	CDC42BPA	ENSG00000143776	transcript	ENST00000334218.9	c.*7636dupC	NA	NA	NA	NA	NA	3233	NA	(COQ8A|ENSG00000163050|1|1.00)	NA	8.236e-05	NA	NA	NA	NA	NA	5	not_provided	CN221809	MedGen	NA	NA	612016(3)	NA	Coenzyme~Q10~deficiency~primary~4	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	144	NA	NA	NA	NA	NA	NA
chr1	228157866	rs75469429	C	T	PASS	T	synonymous_variant	LOW	GJC2	ENSG00000198835	transcript	ENST00000366714.2	c.108C>T	p.Ile36Ile	2/2	283/2243	36/439	108/1320	NA	NA	NA	NA	0.003577	0.0251597	0.974441	2440,1	0.000399361	0.0129792	5,3|2	Spastic_paraplegia_44\x2c_autosomal_recessive,not_provided|Spastic_paraplegia	C2750784:613206:ORPHA320401,CN221809|C0037772	MedGen:OMIM:Orphanet,MedGen|MedGen	NA	NA	613206(3),613480(3),608804(3)	NA	Spastic~paraplegia~44~autosomal~recessive,Lymphedema~hereditary~IC,Leukodystrophy~hypomyelinating~2	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR,AD,AR	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	131	NA	NA	NA	NA	NA	GJC2
chr1	229431637	rs74897770	G	T	PASS	T	synonymous_variant	LOW	ACTA1	ENSG00000143632	transcript	ENST00000366684.7	c.996C>A	p.Ile332Ile	7/7	1099/1491	332/377	996/1134	NA	NA	NA	NA	0.00523	0.0371406	0.961661	2408,3	0.00119808	0.0197684	255	not_specified	CN169374	MedGen	NA	NA	161800(3),616852(3),255310(3),161800(3),161800(3)	NA	Nemaline~myopathy~3~autosomal~dominant~or~recessive,?Myopathy~scapulohumeroperoneal,Myopathy~congenital~with~fiber-type~disproportion~1,Myopathy~actin~congenital~with~excess~of~thin~myofilaments,Myopathy~actin~congenital~with~cores	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AD,AR/AD,AR/AD,AR/AD	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	131	NA	NA	NA	NA	NA	NA
chr1	229432890	rs41271481	C	G	PASS	G	intron_variant	MODIFIER	ACTA1	ENSG00000143632	transcript	ENST00000366684.7	c.130-10G>C	NA	2/6	NA	NA	NA	NA	NA	NA	NA	0.186	0.315895	0.630192	1578,135	0.0539137	0.211861	255|3|3|3	not_specified|Familial_restrictive_cardiomyopathy|Nemaline_myopathy|Congenital_fiber-type_disproportion	CN169374|C0340429:ORPHA217635:233878008|C0206157:ORPHA607:75072002|CN235628	MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:Orphanet:SNOMED_CT|MedGen	NA	1	161800(3),616852(3),255310(3),161800(3),161800(3)	NA	Nemaline~myopathy~3~autosomal~dominant~or~recessive,?Myopathy~scapulohumeroperoneal,Myopathy~congenital~with~fiber-type~disproportion~1,Myopathy~actin~congenital~with~excess~of~thin~myofilaments,Myopathy~actin~congenital~with~cores	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR/AD,AD,AR/AD,AR/AD,AR/AD	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	NA	NA	NA	NA	NA
chr1	230710048	rs699	A	G	PASS	G	missense_variant	MODERATE	AGT	ENSG00000135744	transcript	ENST00000366667.4	c.803T>C	p.Met268Thr	2/5	1018/2291	268/485	803/1458	NA	NA	NA	NA	0.548	0.338259	0.125799	315,1342	0.535942	0.705072	255|255|255|2|2	Hypertension\x2c_essential\x2c_susceptibility_to|Preeclampsia\x2c_susceptibility_to|Susceptibility_to_progression_to_renal_failure_in_IgA_nephropathy|not_specified|Renal_dysplasia	.|.|C1862886|CN169374|C0266313:267430:204949001	.|.|MedGen|MedGen|MedGen:OMIM:SNOMED_CT	NA	1	NA	NA	NA	Chromosome~1q41-q42~deletion~syndrome	NA	AR,Mu	NA	NA	NA	NA	NA	267430(3),145500(3)	NA	612530(4)	NA	IC	NA	{Preeclampsia~susceptibility~to}~(3)/~Renal~tubular~dysgenesis,{Hypertension~essential~susceptibility~to}	N	P	0	-0.372	././ANGT_HUMAN	B	B	5.1	268	0.001	-1.013	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	36	NA	NA	NA	NA	NA	AGT
chr1	231272345	rs11558492	A	G	PASS	G	missense_variant	MODERATE	GNPAT	ENSG00000116906	transcript	ENST00000366647.8	c.1556A>G	p.Asp519Gly	11/16	1725/2643	519/680	1556/2043	NA	NA	NA	NA	0.161	0.225639	0.751597	1882,57	0.0227636	0.135583	5|2|3	Rhizomelic_chondrodysplasia_punctata_type_2|not_specified|Rhizomelic_chondrodysplasia_punctata	C1857242:222765:ORPHA309796|CN169374|C0282529:ORPHA177:56692003	MedGen:OMIM:Orphanet|MedGen|MedGen:Orphanet:SNOMED_CT	NA	1	222765(3)	NA	Rhizomelic~chondrodysplasia~punctata~type~2	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	M	P/P	0.794	-0.263	./GNPAT_HUMAN	B	B	4.71	458,519	17.87	1.194	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	120	NA	NA	NA	NA	NA	NA
chr1	231421509	rs12097901	C	G	PASS	G	missense_variant	MODERATE	EGLN1	ENSG00000135766	transcript	ENST00000366641.3	c.380G>C	p.Cys127Ser	1/5	3536/7097	127/426	380/1281	NA	NA	NA	NA	0.094	0.353035	0.563099	1410,210	0.0838658	0.260383	255|2	Hemoglobin\x2c_high_altitude_adaptation|Familial_erythrocytosis	C1836778:609070|C0152264:17342003	MedGen:OMIM|MedGen:SNOMED_CT	NA	1	609820(3),609820(3)	NA	Erythrocytosis~familial~3,Erythrocytosis~familial~3	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	609070(3)	NA	[Hemoglobin~high~altitude~adaptation]	AD	NA	AD,AD	612530(4)	NA	IC	NA	NA	N	P	0.001	3.26	EGLN1_HUMAN	B	B	3.26	127	0.053	-0.025	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	120	NA	NA	NA	NA	NA	NA
chr1	235458753	rs367543076	C	T	PASS	T	missense_variant	MODERATE	B3GALNT2	ENSG00000162885	transcript	ENST00000366600.7	c.875G>A	p.Arg292His	8/12	1104/2015	292/500	875/1503	NA	NA	NA	NA	8.237e-06	0.000798722	0.999201	2502,0	0	0.000399361	255|1	Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies)\x2c_type_a\x2c_11|not_provided	C3554638:615181|CN221809	MedGen:OMIM|MedGen	NA	NA	615181(3)	NA	Muscular~dystrophy-dystroglycanopathy~(congenital~with~brain~and~eye~anomalies~type~A~11	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	M	D	0.596	5.39	B3GL2_HUMAN	D	D	5.39	292	27.8	0.934	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	NA	NA	NA	NA	NA
chr1	235470872	rs367543072	C	T	PASS	T	missense_variant	MODERATE	B3GALNT2	ENSG00000162885	transcript	ENST00000366600.7	c.740G>A	p.Gly247Glu	6/12	969/2015	247/500	740/1503	NA	NA	NA	NA	8.236e-06	0.000399361	0.999601	2503,0	0	0.000199681	255|1	Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies)\x2c_type_a\x2c_11|not_provided	C3554638:615181|CN221809	MedGen:OMIM|MedGen	NA	NA	615181(3)	NA	Muscular~dystrophy-dystroglycanopathy~(congenital~with~brain~and~eye~anomalies~type~A~11	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	M	D/D	0.88	5.33	./B3GL2_HUMAN	D/P	D	5.33	288,247	25.9	0.892	T/.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	NA	NA	NA	NA	NA
chr1	235766122	rs80338660	G	A	PASS	A	synonymous_variant	LOW	LYST	ENSG00000143669	transcript	ENST00000389793.6	c.6078C>T	p.Tyr2026Tyr	21/53	6253/13480	2026/3801	6078/11406	NA	NA	NA	NA	0.0007001	0.00279553	0.997204	2497,0	0	0.00139776	5	Chédiak-Higashi_syndrome	C0007965:214500:ORPHA167:111396008	MedGen:OMIM:Orphanet:SNOMED_CT	NA	2	214500(3)	NA	Chediak-Higashi~syndrome	Chromosome~1q41-q42~deletion~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	AR	612530(4)	NA	IC	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	131	NA	NA	NA	NA	NA	LYST
chr1	236686699	rs121434525	A	G	PASS	G	missense_variant	MODERATE	ACTN2	ENSG00000077522	transcript	ENST00000366578.5	c.26A>G	p.Gln9Arg	1/21	192/4863	9/894	26/2685	NA	NA	NA	NA	0.0007177	0.00119808	0.998802	2501,0	0	0.000599042	5|0|3|0	Dilated_cardiomyopathy_1AA|not_specified|Dilated_cardiomyopathy|Cardiovascular_phenotype	C2677338:612158|CN169374|EFO_0000407:HP:0001644:CN001497|CN230736	MedGen:OMIM|MedGen|EFO:Human_Phenotype_Ontology:MedGen|MedGen	NA	NA	612158(3),612158(3)	NA	Cardiomyopathy~hypertrophic~23~with~or~without~LVNC,Cardiomyopathy~dilated~1AA~with~or~without~LVNC	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	N	A/A	0.998	3.74	./ACTN2_HUMAN	B	B	3.74	9	14.80	1.086	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	NA	NA	NA	NA	NA
chr1	236744668	rs143749154	C	T	PASS	T	missense_variant	MODERATE	ACTN2	ENSG00000077522	transcript	ENST00000366578.5	c.1298C>T	p.Ser433Leu	12/21	1464/4863	433/894	1298/2685	NA	NA	NA	NA	0.0007907	0.00319489	0.996805	2496,0	0	0.00159744	255|2|2|3	not_specified|Dilated_cardiomyopathy_1AA|Primary_familial_hypertrophic_cardiomyopathy|Cardiovascular_phenotype	CN169374|C2677338:612158|C0949658:ORPHA155:83978005|CN230736	MedGen|MedGen:OMIM|MedGen:Orphanet:SNOMED_CT|MedGen	NA	2	612158(3),612158(3)	NA	Cardiomyopathy~hypertrophic~23~with~or~without~LVNC,Cardiomyopathy~dilated~1AA~with~or~without~LVNC	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	D/D/D	0.01	5.17	./././ACTN2_HUMAN	B	B/P/B/P	5.17	218,433,203,433	21.9	0.836	./D/D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	NA
chr1	236744753	rs34827377	C	T	PASS	T	synonymous_variant	LOW	ACTN2	ENSG00000077522	transcript	ENST00000366578.5	c.1383C>T	p.Ile461Ile	12/21	1549/4863	461/894	1383/2685	NA	NA	NA	NA	0.0008566	0.00199681	0.998003	2499,0	0	0.000998403	255|2|2|0|0	not_specified|Dilated_cardiomyopathy_1AA|Primary_familial_hypertrophic_cardiomyopathy|Hypertrophic_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant	CN169374|C2677338:612158|C0949658:ORPHA155:83978005|HP:0001639:C0007194:ORPHA217569|CN239310	MedGen|MedGen:OMIM|MedGen:Orphanet:SNOMED_CT|Human_Phenotype_Ontology:MedGen:Orphanet|MedGen	NA	3	612158(3),612158(3)	NA	Cardiomyopathy~hypertrophic~23~with~or~without~LVNC,Cardiomyopathy~dilated~1AA~with~or~without~LVNC	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	126	NA	NA	NA	NA	NA	NA
chr1	236747686	rs142943120	G	A	PASS	A	missense_variant	MODERATE	ACTN2	ENSG00000077522	transcript	ENST00000366578.5	c.1426G>A	p.Ala476Thr	13/21	1592/4863	476/894	1426/2685	NA	NA	NA	NA	0.0004859	0.00119808	0.998802	2501,0	0	0.000599042	3|255|2|2|0|0	not_provided|not_specified|Dilated_cardiomyopathy_1AA|Primary_familial_hypertrophic_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant|Hypertrophic_cardiomyopathy	CN221809|CN169374|C2677338:612158|C0949658:ORPHA155:83978005|CN239310|HP:0001639:C0007194:ORPHA217569	MedGen|MedGen|MedGen:OMIM|MedGen:Orphanet:SNOMED_CT|MedGen|Human_Phenotype_Ontology:MedGen:Orphanet	NA	NA	612158(3),612158(3)	NA	Cardiomyopathy~hypertrophic~23~with~or~without~LVNC,Cardiomyopathy~dilated~1AA~with~or~without~LVNC	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	L	D/D/D	0.975	5.73	./././ACTN2_HUMAN	P/B/P/B	D/B/D/P	5.73	261,476,246,476	26.5	1.048	./T/T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	NA
chr1	236747712	rs200529923	G	A	PASS	A	synonymous_variant	LOW	ACTN2	ENSG00000077522	transcript	ENST00000366578.5	c.1452G>A	p.Gln484Gln	13/21	1618/4863	484/894	1452/2685	NA	NA	NA	NA	0.0005848	NA	NA	NA	NA	NA	255|2|2|0|0	not_specified|Dilated_cardiomyopathy_1AA|Primary_familial_hypertrophic_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant|Hypertrophic_cardiomyopathy	CN169374|C2677338:612158|C0949658:ORPHA155:83978005|CN239310|HP:0001639:C0007194:ORPHA217569	MedGen|MedGen:OMIM|MedGen:Orphanet:SNOMED_CT|MedGen|Human_Phenotype_Ontology:MedGen:Orphanet	NA	NA	612158(3),612158(3)	NA	Cardiomyopathy~hypertrophic~23~with~or~without~LVNC,Cardiomyopathy~dilated~1AA~with~or~without~LVNC	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	NA	NA	NA	NA	NA
chr1	236753971	rs138452803	G	A	PASS	A	structural_interaction_variant	HIGH	ACTN2	ENSG00000077522	interaction	1HCI:A_562-A_622:ENST00000366578	c.1864G>A	NA	16/21	NA	NA	NA	NA	NA	NA	NA	0.0002965	0.00119808	0.998802	2501,0	0	0.000599042	255|0|0|0	not_specified|Cardiovascular_phenotype|Hypertrophic_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant	CN169374|CN230736|HP:0001639:C0007194:ORPHA217569|CN239310	MedGen|MedGen|Human_Phenotype_Ontology:MedGen:Orphanet|MedGen	NA	1	612158(3),612158(3)	NA	Cardiomyopathy~hypertrophic~23~with~or~without~LVNC,Cardiomyopathy~dilated~1AA~with~or~without~LVNC	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	D/D/D	0.991	5.27	./././ACTN2_HUMAN	D	D	5.27	407,622,392,622	34	1.047	./D/D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	NA
chr1	236753971	rs138452803	G	A	PASS	A	structural_interaction_variant	HIGH	ACTN2	ENSG00000077522	interaction	1HCI:B_562-B_622:ENST00000366578	c.1864G>A	NA	16/21	NA	NA	NA	NA	NA	NA	NA	0.0002965	0.00119808	0.998802	2501,0	0	0.000599042	255|0|0|0	not_specified|Cardiovascular_phenotype|Hypertrophic_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant	CN169374|CN230736|HP:0001639:C0007194:ORPHA217569|CN239310	MedGen|MedGen|Human_Phenotype_Ontology:MedGen:Orphanet|MedGen	NA	1	612158(3),612158(3)	NA	Cardiomyopathy~hypertrophic~23~with~or~without~LVNC,Cardiomyopathy~dilated~1AA~with~or~without~LVNC	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	D/D/D	0.991	5.27	./././ACTN2_HUMAN	D	D	5.27	407,622,392,622	34	1.047	./D/D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	NA
chr1	236753971	rs138452803	G	A	PASS	A	missense_variant	MODERATE	ACTN2	ENSG00000077522	transcript	ENST00000366578.5	c.1864G>A	p.Asp622Asn	16/21	2030/4863	622/894	1864/2685	NA	NA	NA	NA	0.0002965	0.00119808	0.998802	2501,0	0	0.000599042	255|0|0|0	not_specified|Cardiovascular_phenotype|Hypertrophic_cardiomyopathy|Dilated_Cardiomyopathy\x2c_Dominant	CN169374|CN230736|HP:0001639:C0007194:ORPHA217569|CN239310	MedGen|MedGen|Human_Phenotype_Ontology:MedGen:Orphanet|MedGen	NA	1	612158(3),612158(3)	NA	Cardiomyopathy~hypertrophic~23~with~or~without~LVNC,Cardiomyopathy~dilated~1AA~with~or~without~LVNC	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	D/D/D	0.991	5.27	./././ACTN2_HUMAN	D	D	5.27	407,622,392,622	34	1.047	./D/D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	NA
chr1	237330940	rs376225470	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.231G>A	p.Ala77Ala	3/105	548/16562	77/4967	231/14904	NA	NA	NA	NA	0.0002478	0.000798722	0.999201	2502,0	0	0.000399361	255	not_specified	CN169374	MedGen	NA	2	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	RYR2	KP	AD	180902	NA
chr1	237377442	rs10925392	G	C	PASS	C	splice_region_variant&intron_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.576+7G>C	NA	8/104	NA	NA	NA	NA	NA	NA	NA	0.001919	0.014377	0.985623	2468,0	0	0.0071885	2|255|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	120	NA	RYR2	KP	AD	180902	NA
chr1	237441448	rs199693714	G	A	PASS	A	missense_variant	MODERATE	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.1135G>A	p.Val379Met	13/105	1452/16562	379/4967	1135/14904	NA	NA	NA	NA	0.0002566	0.000798722	0.999201	2502,0	0	0.000399361	255|0	not_specified|Cardiovascular_phenotype	CN169374|CN230736	MedGen|MedGen	NA	1	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	N	D	0.036	4.43	RYR2_HUMAN	B	P	5.34	379	24.2	0.143	D/.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	RYR2	KP	AD	180902	NA
chr1	237441456	rs368844286	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.1143C>T	p.Ser381Ser	13/105	1460/16562	381/4967	1143/14904	NA	NA	NA	NA	0.0002649	0.00119808	0.998802	2501,0	0	0.000599042	255|3	not_specified|Cardiovascular_phenotype	CN169374|CN230736	MedGen|MedGen	NA	2	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	RYR2	KP	AD	180902	NA
chr1	237445448	rs147389346	G	A	PASS	A	structural_interaction_variant	HIGH	RYR2	ENSG00000198626	interaction	4JKQ:A_235-A_406:ENST00000366574	c.1218G>A	NA	14/105	NA	NA	NA	NA	NA	NA	NA	0.0007033	0.00279553	0.997204	2497,0	0	0.00139776	2|255|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	RYR2	KP	AD	180902	NA
chr1	237445448	rs147389346	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.1218G>A	p.Ser406Ser	14/105	1535/16562	406/4967	1218/14904	NA	NA	NA	NA	0.0007033	0.00279553	0.997204	2497,0	0	0.00139776	2|255|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	RYR2	KP	AD	180902	NA
chr1	237445488	rs190140598	C	T	PASS	T	structural_interaction_variant	HIGH	RYR2	ENSG00000198626	interaction	4JKQ:A_300-A_420:ENST00000366574	c.1258C>T	NA	14/105	NA	NA	NA	NA	NA	NA	NA	1.656e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5	not_provided|Ventricular_fibrillation|Catecholaminergic_polymorphic_ventricular_tachycardia	CN221809|HP:0001663:C1962976|C1631597:ORPHA3286	MedGen|Human_Phenotype_Ontology:MedGen|MedGen:Orphanet	NA	3	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	D	0.99	5.84	RYR2_HUMAN	P	D	5.84	420	34	0.892	D/.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	135	NA	RYR2	KP	AD	180902	NA
chr1	237445488	rs190140598	C	T	PASS	T	missense_variant	MODERATE	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.1258C>T	p.Arg420Trp	14/105	1575/16562	420/4967	1258/14904	NA	NA	NA	NA	1.656e-05	0.000399361	0.999601	2503,0	0	0.000199681	5|5|5	not_provided|Ventricular_fibrillation|Catecholaminergic_polymorphic_ventricular_tachycardia	CN221809|HP:0001663:C1962976|C1631597:ORPHA3286	MedGen|Human_Phenotype_Ontology:MedGen|MedGen:Orphanet	NA	3	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	D	0.99	5.84	RYR2_HUMAN	P	D	5.84	420	34	0.892	D/.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	135	NA	RYR2	KP	AD	180902	NA
chr1	237456575	rs60132900	AT	A	PASS	A	intron_variant	MODIFIER	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.1477-11delT	NA	15/104	NA	NA	NA	NA	INFO_REALIGN_3_PRIME	NA	NA	0.247	NA	NA	50,117	NA	0.257588	255	not_specified	CN169374	MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	RYR2	KP	AD	180902	NA
chr1	237456671	rs146129084	T	C	PASS	C	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.1548T>C	p.Asp516Asp	16/105	1865/16562	516/4967	1548/14904	NA	NA	NA	NA	0.0004385	0.000798722	0.999201	2502,0	0	0.000399361	255	not_specified	CN169374	MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	RYR2	KP	AD	180902	NA
chr1	237492989	rs17686573	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.1863C>T	p.His621His	19/105	2180/16562	621/4967	1863/14904	NA	NA	NA	NA	0.004491	0.00359425	0.996006	2494,1	0.000399361	0.00219649	2|2|255|2|3	Cardiomyopathy|not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	C0878544:ORPHA167848:85898001|CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen:Orphanet:SNOMED_CT|MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	123	NA	RYR2	KP	AD	180902	NA
chr1	237496595	rs116098815	A	G	PASS	G	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.2046A>G	p.Thr682Thr	20/105	2363/16562	682/4967	2046/14904	NA	NA	NA	NA	0.001994	0.0135783	0.986022	2469,1	0.000399361	0.0071885	2|255|2|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237500704	rs147479514	C	G	PASS	G	splice_region_variant&intron_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.2204-7C>G	NA	20/104	NA	NA	NA	NA	NA	NA	NA	0.009799	0.0091853	0.990815	2481,0	0	0.00459265	2|2|255|3	Cardiomyopathy|not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	C0878544:ORPHA167848:85898001|CN169374|C1631597:ORPHA3286|CN239181	MedGen:Orphanet:SNOMED_CT|MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	RYR2	KP	AD	180902	NA
chr1	237500808	rs117588730	G	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.2301G>T	p.Ser767Ser	21/105	2618/16562	767/4967	2301/14904	NA	NA	NA	NA	0.002532	0.0115815	0.988019	2474,1	0.000399361	0.0061901	255|255|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	1	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237503283	rs78165942	C	T	PASS	T	splice_region_variant&intron_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.2397-6C>T	NA	21/104	NA	NA	NA	NA	NA	NA	NA	0.004094	0.0263578	0.973642	2438,0	0	0.0131789	2|255|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237511729	rs186181155	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.2760G>A	p.Glu920Glu	24/105	3077/16562	920/4967	2760/14904	NA	NA	NA	NA	0.001315	0.000399361	0.999601	2503,0	0	0.000199681	255|255|0	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	1	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	135	NA	RYR2	KP	AD	180902	NA
chr1	237548554	rs138064129	T	C	PASS	C	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.3030T>C	p.Asp1010Asp	26/105	3347/16562	1010/4967	3030/14904	NA	NA	NA	NA	0.00187	0.0127796	0.986821	2471,1	0.000399361	0.00678914	2|255|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	RYR2	KP	AD	180902	NA
chr1	237566732	rs200525962	A	G	PASS	G	missense_variant	MODERATE	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.3380A>G	p.Glu1127Gly	28/105	3697/16562	1127/4967	3380/14904	NA	NA	NA	NA	0.001124	0.00119808	0.998802	2501,0	0	0.000599042	255|0|3	not_specified|Sudden_cardiac_death|not_provided	CN169374|EFO_0004278:D016757:C0085298:95281009|CN221809	MedGen|EFO:MeSH:MedGen:SNOMED_CT|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	L	D	0.293	5.29	RYR2_HUMAN	P	D	5.29	1127	31	1.088	D/.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	RYR2	KP	AD	180902	NA
chr1	237569258	rs397516526	T	C	PASS	C	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.3537T>C	p.Gly1179Gly	29/105	3854/16562	1179/4967	3537/14904	NA	NA	NA	NA	0.001057	0.00399361	0.996006	2494,0	0	0.00199681	255|255|0	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	RYR2	KP	AD	180902	NA
chr1	237589774	rs371111802	AT	A	PASS	A	intron_variant	MODIFIER	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.3599-9delT	NA	29/104	NA	NA	NA	NA	INFO_REALIGN_3_PRIME	NA	NA	0.403	NA	NA	1330,267	NA	0.285144	2|255	Cardiomyopathy|not_specified	C0878544:ORPHA167848:85898001|CN169374	MedGen:Orphanet:SNOMED_CT|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	RYR2	KP	AD	180902	NA
chr1	237590720	rs373721253	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.3888C>T	p.Asn1296Asn	31/105	4205/16562	1296/4967	3888/14904	NA	NA	NA	NA	0.0007941	0.00119808	0.998802	2501,0	0	0.000599042	255	not_specified	CN169374	MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	RYR2	KP	AD	180902	NA
chr1	237590901	rs193922626	G	A	PASS	A	missense_variant	MODERATE	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.4069G>A	p.Asp1357Asn	31/105	4386/16562	1357/4967	4069/14904	NA	NA	NA	NA	2.482e-05	0.000399361	0.999601	2503,0	0	0.000199681	4|0	Cardiomyopathy|not_specified	C0878544:ORPHA167848:85898001|CN169374	MedGen:Orphanet:SNOMED_CT|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	N	D	0.343	5.35	RYR2_HUMAN	B	B	5.35	1357	18.68	1.044	T/.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	136	NA	RYR2	KP	AD	180902	NA
chr1	237602033	rs201916326	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.4605G>A	p.Pro1535Pro	35/105	4922/16562	1535/4967	4605/14904	NA	NA	NA	NA	0.003354	0.00239617	0.997604	2498,0	0	0.00119808	2|255|2|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	RYR2	KP	AD	180902	NA
chr1	237610757	rs7522981	G	C	PASS	C	splice_region_variant&intron_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.4684-5G>C	NA	35/104	NA	NA	NA	NA	NA	NA	NA	0.004256	0.0311502	0.967252	2422,4	0.00159744	0.0171725	2|255|2|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	116	NA	RYR2	KP	AD	180902	NA
chr1	237610818	rs79811945	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.4740G>A	p.Pro1580Pro	36/105	5057/16562	1580/4967	4740/14904	NA	NA	NA	NA	0.003682	0.0167732	0.982827	2461,1	0.000399361	0.00878594	255|255|2|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen|MedGen:Orphanet|MedGen|MedGen	NA	2	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	131	NA	RYR2	KP	AD	180902	NA
chr1	237614282	rs114534505	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.5154G>A	p.Arg1718Arg	37/105	5471/16562	1718/4967	5154/14904	NA	NA	NA	NA	0.001271	0.0115815	0.988419	2475,0	0	0.00579073	2|255|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237614282	rs114534505	G	C	PASS	C	missense_variant	MODERATE	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.5154G>C	p.Arg1718Ser	37/105	5471/16562	1718/4967	5154/14904	NA	NA	NA	NA	8.254e-06	NA	NA	NA	NA	NA	2|255|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	M	D	0.996	2.58	RYR2_HUMAN	D	D	5.43	1718	24.5	-0.318	D/.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237614782	rs41315858	G	A	PASS	A	missense_variant	MODERATE	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.5654G>A	p.Gly1885Glu	37/105	5971/16562	1885/4967	5654/14904	NA	NA	NA	NA	0.015	0.0195687	0.980431	2455,0	0	0.00978435	2|2|255|2|3	Arrhythmogenic_right_ventricular_cardiomyopathy|not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	C0349788:ORPHA247:253528005:281170005|CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen:Orphanet:SNOMED_CT:SNOMED_CT|MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	N	N	0.565	-2.35	RYR2_HUMAN	B	B	4.8	1885	0.002	1.048	T/.	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	RYR2	KP	AD	180902	NA
chr1	237631547	rs372661934	G	A	PASS	A	splice_region_variant&intron_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.6555+6G>A	NA	42/104	NA	NA	NA	NA	NA	NA	NA	0.000678	0.000798722	0.999201	2502,0	0	0.000399361	255|3|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	1	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	RYR2	KP	AD	180902	NA
chr1	237638496	rs79862521	G	A	PASS	A	splice_region_variant&intron_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.6928+4G>A	NA	45/104	NA	NA	NA	NA	NA	NA	NA	0.004354	0.0291534	0.970847	2431,0	0	0.0145767	2|255|2|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	131	NA	RYR2	KP	AD	180902	NA
chr1	237639124	rs116601686	A	C	PASS	C	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.7038A>C	p.Ala2346Ala	46/105	7355/16562	2346/4967	7038/14904	NA	NA	NA	NA	0.00134	0.00958466	0.990415	2480,0	0	0.00479233	2|255|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237640942	rs371560909	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.7161G>A	p.Ala2387Ala	47/105	7478/16562	2387/4967	7161/14904	NA	NA	NA	NA	0.0003966	0.00239617	0.997604	2498,0	0	0.00119808	255|3	not_specified|Cardiovascular_phenotype	CN169374|CN230736	MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	RYR2	KP	AD	180902	NA
chr1	237643306	rs138152176	G	GT	PASS	GT	intron_variant	MODIFIER	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.7222-12dupT	NA	47/104	NA	NA	NA	NA	INFO_REALIGN_3_PRIME	NA	NA	0.00519	0.0251597	0.974441	2440,1	0.000399361	0.0129792	255	not_specified	CN169374	MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	RYR2	KP	AD	180902	NA
chr1	237648466	rs72549416	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.7365C>T	p.Asp2455Asp	49/105	7682/16562	2455/4967	7365/14904	NA	NA	NA	NA	0.003757	0.00319489	0.996805	2496,0	0	0.00159744	2|2|255|3|3	Cardiomyopathy|not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	C0878544:ORPHA167848:85898001|CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen:Orphanet:SNOMED_CT|MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	130	NA	RYR2	KP	AD	180902	NA
chr1	237648589	rs143906555	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.7488C>T	p.Leu2496Leu	49/105	7805/16562	2496/4967	7488/14904	NA	NA	NA	NA	0.003709	0.00279553	0.997204	2497,0	0	0.00139776	2|2|255|3	Cardiac_arrhythmia|not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN029864:115000|CN169374|C1631597:ORPHA3286|CN239181	MedGen:OMIM|MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	RYR2	KP	AD	180902	NA
chr1	237666523	rs144876996	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.8448C>T	p.Asp2816Asp	57/105	8765/16562	2816/4967	8448/14904	NA	NA	NA	NA	0.009426	0.0131789	0.986422	2470,1	0.000399361	0.00698882	2|255|2|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	RYR2	KP	AD	180902	NA
chr1	237707034	rs116442127	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.9666C>T	p.Ala3222Ala	68/105	9983/16562	3222/4967	9666/14904	NA	NA	NA	NA	0.0008933	0.00559105	0.994409	2490,0	0	0.00279553	2|255|0	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237707235	rs190537182	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.9867G>A	p.Gly3289Gly	68/105	10184/16562	3289/4967	9867/14904	NA	NA	NA	NA	0.0008943	0.00399361	0.996006	2494,0	0	0.00199681	2|255|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	135	NA	RYR2	KP	AD	180902	NA
chr1	237711740	rs186326951	C	T	PASS	T	splice_region_variant&intron_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.10231-5C>T	NA	70/104	NA	NA	NA	NA	NA	NA	NA	0.0005558	0.00119808	0.998802	2501,0	0	0.000599042	255|255|0	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	135	NA	RYR2	KP	AD	180902	NA
chr1	237711741	rs117180147	T	C	PASS	C	splice_region_variant&intron_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.10231-4T>C	NA	70/104	NA	NA	NA	NA	NA	NA	NA	0.000647	0.00479233	0.995208	2492,0	0	0.00239617	255|255|3|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237717194	rs72751287	A	G	PASS	G	splice_region_variant&intron_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.10324-4A>G	NA	71/104	NA	NA	NA	NA	NA	NA	NA	0.001614	0.00119808	0.998802	2501,0	0	0.000599042	255|2|2|3	not_specified|Ventricular_tachycardia\x2c_catecholaminergic_polymorphic\x2c_1|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype	CN169374|CN033270:604772|C1631597:ORPHA3286|CN230736	MedGen|MedGen:OMIM|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	130	NA	RYR2	KP	AD	180902	NA
chr1	237723214	rs144256966	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.10641G>A	p.Thr3547Thr	74/105	10958/16562	3547/4967	10641/14904	NA	NA	NA	NA	0.0005379	0.00319489	0.996805	2496,0	0	0.00159744	255|255|0	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN239181	MedGen|MedGen:Orphanet|MedGen	NA	1	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	RYR2	KP	AD	180902	NA
chr1	237757685	rs397516503	TA	T	PASS	T	intron_variant	MODIFIER	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.11246-11delA	NA	81/104	NA	NA	NA	NA	NA	NA	NA	4.967e-05	NA	NA	NA	NA	NA	255	not_specified	CN169374	MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	RYR2	KP	AD	180902	NA
chr1	237778725	rs78939657	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.11835C>T	p.Val3945Val	88/105	12152/16562	3945/4967	11835/14904	NA	NA	NA	NA	0.002639	0.0219649	0.977636	2448,1	0.000399361	0.0113818	2|255|2|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237783700	rs56226196	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.11988C>T	p.Gly3996Gly	90/105	12305/16562	3996/4967	11988/14904	NA	NA	NA	NA	0.012	0.0247604	0.97524	2442,0	0	0.0123802	2|255|2|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	129	NA	RYR2	KP	AD	180902	NA
chr1	237783871	rs41267517	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.12159G>A	p.Glu4053Glu	90/105	12476/16562	4053/4967	12159/14904	NA	NA	NA	NA	0.0008438	0.000399361	0.999601	2503,0	0	0.000199681	255|3|0|0	not_specified|Cardiovascular_phenotype|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|CN230736|C1631597:ORPHA3286|CN239181	MedGen|MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	RYR2	KP	AD	180902	NA
chr1	237784417	rs373606009	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.12705C>T	p.Phe4235Phe	90/105	13022/16562	4235/4967	12705/14904	NA	NA	NA	NA	0.000306	0.000798722	0.999201	2502,0	0	0.000399361	255	not_specified	CN169374	MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	RYR2	KP	AD	180902	NA
chr1	237792281	rs115854664	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.13740G>A	p.Thr4580Thr	94/105	14057/16562	4580/4967	13740/14904	NA	NA	NA	NA	0.001174	0.0091853	0.990815	2481,0	0	0.00459265	2|255|2|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237798057	rs78369334	G	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.13977G>A	p.Glu4659Glu	97/105	14294/16562	4659/4967	13977/14904	NA	NA	NA	NA	0.00298	0.0227636	0.97524	2442,5	0.00199681	0.0133786	2|255|2|3	not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237798063	rs138498780	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.13983C>T	p.Tyr4661Tyr	97/105	14300/16562	4661/4967	13983/14904	NA	NA	NA	NA	0.00245	0.00119808	0.998802	2501,0	0	0.000599042	255|2|0|0	not_specified|Ventricular_tachycardia\x2c_catecholaminergic_polymorphic\x2c_1|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	CN169374|CN033270:604772|C1631597:ORPHA3286|CN239181	MedGen|MedGen:OMIM|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	RYR2	KP	AD	180902	NA
chr1	237801833	rs35563566	A	AT	PASS	AT	intron_variant	MODIFIER	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.14091-11dupT	NA	97/104	NA	NA	NA	NA	INFO_REALIGN_3_PRIME	NA	NA	0.305	0.41893	0.41254	1033,422	0.16853	0.377995	255,3	not_specified,not_specified	CN169374,CN169374	MedGen,MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	126	NA	RYR2	KP	AD	180902	NA
chr1	237801833	rs35563566	A	ATTT	PASS	ATTT	intron_variant	MODIFIER	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.14091-13_14091-11dupTTT	NA	97/104	NA	NA	NA	NA	INFO_REALIGN_3_PRIME	NA	NA	0.007377	NA	NA	NA	NA	NA	255,3	not_specified,not_specified	CN169374,CN169374	MedGen,MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	126	NA	RYR2	KP	AD	180902	NA
chr1	237801833	rs35563566	A	ATT	PASS	ATT	intron_variant	MODIFIER	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.14091-12_14091-11dupTT	NA	97/104	NA	NA	NA	NA	INFO_REALIGN_3_PRIME	NA	NA	0.034	NA	NA	NA	NA	NA	255,3	not_specified,not_specified	CN169374,CN169374	MedGen,MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	126	NA	RYR2	KP	AD	180902	NA
chr1	237819083	rs114303476	C	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.14481C>T	p.Ile4827Ile	101/105	14798/16562	4827/4967	14481/14904	NA	NA	NA	NA	0.002771	NA	NA	2443,1	NA	0.00978435	255,2|255|2|3	not_specified,not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374,CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen,MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237819083	rs114303476	C	A	PASS	A	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.14481C>A	p.Ile4827Ile	101/105	14798/16562	4827/4967	14481/14904	NA	NA	NA	NA	0.0009514	NA	NA	2443,0	NA	0.00279553	255,2|255|2|3	not_specified,not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiovascular_phenotype|Cardiomyopathy\x2c_ARVC	CN169374,CN169374|C1631597:ORPHA3286|CN230736|CN239181	MedGen,MedGen|MedGen:Orphanet|MedGen|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	RYR2	KP	AD	180902	NA
chr1	237819086	rs370996795	G	T	PASS	T	synonymous_variant	LOW	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.14484G>T	p.Gly4828Gly	101/105	14801/16562	4828/4967	14484/14904	NA	NA	NA	NA	0.0001903	0.00159744	0.998403	2500,0	0	0.000798722	255	not_specified	CN169374	MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	NA	RYR2	KP	AD	180902	NA
chr1	237830642	rs2275693	C	T	PASS	T	intron_variant	MODIFIER	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.14756+12C>T	NA	103/104	NA	NA	NA	NA	NA	NA	NA	0.003086	0.0191693	0.980032	2454,2	0.000798722	0.0103834	255|3|3	not_specified|Cardiomyopathy\x2c_ARVC|Catecholaminergic_polymorphic_ventricular_tachycardia	CN169374|CN239181|C1631597:ORPHA3286	MedGen|MedGen|MedGen:Orphanet	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	100	NA	RYR2	KP	AD	180902	NA
chr1	237832537	rs790897	C	G	PASS	G	intron_variant	MODIFIER	RYR2	ENSG00000198626	transcript	ENST00000366574.6	c.14809-15C>G	NA	104/104	NA	NA	NA	NA	NA	NA	NA	0.00537	0.00359425	0.996406	2495,0	0	0.00179712	2|255|3|3	Cardiomyopathy|not_specified|Catecholaminergic_polymorphic_ventricular_tachycardia|Cardiomyopathy\x2c_ARVC	C0878544:ORPHA167848:85898001|CN169374|C1631597:ORPHA3286|CN239181	MedGen:Orphanet:SNOMED_CT|MedGen|MedGen:Orphanet|MedGen	NA	NA	604772(3),600996(3)	NA	Ventricular~tachycardia~catecholaminergic~polymorphic~1,Arrhythmogenic~right~ventricular~dysplasia~2	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	86	NA	RYR2	KP	AD	180902	NA
chr1	241497927	rs367543046	A	ATTT	PASS	ATTT	disruptive_inframe_insertion	MODERATE	FH	ENSG00000091483	transcript	ENST00000366560.3	c.1431_1433dupAAA	p.Lys477dup	10/10	1472/1797	478/510	1433/1533	NA	NA	NA	NA	0.0009061	NA	NA	NA	NA	NA	255|255|4	not_provided|Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome	CN221809|C0342770:606812:ORPHA24:237983002|C0027672:699346009	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:SNOMED_CT	NA	NA	150800(3),606812(3)	NA	Leiomyomatosis~and~renal~cell~cancer,Fumarase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	NA	NA	NA	NA	FH
chr1	241506178	rs201971572	A	G	PASS	G	intron_variant	MODIFIER	FH	ENSG00000091483	transcript	ENST00000366560.3	c.739-10T>C	NA	5/9	NA	NA	NA	NA	NA	NA	NA	0.000767	0.00319489	0.996805	2496,0	0	0.00159744	255|3|3|3	Fumarase_deficiency|not_specified|Hereditary_leiomyomatosis_and_renal_cell_cancer|Multiple_Cutaneous_and_Uterine_Leiomyomas	C0342770:606812:ORPHA24:237983002|CN169374|C1708350:150800:ORPHA523|CN239164	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MedGen	NA	NA	150800(3),606812(3)	NA	Leiomyomatosis~and~renal~cell~cancer,Fumarase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	137	NA	NA	NA	NA	NA	FH
chr1	241513679	rs75086406	C	T	PASS	T	missense_variant	MODERATE	FH	ENSG00000091483	transcript	ENST00000366560.3	c.302G>A	p.Arg101Gln	3/10	341/1797	101/510	302/1533	NA	NA	NA	NA	0.00014	0.000798722	0.999201	2502,0	0	0.000399361	5	Hereditary_leiomyomatosis_and_renal_cell_cancer	C1708350:150800:ORPHA523	MedGen:OMIM:Orphanet	NA	NA	150800(3),606812(3)	NA	Leiomyomatosis~and~renal~cell~cancer,Fumarase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR	NA	NA	NA	NA	NA	N	D	0.979	4.95	FUMH_HUMAN	B	P	5.85	101	23.6	0.935	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	131	NA	NA	NA	NA	NA	FH
chr1	241519618	rs181655698	C	T	PASS	T	synonymous_variant	LOW	FH	ENSG00000091483	transcript	ENST00000366560.3	c.105G>A	p.Ser35Ser	1/10	144/1797	35/510	105/1533	NA	NA	NA	NA	0.0006388	0.00798722	0.992013	2484,0	0	0.00399361	2|255|3|3	Hereditary_cancer-predisposing_syndrome|Fumarase_deficiency|Multiple_Cutaneous_and_Uterine_Leiomyomas|Hereditary_leiomyomatosis_and_renal_cell_cancer	C0027672:699346009|C0342770:606812:ORPHA24:237983002|CN239164|C1708350:150800:ORPHA523	MedGen:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet	NA	NA	150800(3),606812(3)	NA	Leiomyomatosis~and~renal~cell~cancer,Fumarase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	135	NA	NA	NA	NA	NA	FH
chr1	241519646	rs187226800	G	A	PASS	A	missense_variant	MODERATE	FH	ENSG00000091483	transcript	ENST00000366560.3	c.77C>T	p.Pro26Leu	1/10	116/1797	26/510	77/1533	NA	NA	NA	NA	0.000623	0.0103834	0.989217	2477,1	0.000399361	0.00559105	2|255|3|3	not_specified|Fumarase_deficiency|Multiple_Cutaneous_and_Uterine_Leiomyomas|Hereditary_leiomyomatosis_and_renal_cell_cancer	CN169374|C0342770:606812:ORPHA24:237983002|CN239164|C1708350:150800:ORPHA523	MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet	NA	NA	150800(3),606812(3)	NA	Leiomyomatosis~and~renal~cell~cancer,Fumarase~deficiency	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AR	NA	NA	NA	NA	NA	N	N	0.002	0.895	FUMH_HUMAN	B	B	4.9	26	0.617	1.048	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	135	NA	NA	NA	NA	NA	FH
chr1	247424041	rs121908147	G	A	PASS	A	missense_variant	MODERATE	NLRP3	ENSG00000162711	transcript	ENST00000336119.7	c.598G>A	p.Val200Met	3/9	1344/4170	200/1036	598/3111	NA	NA	NA	NA	0.008228	0.00798722	0.992013	2484,0	0	0.00399361	5|3|3|3	Familial_cold_urticaria|not_provided|not_specified|Familial_cold_autoinflammatory_syndrome	C0343068:120100:ORPHA47045:238687000|CN221809|CN169374|CN230757	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MedGen	NA	NA	191900(3),120100(3),607115(3)	NA	Muckle-Wells~syndrome,Familial~cold-induced~inflammatory~syndrome~1,CINCA~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-	NA	NA	NA	NA	NA	N	A/A/A/A/A/A	0.032	-7.37	././././NALP3_HUMAN	B	B	4.27	200	0.002	-0.81	T	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132	NA	NA	NA	NA	NA	NA
chr1	247424469	rs41311573	C	T	PASS	T	synonymous_variant	LOW	NLRP3	ENSG00000162711	transcript	ENST00000336119.7	c.1026C>T	p.Pro342Pro	3/9	1772/4170	342/1036	1026/3111	NA	NA	NA	NA	0.004917	0.00359425	0.996406	2495,0	0	0.00179712	255|3	not_specified|Familial_cold_autoinflammatory_syndrome	CN169374|CN230757	MedGen|MedGen	NA	NA	191900(3),120100(3),607115(3)	NA	Muckle-Wells~syndrome,Familial~cold-induced~inflammatory~syndrome~1,CINCA~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	127	NA	NA	NA	NA	NA	NA
chr1	247424912	rs145268073	G	A	PASS	A	missense_variant	MODERATE	NLRP3	ENSG00000162711	transcript	ENST00000336119.7	c.1469G>A	p.Arg490Lys	3/9	2215/4170	490/1036	1469/3111	NA	NA	NA	NA	0.0005848	0.000399361	0.999601	2503,0	0	0.000199681	1|4|3	Familial_cold_urticaria|not_provided|Familial_cold_autoinflammatory_syndrome	C0343068:120100:ORPHA47045:238687000|CN221809|CN230757	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen	NA	NA	191900(3),120100(3),607115(3)	NA	Muckle-Wells~syndrome,Familial~cold-induced~inflammatory~syndrome~1,CINCA~syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	AD,AD,-	NA	NA	NA	NA	NA	L	N/N/N/N/N/N	0.037	4.17	././././NALP3_HUMAN	B/P/P/B/B	B/P/D/B/B	4.17	490	22.3	1.048	D	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134	NA	NA	NA	NA	NA	NA
